{
  "pmid_sentences": {
    "10612066": ["If Al is a cause of AD it is effective at the level of our everyday exposure to the metal and AD will be one possible outcome of the life-long presence of a low, though burgeoning, brain Al burden.", "A molecular mechanism of aluminium-induced Alzheimer's disease?"],
    "10656181": ["Prolonged exposure of rats to aluminium (Al) can result in an Alzheimer-like condition.", "Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria."],
    "11307619": ["This study examines the role of aluminium in the etiology of Alzheimer's disease (AD)."],
    "11470314": ["Considerable evidence exists that Al may play a role in the aetiology or pathogenesis of Alzheimer's disease (AD), but whether the link is causal is still open to debate."],
    "12039845": ["Epidemiological studies have implicated aluminum (Al) exposure in the pathogenesis of Alzheimer's disease (AD); however, other studies have failed to confirm these results."],
    "12755500": ["The serum concentrations of aluminum, a metal potentially involved in the pathogenesis of Alzheimer's disease, increase with age."],
    "1436075": ["Controversy exists over whether aluminium has a role in the aetiology of Alzheimer's disease."],
    "14507468": ["Although there is increasing evidence suggesting the implication of aluminum in the pathogenesis of Alzheimer's disease, it is still controversial."],
    "1490420": ["Extensive studies of the pathology of AD and Al-induced encephalopathy by our group and others indicate that Al does not cause Alzheimer's disease neuropathology."],
    "15201486": ["However, to date, there have been few accounts of the interference of Al with aging and its relevance to the pathogenesis of AD."],
    "15666086": ["Aluminium, an environmentally abundant non-redox trivalent cation has long been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "15688540": ["[The role of aluminum in the genesis of Alzheimer's disease: relax in the absence of sufficient proof in the current state of our knowledge."],
    "1575096": ["Several lines of evidence suggest that aluminium may be involved in the aetiology of AD."],
    "15998000": ["It has been implicated that Al is involved in the etiology of Alzheimer's disease and other neurodegenerative disorders, though this is controversial."],
    "1614358": ["A compromised defensive system of brain cells against aluminium, together with local defects in glucose metabolism, causes AD."],
    "16988476": ["There are unexplained links between human exposure to aluminium and the incidence, progression and aetiology of Alzheimer's disease."],
    "17004365": ["Although it is unlikely that aluminum represents an etiologic cause of Alzheimer's disease, we believe that this highly reactive element, known to cross-link hyperphosphorylated proteins, may play an active role in the pathogenesis of critical neuropathologic lesion in Alzheimer's disease and other related disorders."],
    "1708474": ["A number of studies have implicated aluminium as a possible factor in the pathogenesis of Alzheimer's disease (AD)."],
    "17119287": ["Although objects of methodological controversies for scientists and oversimplification for lay spectators, several lines of evidence have strongly supported the involvement of Al as a secondary aggravating factor or risk factor in the pathogenesis of AD."],
    "17467804": ["Aluminum (Al) has been proposed as one of the critical environmental factors responsible for several neurodegenerative diseases such as Alzheimer's disease."],
    "1784417": ["The present findings are of interest as a number of studies have implicated aluminium as a factor in the pathogenesis of Alzheimer's disease."],
    "18228200": ["Aluminium (Al) is a neurotoxic metal and Al exposure may be a factor in the aetiology of various neurodegenerative diseases such as Alzheimer's disease (AD).", "Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain."],
    "18571827": ["As Tg 2576 mice have been considered as a potential model for Alzheimer's disease (AD), the present results would not support the hypothetical role of Al in the etiology of AD."],
    "19376155": ["Direct and indirect intakes of aluminium have been reported to be involved in the etiology of several neurodegenerative disorders like Alzheimer's and Parkinson's diseases."],
    "19744735": ["Aluminum (Al) exposure has been reported to be a risk factor for Alzheimer's disease (senile dementia of Alzheimer type), although the role of Al in the etiology of Alzheimer's disease remains controversial."],
    "19939225": ["Although it is well established that aluminum (Al) is neurotoxic, the potential role of this element in the etiology of Alzheimer's disease (AD) is not well established."],
    "2016974": ["[Genetic factors and aluminum are possible causes of Alzheimer's disease]."],
    "21157018": ["Misconceptions about Al bioavailability may have misled scientists regarding the significance of Al in the pathogenesis of AD."],
    "21440537": ["Aluminum, a known neurotoxin, has long been implicated in the pathogenesis of Alzheimer's disease."],
    "21567285": ["Evidence regarding the role of mercury and aluminum in the pathogenesis of Alzheimer's disease (AD) remains controversial."],
    "21614097": ["CONCLUSION: Combined use of D-gal and Al is an effective way to establish the non-transgenic Alzheimer's disease (AD) animal model, and is useful for studies of AD pathogenesis and therapeutic evaluation.", "Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain."],
    "21889563": ["Aluminium, a well established neurotoxicant, is reported to be involved in the aetiology of Alzheimer's disease (AD) due to its easy admittance and accumulation in central nervous system (CNS)."],
    "22467401": ["[Locomotor activity and learning and memory abilities in Alzheimer's disease induced by aluminum in an acid environment in zebrafish]."],
    "22512666": ["At present, there is no evidence to substantiate the hypothesis that the pathogenesis of Alzheimer's Disease is caused by Al found in food and drinking water at the levels consumed by people living in North America and Western Europe."],
    "22878356": ["Recently, aluminium (Al) has been proposed to be one of the environmental factors responsible for cause Alzheimer's disease (AD)."],
    "23085282": ["The significant shift in the amide I and amide II protein peaks may indicate the progression of aluminium induced Alzheimer's disease."],
    "23103708": ["This result confirms the hypothesis of aluminum as a possible factor inducing the Alzheimer's disease and opens the ways to possible new diagnostic tests."],
    "23494944": ["Aluminium may have an important role in the aetiology/pathogenesis/precipitation of Alzheimer's disease."],
    "23806774": ["Considering that aluminum (Al(III)) is well known for its potential neurotoxicity in the pathogenesis of AD, we examined whether Al(III) affects the structure and function of Pin1, by means of a PPIase activity assay, intrinsic fluorescence, circular dichroism (CD) spectroscopy, FTIR, and differential scanning calorimetry (DSC)."],
    "24202576": ["Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease."],
    "24343096": ["In addition, it should be noted the important role that low molecular mass fractions of iron, copper, aluminium and cobalt appear to play in pathogenesis of Alzheimer."],
    "24793376": ["Aluminum (Al) is a known neurotoxic element involved in the etiology of some serious neurodegenerative disorders such as Alzheimer disease (AD)."],
    "24806729": ["The Aluminum Hypothesis, the idea that aluminum exposure is involved in the etiology of Alzheimer disease, dates back to a 1965 demonstration that aluminum causes neurofibrillary tangles in the brains of rabbits."],
    "25312136": ["Effect of wheat grass powder on aluminum induced Alzheimer's disease in Wistar rats.", "OBJECTIVE: To find out the effect of wheat grass on aluminum induced Alzheimer's disease in Wistar rats."],
    "2614472": ["Recent studies have emphasised the potential neurotoxicity of aluminium in dialysis encephalopathy and it has also been suggested that this element may have a role in the pathogenesis of Alzheimer's disease."],
    "26494454": ["Many continue to regard aluminum as controversial although increasing evidence supports the implications of aluminum in the pathogenesis of AD."],
    "27709498": ["Aluminum is associated with etiology of many neurodegenerative diseases specially Alzheimer's disease."],
    "30090569": ["Studies have shown that aluminum (Al) is the most abundant neurotoxic element on Earth, and is implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "30315452": ["In this chapter, we analyzed the research status of animal model of aluminum-induced Alzheimer's disease.", "Animal Model of Aluminum-Induced Alzheimer's Disease.", "Lack of a satisfactory animal model for Alzheimer's disease (AD) has limited the reach progress of the pathogenesis of the disease and of therapeutic agents aiming to important pathophysiological points."],
    "30315453": ["Finally, we verify the cell death pathways attributed to the neural cell death in Al-induced AD-like mice model."],
    "30337026": ["OBJECTIVE: The present study was undertaken to evaluate the anti-Alzheimer's activity of Vitis vinifera in aluminum induced Alzheimer's disease."],
    "30624431": ["Detrimental effects of chia (Salvia hispanica L.) seeds on learning and memory in aluminum chloride-induced experimental Alzheimer's disease.", "Seeds of chia (Salvia hispanica L.) are highly rich in these nutrients, and thus, the present study investigated the effects of chia seeds on behavior and cognition in an aluminum-induced Alzheimer's disease model in rats."],
    "30764938": ["Since aluminum elements are reported to lead to Alzheimer disease in human, high corrosion resistance is required to use Ti-39Nb-6Zr-0.45Al alloy containing a small amount of Al."],
    "31175888": ["Henceforth, this study aimed to investigate the potential neuroprotective effect of vinpocetine in aluminum-induced AD model associated with social isolation."],
    "31321719": ["Further, AD- and Al-induced neurotoxic effects are more common among women following reproductive senescence due to decline in estrogen."],
    "31332715": ["Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats."],
    "31460853": ["This study was carried out to evaluate the neuroprotective effect of aqueous cinnamon extract against aluminum chloride (AlCl3)-induced Alzheimer's disease.", "Neuro-amelioration of cinnamaldehyde in aluminum-induced Alzheimer's disease rat model."],
    "3412205": ["The possible involvement of environmental aluminum in the etiology of Alzheimer disease and of senile dementia of the Alzheimer type is supported by both direct and indirect relationships between some encephalopathies and the abnormal presence of aluminum(III) in human and animal brain tissues."],
    "7016437": ["Even though the laboratory animals develop tangles resembling those seen in patients with Alzheimer's Disease, no evidence has been published to show that the tangles seen in Alzheimer's Disease are induced by the elevated brain aluminum content."],
    "7430560": ["The accumulation of aluminum in the cerebral cortex has been implicated as a factor in the pathogenesis of Alzheimer type senile dementia (SD) and in the dialysis dementia found in patients with chronic renal failure on long-term intermittent hemodialysis treatment."],
    "7606282": ["If aluminium neurotoxicity is implicated in the pathophysiology of Alzheimer's disease, it may result either from excessive aluminium exposure or increased brain aluminium uptake."],
    "7746806": ["A great deal of research has focused on aluminium as a putative causative factor in Alzheimer's disease."],
    "7845533": ["The discrepancy between the distribution of transferrin receptors in the hippocampus and those areas which are prone to the formation of senile plaques and neurofibrillary tangles suggests that if transferrin-mediated uptake of aluminium in AD/SDAT is significant in the pathogenesis of this disorder, it is not the only determinant of Alzheimer-type neuropathology."],
    "8014196": ["Aluminum, the third most common element in the earth's crust (second to oxygen and silicon) and recently suspected by some investigators to be implicated in Alzheimer disease etiology, has been studied in relation to its effect on mitogenesis, mitosis, and cell cycle."],
    "8167440": ["The involvement of aluminum in the etiology of AD has been proposed by some authors on the basis of abnormal concentration of aluminum in autopsied brain samples from AD patients (Krishnan et al., 1987), in the neurofibrillary tangles (Perl and Pendlebury, 1986) and the neuritic plaques (Candy et al., 1986)."],
    "8574016": ["Since the first reports of aluminum-induced neurofibrillary degeneration in experimental animals, extensive studies have been performed to clarify the role played by aluminum in the pathogenesis of Alzheimer's disease (AD)."],
    "8772802": ["(3) Is treatment with DFO a potentially useful therapeutic approach and to what extent might beneficial effects of DFO implicate Al in the etiology of Alzheimer's disease?"],
    "8950699": ["The environmental agent aluminium has been extensively investigated for a potential role in the aetiology of Alzheimer's disease."],
    "9187935": ["Since the first reports of aluminum-induced neurofibrillary degeneration in experimental animals, extensive studies have been performed to clarify the role played by aluminum in the pathogenesis of Alzheimer's disease (AD)."],
    "9401741": ["Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates."],
    "9423325": ["There are some reports which indicate that the aluminum in the brain are toxic to nerve cells and produce Alzheimer's disease-like pathological or biochemical changes in animal brain."],
    "9510431": ["Since aluminum has been implicated in the etiology of AD, we investigated the effects of aluminum on lipid peroxidation and whether the harmful effects of beta-amyloid are aggravated by aluminum."],
    "9861186": ["OBJECTIVES: To study the role of occupational exposures to solvents and aluminium in the aetiology of Alzheimer's disease (AD)."],
    "9863396": ["However, there is, as yet, no adequate evidence that neurotoxicity of aluminium leads to progressive dementia and Alzheimer's disease."],
    "22464639": ["DESIGN: Sixty female Sprague Dawley rats were divided into four groups n=15, (1) normal control group (con), (2) group underwent surgery to remove ovaries (ovx control group), (3) ovx group received aluminum chloride in a dose of 17 mg/kg daily for 2 months to induce AD (AD group), (4) AD group treated with alpha-chymotrypcin (alpha-ch) at dose (8.1 unit/rat/day) which is equivalent to the recommended human dose (alpha-ch-treated group) for three months."],
    "23821590": ["Oral administration of aluminium chloride (AlCl3) in a dose of 17 mg/kg body weight (bw) daily for 45 days induced AD-like pathology in male rats with a significant increase in brain acetylcholinesterase (AchE) activity, transforming growth factor beta (TGF-beta), Fas and interleukin-6 (IL-6) levels."],
    "25613582": ["Protective effect of selenium against aluminum chloride-induced Alzheimer's disease: behavioral and biochemical alterations in rats."],
    "25630717": ["Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer's disease in Wistar rats."],
    "25842984": ["The present study has been designed to explore the memory-enhancing effect of the tannoid principles of E. officinalis (EoT) at the biochemical, anatomical, behavioral, and molecular levels against aluminum chloride (AlCl3) induced Alzheimer's disease (AD) in rats."],
    "26306462": ["Erratum to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats."],
    "26622218": ["70 female albino rats were divided equally into 7 groups as follows: group 1: healthy control; group 2: Aluminium chloride induced Alzheimer disease; group 3: induced Alzheimer rats that received intravenous injection of MSCs; group 4: induced Alzheimer rats that received MSCs and HO inducer cobalt protoporphyrin; group 5: induced Alzheimer rats that received MSCs and HO inhibitor zinc protoporphyrin; group 6: induced Alzheimer rats that received HO inducer; group7: induced Alzheimer rats that received HO inhibitor."],
    "26897372": ["AD was induced by aluminum chloride (17 mg/kg, p.o. for 6 weeks) and confirmed by Morris water maze and Y-maze behavioral tests."],
    "28003750": ["Baicalein improves behavioral dysfunction induced by Alzheimer's disease in rats.", "Group I: normal control group treated with water; Group II: disease control treated with AlCl3 to induce the mimicking AD for 4 successive weeks (SW); Group III: normal control group treated with baicalein (5 mg/kg) for 2 SW followed by combination of baicalein and AlCl3 for 4 SW; Group IV: normal control group treated with baicalein (10 mg/kg) for 2 SW followed by combination of baicalein and AlCl3 for 4 SW; Group V: normal control group treated with rivastigmine (0.3 mg/kg) for 2 SW followed by combination of rivastigmine and AlCl3 for 4 SW."],
    "28499970": ["We also detected that chitnase1 could weaken the deposition of Abeta oligomers in the brain of D-galactose/ AlCl3-induced AD rats.", "Furthermore, anti-inflammation factors (Arginase 1, Arg-1, mannose receptor type C 1, MRC1/CD206) were increased and pro-inflammation factors (tumor necrosis factor alpha, TNFalpha, interleukin 1 beta, IL-1beta) were decreased in D-galactose/AlCl3-induced AD rats with chitinase1 treatment."],
    "28514831": ["Our results showed HPE improved cognitive function in AlCl3-induced AD rats, and attenuated AlCl3-induced increase in acetylcholinesterase activity and glutamic acid level as well as decreased in noradrenaline and dopamine level.", "The present study aimed to identify the potential neuroprotective of HPE on AlCl3-induced AD rats.", "Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer's disease rats.", "Thus, HPE is conferred neuroprotection against AlCl3-induced AD like pathology."],
    "28650335": ["These findings suggest that co-administration of AlCl3 and D-gal for one week could induce AD like symptoms and may be used to develop AD animal model."],
    "28697918": ["Sausage tree (Kigelia africana) flavonoid extract is neuroprotective in AlCl3-induced experimental Alzheimer's disease.", "In this study, the neuroprotective properties of a methanol extract of the leaves of Kigelia africana (KAE) and its flavonoid-rich fraction (FKAE) in aluminum chloride (AlCl3)-induced experimental AD was evaluated."],
    "28715867": ["Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer's disease."],
    "29448848": ["Chronic treatment with morin-loaded micelles significantly increased the memory in AlCl3 induced Alzheimer's disease in Wistar rats."],
    "29770796": ["In a D-galactose- and AlCl3-induced AD mouse model, administration of the FFDS composite solution significantly improved the learning and memory, as well as neuronal morphology, and decreased the serum levels of INF-gamma."],
    "30010139": ["Our findings therefore show that VCO preserved the ultrastructural morphology of the hippocampus and cortex of the AlCl3-induced AD rat model, potentially providing protection against the neurodegeneration in AD of both cortical and hippocampal neurons.", "Moreover, VCO significantly increased the glutathione (GSH) level in both the hippocampus and cortex and significantly decreased the malondialdehyde (MDA) level in only the cortex of the AlCl3-induced AD rat model compared to an AlCl3-induced AD rat model with no VCO."],
    "30537804": ["Furthermore, TM-10 exhibited a favorable dyskinesia recovery rate and response efficiency on an AlCl3-induced zebrafish AD model and a potent neuroprotective effect on Abeta1-40-induced zebrafish vascular injury."],
    "30802512": ["After molecular docking simulation, AlCl3-induced Alzheimer's disease zebrafish model was established."],
    "31014012": ["Results showed that co-administration of CA to d-gal/AlCl3 induced AD-like rat models significantly increased the levels of protein phosphatase 2 (PP2A) and decreased the levels of glycogen synthase kinase-3 beta (GSK-3beta).", "The results clearly demonstrated for the first time that CA could alleviate d-gal/AlCl3 induced AD-like pathologies in rats via inhibition of hyperphosphorylated tau (P-tau) bio-synthetic proteins, anti-apoptosis and maintenance of cytoarchitecture.", "This study aimed to evaluate the effectiveness of CA in preventing d-galactose/aluminium chloride (d-gal/AlCl3) induced AD-like pathologies and the underlying mechanisms of action were further investigated for the first time."],
    "31103976": ["Neuroprotective evaluation of Tribulus terrestris L. in aluminum chloride induced Alzheimer's disease."],
    "31137621": ["Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer's Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats."],
    "31148478": ["Both extracts significantly decreased the acetylcholinesterase activity and improved the histopathological changes in the cerebral cortex and cerebellum of rat model of aluminium chloride-induced Alzheimer disease."],
    "31553175": ["The study reported improved brain bioavailability of MEM in AlCl3-induced Alzheimer's mice leading to improved memory, with the resultant mechanism behind in a descriptive manner.", "Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.", "The in vivo study in an AlCl3-induced Alzheimer's (AD) mice model showed a significant improvement in behavioral responses."],
    "31734542": ["Group II: received aluminum chloride to induce Alzheimer's disease."],
    "31860774": ["Nootropic effect of neferine on aluminium chloride-induced Alzheimer's disease in experimental models.", "Nootropic effect of neferine on aluminium chloride-induced Alzheimer's disease in experimental models.Alzheimer's disease (AD) is an age-associated neurodegenerative disease, which is developed by oxidative stress and acetylcholine contraction in the synaptic cleft of the neurons."],
    "32030557": ["Thus, ethyl pyruvate is effective against in vitro and in vivo models of AlCl     3      -induced AD.", "Neuroprotective Effects of Ethyl Pyruvate against Aluminum Chloride-Induced Alzheimer's Disease in Rats via Inhibiting Toll-Like Receptor 4.", "Neuroprotective Effects of Ethyl Pyruvate against Aluminum Chloride-Induced Alzheimer's Disease in Rats via Inhibiting Toll-Like Receptor 4.Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the formation of insoluble deposits of beta-amyloid (Abeta) plaques within the parenchyma of the brain.", "The present study aimed to investigate the neuroprotective role of ethyl pyruvate against in vitro and in vivo model of aluminum chloride (AlCl     3      )-induced AD."],
    "32329360": ["This study aimed at investigating the neuroprotective effects of Gallic Acid (GA) against aluminum-chloride induced AD in adult Wistar rats.", "Nutritional supplementation of GA preserve the morphological and physiological integrity of the hippocampus against environmental neurotoxins (AlCl     3      ) by mopping up free radicals associated with oxidative stress induced AD."],
    "32383521": ["Biotin, coenzyme Q10, and their combination ameliorate aluminium chloride-induced Alzheimer's disease via attenuating neuroinflammation and improving brain insulin signaling."],
    "32932753": ["Here, we elucidated the neuroprotective effects of silymarin (SM) on the hippocampal tissues of aluminum chloride (AlCl     3      )-induced Alzheimer-like disease in rats using biochemical, histological, and ultrastructural approaches."],
    "33327909": ["OBJECTIVE: Here the aim was to evaluate the antioxidant therapeutic effects of ellagic acid (EA) and EA-loaded nanoparticles (EA-NP) in an aluminum chloride-induced AD rat model."],
    "33582452": ["The present investigation established that the betalain treatment ameliorated the AlCl     3       induced AD by modulating NF-kappaB pathway activation.", "Neuroprotective effect of Betalain against AlCl     3      -induced Alzheimer's disease in Sprague Dawley Rats via putative modulation of oxidative stress and nuclear factor kappa B (NF-kappaB) signaling pathway.", "AlCl     3       (100 mg/kg) was administrated orally to induce the AD in SD rats.", "Hence, this study was intended to investigate the possible protective effect of betalain against aluminum chloride (AlCl     3      ) induced AD on Sprague Dawley (SD) rats."],
    "33587299": ["The objective of this study was to investigate the neuroprotective activity in an aluminum chloride (AlCl     3       )-induced AD in vivo model and phytochemical profile of the traditional Egyptian herb Mentha longifolia (Ml)."],
    "33971493": ["METHODS: Aluminum chloride (70 mg/kg, I.P for 5 weeks) was used to induce AD in rats that either normally fed or socially isolated and protein malnourished (SI&PM)."],
    "34070220": ["Additionally, histopathological analysis of hippocampus revealed the potential of CUR in decreasing the hallmarks in the AlCl     3      -induced AD."],
    "34103557": ["An AD-like rat model was induced by aluminum chloride (AlCl     3      ; 50 mg/kg/day for six consecutive weeks; i.p), whereas a methanolic standardized P. harmala seed extract (187.5 mg/kg; p.o) was given to AD rats starting 2 weeks post AlCl     3       exposure."],
    "34208063": ["A Leaf Extract of    Harrisonia abyssinica     Ameliorates Neurobehavioral, Histological and Biochemical Changes in the Hippocampus of Rats with Aluminum Chloride-Induced Alzheimer's Disease."],
    "34354404": ["Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer's disease in rats."],
    "34537230": ["The present study aimed to evaluate the alpha-secretase stimulatory function of Q through activation of ADAM10 and ADAM17 gene expression in the aluminum chloride (AlCl3)-induced AD rat model.", "Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model."],
    "34542066": ["Taurine and Camel Milk Modulate Neurobehavioral and Biochemical Changes in Aluminum Chloride-Induced Alzheimer's Disease in Rats."],
    "34706318": ["To explore the possible neuroprotective effect as well as mechanism of action of Vinpocetine either alone or in combination with EGCG, CoQ10, or VE & Se in ameliorating aluminum chloride-induced AD in rats."],
    "34727278": ["The present research work is designed to investigate the neuroprotective effect of spermine in aluminium chloride (AlCl     3      ), and iron (Fe) induced AD-like symptoms in rats."],
    "34954699": ["We also found that supplementation of B. coagulans JA845 alleviated amyloid-beta deposits and hyperphosphorylated tau in hippocampus of D-gal/AlCl3-induced AD model mice."],
    "34971104": ["Effect of taurine and camel milk on amyloid beta peptide concentration and oxidative stress changes in aluminium chloride-induced Alzheimer's disease rats."],
    "35236271": ["OBJECTIVES: The present study aimed to: (1) study the effect of MSCs with/without acitretin on the regulation of Adam10 gene expression in AlCl3-induced AD rat model, (2) validate the hypothesis that AD is a time-dependent progressive disease that spreads spontaneously even after the stopping of exposure to AlCl3."],
    "35243060": ["Captopril is more effective than Perindopril against aluminium chloride induced amyloidogenesis and AD like pathology.", "Aluminium chloride induces AD like pathology in rats.", "Both Captopril and Perindopril protects against aluminium chloride induced amyloidogenesis and AD like pathology."],
    "35453412": ["We evaluated the drug release profile and cytotoxicity of PGC and its effects on AD pathology through in vitro and in vivo studies and on cognitive function through an aluminum-chloride-induced AD rat model."],
    "35507244": ["Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats."],
    "35525893": ["Differential neuroprotective effect of curcuminoid formulations in aluminum chloride-induced Alzheimer's disease."],
    "35596040": ["Hence, the present study aims to investigate the potential of chronic intranasal oxytocin in halting memory impairment & AD pathology in aluminum chloride-induced AD in female rats."],
    "36015156": ["Neuroprotective Effects of Phytochemicals against Aluminum Chloride-Induced Alzheimer's Disease through ApoE4/LRP1, Wnt3/beta-Catenin/GSK3beta, and TLR4/NLRP3 Pathways with Physical and Mental Activities in a Rat Model."],
    "36194986": ["Interestingly, treatment with p-CA alleviated all the above-mentioned neuropathological changes in the AlCl     3      -induced AD rat model."],
    "36246933": ["Herein, we evaluated the protective effects of    Lactobacillus casei     ATCC 393 (   L. casei     ATCC 393) and selenium nanoparticles-enriched    L. casei     ATCC 393 (   L. casei     ATCC 393-SeNPs) against D-galactose/aluminum chloride-induced AD model mice."],
    "36290710": ["The present study aims to evaluate the role of quercetin nanoemulsion (QCNE) in attenuating neuronal dysfunction in aluminum chloride (AlCl     3      )-induced experimental AD."],
    "36312298": ["Collectively, these findings suggested that naringin could contribute to the combat of oxidative and autophagic stress in the cerebellum of AlCl     3      -induced AD.", "This work aimed to comprehend the role of naringin in the defense of the cerebellum against aluminum chloride (AlCl     3      )-induced AD in rats by investigating the behavioral, neurochemical, immunohistochemical, and molecular mechanisms that underpin its possible neuroprotective effects."],
    "36385687": ["In this study, for the first time, the potential prophylactic and therapeutic effects of leflunomide were investigated either alone or in combination with rivastigmine in aluminum chloride (AlCl     3      )-induced AD-like rats using behavioral, biochemical, and histological approaches.", "However, administration of leflunomide alone or with rivastigmine in AlCl     3      -induced AD rats restored most of the behavioral, biochemical, and histological parameters triggered by AlCl     3       in rats.", "Our findings suggest that leflunomide can potentially restore most of the neuronal damage in the hippocampal tissues of AlCl     3      -induced AD rats."],
    "36462588": ["The potential ameliorative effect of bromelain compared to donepezil was evaluated in an aluminum chloride (AlCl3)-induced AD in rats."],
    "36554305": ["Wistar rats were given an i.p. injection of 60 mg/kg D-gal and 10 mg/kg AlCl     3       to induce AD and three doses of 1 mg/kg, 5 mg/kg or 10 mg/kg 5-MTHF by oral gavage."],
    "36678510": ["Characterization of Orange Peel Extract and Its Potential Protective Effect against Aluminum Chloride-Induced Alzheimer's Disease."],
    "36761834": ["In the Alcl3-induced AD model in rats, disease progression was confirmed by Y-maze, the preliminary histopathology evaluation showed significantly higher efficacy of the prepared liposomes (CLCAE and CLAA) compared to the    Centella asiatica     extract (CAE) and they were found to have equivalent efficacy to the standard drug (rivastigmine tartrate)."],
    "37035098": ["Insights into the function of the retina by electroretinogram (ERG) and the changes thought to have occurred in the molecular structure of the retina and brain using Fourier transform infrared spectroscopy (FTIR) as a result of AD progression induced by AlCl     3       in rats were done."],
    "37242536": ["This study aims to examine the possible mechanisms of the neuroprotective effects of dapagliflozin against aluminum chloride (AlCl     3      )-induced AD.", "The current data demonstrate that dapagliflozin represents a possible approach to combat AlCl     3      -induced AD in rats through inhibiting oxidative stress, enhancing glucose metabolism and activating AMPK signaling.", "Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer's Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism."],
    "37323056": ["Aluminum chloride was used to induce AD in rats, and afterward, a group of AD-induced rats received a single dose of Ad-MSCs (2 * 10     6       cell, I.V per rat)."],
    "37368609": ["Jambolan fruit extract and choline were investigated for Aluminum tri chloride (AlCl     3      )-induced Alzheimer's disease in rats."],
    "37380861": ["Therefore, its activity was evaluated against an aluminum chloride (AlCl     3      )-induced AD rat model, and a berberine-enriched extract (BEE) was used to determine if its activity is equivalent to pure berberine (PB).", "The rats were administered 300 mg/kg of oral AlCl     3       to induce AD and were then treated with oral PB at a dosage of 50 mg/kg, BEE at a dosage of 50 mg/kg, and rivastigmine at a dosage of 1 mg/kg as a standard drug for 21 days."],
    "37454825": ["AD was induced by AlCl     3       (50mg/kg) for 6 weeks."],
    "37505462": ["The mice model of Alzheimer's disease (AD) induced by aluminum chloride (AlCl3) combined with D-galactose (D-gal) was established to comprehend the mechanism behind PAF's anti-AD activity from both behavioural and pathological perspectives."],
    "37631278": ["These alterations contributed to the observed behavioral and histological changes in the AlCl     3      -induced AD model."],
    "37851769": ["Neuroprotective effects of a combination of Boswellia papyrifera and Syzygium aromaticum on AlCl3 induced Alzheimer's disease in male albino rat.", "Therefore, the current study explored the possible mitigating effects of a combination of Boswellia papyrifera and Syzygium aromaticum against aluminum chloride (AlCl3) induced AD.", "In conclusion, the present study provided primary evidence for using a combination of B. papyrifera and S. aromaticum to treat cognitive dysfunction associated with AlCl3 Induced AD by improving the AChE levels and modulating oxidative stress in the brain."],
    "38052316": ["These findings suggest that coconut oil shows protective effects against cognitive and non-cognitive impairment, AD pathology markers, oxidative stress, synaptic transmission, and cholinergic function in a D-GAL/AlCl     3      -induced AD rat model."],
    "38074017": ["Enhanced Neuroprotective Synergy of Atorvastatin and Magnesium L-Threonate in a Rat Model of Alzheimer's Disease Induced by Aluminum Chloride."],
    "38090736": ["The    in-vivo     studies were performed using aluminum chloride-induced experimental AD in rats."],
    "38141332": ["Summarily, the results demonstrated intranasal delivery of CurCOO to show better efficacy than Cur and COO in preventing neurodegeneration associated with AlCl     3       induced Alzheimer's disease.", "A supercritical fluid co-extract of turmeric powder and dried coconut shreds shows neuroprotection against AlCl     3      -induced Alzheimer's disease in rats through nose to brain delivery.", "This study was aimed at investigating the neuroprotective potential of a co-extract obtained by supercritical fluid extraction (SFE) of turmeric powder and dried coconut shreds against aluminium chloride (AlCl     3      )-induced Alzheimer's disease (AD) in male Wistar rats."],
    "38181932": ["Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer's disease: Relevance to its anti-inflammatory and antioxidant effects."],
    "38448794": ["3-Acetyl coumarin alleviate neuroinflammatory responses and oxidative stress in aluminum chloride-induced Alzheimer's disease rat model."],
    "10404929": ["CONCLUSIONS: Although Alzheimer's disease is widely regarded as a leading cause of death, dementias are reported on the death certificates of only a quarter of demented individuals in the population at large."],
    "10459279": ["Alzheimer's disease is a major cause of death, which exhibits variations by age, sex, race, and geographic area.", "The trend likely reflects changes in attitudes of physicians and the public about attributing Alzheimer's disease as a cause of death as well as the availability of improved diagnostic procedures; the recent leveling in mortality trends from this condition may signal that death certificate diagnoses for Alzheimer's disease are more reliable now.", "Physicians report that Alzheimer's disease caused the death of 21,397 persons in 1996 and contributed to the death of 21,703 additional persons."],
    "10681274": ["Alzheimer disease is one of the leading causes of death among older individuals."],
    "10822478": ["Alzheimer's disease as a cause of death in the United States.", "OBJECTIVE: To describe the scope of mortality from and trends in Alzheimer's disease, to show how Alzheimer's disease ranks as a leading cause of death, to describe a methodological change regarding ranking, and to discuss issues related to the reporting of Alzheimer's disease on death certificates.", "CONCLUSIONS: In recognition of the importance of the condition as a major public health problem, Alzheimer's disease was added to the list of causes eligible to be ranked as leading causes of death in the United States beginning with mortality data for 1994.", "Overall, Alzheimer's disease was the 14th leading cause of death in 1995; for people 65 years of age or older, it was the 8th leading cause of death.", "RESULTS: Alzheimer's disease has increasingly been reported as a cause of death on death certificates in the United States; however, this increase may represent a variety of factors including improved diagnosis and awareness of the disease or changes in the perception of Alzheimer's disease as a cause of death."],
    "10934557": ["Alzheimer's disease (AD), by far the most common form of dementia in the elderly, is clinically characterized by gradual, progressive loss in cognitive functioning and changes in personality, ultimately leading to death.", "So far, three genes have been identified in which mutations cause autosomal-dominant AD: the amyloid precursor protein (APP) gene on chromosome 21, the presenilin 1 (PSEN1) gene on chromosome 14, and the homologous presenilin 2 (PSEN2) gene on chromosome 1."],
    "10993580": ["Alzheimer's disease type dementia is a growing health problem and is one of the leading causes of death among elderly people."],
    "11182240": ["(6) AD is associated with a reactivation of developmental programmes that are incompatible with a differentiated cellular background and, therefore, lead to neuronal death."],
    "11279271": ["beta-Amyloid (A beta) has been strongly implicated in the pathophysiology of Alzheimer's disease (AD), but the means by which the aggregated form of this molecule induces neuronal death have not been fully defined."],
    "11400868": ["Alzheimer's disease is a neurodegenerative condition that affects approximately 5 million people and is the fourth leading cause of death in America."],
    "11433428": ["beta-amyloid peptide (Abeta) has been implicated in the pathogenesis of Alzheimer disease and has been reported to induce apoptotic death in cell culture."],
    "11726544": ["Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death."],
    "11803006": ["Alzheimer's disease was the 11th leading cause of death."],
    "12410910": ["In addition, AD is often not mentioned on death certificates, although it may be the proximate cause of death."],
    "12861345": ["In our opinion, the pharmacological treatment of AD should rely on a better understanding of AD etiopathogenesis in order to use current drugs that protect the AD brain against deleterious events and/or to develop new drugs specifically designed to inhibit and/or regulate those factors responsible for premature neuronal death in AD."],
    "12907842": ["Among neurodegenerative diseases, Alzheimer's disease (AD) is a leading cause of death in elderly individuals."],
    "14769384": ["Amyloid beta-peptide (Abeta) contributes to the pathogenesis of Alzheimer's disease (AD), causing neuronal death through apoptosis."],
    "15519530": ["Alzheimer's disease is the fourth largest cause of death for people over 65 years of age."],
    "15526713": ["Humanin and its analogues have been shown to protect cells against death induced by various Alzheimer's disease genes and amyloid-beta-peptides in vitro: the analogue [Gly14]-humanin has also been shown to be potent in reversing learning and memory impairment induced by scopolamine in mice in vivo."],
    "15639804": ["Neurodegenerative diseases such as Huntington's disease, ischemia, and Alzheimer's disease (AD) are major causes of death."],
    "15825927": ["Alzheimer's disease is the fourth leading cause of death among seniors but its insidious onset makes it difficult to distinguish from age-related decline and little is known about how much knowledge and fear people entertain about this disease."],
    "15883266": ["BACKGROUND: Alzheimer disease (AD) is considered a leading cause of death, but few studies have examined the contribution of AD to mortality based on follow-up of representative US cohorts."],
    "16189900": ["Alzheimer's disease was the eighth-leading cause of death in 2001."],
    "16199521": ["Alzheimer's disease (AD) is a neurodegenerative disease with an insidious onset and progressive course that inevitably leads to death."],
    "16712493": ["In addition to Abeta pathology, an invariant trait of Alzheimer's disease, disruption of tau processing is a necessary event in the neurotoxic cascade which eventually leads to neuronal death and subsequent dementia."],
    "16787840": ["In the slowly progressive neurodegenerative disorders like Parkinson's disease and Alzheimer's disease very different neuronal populations undergo degenerative processes, although the cascades of cellular events leading to death are supposed to be similar."],
    "17017864": ["Although oxidative stress and mitochondrial dysfunction have been linked to neurodegenerative diseases such as Alzheimer's disease (AD), it remains unclear how mitochondrial oxidative stress may induce neuronal death."],
    "17115369": ["Alzheimer's Disease (AD) is the most common neurodegenerative disorder in western societies affecting up to 15 million individuals worldwide.It leads to death after a progressive memory deficit and cognitive impairment accompanied by the appearance of two pathological hallmarks in specific brain areas: neurofibrillary tangles and amyloid plaques."],
    "17192682": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive impairments that become severe enough to interfere with the daily activities of patients and eventually lead to death (Chung and Cummings, 2000)."],
    "17401657": ["Alzheimer's disease is an irreversible, progressive neurodegenerative disorder leading invariably to death, usually within 7-10 years after diagnosis and is the leading cause of dementia in the elderly."],
    "18042001": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by severe cognitive impairment that ultimately leads to death."],
    "1830977": ["Alzheimer's disease, a devastating, irreversible and progressive degenerative disease of unknown cause or cure, is the fourth leading cause of adult death."],
    "18322383": ["Structural and functional genomics studies demonstrate that genomic factors, probably induced by environmental factors, cerebrovascular dysfunction, and epigenetic phenomena, might be responsible for AD pathogenesis leading to premature neuronal death."],
    "18406539": ["Recent studies have indicated that amyloid beta peptide, which is implicated in the progression of Alzheimer's disease, may be also responsible for retinal ganglion cells death in glaucoma."],
    "18488798": ["Every 72 seconds, someone in the United States develops Alzheimer's disease, an incurable affliction that kills at least 66,000 people annually, making it the nation's seventh leading cause of death."],
    "18631956": ["Alzheimer's disease is the seventh leading cause of all deaths in the United States and the fifth leading cause of death in Americans older than the age of 65 years."],
    "18647630": ["Humanin (HN) and its analogues have been shown to protect cells against death induced by various Alzheimer's disease (AD) genes and amyloid-beta-peptides in vitro; the analogues [Gly(14)]-HN and colivelin have also been shown to be potent in reversing learning and memory impairment induced by scopolamine or quinuclidinyl benzilate (QNB) in mice or rats in vivo using the Y-maze or multiple T-maze tests."],
    "18800967": ["Alzheimer's disease, the most common neurodegenerative disorder, and cerebral ischaemia, the most common cause of neurological death, are used to illustrate our current understanding of death signalling in neurodegenerative diseases."],
    "19036982": ["Alzheimer's disease (AD) is the most prevalent form of dementia, resulting in progressive neuronal death and debilitating damage to brain loci that mediate memory and higher cognitive function."],
    "19177976": ["AD is the seventh-leading cause of death in the United States (Centers for Disease Control 2006)."],
    "19426951": ["Whereas other major causes of death have been on the decrease, deaths attributable to AD have been rising dramatically.", "Alzheimer's disease (AD) is the sixth leading cause of all deaths in the United States, and the fifth leading cause of death in Americans aged 65 and older."],
    "19864195": ["In the United States, Alzheimer's disease (AD) is the leading type of dementia and was the fifth and eighth leading cause of death in women and men aged > or = 65 years, respectively, in 2003."],
    "19897016": ["Alzheimer's disease (AD) is the most common form of dementia, which is one of the four leading causes of death in developed nations."],
    "19903243": ["The cellular pathology of Alzheimer's disease is progressive and protracted leading eventually to considerable neuronal death."],
    "19912228": ["Chronic degenerative inflammatory diseases, such as chronic obstructive pulmonary disease and Alzheimer's dementia, afflict millions of people around the world, causing death and debilitation."],
    "20064601": ["The neurodegenerative disorder Alzheimer's disease (AD) is the 6th leading cause of death in the USA."],
    "20298981": ["Although other major causes of death have been on the decrease, deaths because of AD have been rising dramatically.", "AD is the fifth leading cause of death in Americans aged 65 and older."],
    "20345790": ["Our study suggests that decedents >65 years of age in an ME practice are afflicted by common causes of dementia such as AD and FTLD which could contribute wholly or in part to their causes of death."],
    "20383807": ["Currently AD is the major form of dementia and the fourth leading cause of death in aged population."],
    "20615444": ["Beta-amyloid (Abeta) peptide, the hallmark of Alzheimer's disease (AD), invokes a cascade of oxidative damages to neurons and eventually leads to neuronal death."],
    "20664211": ["Whereas other major causes of death have been decreasing, the number of deaths due to Alzheimer's disease is rising."],
    "20667675": ["RESULTS: In France, in 2006, AD or dementia was reported as the underlying cause or a multiple cause of death on 45,597 death certificates."],
    "20739349": ["beta-Amyloid deposition is one of the main hallmarks of Alzheimer's disease thought to eventually cause neuronal death."],
    "20926742": ["More than 5 million people in the United States are afflicted with Alzheimer disease, a condition that is the seventh leading cause of death in the nation."],
    "21155625": ["Alzheimer's disease (AD) is characterized by dysfunctional intracellular and extracellular biochemical processes that result in neuron death."],
    "21238939": ["We will examine the current understanding of caspase function in developmental neuronal death and then illustrate the role of caspases in neuronal death in disease employing two diseases of neuronal loss, Alzheimer's Disease (AD), which is the most common chronic neurodegenerative disorder, and cerebral ischemia/stroke, the third most common cause of death in Western society, which is an acute neuronal disorder with chronic sequelae.", "Alzheimer's Disease, the most common neurodegenerative disorder, and cerebral ischemia, the most common cause of neurologic death, are used to illustrate our current understanding of death signaling in neurodegenerative diseases."],
    "21374507": ["Alzheimer's disease (AD) is the fourth commonest cause of death in the United States; the recent outbreak of new variant Creutzfeldt-Jakob disease (nvCJD) has raised the specter of a large population being at risk to develop this prionosis."],
    "21414557": ["Although other major causes of death have been on the decrease, deaths because of AD have been rising dramatically.", "Alzheimer's disease (AD) is the sixth leading cause of all deaths in the United States and is the fifth leading cause of death in Americans aged >=65 years."],
    "21694457": ["Synapse loss is considered to be the best correlate of cognitive impairments in Alzheimer's disease (AD), and growing evidence supports the notion that certain events that trigger neuronal death in AD can be initiated by the local activation of caspases within the synaptic compartment."],
    "21695038": ["We analyzed the US multiple cause of death files for 2005-2006 and 1999-2000 US deaths with Alzheimer's Disease (International Classification of Disease 10th revision code G30) and other dementias (codes F01, F02, R54) coded as underlying or contributing cause of death based on the death certificate."],
    "21766442": ["Alzheimer's disease (AD) is the fourth leading cause of death in adults, characterized by hallmark neuritic plaques and neurofibrillary tangles."],
    "21793014": ["In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compound targeting two or more of the pathogenic mechanisms leading to neuronal death."],
    "21840361": ["Alzheimer's disease (AD) is the 6th leading cause of death in United States afflicting >5 million Americans."],
    "21920373": ["Alzheimer Disease (AD) is the most prevalent form of dementia and the sixth leading cause of death in developed world."],
    "22133718": ["Alzheimer's disease (AD) is the only leading cause of death for which no disease-modifying therapy is currently available."],
    "22212311": ["Alzheimer's disease (AD) is the most common form of dementia, and one of the principal causes leading to death around the world."],
    "22254735": ["AD is a neurodegenerative disorder characterized by neurofibrillary plaques and tangles in the brain that leads to neuronal death and dementia."],
    "22265578": ["The characterization of AD as a leading cause of death among the elderly was crucial to sustaining the movement, but also operated as a \\double edged sword\\."],
    "2231117": ["Senile dementia and Alzheimer's disease (often considered a single process) rank as the fourth most common cause of death in the United States and outrank in cost to the nation the three leading causes of death combined."],
    "22404854": ["Although the proportions of deaths due to other major causes of death have decreased in the last several years, the proportion due to AD has risen significantly.", "AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age >=65 years."],
    "22543304": ["AD is a complex multifactorial disorder with a number of genetic, epigenetic and environmental factors which ultimately lead to premature neuronal death."],
    "22681044": ["Alzheimer's disease is a fatal neurological disorder that is a leading cause of death, with its prevalence increasing as the average life expectancy increases worldwide."],
    "22696871": ["In AD, neurons have been shown to enter the cell cycle inappropriately without the ability to complete it fully and the aberrant re-entry leads to its death."],
    "22778828": ["Alzheimer's disease (AD), an age-related neurodegenerative disorder, is the most common form of dementia, and the seventh-leading cause of death in the United States."],
    "22888398": ["Alzheimer's disease (AD) is the most common neurodegenerative disease featuring progressive impairments in memory, cognition, and behavior and ultimately leads to death."],
    "23106978": ["Tacrine-6-ferulic acid, a novel multifunctional dimer against Alzheimer's disease, prevents oxidative stress-induced neuronal death through activating Nrf2/ARE/HO-1 pathway in HT22 cells."],
    "23113839": ["Because of the toxicity caused by the heme redox-active iron proteins, their elevated levels, localization, and accumulation in the brain, many forms of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, occur as a result of which the brain becomes vulnerable to oxidative stress, ultimately resulting in neuronal death."],
    "23161037": ["Alzheimer's disease (AD) is the sixth leading cause of all deaths in the United States, and the fifth leading cause of death in Americans aged 65 and older."],
    "23170058": ["PURPOSE: Recent studies have indicated that accumulation of amyloid beta(1-42) (Abeta(1-42)), which is associated with the progression of Alzheimer disease, may also be responsible for retinal ganglion cell death in glaucoma."],
    "23376032": ["Neurologic conditions including stroke, Alzheimer disease, Parkinson disease, and Huntington disease are leading causes of death and long-term disability in the United States, and efforts to develop novel therapeutics for these conditions have historically had poor success in translating from bench to bedside."],
    "23397250": ["Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Multiple sclerosis (MS) involve activation of glial cells and release of inflammatory mediators leading to death of neurons."],
    "23399672": ["Alzheimer's disease (AD) is the most common cause of dementia, and its pathological hallmarks are senile plaques and neurofibrillary tangles in the brain, which eventually induce neuronal death."],
    "23424127": ["Alzheimer's disease (AD) is one of the leading causes of death for older people in US with rapidly increasing incidence."],
    "23507120": ["AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older."],
    "23507421": ["Potential gains in life expectancy from reducing heart disease, cancer, Alzheimer's disease, kidney disease or HIV/AIDS as major causes of death in the USA."],
    "23624206": ["Alzheimer's disease (AD) is a neurodegenerative disorder that leads to neuron death and synapse loss in the hippocampus and cortex, with consequent cognitive disability and dementia."],
    "23650720": ["The basis of AD is neurodegenerative process that leads to death of neurons in the cerebral cortex."],
    "23653484": ["RESULTS: AD and pneumonia were causes of significant excess mortality and the most common underlying causes of death in the AD patient group (23.53 and 17.65%, respectively)."],
    "23742787": ["Alzheimer's disease is the sixth leading cause of death in the United States and the fifth leading cause for people aged 65 years and over (1)."],
    "23984328": ["Alzheimer's disease is the most common form of dementia and is the only top 10 cause of death in the United States that lacks disease-altering treatments."],
    "24201446": ["We have also focused on their involvement in neurodegenerative diseases including Parkinson's and Alzheimer's diseases, discussing the contribution of this type of glial cell toward mechanisms that can lead to neuronal death, which was previously attributed exclusively to neurons."],
    "24471710": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of beta-amyloid peptides and neurofibrilllary tangles in brain, resulting in neuronal death and loss of cognitive abilities."],
    "24689364": ["Alzheimer's disease (AD) is the most common form of dementia and the sixth leading cause of death in the United States."],
    "24818261": ["In 2010, official death certificates recorded 83,494 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death in Americans aged 65 years or older."],
    "24838579": ["Alzheimer's disease (AD) is a neurodegenerative condition that leads to neuronal death and memory dysfunction."],
    "24846640": ["Alzheimer's disease (AD) is the most common type of dementia (accounting for 60% to 80%) and is the fifth leading cause of death for those people who are 65 or older."],
    "24850589": ["Alzheimer's disease (AD) is one of the most frequent causes of death and disability worldwide and has a significant clinical and socioeconomic impact."],
    "24878198": ["Alzheimer's disease is the most common neurodegenerative disease and is one of the main causes of death in developed countries."],
    "24922524": ["This study was designed to uncover the cellular and biochemical mechanisms underlying the neuroprotective effects of tacrine-3-caffeic acid (T3CA), a novel promising multifunctional anti-Alzheimer's dimer, against OS-induced neuronal death."],
    "25075874": ["Alzheimer's disease, the seventh leading cause of death in 2006, became the sixth leading cause in 2007, and Diabetes mellitus, the sixth leading cause in 2006, dropped to the seventh leading cause in 2007."],
    "25220527": ["Alzheimer's disease (AD) is the most common form of dementia characterized by deterioration of memory and other cognitive domains which leads to death in 3-9years after diagnosis."],
    "25250042": ["AD is the sixth leading cause of death, and one of the leading causes of dementia amongst the aged population in the USA."],
    "25405415": ["Alzheimer?s disease (AD) is the only cause of death among the top 10 diseases that cannot be prevented, cured, or slowed with the current treatments available."],
    "25408208": ["RESULTS: The National Death Index identified 175 subjects who died with AD listed as an underlying (n = 116) or contributing (n = 59) cause of death during 11.6-year average mortality surveillance."],
    "25472798": ["Alzheimer's disease is one of the most common causes of death worldwide, with poor treatment options."],
    "25609918": ["Alzheimer's disease, the most common type of dementia, is a progressive brain disease that destroys cognitive function and eventually leads to death."],
    "25833944": ["The expression and subcellular localization of Set-beta are altered in Alzheimer disease, cleavage of Set-beta leads to neuronal death after stroke, and the full-length Set-beta regulates retinal ganglion cell (RGC) and hippocampal neuron axon growth and regeneration in a subcellular localization-dependent manner."],
    "25857971": ["Beta-amyloid (Abeta) peptide, the hallmark of Alzheimer's disease, invokes oxidative damage to neurons and eventually leads to neuronal death."],
    "25954942": ["AD is the sixth leading cause of death in the United States and the only 1 among the top 10 that cannot be prevented, cured, or even slowed.", "Vitamin D and neurocognitive disorder due to Alzheimer's disease: A review of the literature."],
    "2597884": ["The distinction between Alzheimer's dementia and depressive illness, based on their natural history and causes of death, was reinforced."],
    "25984581": ["In 2013, official death certificates recorded 84,767 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years."],
    "25989911": ["Alzheimer's disease (AD) is the most common type of dementia that leads to increasing death and mental disability among humans."],
    "26022359": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by severe cognitive impairment that ultimately leads to death."],
    "26265552": ["The number of patients with AD will grow rapidly each year and AD is the fifth leading cause of death for those aged 65 and older."],
    "26435705": ["BACKGROUND: Alzheimer's disease (AD) is the sixth leading cause of death and the most costly disease in the US."],
    "26470401": ["Vitamin D and neurocognitive disorder due to   Alzheimer's disease: A review of the literature.", "AD is the sixth leading cause of death in the United States and the only 1 among the top 10 that cannot be prevented, cured, or even slowed."],
    "26510980": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the fourth leading cause of death in the United States and most common cause of adult-onset dementia."],
    "26517378": ["A variety of stressors, including beta-amyloid (Abeta) in the case of AD, can force neurons to leave quiescence and to initiate an ectopic DNA replication process, leading to neuronal death rather than division."],
    "26690394": ["Alzheimer's disease (AD) is a debilitating progressive neurodegenerative disorder that ultimately leads to the patient's death."],
    "2680026": ["Alzheimer's disease is the fourth most common cause of death in the United States, and is the leading cause of functional disability in the elderly."],
    "2682166": ["Alzheimer's disease, once a rarely applied medical diagnosis, is now considered to be the fourth or fifth leading cause of death in the United States."],
    "26983930": ["Alzheimer's disease (AD) is the fourth leading cause of death in Puerto Rico."],
    "27127760": ["In Western societies, Alzheimer's disease (AD) is the most common form of dementia and the sixth leading cause of death."],
    "27182464": ["As a result, Alzheimer's disease (AD), the 5th leading cause of death for people aged 65 and older, is likely to increase in these groups."],
    "27190276": ["Alzheimer's disease (AD) is a leading cause of death and disability among older adults."],
    "27235708": ["AD is now considered to be the third major cause of death in developed countries, after cardiovascular disease and cancer."],
    "27570871": ["In 2013, official death certificates recorded 84,767 deaths from Alzheimer's disease, making it the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age >= 65 years."],
    "27758699": ["BACKGROUND: In 2016, the statistical reports stated that Alzheimer is not just memory loss but it kills and has become the 6th leading cause of death."],
    "27776890": ["AD is the sixth leading cause of death in the United States and is the only cause of death among the top ten that cannot currently be treated or cured (Alzheimer's Association, 2011; Selkoe, 1996)."],
    "27942104": ["BACKGROUND: Cognitive disorders and dementia are common problems, and Alzheimer's disease is one of the major leading causes of death worldwide."],
    "28043897": ["Alzheimer's disease (AD) is a severe, chronic and progressive neurodegenerative disease associated with memory and cognition impairment ultimately leading to death."],
    "28246336": ["Alzheimer's disease (AD) is one of the fastest-growing causes of death and disability in persons 65 years of age or older, affecting more than 5 million Americans alone."],
    "28396328": ["METHODS: We obtained data on all community-dwelling adults with a recent diagnosis of Alzheimer disease in Finland (2005-2011) from the Medication use and Alzheimer disease (MEDALZ) cohort, which incorporates national registry data on prescriptions, reimbursement, hospital discharges and causes of death."],
    "28417590": ["Alzheimer's disease (AD) is leading cause of death among older characterized by neurofibrillary tangles, oxidative stress, progressive neuronal deficits, and increased levels of amyloid-beta (Abeta) peptides."],
    "28426958": ["Alzheimer's disease (AD) is the sixth leading cause of death in the United States and the most common cause of dementia in the elderly."],
    "28442216": ["Alzheimer's disease (AD) is the most common form of dementia and the 6th leading cause of death in the US."],
    "28490901": ["Breast cancer and Alzheimer's disease (AD) are major causes of death in older women."],
    "28542120": ["Alzheimer's disease (Alzheimer's), an ultimately fatal form of dementia, is the sixth leading cause of death in the United States, accounting for 3.6% of all deaths in 2014 (1,2)."],
    "28624131": ["Alzheimer disease (AD) is an irreversible, progressive brain disorder that causes slow loss of memory and thinking skills, normally leading to death in 3-9 y."],
    "28634681": ["Currently, AD is one of the leading causes of death in developed countries and the only one of the top ten diseases without a means to prevent, cure, or significantly slow down its progression."],
    "28825647": ["Alzheimer's disease (AD) is currently ranked as the sixth leading cause of death in the United States and recent estimates indicate that the disorder may rank third, just behind heart disease and cancer, as a cause of death for older people."],
    "28889269": ["Alzheimer's disease (AD) is the most common form of adult neurode-generation and is characterised by progressive loss of cognitive function leading to death."],
    "29024348": ["Alzheimer's disease (AD) is the sixth leading cause of death in the USA today; therefore, it is imperative that public health initiatives and clinical strategies are developed to prevent and effectively treat AD."],
    "29060753": ["Alzheimer's Disease (AD) is one of the leading causes of death and dementia worldwide."],
    "29061973": ["Alzheimer's disease (AD) is one of the leading causes of death for people over 65 years."],
    "29164499": ["Alzheimer's disease, thought to be the most common underlying pathology for elders' cognitive dysfunction (Willis and Hakim 2013), is already the sixth leading cause of death in the United States (Alzheimer's Association 2016)."],
    "29270150": ["Alzheimer's disease is the most common neurodegenerative form of dementia that steadily worsens and eventually leads to death."],
    "29336270": ["Characterized by the formation of beta-amyloid plaques, Alzheimer's disease (AD) is currently one of the leading causes of death across the world."],
    "29372919": ["In Alzheimer's disease, it is believed that amyloid-beta proteins may be responsible for pore and defect formation within cellular membranes, leading to a breakdown of cellular homeostasis causing eventual neuronal death."],
    "29446066": ["Those who died of AD were selected based on underlying cause of death."],
    "29538632": ["Background: Alzheimer's disease is a progressive disease that degrades cognitive functioning and ultimately results in death."],
    "29549645": ["Among different neurological disorders, Alzheimer's disease (AD) is recognized as the sixth leading cause of death globally."],
    "29677545": ["Beta-amyloid (Abeta) peptide, the hallmark of Alzheimer's disease (AD), invokes a cascade of oxidative damage to neurons and eventually leads to neuronal death."],
    "29714994": ["Alzheimer disease (AD) occurs in 8.8% of older US adults and is the sixth leading cause of death among older adults."],
    "29749899": ["Alzheimer's disease is one of the leading causes of death worldwide and currently does not have any cure."],
    "29772289": ["According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is the 6th primary cause of death in the USA, which affects nearly 5.5 million people."],
    "29862455": ["Alzheimer's disease (AD) is the sixth leading cause of death in the United States where it is estimated that one in three seniors dies with AD or another dementia."],
    "29932100": ["Alzheimer&rsquo;s disease (AD) is the most prevalent neurodegenerative disease, distinctively characterized by senile plaques, neurofibrillary tangles, and synaptic loss, finally resulting in neuronal death."],
    "30039745": ["With rapid aging of world population, Alzheimer's disease is becoming a leading cause of death after cardiovascular disease and cancer."],
    "30106219": ["AIMS: Alzheimer's disease (AD) is one of the leading causes of death in elderly people."],
    "30108425": ["Prolonged AD leads to moderate-to-severe AD, which is one of the leading causes of death."],
    "30110946": ["Alzheimer's disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and causes death due to dementia."],
    "30171866": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause of dementia and the 6th leading cause of death."],
    "30236015": ["Alzheimer disease (AD) is a progressive neurodegenerative disorder that affects approximately 5 million people in the United States and is the sixth leading cause of death in the country."],
    "30243157": ["Alzheimer, the fourth leading cause of death embodies a key responsible event including formation of beta-amyloid protein clustering to amyloid plaque on blood vessels."],
    "30328325": ["PURPOSE: Alzheimer's disease (AD) is the sixth most common cause of death in the United States."],
    "30371351": ["SIGNIFICANCE: AD is one of the leading causes of death in America and continues to affect a growing population."],
    "30486438": ["Alzheimer's disease (AD) is a progressive neurodegenerative disease that represents a major cause of death in many countries."],
    "30532546": ["Nowadays, due to the increase in the number of aging population groups, there is also a growth of aging diseases such as Alzheimer's disease (AD), which is a progressive brain disorder that eventually results in death."],
    "30545070": ["Brain ischemia is the second naturally occurring neuropathology, such as Alzheimer's disease, which causes the death of neurons in the CA1 region of the hippocampus."],
    "30560544": ["Despite major academic and industry efforts, Alzheimer's disease (AD) remains the only leading cause of death for which no disease-modifying treatment is available."],
    "30565076": ["Alzheimer's disease (AD) is the sixth leading cause of death globally and the main reason for dementia in elderly people."],
    "30707915": ["The pathogenesis of Alzheimer's disease (AD) is involved in the aggregation of misfolded amyloid beta (Abeta), which upregulates the activity of acetylcholinesterase (AChE), increases the production of reactive oxygen species (ROS), enhances neuroinflammation, and eventually leads to neuronal death."],
    "30740125": ["Alzheimer disease (AD) is the fourth major cause of death in the elderly following cancer, heart disease and cerebrovascular disease.", "In this study, we combined expression quantitative trait locus (eQTL) studies with the GWAS, to comprehensively define the genes that cause Alzheimer disease."],
    "30747418": ["In the aging world population, Alzheimer's disease accounts for more than 70% of all cases of dementia and is the sixth leading cause of death."],
    "30881282": ["Alzheimer's disease (AD) and cancer are among the leading causes of human death around the world."],
    "30922415": ["OBJECTIVE: Alzheimer's disease (AD) is the sixth leading cause of death, with an average survival estimated between 5 and 10 years after diagnosis."],
    "31068785": ["Alzheimer's disease (AD) has been categorized by the Centers for Disease Control and Prevention (CDC) as the 6th leading cause of death in the United States."],
    "31201463": ["Alzheimer's Disease (AD) is the sixth-leading cause of death in industrialized countries."],
    "31211444": ["AD is one of the leading causes of death in the United States."],
    "31262433": ["In recent years, autophagy dysfunction has gained considerable attention in AD and other neurodegenerative diseases because it has been linked to the accumulation of misfolded proteins that ultimately causes neuronal death in many of these disorders."],
    "31354494": ["AD is a leading cause of death worldwide and is progressive in nature with symptoms worsening over time."],
    "31379558": ["Alzheimer's disease (AD) afflicts an estimated 20 million people worldwide and is the fourth-leading cause of death in the developed world."],
    "31422384": ["Alzheimer's disease (AD) is a progressive neurodegenerative disease that ranks as the fourth most common cause of death in developed countries."],
    "31430752": ["AD is the sixth leading cause of death in the USA, affecting an estimated 5 million Americans."],
    "31524171": ["Most ADRDs are characterized by progressive neurodegeneration, and Alzheimer's disease (AD) is the sixth leading cause of death in the United States."],
    "31540705": ["Alzheimer's and Parkinson's diseases are one of the world's leading causes of death."],
    "31592230": ["In 2018, AD was the fifth leading cause of death in Americans with 65 years of age or older, but the progress of AD drug research is very limited."],
    "31689949": ["Increasing evidence has demonstrated that amyloid-beta peptide (Abeta), the hallmark of Alzheimer's disease (AD), evokes oxidative and inflammatory cascades, which ultimately lead to the death of neurons."],
    "31704512": ["There are several processes which can cause AD, including mitochondrial dysfunction-mediated oxidative stress (OS), intracellular buildup of hyper-phosphorylated tau as neurofibrillary tangles (NFTs) and excessive buildup of extracellular amyloid beta (Abeta) plaques, and/or genetic as well as the environmental factors.", "Alzheimer's disease (AD) is a progressive, chronic and severe neurodegenerative disorder linked with cognitive and memory impairment that eventually lead to death."],
    "31837630": ["Alzheimer's Disease (AD) is one of the leading causes of death in developed countries."],
    "31848379": ["Assessing the therapeutic potential of Graptopetalum paraguayense on Alzheimer's disease using patient iPSC-derived neurons.Alzheimer's disease (AD) is the most common type of dementia and also one of the leading causes of death worldwide."],
    "31862920": ["Alzheimer disease and other dementias have become the 7th cause of death worldwide."],
    "31866858": ["In developed countries, AD is now acknowledged as the third leading cause of death, following cardiovascular disease and cancer."],
    "31871211": ["Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities.Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the sixth leading cause of death and the most common cause of dementia worldwide."],
    "31989900": ["Recent trends in management of Alzheimer's disease: Current therapeutic options and drug repurposing approaches.Alzheimer's disease is one of the most progressive forms of dementia ultimately leading to death in aged populations."],
    "32097673": ["Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models.Alzheimer's disease (AD) as a progressive neurodegenerative disorder is one of the leading causes of death globally."],
    "32157811": ["Official death certificates recorded 122,019 deaths from AD in 2018, the latest year for which data are available, making Alzheimer's the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age 65 and older."],
    "32241275": ["Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease.BACKGROUND: Alzheimer's disease (AD) is one of the leading causes of death in the US and there is no validated drugs to stop, slow or prevent AD."],
    "32265696": ["AD was ranked as the 5     th       leading cause of global deaths in 2016 by the World Health Organization (WHO)."],
    "32327491": ["Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.OBJECTIVE: To evaluate the risk of death in relation to incident antiepileptic drug (AED) use compared with nonuse in people with Alzheimer disease (AD) through the assessment in terms of duration of use, specific drugs, and main causes of death."],
    "32337953": ["miR-143-3p inhibition promotes neuronal survival in an Alzheimer's disease cell model by targeting neuregulin-1.INTRODUCTION: Alzheimer's disease (AD) is still the fifth leading cause of death and most common dementia worldwide."],
    "32341952": ["More than 45 million people worldwide have Alzheimer's disease (AD), a deterioration of memory and other cognitive domains that leads to death within 3 to 9 years after diagnosis."],
    "32481301": ["Acupuncture therapy for Alzheimer's disease: A protocol for an overview of systematic reviews.BACKGROUND: Alzheimer's disease (AD) is the fifth-leading cause of death in people more than 65 years old."],
    "32486897": ["AD is currently ranked as the sixth leading cause of death, but some sources put it as third, following heart disease and cancer."],
    "32515311": ["PTML Modeling for Alzheimer's Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6.BACKGROUND: Alzheimer's disease is characterized by a progressive pattern of cognitive and functional impairment, which ultimately leads to death."],
    "32531244": ["The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway.Alzheimer's disease, obesity-related metabolic syndrome, and cancer are the leading causes of death and among the most costly medical conditions in the Western world."],
    "32593336": ["Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.BACKGROUND: Alzheimer's disease and its complications are the leading cause of death in adults with Down syndrome."],
    "32600151": ["Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report.Alzheimer's disease (AD), the most common form of dementia, is a leading cause of death and a major cause of morbidity in older people."],
    "32628119": ["Diabetes-Related Topics in an Online Forum for Caregivers of Individuals Living With Alzheimer Disease and Related Dementias: Qualitative Inquiry.BACKGROUND: Diabetes and Alzheimer disease and related dementias (ADRD) are the seventh and sixth leading causes of death in the United States, respectively, and they coexist in many older adults."],
    "32709243": ["Alzheimer disease (AD) is the most prominent form of dementia and the 5th leading cause of death in individuals over 65."],
    "32807227": ["Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.BACKGROUND: Alzheimer's disease (AD) is the major cause of death in adults with Down syndrome (DS)."],
    "3285438": ["This could be responsible for the occurrence of senile changes (senile plaques and neurofibrillary tangles) which are both characteristic of so-called normal aging of the brain and of Alzheimer's disease and lead to neuronal death."],
    "32894711": ["Multi-view Separable Pyramid Network for AD Prediction at MCI Stage by 18F-FDG Brain PET Imaging.Alzheimer's Disease (AD), one of the main causes of death in elderly people, is characterized by Mild Cognitive Impairment (MCI) at prodromal stage."],
    "33011665": ["Estimates indicate that AD may rank third as a cause of death for older people, after heart disease and cancer."],
    "33047398": ["RATIONALE: Alzheimer's disease (AD) is a chronic, severe, progressive neurodegenerative disorder associated with cognitive and memory impairment that ultimately causes death."],
    "33126501": ["Alzheimer's Disease (AD) is a progressive multifactorial age-related neurodegenerative disorder that causes the majority of deaths due to dementia in the elderly."],
    "33138782": ["BACKGROUND: Alzheimer's disease (AD) is related to higher mortality but it is not entirely evident which causes of death explain this."],
    "33282526": ["AD is considered the fifth leading cause of death in Americans who are older than 65 years which prioritizes the importance of understanding the etiology of AD in its early stages before the onset of symptoms."],
    "33316174": ["Diabetes, Alzheimer disease, and heart disease caused the most non-COVID-19 excess deaths."],
    "33434704": ["Alzheimer's dementia (AD) is the sixth leading cause of death in the U.S., with an estimated $305 billion cost of care in 2020."],
    "33438444": ["OBJECTIVES: Neurodegenerative diseases (NDs), such as Parkinson's disease and Alzheimer's disease and related dementias, are a leading cause of death and disability in China."],
    "33500732": ["Alzheimer's disease (AD) is currently ranked as the third leading cause of death for eldly people, just behind heart disease and cancer."],
    "33529936": ["Alzheimer's Disease (AD) is the most frequent illness and cause of death amongst the age related-neurodegenerative disorders."],
    "33532133": ["Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and a major cause of death among elderly individuals."],
    "33532699": ["Background: Alzheimer's disease (AD) is the 6th leading cause of death in the United States and has no cure or progression prevention."],
    "33750334": ["BACKGROUND: Alzheimer's disease (AD) is one of the leading causes of death world-wide, but little is known on the role of comorbidities on mortality among people with AD."],
    "33756057": ["Official death certificates recorded 121,499 deaths from AD in 2019, the latest year for which data are available, making Alzheimer's the sixth-leading cause of death in the United States and the fifth-leading cause of death among Americans age 65 and older."],
    "33802718": ["Specifically, 3.2 million deaths are reported yearly due to heart disease, cancer, Alzheimer's disease, diabetes, and COVID-19."],
    "33839469": ["The paper recognizes the value and need to fight the image of AD as social death in research, the medical system, and popular understanding, but proposes a family Memory-Relationship self to conceptually capture the trauma many families feel as AD increasingly impairs the loved one with AD and leads to their death (unless they die of something else first)."],
    "33916001": ["Alzheimer's disease (AD), a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, is a major cause of death and disability among the older population."],
    "34021875": ["Alzheimer's disease (AD) is the fourth leading cause of death in the United States and the most common cause of adult-onset dementia."],
    "34030620": ["Alzheimer's disease (AD) is the only leading cause of death for which no disease-modifying therapy is currently available."],
    "34098466": ["Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disease, characterized by irreversible cognitive impairment, memory loss and behavioral disturbances, ultimately leading to death."],
    "34208980": ["Alzheimer's disease (AD) and other dementias are now the seventh leading cause of death in the world and are projected to affect 115.4 million people by 2050."],
    "34219726": ["BACKGROUND: Hispanic older adults are a high-risk population for Alzheimer's disease and related dementias (ADRD) but are less likely than non-Hispanic White older adults to have ADRD documented as a cause of death on a death certificate."],
    "34228042": ["Importance: Alzheimer disease (AD) is the leading cause of death in individuals with Down syndrome (DS)."],
    "34229061": ["Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death."],
    "34273065": ["Alzheimer's disease (AD) is now ranked as the third leading cause of death after heart disease and cancer."],
    "34350508": ["Alzheimer's disease (AD) is a neurodegenerative disease characterized by amyloid plaques and tangles that have become the fifth leading cause of death worldwide."],
    "34353220": ["BACKGROUND AND PURPOSE: Alzheimer disease (AD) is the most common form of dementia and the sixth leading cause of death in the United States."],
    "34424488": ["AD is recognized as the sixth leading cause of death in the USA, and its prevalence is predicted to increase exponentially in the coming years."],
    "34522196": ["Background and purpose: Alzheimer's disease is considered one of the lead causes of elderly death around the world."],
    "34535721": ["Alzheimer's disease (AD) and other dementias have become the fifth leading cause of death worldwide."],
    "34572985": ["Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all dementia patients and representing a leading cause of death worldwide for the global ageing population."],
    "34577590": ["Several risk factors are involved in the progression of AD, modifying neuronal circuits and brain cognition, and eventually leading to neuronal death."],
    "34606321": ["Compared with White males and females, non-COVID-19 excess deaths per 100 000 persons were 2 to 4 times higher in Black, AI/AN, and Latino males and females, including deaths due to diabetes, heart disease, cerebrovascular disease, and Alzheimer disease."],
    "34646644": ["Alzheimer's disease (AD) is the most common type of dementia and is among the leading cause of death in the United States."],
    "34687637": ["Adults with Down syndrome develop the neuropathological hallmarks of Alzheimer's disease and are at very high risk of developing early-onset dementia, which is now the leading cause of death in this population."],
    "34707479": ["Given that Alzheimer's Disease is the sixth leading cause of adult death in the U.S., elucidating the molecular interactions that characterize Alzheimer's Disease pathogenesis will allow for better treatment options."],
    "34712129": ["Around 58% of the affected patients live in low and middle-income countries, with estimates of increasing deaths caused by AD in the coming decade."],
    "34751889": ["Alzheimer's disease (AD) is considered the sixth leading cause of death in elderly patients and is characterized by progressive neuronal degeneration and impairment in memory, language, etc."],
    "34867153": ["Alzheimer's disease (AD) is a neurodegenerative disease that impacts 45 million people worldwide and is ranked as the 6th top cause of death among all adults by the Centers for Disease Control and Prevention."],
    "34891761": ["Alzheimer's Disease (AD) is the sixth leading cause of death in the US."],
    "34971144": ["BACKGROUND: Alzheimer's Disease (AD), a progressive neurodegenerative disease and the second most common cause of death in Australia (ABS 2019), is an increasingly prominent societal issue, exacerbated by an ageing population and the absence of effective disease modifying treatments."],
    "35023084": ["INTRODUCTION: Alzheimer's disease is one of the irreversible dementias and leads to death."],
    "35109084": ["BACKGROUND: Alzheimer's disease (AD) is the leading cause of disability and 5th cause of death in people over 65 years of age."],
    "35109462": ["Alzheimer's disease is the 6th leading cause of death in the United States."],
    "35186657": ["Alzheimer's disease (AD) is a neurodegenerative disease and the fourth leading cause of death after cardiovascular disease, tumors, and stroke."],
    "35218718": ["Apart from deaths due to AD, expenditure of treatment and care of AD patients is higher than that of treatment of HIV and cancer diseases combined."],
    "35280344": ["AD is a progressive neurodegenerative disorder characterized by decline of memory, behavioral impairments that affects a person's ability to function independently ultimately leading to death."],
    "35289055": ["Alzheimer's disease was officially listed as the sixth-leading cause of death in the United States in 2019 and the seventh-leading cause of death in 2020 and 2021, when COVID-19 entered the ranks of the top ten causes of death."],
    "35431257": ["Alzheimer's disease (AD) is the only cause of death ranked in the top ten globally without precise early diagnosis or effective means of prevention or treatment."],
    "35458896": ["Alzheimer's disease is the most common form of dementia and the fifth-leading cause of death among people over the age of 65."],
    "35486224": ["Alzheimer's disease (AD), currently the single leading cause of death still on the rise, almost always coexists alongside vascular cognitive impairment (VCI)."],
    "35556967": ["Currently, an estimated 6.2 million Americans are living with AD, and it is ranked as the 6     th       leading cause of death in the United States."],
    "35599847": ["It ranks as the sixth leading cause of death in the United States, and the proportion of deaths due to AD has been increasing since 2000, while the proportion of many other leading causes of deaths have decreased or remained constant."],
    "35624938": ["Alzheimer's disease (AD) is an incurable neurodegenerative disorder and the leading cause of death among older individuals."],
    "35665670": ["Alzheimer's disease is the sixth leading cause of death in the United States, and the number of patients with the disease is set to hit 20 million by 2050."],
    "35748395": ["Alzheimer's disease (AD) is a cumulative form of dementia associated with memory loss, cognition impairment, and finally leading to death."],
    "35784755": ["In recent years, neurological diseases including Alzheimer's disease, Parkinson's disease and stroke are one of the main causes of death in the world."],
    "35836098": ["Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disease, characterized by irreversible cognitive impairment, memory loss, and behavioral disturbances, ultimately resulting in death."],
    "35858523": ["Alzheimer's disease (AD), as the fourth leading cause of death among the elderly worldwide, has brought enormous challenge to the society."],
    "35887134": ["As a neurodegenerative disease, Alzheimer's disease (AD) shows a higher incidence during the aging process, mainly revealing the characteristics of a significant decrease in cognition, uncontrolled emotion, and reduced learning and memory capacity, even leading to death."],
    "35961638": ["Introduction    : Alzheimer's disease (AD) dementia is the sixth leading cause of death in the United States."],
    "35968378": ["Alzheimer's disease (AD) is the sixth leading cause of death worldwide and cannot be effectively cured or prevented; thus, early diagnosis, and intervention are important."],
    "36165518": ["Alzheimer's disease (AD) has become the fourth leading cause of death in the world."],
    "36197131": ["AD is the leading type of dementia, accounting for 60% to 80% of cases, and the sixth leading cause of death in the United States."],
    "36268188": ["Alzheimer's disease (AD) is the most common form of dementia and is ranked as the 6th leading cause of death in the US."],
    "36408377": ["Background: Alzheimer's disease (AD) is the most common form of dementia, which is among the top five causes of death in the United States."],
    "36475205": ["Alzheimer's dementia (AD) is the most common major neurocognitive impairment and the fifth leading cause of death in older adults in the United States."],
    "36502321": ["Later in life, AD leads to death as a result of the degeneration of specific brain areas."],
    "36537919": ["Alzheimer's disease is the sixth-leading cause of death in the United States, and the number of deaths from all related dementias may be twice as high.[i] Years of investment and research in Alzheimer's disease and related dementias (ADRD) are sowing seeds of hope."],
    "36583187": ["AD is the fifth leading cause of death among Americans age 65 and older."],
    "36589440": ["Non-communicable diseases, like diabetes, cardiovascular diseases, cancer, stroke, chronic obstructive pulmonary disease, osteoporosis, arthritis, Alzheimer's disease and other more are a leading cause of death in almost all countries."],
    "36593834": ["Alzheimer's disease is ranked among the top five causes of death for old people."],
    "36674771": ["Nowadays, cancers and dementia, such as Alzheimer's disease, are the most fatal causes of death."],
    "36708701": ["The pivotal characteristics of Alzheimer's disease (AD) are irreversible memory loss and progressive cognitive decline, eventually causing death from brain failure."],
    "36780546": ["RESULTS: When analyzing death certificates without addressing the reporting of Down syndrome as the underlying cause of death, rates of death due to Alzheimer disease and dementia ranked as the third leading cause of death for both adults with and without Down syndrome.", "After amending death certificates that reported Down syndrome as the underlying cause of death, Alzheimer disease and dementia were the leading cause of death among those with Down syndrome, occurring 2.7 times more in adults with compared to without Down syndrome."],
    "36841050": ["Alzheimer's disease (AD) implicates neuronal loss, plaque and neurofibrillary tangle formation, and disturbed neuronal Ca     2+       homeostasis, which leads to severe dementia, memory loss, as well as thinking and behavioral perturbations that could ultimately lead to death."],
    "36842068": ["BACKGROUND AND OBJECTIVES: Alzheimer's disease or related dementia are a major cause of death in the United States."],
    "36918389": ["Official death certificates recorded 121,499 deaths from AD in 2019, and Alzheimer's disease was officially listed as the sixth-leading cause of death in the United States."],
    "36940723": ["Wealth of data has shown that oxidative stress and AD are closely connected that causes the death of neuronal cells by producing reactive oxygen species (ROS)."],
    "36961417": ["The notion that AD causes the death of neurons point towards protection of neuronal morphology and function as important therapeutic strategies."],
    "36993752": ["Alzheimer's Disease (AD) continues to be a leading cause of death in the US."],
    "36995136": ["METHODS: publicly accessible data on the prevalence, death and disability-adjusted life years (DALYs) because of AD, and other types of dementia, were retrieved from the global burden of disease 2019 project for all MENA countries from 1990 to 2019."],
    "37038213": ["BACKGROUND: Alzheimer's disease (AD) is the 5th leading cause of death in people 65 years and older."],
    "37109528": ["Presently more than 55 million individuals are affected by AD all over the world, and it is a leading cause of death in old age."],
    "37208979": ["Compared with AD, hazard ratios for \\nervous system\\ causes of death were significantly elevated in all LBD groups."],
    "37256433": ["INTRODUCTION: Clinical Alzheimer's disease (AD) begins with mild cognitive impairment (MCI) and progresses to mild, moderate, or severe dementia, constituting a disease continuum that eventually leads to death."],
    "37304012": ["Alzheimer's Disease (AD) and related dementias are a leading cause of death globally and are predicted to increase in prevalence."],
    "37375767": ["Alzheimer's disease (AD) is the most common type of dementia and is listed as the sixth-leading cause of death in the United States."],
    "37486697": ["Alzheimer's disease is the only major cause of death that is still growing."],
    "37507902": ["Currently, no drug is effective in delaying the cognitive impairment of Alzheimer's disease, which ranks as one of the top 10 causes of death worldwide."],
    "37612307": ["In 2015, AD is reported the US's sixth cause of death."],
    "37672968": ["Alzheimer's disease (AD) is the most common dementia type and a leading cause of death and disability in the elderly."],
    "37679478": ["Alzheimer's Disease (AD) continues to be a leading cause of death in the US."],
    "37693600": ["Alzheimer's Disease (AD) is the 6th leading cause of death in the US."],
    "37955252": ["Alzheimer's disease (AD) is a progressive brain disease characterised by progressive memory loss and cognition impairment, ultimately leading to death."],
    "37997077": ["BACKGROUND: Dementia and Alzheimer's disease are the leading cause of death in England, with prevalence estimated to rise with an ageing population."],
    "38131985": ["In 2021, Alzheimer's disease resulted in 36 deaths per 100,000 in the U.S.", "Alzheimer's disease is the sixth most common cause of death in the United States (U.S.), with one in three adults 65 years of age and older dying of the disease each year."],
    "38137554": ["Conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), and dementia are becoming more prevalent and are now the fourth leading cause of death, following heart disease, cancer, and stroke."],
    "38213663": ["AD (for which there is no exact cause and cure known so far) is the sixth leading cause of deaths in the United States."],
    "38326859": ["Alzheimer's disease (AD) is the sixth leading cause of death in the USA."],
    "38371416": ["A recent report from the Office of National Statistics showed that AD is the leading cause of death in 2022."],
    "38381402": ["We know that many neurological age-related diseases, such as Alzheimer's disease, stroke, dementia, and Parkinson's disease, are the main cause of death in the last decades of life."],
    "38414336": ["INTRODUCTION: There is no cure for Alzheimer's disease, which is the sixth leading cause of death in the U.S.A.."],
    "38429957": ["RESULTS: During the study period, 751,493 deaths (1.7%, 233,271 males and 518,222 females) occurred in the EU-27 because of AD."],
    "38612514": ["Interestingly, as AD progresses, less Abeta42 is detectable in the plasma, a phenomenon thought to result from Abeta becoming more aggregated in the brain and less Abeta42 and Abeta40 being transported from the brain to the plasma via the CSF.", "Alzheimer's disease (AD) is the fifth leading cause of death among adults aged 65 and older, yet the onset and progression of the disease is poorly understood."],
    "38640743": ["Although Alzheimer's Disease is a leading cause of death in Vietnam and other post-conflict, low- and middle-income countries, aside from studies of veterans in western populations, research on war-related violence and deprivation as risk factors for cognitive disorders remains sparse."],
    "3876409": ["Such a DNA repair defect could cause an abnormal accumulation of spontaneously occurring DNA damage in Parkinson's disease and Alzheimer's disease neurons in vivo, resulting in their premature death."],
    "7485229": ["AD is the fourth leading cause of death in elderly persons 65 years or older in Western industrialized societies."],
    "7921490": ["Alzheimer's disease is the fourth major cause of death in the developed world and is a major social and health care issue."],
    "7997077": ["After heart disease, cancer and stroke, Alzheimer's disease (AD) is the fourth major cause of death in the developed countries."],
    "8195568": ["AD is the fourth leading cause of death for adults, taking more than 100,000 lives annually."],
    "8195569": ["Alzheimer's disease (AD) is the fourth leading cause of death of older persons."],
    "8610107": ["In rat hippocampal culture, betaA exposure activates tau protein kinase I/glycogen synthase kinase 3beta (TPKI/GSK-3beta), which phosphorylates tau protein into Alzheimer disease-like forms, resulting in neuronal death."],
    "8752460": ["Other forms of dementias like Alzheimer disease (AD) and vascular dementias are on the rise and the leading cause of death is cerebro- and cardiovascular diseases."],
    "9154214": ["Since its first description by Aloys Alzheimer about 90 years ago, this neurodegenerative condition has advanced to become the fourth most common cause of death in the elderly, and is found in more than half of the very elderly demented."],
    "9165306": ["The major hurdle in understanding Alzheimer's disease (AD) is a lack of knowledge about the etiology and pathogenesis of selective neuron death."],
    "9333421": ["AD is the fourth commonest cause of death in humans, after heart attack, cancer and stroke."],
    "9413702": ["Alzheimer's disease (AD) is a common neurodegenerative disorder and a leading cause of death among the elderly."],
    "9460797": ["There was no significant association detected between a diagnosis of presenile Alzheimer's disease and dementia as a parental cause of death (p = 0.25), nor for vascular dementia (p = 0.67)."],
    "9520072": ["Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive dementia that ultimately leads to death."],
    "9647903": ["We examined exposure to magnetic fields, assessed as duration of work in exposed jobs and through an index of cumulative exposure based on magnetic field measurements, in relation to mortality from Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, considering both underlying and all mentioned causes of death."],
    "10559765": ["In conclusion, the quality of life for adults with DS can be improved by routine, systematic health care screening to identify treatable diseases that may be missed because of poor communication or confusion due to Alzheimer disease."],
    "10993489": ["Cerebrovascular pathology, Lewy bodies, or hippocampal sclerosis in combination with neuropathological signs of AD of only limited severity results in a disease that is essentially different from severe, purely degenerative AD."],
    "11450439": ["The systematization of modern biochemical and structural date related to the action of physiologically active compounds on the nervous system apparatus engaged in the AD-like disorders pathogenesis was performed."],
    "11513911": ["INTERPRETATION: In-vivo detection of increased [11C](R)-PK11195 binding in Alzheimer-type dementia, including mild and early forms, suggests that microglial activation is an early event in the pathogenesis of the disease."],
    "11532247": ["All three isoforms are aberrantly expressed in Alzheimer's disease giving rise to elevated levels of nitric oxide apparently involved in the pathogenesis of this disease by various different mechanisms including oxidative stress and activation of intracellular signalling mechanisms."],
    "11585670": ["Utilizing both cDNA- and genomic-based approaches, these mouse models for Alzheimer's disease have already provided valuable insights into the pathogenesis of the disease and potential therapeutic interventions."],
    "11813874": ["A central question involving the role of A beta in AD concerns how A beta causes disease and whether it is extracellular A beta deposition and/or intracellular A beta accumulation that initiates the disease process.", "The discovery of familial AD (FAD) mutations in the genes for the amyloid precursor protein (APP) and presenilins (PSs), all of which increase A beta42 production, support the view that A beta is centrally involved in the pathogenesis of AD."],
    "11816795": ["Further investigation of alpha-synuclein and its relationship to pathological conditions promoting Lewy body formation in AD, PD, and DLB may yield further insight into pathogenesis of these diseases."],
    "11935076": ["BACKGROUND: The main stumbling block in the clinical management and in the search for a cure of Alzheimer disease (AD) is that the cause of this disorder has remained uncertain until now."],
    "12459889": ["In addition to the association between apoE4 and an increased risk of AD, oxidative stress is believed to play a role in the pathogenesis of this disease."],
    "12464614": ["The abnormal accumulation of beta-amyloid (Abeta) in the brain is an early and invariant feature in Alzheimer's disease (AD) and is believed to play a pivotal role in the etiology and pathogenesis of the disease."],
    "12473185": ["The controlled activation of PKC-epsilon plays a protective role in the development of cardiac ischemia and Alzheimer's disease, whereas its uncontrolled chronic activation results in severe diseases such as malignant tumors and diabetes."],
    "12587940": ["Recent research, however, has shown that inflammatory mechanisms are also associated with AD and that they could have a role in contributing to the pathogenesis of this disease."],
    "12629906": ["Research in the field of Alzheimer's disease has shown that genetic factors play an important role in the aetiology of the disease."],
    "12845151": ["The prolongation of life and the rapidly increasing incidence of Alzheimer's disease have brought to the foreground the need for greater understanding of the etiology of the disease and the means to prevent or at least slow down the process."],
    "12884970": ["Small animal models that manifest many of the characteristic neuropathological and behavioral features of Alzheimer's disease (AD) have been developed and have proven of great value for studying the pathogenesis of this disorder at the molecular, cellular and behavioral levels."],
    "12900170": ["Although it remains uncertain whether the UPR plays a mechanistic role in prototypical neurodegenerative disorders such as Alzheimer's disease, this is plausible because misfolded proteins are directly implicated in the pathogenesis of these disorders."],
    "14599482": ["Cholinergic deficits in Alzheimer's disease are accompanied by a number of alterations in other transmitter systems including glutamate, noradrenaline and serotonin, suggesting the involvement also of other neurotransmitter systems in the pathogenesis of the disease."],
    "14720176": ["Pathological relationships between damage to the deep white matter of the cerebral cortex [as evidenced by myelin loss (ML)], cerebral amyloid angiopathy (CAA) and arteriosclerosis (ART) were investigated in the brains of 137 patients with autopsy-confirmed Alzheimer's disease (AD), in order to better understand the causes of white matter damage in AD, and the contribution of this to the pathogenesis of the disorder."],
    "14758647": ["The specifics of disorders in the operative memory due to Alzheimer's disease suggest that cholinergic mechanisms determining the sensory processing differ from those involved in decision-making."],
    "15172740": ["Despite very numerous studies on Alzheimer's disease (AD), especially on amyloid plaques and neurofibrillary tangles, little information has been obtained thus on the causes of the disease."],
    "15219712": ["Behavioral assessment of genetically-manipulated mouse lines for Alzheimer's disease has become an important index for determining the efficacy of therapeutic interventions and examining disease pathogenesis."],
    "15708428": ["It is well established that oxidative stress plays a key role in the degenerative neuronal death and progression of Alzheimer's disease (AD), although it is not clear if it is the primary triggering event in the pathogenesis of this disorder."],
    "15723159": ["The recent elucidation of the inflammatory pathways involved in Alzheimer's disease however, has opened doors for better treatment and prevention by identification of areas of therapeutic intervention that target the cause of the disease rather than the symptoms."],
    "15964666": ["Aging represents the main risk factor to develop Alzheimer disease (AD) and protein aggregation constitutes a pathological hallmark thought to be involved in the etiology of this disease."],
    "16139258": ["BACKGROUND: Identification of all susceptibility loci for Alzheimer's disease has been a major goal in resolving the pathogenesis of this disease."],
    "16250840": ["Genetic and pharmacological manipulation of these Abeta-depositing transgenic mice is providing some intriguing and unexpected insights into the role of innate and adaptive immune mechanisms in the pathogenesis of AD.", "There is extensive evidence that changes in immune system activation accompany the pathological changes of Alzheimer's disease (AD), but a mechanistic understanding of how the immune system actually participates in disease pathogenesis is still largely lacking."],
    "16396232": ["During the past 20 years, research on AD has increased the knowledge of the physiopathological mechanisms leading to the disease."],
    "16471078": ["The overlap between cerebrovascular disease and Alzheimer disease produces a disorder that might be amenable to therapeutic approaches based on either mechanism."],
    "16472207": ["Most investigators studying the underlying cause of AD have focused on amyloid-beta (Abeta) such that the Amyloid Cascade Hypothesis is the predominant mechanism thought to be responsible for the disease."],
    "16624449": ["Besides the genetic, biochemical and neuropathological analogies between Down's syndrome (DS) and Alzheimer's disease (AD), there is ample evidence of the involvement of oxidative stress (OS) in the pathogenesis of both disorders."],
    "16752360": ["These data suggest that ABCA2 may exert population-dependent effects on the genetic risk for sporadic AD and support a role of ABC lipid transporters in the pathogenesis of this disease."],
    "16782202": ["Lack of an adequate animal model for Alzheimer's disease (AD) has limited an understanding of the pathogenesis of the disease and the development of therapeutic agents targeting key pathophysiological processes."],
    "16914877": ["For Alzheimer's disease (AD), the classical pathology is now known for quite some time; however, the disease pathogenesis has eluded our understanding for a complete century."],
    "16999991": ["Autophagic vacuoles also accumulate abnormally in affected neurons of several major neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, where they have been linked to various aspects of disease pathogenesis including neuronal cell death."],
    "17119296": ["Although the causes of AD remain still unknown, it seems that certain environmental factors may be involved in the etiology and pathogenesis of the disease."],
    "17229880": ["To determine which hypothesis relates best to Alzheimer disease requires a broader view of disease pathogenesis and is discussed herein."],
    "17245412": ["The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders."],
    "17305591": ["There is considerable evidence showing that oxidative damage is one of the earliest neuronal and pathological changes of Alzheimer disease and many, if not all, of the etiological and pathological causes of the disease are related, directly or indirectly, to free radical production and oxidative damage."],
    "17556794": ["It is accepted that amyloid beta (A beta) peptides are responsible for the etiopathology of AD, but the precise signaling pathways leading to the disease have not been elucidated."],
    "17557921": ["Statins are reported to be beneficial in treating a multitude of disorders including dementia due to Alzheimer disease (AD) and vascular dementia (VaD) with varying, yet-to-be determined mechanisms of actions."],
    "17605000": ["Oxidative stress is one of the earliest events of Alzheimer disease (AD), with implications as an important mediator in the onset, progression and pathogenesis of the disease."],
    "17940659": ["With respect to Alzheimer's disease, several proteins involved in the etiology of the disease, including tau, neurofilaments, beta-amyloid precursor protein, and synaptosomal proteins are GlcNAcylated in normal brain."],
    "17981707": ["The neurobiological links between the renin-angiotensin system and Alzheimer's disease have been investigated and become a source of interest in the pathogenesis of the disease."],
    "17986152": ["Alterations in lipid molecular species in the brain induced by neurodegenerative diseases, such as Alzheimer's disease (AD) could provide fundamental clues to disease pathogenesis."],
    "1814411": ["In Alzheimer's disease, we found all ganglio-series gangliosides (GM1, GD1a, GD1b, GT1b) to be decreased in regions (temporal and frontal cortex and nucleus basalis of Meynert) involved in pathogenesis of disease."],
    "18245893": ["The impact of genotype of apoE, a major vitamin K transporter, on ostepporosis as well as Alzheimer disease and atherosclerosis, raises a question whether vitamin K is involved in the pathogenesis of these diseases."],
    "18289026": ["Alzheimer disease and the role of free radicals in the pathogenesis of the disease."],
    "18302763": ["Explorations of IL-1's role in chronic neurodegenerative disease have mainly focused on Alzheimer disease (AD), where indirect evidence has implicated it in disease pathogenesis."],
    "18378224": ["We postulate that a combination of diet, lifestyle, vascular, genetic, and amyloid related factors, which enhance each other's contribution in the onset and course of Alzheimer's disease, will be more likely the cause of the disease instead of one sole mechanism."],
    "18629638": ["Alzheimer's and Parkinson's diseases or Friedreich ataxia are neurological diseases sharing, as a common denominator, production of abnormal proteins, mitochondrial dysfunction and oxidative stress, which contribute to the pathogenesis of these so called \\protein conformational diseases\\."],
    "1877089": ["Molecular dissection of the neuropathology of AD has provided insight into the pathogenesis of this disease and has defined areas where investigation may prove useful in elucidating the cause of this disorder and suggest new treatments."],
    "18855662": ["Furthermore, several therapeutic strategies for treating AD on the basis of the important role of tau hyperphosphorylation in the pathogenesis of the disease are described.", "Recent studies have suggested that abnormal hyperphosphorylation of tau in the brain plays a vital role in the molecular pathogenesis of AD and in neurodegeneration."],
    "1927686": ["Metabolic abnormalities of the neocortices in late-stage AD correlate with regional densities of neurofibrillary tangles but not of senile plaques post mortem, suggesting that tangle formation is important in disease pathogenesis."],
    "19288120": ["Studies conducted on arguably the earliest stage of AD, MCI, may elucidate the mechanism(s) leading to AD pathogenesis by identifying early markers of the disease, and to develop therapeutic strategies to slow or prevent the progression of AD.", "Further, Abeta models of AD strongly support the notion that oxidative stress induced by Abeta may be a driving force in AD pathogenesis."],
    "19424834": ["Murine models that mimic the neuropathology of Alzheimer's disease (AD) have the potential to provide insight into the pathogenesis of the disease and lead to new strategies for the therapeutic management of afflicted patients."],
    "19746990": ["Our results provide further evidence for the capacity of proteomics applications to identify conserved sets of disease-specific proteins in AD, to enhance our understanding of disease pathogenesis, and to deliver new candidates for the development of effective therapies for this, and other, devastating neurodegenerative disorders."],
    "20021415": ["Here we provide further characterization of a genomic-based, amyloid precursor protein yeast artificial chromosome transgenic mouse model of AD, R1.40, that makes few assumptions regarding disease pathogenesis to study the relationship between brain pathology and altered behavior."],
    "20049724": ["Surrogate markers for the Alzheimer disease (AD)-associated 42-amino acid form of amyloid-beta (Abeta42) have been sought because they may aid in the diagnosis of AD and for clarification of disease pathogenesis."],
    "20054780": ["Such a conclusion has implications both for the diagnosis of AD and in studies of disease pathogenesis."],
    "20064547": ["Alzheimer's disease (AD) and age-related cataract, disorders characterized by protein aggregation causing late-onset disease, both involve oxidative stress."],
    "20157260": ["The present study was aimed to investigate neuropathological changes in AbetaPP/PS1 transgenic mice (Tg), as a model of Alzheimer's disease, subjected to supplementary iron administration in a critical postnatal period, in order to reveal the interaction of genetic and environmental risk factors in the pathogenesis of the disease."],
    "20308790": ["Circulating angiogenic cells and Alzheimer's disease: contribution of the bone marrow to the pathogenesis of the disease."],
    "20431570": ["Among these, strategies targeting the production and clearance of the amyloid-beta peptide - a cardinal feature of Alzheimer's disease that is thought to be important in disease pathogenesis - are the most advanced."],
    "20471965": ["Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease."],
    "20497615": ["Neuropathological assessment using molecular biology and immunohistochemistry, homogeneous definitions, harmonized interlaboratory methods, and assessment standards can identify 54 to 97% of AD cases and can eliminate 62 to 100% of nondemented subjects, but only between 8 and 42% of non-AD dementias, without, however, being able to clarify the etiology of most of these disorders."],
    "20558146": ["Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease."],
    "20608291": ["Based on this viewpoint, this review article emphasizes that the morphological changes to small blood vessels in the brain with Alzheimer's disease convey crucial information and clues for solving the underlying mechanism that causes the disease."],
    "20676620": ["Models of disease or the response of cellular networks to pharmacological compounds can be studied in vitro, allowing one to investigate pathologies, such as cardiac arrhythmias, memory impairment due to Alzheimer's disease, or vision impairment caused by ganglion cell degeneration in the retina."],
    "20840725": ["The global pathway crosstalk network and the clusters of relevant pathways of AD provide evidence of cooperativity among pathways for potential pathogenesis of the neuron complex disease."],
    "20936705": ["The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression."],
    "21091946": ["The identification of disease-causing mutations in Alzheimer's disease has contributed greatly to the understanding of the pathogenesis of this disease.", "The amyloid-beta (Abeta) peptide has come into focus and is believed to be central to the pathogenesis of Alzheimer's disease."],
    "21150306": ["These diseases, including Morbus Alzheimer, Parkinson disease and Transmissible Spongiform Encephalopathies (TSEs)--also termed prion disorders--afflict a substantial proportion of the human population and as such the etiology and pathogenesis of these diseases has been the focus of mounting research."],
    "21439035": ["Although the idea that vascular defects are present in AD and may be important in disease pathogenesis was suggested over 25 years ago, little work has focused on an active role for cerebrovascular mechanisms in the pathogenesis of AD."],
    "2149746": ["These results suggest that Alzheimer's disease may be an heterogeneous disorder and that a modification on the catalytic activity of hexokinase may play a role in the pathogenesis of the disease in at least a subgroup of patients."],
    "2184091": ["Recent linkage findings for psychiatric disorders, in particular schizophrenia, manic-depression, and Alzheimer disease, have raised a number of important conceptual issues regarding the genetic etiology of these diseases, as well as the appropriate interpretation of linkage results in studying complex diseases."],
    "21902668": ["The origins of the sporadic cases of AD are still not known but there is evidence for a role of epigenetics in the etiology of the disease."],
    "22079091": ["Furthermore, endocytic abnormalities have been identified in cases of Alzheimer's disease (AD), however, the relevance of these changes to the aetiology of the disease remains unclear."],
    "22178988": ["Our data point to common deficits in the insulin-signaling pathway in both neurodegenerative diseases and support the idea that AD may cause disorders outside the higher CNS."],
    "22251135": ["In Alzheimer's disease, for example, astrocytes may contribute to the etiology of this disorder."],
    "22374313": ["Alzheimer's disease (AD) is the most common form of dementia among older people and the pathogenesis of this disease is associated with oxidative stress."],
    "22458501": ["EXPERT OPINION: The use of transgenic mouse models that recapitulate various aspects of AD has expanded our knowledge and understanding of disease pathogenesis immensely."],
    "22784036": ["Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to determine the sequence and magnitude of pathologic changes that culminate in symptomatic disease."],
    "22795785": ["These data suggest that although the characteristic features of AD appear later in life, hypoxemia in the prenatal stage may contribute to the pathogenesis of the disease, supporting the notion that environmental factors can trigger or aggravate AD."],
    "22805236": ["These findings suggest that bepridil is a plausible therapeutic candidate in AD or stroke owing to its multifunctional role in key cellular events that are relevant for the pathogenesis of these diseases."],
    "22815194": ["Alzheimer's disease (AD) poses a huge challenge for society and health care worldwide as molecular pathogenesis of the disease is poorly understood and curative treatment does not exist."],
    "22922141": ["The research conducted on animal models of Alzheimer's disease (AD) has provided valuable information about the pathogenesis of this disease and associated behavioral and cognitive deficits as well as the disease-associated anatomical and histopathological lesions of the brain."],
    "23036020": ["However, therapeutic approaches in neurological diseases such as AD, including those for BM-MSCs, are increasingly centered on the potential for prophylactic therapy in pro-dromal states where the underlying cause of the disease is apparent but functional deficits are not."],
    "23104637": ["The molecular basis of Alzheimer's disease has not been clearly established, but disruption of brain metal ion homeostasis, particularly copper and zinc, might be closely involved in the pathogenesis of this disease and its characteristic beta-amyloid neuropathological features."],
    "23395747": ["This review focuses on the role of Zn(II) and Cu(II) in AD, and revisits the amyloid cascade hypothesis demonstrating the possible roles of Zn(II) and Cu(II) in the disease pathogenesis."],
    "23546882": ["Amyloid beta-peptide (Abeta) accumulating in the brain of Alzheimer disease (AD) patients is believed to be the main pathophysiologcal cause of the disease."],
    "23604855": ["Extensive studies of AD have yet to result in a generally accepted hypothesis on the pathogenesis of the disorder."],
    "23695007": ["According to the amyloid hypothesis of Alzheimer's disease (AD), the amyloid beta (Abeta) peptide, as the primary neurotoxic species, plays a key role in the pathogenesis of the disease."],
    "23834172": ["The elucidation of the intriguing relationship between oxidative stress and Alzheimer's disease is crucial to understand the pathogenesis of the disease as also to design a suitable drug trial with antioxidants against this condition."],
    "23847532": ["We suggest that Abeta*56 has a critical role during the earliest phase of AD and might serve as a molecular trigger of the disease."],
    "23850509": ["Perturbed cerebral glucose metabolism, an invariant pathophysiological feature of AD, may be a critical contributor to the pathogenesis of this disease."],
    "24032632": ["Studies of oxidative damage during the progression of Alzheimer's disease (AD) suggest its central role in disease pathogenesis."],
    "24059309": ["According to recent studies, there are molecular similarities in the inflammatory pathways involved in both AD and T2DM, which opens a new avenue for researchers with different perspectives to target the cause of these diseases rather than their obvious symptoms."],
    "24059311": ["Although a number of risk factors have been postulated that may trigger the development of AD, the root cause of this disease is still a matter of debate."],
    "24059319": ["In this review, we provide evidence for the link between T2D and AD, highlighting the critical role of insulin in the pathogenesis of these diseases, and we provide information on the genes that might be involved in the interplay between these two disorders."],
    "24124693": ["Extensive research into the genetic etiology of AD has yielded knowledge of some genetic factors that are causative and other genetic factors that increase risk for disease."],
    "24190781": ["Over the past 3 decades, advances in the understanding of the biology of AD have led to a somewhat unified hypothesis of disease pathogenesis that emphasizes the precipitating role of beta amyloid protein."],
    "24198785": ["A change in the normal tau protein phosphorylation is also characteristic of AD, which contributes to the pathogenesis of the disease and is useful in early diagnosis."],
    "24204258": ["Once thought to be unique to these diseases, this mechanism is now recognized as a ubiquitous means of information transfer in biological systems, including other protein misfolding disorders such as those causing Alzheimer's and Parkinson's diseases."],
    "24486820": ["Three points of interest lie in considering how Alzheimer, and more significantly Perusini, struggled to throw light on the cause of this devastating disease."],
    "24737939": ["Because there are only a few therapeutic strategies against Alzheimer's disease, we need to understand the pathogenesis of this disease."],
    "24778618": ["The fact that alterations in SUMO/deSUMOylation equilibrium occur from the early phases of AD suggests that global posttranslational modifications may play an important role in the mechanisms underlying disease pathogenesis, thus providing potential targets for pharmacological interventions."],
    "24852227": ["We review the genetics, epidemiology and pathology of sporadic AD and give an updated account of what is currently known about the molecular pathogenesis of the disease."],
    "24951455": ["Alzheimer's disease risk genes and mechanisms of disease pathogenesis."],
    "25080056": ["The development of a cure for Alzheimer's disease (AD) has been impeded by an inability to pinpoint the root cause of this disorder."],
    "25120477": ["Several lines of research are focused on understanding AD pathophysiology, and although the etiology of the disease remains a matter of intense debate, increased brain levels of amyloid-beta (Abeta) appear to be a critical event in triggering a wide range of molecular alterations leading to AD."],
    "25225492": ["Diseases once considered constrained to a limited range of organ systems, e.g., central neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington' disease (HD), the role of multiple central and peripheral organ systems in the etiology of such diseases is now widely accepted."],
    "25516763": ["Investigations on environmental factors implicated in AD are scarce and the etiology of the disease remains up to now obscure."],
    "2554169": ["Young provides an excellent discussion of the alterations in excitatory amino acid transmitter systems that accompany Alzheimer's disease, and the interesting possibility that excitotoxicity may participate in disease pathogenesis."],
    "25597552": ["Medical history, psychiatric and physical status, basic and instrumental activities of daily living, as well as scores on the Cambridge cognitive examination-revised (CAMCOG-R), and the clinical dementia rating (CDR) scale were used to establish DSM-5 diagnoses of major or mild neurocognitive disorders (NCD) due to possible AD or no cognitive decline.", "BACKGROUND: The aim of this study was to examine the efficiency of the mini-Kingston standardized cognitive assessment-revised (mini-KSCAr) in classifying patients according to DSM-5 major and mild neurocognitive disorders (NCD) due to possible Alzheimer's disease (AD).", "An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.", "CONCLUSIONS: The mini-KSCAr is an efficient instrument for the diagnosis of DSM-5 major and mild NCD due to possible AD in a specialized psychogeriatric setting, and its utility is greater than that of the MMSE and the CDT."],
    "25680928": ["Neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) are characterized by neuronal impairment that leads to disease-specific changes in the neuronal proteins."],
    "25792373": ["Despite a causative link between diabetes and AD, general molecular mechanisms underlying pathogenesis of these disorders are still far from being understood."],
    "25847999": ["These findings suggest that Edaravone holds a promise as a therapeutic agent for AD by targeting multiple key pathways of the disease pathogenesis."],
    "26236550": ["The review, therefore, emphasizes the importance of AD related risk factors, especially those with metabolic implications, identified from various epidemiological studies, in providing clues to the pathogenesis of this complex disorder."],
    "26396519": ["In our review, the specific disease is dementia caused by Alzheimer's disease."],
    "26398935": ["Animal models of familial juvenile onset of Alzheimer's disease (AD) often fail to produce diverse pathological features of the disease by modification of single gene mutations that are responsible for the disease."],
    "26401704": ["New therapeutic strategies in Alzheimer's disease (AD) are focused on targeting amyloid-beta (Abeta) to modify the underlying cause of the disease rather than just the symptoms."],
    "26499250": ["Would transcranial direct current stimulation (tDCS) enhance the effects of working memory training in older adults with mild neurocognitive disorder due to Alzheimer's disease: study protocol for a randomized controlled trial.", "Chinese older adults (aged 60 to 90 years) with mild neurocognitive disorder due to Alzheimer's disease (DSM-5 criteria) would be randomized into a 4-week intervention of either tDCS-working memory (DCS-WM), tDCS-control cognitive training (DCS-CC), and sham tDCS-working memory (WM-CD) groups."],
    "26567746": ["Neuroinflammation in Alzheimer's disease has been identified as major contributor to disease pathogenesis."],
    "26639971": ["Although the neuropathological characteristics of AD have been known for decades, the molecular mechanisms causing the disease are still under investigation."],
    "26733416": ["The level of RPS23RG1 mRNA is significantly lower in the brains of AD compared to non-AD patients, suggesting its potential role in the pathogenesis of the disease."],
    "26741695": ["METHODS: 36 adults with NCD due to Alzheimer's disease (NCD-AD), 31 adults with NCD due to vascular disease (NCD-vascular) and 137 healthy controls were recruited."],
    "26756385": ["Alzheimer disease (AD) is the most frequent cause of major neurocognitive disorders with a huge economical and medical burden."],
    "26801191": ["A reduction in glucose transporters at the blood-brain barrier that occurs before the onset of the main pathophysiological changes and symptoms of Alzheimer's disease is a potential causative effect in the vascular hypothesis of the disease."],
    "2690095": ["Clinical research in Alzheimer's disease (AD) is complicated by inadequate understanding of the etiology and pathogenesis of the disorder, lack of good animal models to predict potentially useful compounds, and methodological issues such as the need for new diagnostic tools and validated assessment criteria."],
    "26907663": ["Response to the Letter from Lu et al, \\Utility of Montreal Cognitive Assessment (Hong Kong Version) in the Diagnosis of Mild Neurocognitive Disorders (NCD): NCD Due to Alzheimer Disease (NCD-AD) and NCD Due to Vascular Disease (NCD-Vascular)\\."],
    "27058526": ["Although genetic studies show that beta-amyloid protein (Abeta), the major component of SPs, is the key factor underlying AD pathogenesis, it remains unclear why advanced age often leads to AD.", "Alzheimer's disease (AD) is the major causative disease of dementia and is characterized pathologically by the accumulation of senile plaques (SPs) and neurofibrillary tangles (NFTs) in the brain."],
    "27100611": ["While histological changes in microglia have long been recognized as a pathological feature of Alzheimer's disease (AD), recent genetic association studies have also strongly implicated microglia in the etiology of the disease."],
    "27414695": ["Dementias are disorders that affect memory and intellectual functioning, and are caused primarily by Alzheimer's disease and vascular disorders (multi-infarct dementia)."],
    "27498879": ["Dementia with Lewy bodies shares clinical and pathological features with both Parkinson's disease and Alzheimer's disease so it is therefore likely that it also has similar pathogenic mechanisms leading to disease."],
    "27514990": ["Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases, yet current therapeutic treatments are inadequate due to a complex disease pathogenesis."],
    "27628303": ["Understanding how epigenetic dysregulation in the brainstem contributes to AD susceptibility could be of pivotal importance for understanding the etiology of the disease and for the development of novel diagnostic and therapeutic strategies."],
    "27943641": ["With the gradual aging of the world's population, leading to increased prevalence of AD, and the substantial cost of care for those afflicted, identifying the genetic causes of disease represents a critical effort in identifying therapeutic targets."],
    "28228716": ["Our results suggest that BMP9 may be a promising candidate for treating AD by targeting multiple key pathways in the disease pathogenesis."],
    "28294067": ["Preventive and therapeutic approaches to AD in the context of an infectious etiology of the disease are also discussed."],
    "2836376": ["The voluminous data on Alzheimer's disease raise intriguing possibilities about the key event in the pathogenesis of the disease, but further investigation is necessary to identify the event conclusively."],
    "28364127": ["A flanker test was conducted in 31 adults with NCD due to vascular disease (NCD-vascular), 36 patients with NCD due to Alzheimer's disease (NCD-AD), and 137 healthy controls."],
    "28516241": ["It is now widely known that inflammation plays an important role in the development of AD, a role that is not only a response to the surrounding pathological environment, but rather seems to be strongly implicated in the aetiology of the disease as indicated by the genetic studies."],
    "28527207": ["OBJECTIVE: We aimed to investigate the IPS with two types of measurements in the patients with NCD due to vascular disease (NCD-vascular) and NCD due to Alzheimer's disease (NCD-AD), and examine the associations between IPS measures and morphometric features."],
    "28680398": ["Notably, loss-of-function mutations of either DAP12 or TREM2 result in a disorder known as Nasu-Hakola disease (NHD); and mutations of these genes have been associated with the risk for Alzheimer's disease (AD), suggesting that TREM2 and DAP12 may regulate common signaling pathways in the disease pathogenesis."],
    "28739984": ["Clinical trials for AD are now moving toward these earlier stages of the disease, targeting MCI due to AD and preclinical AD."],
    "28829364": ["While there is no cure for AD, pharmacological approaches to alleviate symptoms and target underlying causes of the disease have been developed, albeit with limited success."],
    "28947385": ["Although the continuous investigations about AD have been made in recent decades, the pathogenesis of this disease is still not definitely confirmed."],
    "29109429": ["Disturbances in calcium homeostasis have been observed in various cellular and animal models of AD and are proposed to underlie the pathogenesis of the disease."],
    "29151989": ["Key messages: Human/mouse chimeric models using iPSCs to study AD offer much promise in better replicating AD pathology and can be further exploited to elucidate disease pathogenesis with regards to the neuroinflammation hypothesis of AD."],
    "29206067": ["In AD, oligomeric Abeta42 species is widely thought to be a major contributor to the disease pathogenesis."],
    "29228201": ["The evolution of Alzheimer's disease tauopathy in cognitively unimpaired individuals needs to be examined to better understand disease pathogenesis."],
    "29492246": ["Alzheimer's disease (AD) is the most common cause of major neurocognitive disorders worldwide."],
    "29551631": ["Mitochondrial dysfunction has been identified as an early event in AD pathogenesis and is reflected by reduced metabolism, disruption of Ca2+ homeostasis, and increased levels of reactive oxygen species, lipid peroxidation, and apoptosis.", "Although an accumulation of brain amyloid-beta (Abeta) peptide and hyperphosphorylated tau protein have been implicated in the pathogenesis of AD, the etiology of the disease remains unclear."],
    "29552692": ["Hyperhomocysteinemia is a trigger for many diseases, such as atherosclerosis, congestive heart failure, age-related macular degeneration, Alzheimer's disease and hearing loss."],
    "29630139": ["The dominant theory of the?AD development is amyloid cascade?hypothesis, but at the same time, important?in the etiology of this disease is?the overphosphorylation of tau protein.?"],
    "29660940": ["The research community is yet to decipher why the ApoE4 variant pre-disposes to AD, and how aging causes the disease."],
    "29689726": ["METHODS: We included 62 patients with mild or major NCDs due to pure AD (with positive CSF biomarker assays), and 174 patients (from the GRECogVASC cohort) with pure VCI."],
    "29745345": ["Till date, there is no cure for AD, but the pathogenesis of the disease could be delayed by the use of natural antioxidants."],
    "29856605": ["Amyloid plaque formation constitutes one of the main pathological hallmarks of Alzheimer's disease (AD) and is suggested to be a critical factor driving disease pathogenesis."],
    "30033062": ["TREM2 is a transmembrane receptor expressed in cells of the myeloid lineage, and its association with Alzheimer's disease supports the involvement of immune and inflammatory pathways in the cause of the disease, rather than as a consequence of the disease."],
    "30040725": ["Although considerable progress has been made to elucidate the pathogenesis of AD, the specific causes of the disease remain highly unknown."],
    "30136680": ["Alzheimer's disease (AD) is the most common form of dementia in the older population, however, the precise cause of the disease is unknown."],
    "30340518": ["Despite considerable progress in the understanding of the pathophysiology of AD, the precise molecular mechanisms that cause the disease remain elusive."],
    "30415068": ["Being the most common type of dementia, AD is studied extensively; however, the data concerning changes in neurogenesis in the pathogenesis of this disease are inconsistent."],
    "30445661": ["Despite its prevalence, only five therapies are currently approved for AD, all dealing with the symptoms rather than the underlying causes of the disease."],
    "30465785": ["As a new starting point for studying AD, genetic and genomic investigations consistently strive to discover causative variants that are related to disease pathophysiology."],
    "30521994": ["The aim of the present study was to investigate whether ebselen (1-10 mg/kg), a multifunctional selenoorganic compound, ameliorates memory impairment, hippocampal oxidative stress, apoptosis and cell proliferation in a mouse model of sporadic AD induced by icv STZ (3 mg/kg, 1 MUl/min).", "In conclusion, the multifunctional selenoorganic compound ebselen was effective to reverse memory impairment, hippocampal oxidative stress and apoptosis in a mouse model of sporadic AD induced by icv STZ.", "The drug discovery to treat AD consists to develop compounds able to act in multiple molecular targets involved in the pathogenesis of the disease and the repositioning of old drugs for new application."],
    "30609547": ["Aluminum ions, as a kind of non-essential element, show a negative impact on plants growth and contribute to diseases caused by nervous breakdown like Alzheimer's disease and Parkinson's disease."],
    "30632506": ["Therefore, investigating the mechanism of APP mutation on Alzheimer's disease may help understanding of disease pathogenesis.", "Approximately 25 mutations in beta-amyloid precursor protein (APP) are pathogenic and cause autosomal dominant Alzheimer's disease.", "Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis."],
    "30741678": ["Air pollution is a risk factor for the development of AD and as the number of Americans with AD continues to grow without a cure, we need to focus on preventable, early causes of this fatal disease and intervene appropriately."],
    "30760863": ["It seems reasonable to hypothesize that the amyloid cascade is intimately involved in AD, in parallel with disease pathogenesis, but that removal of toxic Abeta is insufficient for an effective disease modification."],
    "30819626": ["LINKAGE TO OTHER MAJOR THEORIES: Our hypothesis may link previous theories to establish a bidirectional relationship between sleep disorders and AD, which may finally form a new schematic mechanism to understand the disease pathogenesis and disease progression."],
    "30877738": ["Because of its severity, AD has been the subject of extensive studies that address the pathogenesis of the disease."],
    "30932886": ["Furthermore, the fact that osteoporosis and Alzheimer's disease are two common age-related disorders raises the possibility that these two organ systems are interconnected in terms of disease pathogenesis."],
    "31030513": ["The enzyme is overexpressed in several types of cancer and Alzheimer's disease, and its genetic defect causes different incurable disorders."],
    "31122236": ["This suggest that the threapy should not base on a single cause of Alzheimer's disease but rather a number of different pathways that lead to the disease."],
    "31332445": ["The failure of recent clinical trials in Alzheimer's disease has highlighted the need for the development of a more complete understanding of the pathogenesis of the disorder and also a belief that therapies may only work if given very early in the disease process before overt symptoms occur."],
    "31403949": ["The hallmarks of AD including amyloid-beta (Abeta)/phosphorylated tau (pTau) and pathology-related events such as neural oxidative stress and neuroinflammation play critical roles in pathogenesis of AD with CCH.", "These findings suggest that EDA possesses clinical and pathological benefits for AD with CCH in the present mouse model and has a potential as a therapeutic agent for AD with CCH via targeting multiple key pathways of the disease pathogenesis."],
    "31577960": ["In the last few years the views about the drivers of AD have been changing and nowadays it is believed that neuroinflammation takes center stage in disease pathogenesis."],
    "31771153": ["Hypoxia is a common feature of neurodegenerative diseases, including Alzheimer's disease that may be responsible for disease pathogenesis and progression."],
    "32065096": ["OBJECTIVE: Thus, revealing the interplay between AD and major depression may provide novel insights into the pathogenesis of these diseases."],
    "32292421": ["This process is well documented in Alzheimer's disease (AD), where it may participate in the etiology of the disease."],
    "32390857": ["The data suggest that a 40-Hz light flicker can ameliorate AD-associated circadian rhythm disorders, presenting a new type of therapeutic treatment for rhythm disorders caused by AD."],
    "32592177": ["The discovery that neuron-specific sodium pump activity is impaired in AD and other neurodegenerative diseases such as Parkinson's disease has suggested a role for the sodium pump in the pathogenesis of these diseases."],
    "32625049": ["The expression of miR-29 family is significantly reduced in AD, suggesting a part for the family members in pathogenesis of the disease."],
    "32719612": ["Despite a large improvement in understanding the pathogenesis of AD, the etiology of this disorder remains still unclear, and no current treatment is able to prevent, slow, or stop its progression."],
    "32727580": ["Phosphorylated Abeta peptides in human Down syndrome brain and different Alzheimer's-like mouse models.The deposition of neurotoxic amyloid-beta (Abeta) peptides in extracellular plaques in the brain parenchyma is one of the most prominent neuropathological features of Alzheimer's disease (AD), and considered to be closely related to the pathogenesis of this disease."],
    "32955528": ["Unfortunately, both effective diagnosis and treatment for AD remain elusive, probably owing to the complicated and uncertain etiology of the disease."],
    "32958234": ["Following this view, part of the recent scientific literature has generated a new reading frame for AD pathophysiology, based on the application of the prion paradigm to the amyloid cascade hypothesis in an attempt to definitely explain the key events causing the disease and inducing its occurrence under different clinical phenotypes."],
    "33035604": ["While senile plaques and neurofibrillary tangles have been proposed as the principal histopathologic hallmarks of AD, the exact etiology of this disease is still far from being clearly understood."],
    "33078674": ["Results demonstrated that both AD and control participants generated more self-statements in the odour condition than in the odor-free condition, especially psychological self-statements."],
    "33178313": ["Acorus tatarinowii     (AT) is widely used in the treatment of Alzheimer disease, epilepsy, depression, and stroke, which leads to disorders of consciousness disease."],
    "33228179": ["Aging is the major factor contributing to AD; however, the initial cause that triggers the disease is yet unknown."],
    "33384577": ["Using the APPswe/PS1dE9 (APP/PS1) mouse model of Alzheimer's disease, we utilized the Morris water maze spatial learning paradigm to systematically evaluate mild behavioral deficits that occur during the early stages of disease pathogenesis."],
    "33642365": ["In this review, we briefly examine fragile X syndrome, amyotrophic lateral sclerosis, Alzheimer's disease, and spinal muscular atrophy, with a focus on disease pathogenesis with regard to local mRNA translation and axon transport, suggesting possible treatment directions."],
    "33673244": ["Thus, Al     3+       should be considered as an important factor, alongside the known characteristic hallmarks of AD, in the development and aetiology of the disease."],
    "34161823": ["While the detailed mechanism of the pathogenesis of AD is still unknown, evidence suggests that mitochondrial dysfunction likely plays a fundamental role in the pathogenesis of this disease."],
    "34200581": ["Although the sporadic form of Alzheimer's disease (AD) is the prevalent form, the cellular events underlying the disease pathogenesis have not been fully characterized."],
    "34481234": ["In the classical model for the etiology of AD, amyloid-beta (Abeta)-an APP derivative and hyperphosphorylated tau form aggregates in the brain that underlie the pathogenesis of the disease."],
    "34589757": ["Although tauopathies, such as Alzheimer's disease and Frontotemporal dementia, are common amongst the ageing population, current effective treatment options are scarce, primarily due to the incomplete understanding of disease pathogenesis."],
    "34657885": ["BACKGROUND: Mild cognitive impairment (MCI) is a heterogeneous condition and MCI patients are at increased risk of progression to dementia due to Alzheimer's disease (AD)."],
    "34765631": ["Neurodegenerative disorders, such as Parkinson's and Alzheimer's disease, are claimed to be of major concern causing a significant disease burden worldwide."],
    "34842276": ["Our results support a common molecular basis for initiation of the pathological processes leading to both early and late onset forms of Alzheimer's disease and illustrate the utility of zebrafish and of knock-in, single EOfAD mutation models for understanding the causes of this disease."],
    "35346005": ["The two important hallmarks of AD are the appearance of plaques and tangles of amyloid beta (Abeta) and tau proteins, respectively, in the brain based on the etiology of the disease including cholinergic impairment, metal dyshomeostasis, oxidative stress, and degradation of neurotransmitters."],
    "35555555": ["Although it remains unclear what primarily triggers and drives the progression of AD, different lines of investigation point out to a central role of oligomeric Abeta conformations for the disease pathogenesis."],
    "35710783": ["The most accepted hypothesis in Alzheimer's disease (AD) is the amyloid cascade which establishes that Abeta accumulation may induce the disease development."],
    "35805958": ["Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer's Disease.", "This review highlights aspects of altered mitochondrial dynamics in AD that may contribute to the etiology of this debilitating condition."],
    "35832342": ["Several reports have shown that it has promising potential in the prevention and treatment of AD due to its significant antioxidative, anti-inflammatory, and antiapoptotic properties along with several other mechanisms that target the altered signaling pathways due to the disease pathogenesis."],
    "35965800": ["Conclusions: Using a deep CNN and iterated RF architecture, we showed that brain image stratification is a promising means for evaluating AD, and examining the underlying etiology of the disease, by applying computer and medical images to achieve the early auxiliary diagnosis of AD."],
    "35986296": ["The infectious theory linked various infectious agents with the development of AD, raising the possibility that they serve as etiological causes of the disease."],
    "36073854": ["Innumerable changes have been linked to the pathology of AD; however, there remains much discord regarding which might be the initial cause of the disease."],
    "36324230": ["Alzheimer's disease and related dementias: From risk factors to disease pathogenesis."],
    "36399267": ["For the last decade, human models of AD using induced pluripotent stem cells (iPSCs) have emerged as a powerful way to understand disease pathogenesis in relevant human cell types."],
    "36469008": ["Our hypothesis may establish a linkage between the cerebellum and AD, thereby potentially providing new perspectives on the pathogenesis of the disease."],
    "36552984": ["Herein, we provide a comprehensive review on Alzheimer's disease pathophysiology to provide a better understanding of disease pathogenesis hypotheses and decipher the role of genetic and epigenetic factors in disease development and progression."],
    "36671568": ["Although growing evidence demonstrates that AD is a significant comorbidity of T2D, and there is a ~1.4-2-fold increase in the risk of developing AD among T2D patients, the involvement of possible common triggers in the pathogenesis of these two diseases remains largely unknown."],
    "37158125": ["Emerging evidence suggests that abnormalities in ER/mitochondrial brain functions and dysregulation of Ca     2+       homeostasis are neuropathological hallmarks of neurological disorders like Alzheimer's disease, but little evidence is available to demonstrate their relationship to disease pathogenesis and therapeutic approaches."],
    "37163849": ["Alzheimer's disease (AD) is emerging as a serious problem with the rapid aging of the population, but due to the unclear cause of the disease and the absence of therapy, appropriate preventive measures are the next best thing."],
    "37366656": ["In the elderly, a debilitating condition known as dementia, which is a major health concern, is caused by Alzheimer's disease (AD)."],
    "37395272": ["Clinically diverse neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, frontotemporal lobar degeneration, and amyotrophic lateral sclerosis, exhibit unique and disease-specific biochemical protein signatures and abnormal protein depositions that often correlate with disease pathogenesis."],
    "37452088": ["While our understanding of the molecular biology of Alzheimer's disease (AD) has grown, the etiology of the disease, especially the involvement of peripheral infection, remains a challenge."],
    "37476485": ["The output showed no difference between the patterns of AD-like disorder induction."],
    "37580797": ["Understanding this biology will ensure that people who have Down syndrome access the most appropriate Alzheimer's disease therapeutics and moreover will provide unique insight into disease pathogenesis more broadly."],
    "37631373": ["The etiology and pathogenesis of Alzheimer's disease are multifactorial, so one of the treatment strategies is the development of the drugs that affect several targets associated with the pathogenesis of the disease."],
    "37654709": ["Extracted fingertip interaction digital biomarkers were used to assess participants' SEP disorders, ultimately enabling intelligent diagnosis of MCI due to AD."],
    "37848007": ["The purpose of our study is to explore the genetic linkage between AD and MS through bioinformatic analysis, providing new insights into the shared signatures and possible pathogenesis of two diseases."],
    "37855293": ["Although studies on the discovery of amyloid beta (Abeta) and tau (the essential elements of plaques and tangles in AD) have shed light on the molecular pathological processes of AD, the exact cause of the condition is still largely unknown."],
    "37875373": ["CONCLUSIONS: These findings suggest that sodium benzoate may exert its influence on important pathways associated with AD, thus contributing to the improvement in the pathogenesis of the disease."],
    "38064104": ["Since dysregulation of this kinase affects all the major characteristic features of the disease, such as tau phosphorylation, amyloid formation, memory, and synaptic function, it is thought to be a major player in the pathogenesis of AD.", "Even though a century has passed since the discovery of AD, the exact cause of the disease still remains unknown."],
    "38300883": ["BACKGROUND: Despite the number of people living with Alzheimer disease (AD), awareness of the early stages of this condition, including mild cognitive impairment due to AD-which poses management challenges-continues to be low."],
    "38357597": ["Additionally, the concept of entropy was used to detect the disorder of proteasome system, it was discovered that entropy is down-regulated continually with AD progression against system chaos caused by AD."],
    "38473858": ["Alzheimer's disease is a neurodegenerative condition characterized by a gradual onset and progressive deterioration, making it the primary cause of dementia, although the exact cause of the disease remains elusive."],
    "38623383": ["The molecular links between DS and AD shed insights into the underlying causes of both diseases and highlight potential therapeutic targets."],
    "7582040": ["The genes identified by studying inherited forms of Alzheimer's disease are now being used to understand the initiating steps in the pathogenesis of the disease."],
    "7583683": ["Cerebrospinal fluid (CSF) biochemical markers for Alzheimer's disease (AD) would be of great value, both to improve clinical diagnostic accuracy and to increase our knowledge of the pathogenesis of the disorder."],
    "7653697": ["CONCLUSIONS: Paraventricular CRH neurons in Alzheimer's disease and depression are hyperactivated, and this hyperactivation may contribute to the etiology of these disorders."],
    "7877576": ["There's no cure yet for Alzheimer's, but researchers are narrowing in on possible causes of the disease and identifying patients who may be predisposed to developing it."],
    "7967720": ["Senile plaques (SP) are the most characteristic neuropathologic lesions of Alzheimer's disease (AD) and studies of plaque cortical distribution, density, and morphology may lead to new information about the origin and pathogenesis of this disease."],
    "8090716": ["As an example, a homoplasmic, Caucasian, tRNA(Gln) mutation at nucleotide pair (np) 4336 has been observed in 5% of Alzheimer disease and Parkinson disease patients and may contribute to the multifactorial etiology of these diseases."],
    "8239278": ["Studies of autosomal-dominant forms of AD have established the central role of APP in the pathogenesis of the disease."],
    "8446172": ["Structural alterations of APP are implicated in the pathogenesis of Alzheimer's disease, but it is not known how they cause the disease."],
    "8528377": ["This case confirms that AD may result in prominent white matter disease caused by incomplete infarction or demyelination."],
    "8861021": ["Abnormalities of the endosomal-lysosomal system in Alzheimer's disease: relationship to disease pathogenesis."],
    "8881379": ["This review reports the different genetic factors that have been identified either as risk factor for Alzheimer's disease (AD) or directly causing the disease."],
    "9520006": ["Among subjects diagnosed during life as having DAT or incipient DAT, only 7% were found to have a neuropathologic disorder other than AD causing their dementia."],
    "9546791": ["Alzheimer's disease (AD) is characterized by the accumulation of cerebral plaques composed of 40- and 42-amino acid beta-amyloid (Abeta) peptides, and autosomal dominant forms of AD appear to cause disease by promoting brain Abeta accumulation."],
    "9749615": ["Recently, alpha-synuclein was shown to be a structural component of the filaments in Lewy bodies (LBs) of Parkinson's disease (PD), dementia with LBs (DLB) as well as the LB variant of Alzheimer's disease, and this suggests that alpha-synuclein could play a mechanistic role in the pathogenesis of these disorders."],
    "9990552": ["Four different genes have now been associated with AD and are providing insights into the pathogenesis of the disease."],
    "11640946": ["The novel localization of such a transcriptional activating protein to selectively vulnerable neurons in Alzheimer disease provides compelling evidence for mitotic re-entry as part of the pathogenesis of neuronal dysfunction and death in Alzheimer disease."],
    "12451676": ["Alzheimer's disease(AD) is the most common form of neurodegenerative diseases that causes intellectual dysfunction."],
    "14675724": ["The ensuing homeostatic responses to myelin breakdown further increase intracortical toxicity and results in the relentless progression and non-random anatomical distribution of AD lesions that eventually cause neuronal dysfunction and degeneration."],
    "14970312": ["The pathogenesis of AD is tightly linked to Abeta deposition and oxidative stress, but it remains unclear as to how these factors result in neuronal dysfunction and death."],
    "15249195": ["The calcium hypothesis of Alzheimer's disease (AD) invokes the disruption of calcium signaling as the underlying cause of neuronal dysfunction and ultimately apoptosis."],
    "15950763": ["The pathogenesis of Alzheimer's disease (AD) is now thought to be tightly linked to Abeta deposition and oxidative stress, but it is still unknown how these factors result in neuronal dysfunction and cell death."],
    "16998901": ["Accumulation of the beta-amyloid peptide (Abeta) in the brain is a major pathological hallmark of Alzheimer's disease (AD), leading to synaptic dysfunction, neuronal death, and memory impairment."],
    "17413025": ["Then, we will review preliminary findings applying imaging-guided microarray to AD and normal aging, in an attempt to isolate molecular profiles that dissociate the two main causes of age-related hippocampal dysfunction."],
    "17416103": ["Early caution about the role of tau as a significant factor in neurodegenerative disease, especially Alzheimer's disease, has been superseded by acceptance of its key involvement in pathways which led to cell dysfunction and death."],
    "17908035": ["These data suggest there is a shift in cholinotrophic molecular events in MCI and early AD which may lead to cell dysfunction and eventual cell death over the course of the disease."],
    "18201950": ["I propose that inflammation and cellular stress associated with aging are key events in the development of AD through the induction of glial dysfunction."],
    "18480253": ["Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation."],
    "19332976": ["The causes of cognitive dysfunction range from the devastating effects of Alzheimer's disease (AD) to treatable causes of dysfunction and the normal mild forgetfulness described by many older individuals."],
    "19350381": ["Evidence suggests that amyloid-beta (Abeta) protein is a key factor in the pathogenesis of Alzheimer's disease (AD) and it has been recently proposed that mitochondria are involved in the biochemical pathway by which Abeta can lead to neuronal dysfunction."],
    "19551456": ["While progressive accumulation of oligomeric amyloid-beta protein (Abeta) has been identified as one of the central toxic events in AD leading to synaptic dysfunction, accumulation of alpha-synuclein (alpha-syn) resulting in the formation of oligomers has been linked to PD.", "Most of the studies in AD have been focused on investigating the role of Abeta and Tau; however, recent studies suggest that alpha-syn might also play a role in the pathogenesis of AD."],
    "19614678": ["OBJECTIVE: In Alzheimer's disease, toxic soluble and insoluble forms of amyloid beta (Abeta) cause synaptic dysfunction and neuronal loss."],
    "19774105": ["Functional impairments in ETS components have been reported in several central nervous system (CNS) diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD); however, it remains largely unknown how the suppression of individual ETS complex function could lead to specific dysfunction in different cell types, resulting in distinct disease phenotypes."],
    "19839939": ["These will reveal how key players in the pathogenesis of Alzheimer's disease and frontotemporal dementia, such as the peptide Abeta (amyloid beta) and the protein tau, cause neuronal dysfunction and eventually, neuronal demise."],
    "19860724": ["This datum may be of high relevance for a better understanding of Alzheimer's Disease (AD) since molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Abeta) and other derivatives of the APP are key pathogenic factors in AD, causing mitochondrial dysfunction, free radical generation, oxidative damage, and inflammation."],
    "20445057": ["While Abeta deposition is the most prominent feature of AD, oligomeric forms of Abeta have been implicated as the toxic species inducing the neuronal dysfunction."],
    "20816785": ["There is strong evidence that intracellular calcium dysregulation plays an important pathological role in Alzheimer's disease, and specifically that beta amyloid may induce increases in intracellular calcium and lead to neuronal cell dysfunction and death."],
    "21219931": ["Amyloid plaques composed of the 42 amino acid form of amyloid-beta peptide (Abeta42) are a pathological hallmark of Alzheimer's disease (AD), but soluble and intraneuronal Abeta42 are the more proximal causes of synaptic dysfunction and neurotoxicity."],
    "21237171": ["Mounting evidence points to the soluble oligomers of amyloid beta (Abeta) peptide as important neurotoxic species in Alzheimer's disease, causing synaptic dysfunction and neuronal injury, and finally leading to neuronal death."],
    "21429865": ["Amyloid-beta accumulation in the brain is thought to be one of the earliest events in Alzheimer's disease, possibly leading to synaptic dysfunction, neurodegeneration and cognitive/functional decline."],
    "21799246": ["In this article, we evaluate the hypothesis according to which tau deposition in the anterior subhippocampal region during the earliest stages of the most common form of AD, with predominant MTL dysfunction, will lead to dysfunction of neural networks implicated in context-free memory."],
    "22101739": ["Alzheimer disease (AD) is characterized by chronic neuroinflammation, which may lead to dysfunction in neuronal circuits."],
    "22726800": ["Amyloid-beta 1-42 accumulation is the major pathogenetic event in Alzheimer's disease (AD), believed to be responsible for synaptic dysfunction and neuronal cell death."],
    "22753410": ["Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid."],
    "22879025": ["The vascular hypothesis of Alzheimer's disease (AD) considers cerebral hypoperfusion as a primary trigger for neuronal dysfunction."],
    "23011810": ["The pathology of AD is strongly associated with accumulated misfolding proteins that results in neuronal dysfunction within the brain."],
    "23799536": ["In Alzheimer's disease, soluble amyloid-beta causes synaptic dysfunction and neuronal loss."],
    "23979025": ["In Alzheimer's disease (AD), amyloid-beta (Abeta) deposits in the cerebrovasculature can result in neurovascular dysfunction and/or cerebral amyloid angiopathy."],
    "24024140": ["These data are consistent with a two-hit hypothesis of AD: oxidative stress leads to lipid peroxidation that, in turn, causes oxidative dysfunction of key energy-related complexes in mitochondria, triggering neurodegeneration."],
    "24251395": ["OBJECTIVE: Preclinical and post-mortem studies suggest that Alzheimer disease (AD) causes cerebrovascular dysfunction, and therefore may enhance susceptibility to cerebrovascular disease (CVD)."],
    "24251604": ["With AD, the loss of connectivity should first induce dysfunction in those representational networks with the weakest connectivity."],
    "24715417": ["Based on lots of medical reports, ER stress in postmortem brains from Alzheimer's disease (AD) patients, animals, and vitro models have indicated that ER dysfunction might work as an important part in causing AD."],
    "24918635": ["Deposition of amyloid-beta (Abeta) 1-42, the major component of senile plaques characteristic of Alzheimer disease, affects brain microvascular integrity and causes blood-brain barrier dysfunction, increased angiogenesis, and pericyte degeneration."],
    "24954589": ["Analysis of the literature suggests that the main factors of AD and PD pathogenesis (oxidative stress, structural disorders and aggregation of proteins, mitochondrial dysfunction, energy deficiency) that initiate a cascade of events resulting finally in the dysfunction of neuronal networks are mediated by the disbalance of Zn2+ and Cu2+."],
    "25230232": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid beta, neurofibrillary tangles, astrogliosis and microgliosis, leading to neuronal dysfunction and loss in the brain."],
    "25359615": ["Abeta oligomers (AbetaOs), the typical cause of AD, lead to mitochondrial dysfunction and neuronal loss."],
    "25552414": ["A reduction of this enzyme causes neurodegeneration and aggravates the AD features of the 3xTgAD mouse, inducing neuronal dysfunction, cell death and impairing memory and synaptic plasticity."],
    "25710536": ["Subtle disruptions of APP signaling functions may be major contributors to AD-causing neuronal dysfunction."],
    "25753421": ["The fact that AD-induced cellular dysfunctions can be avoided by UPS activity at mitochondria has potentially far-reaching pathophysiological implications."],
    "25821477": ["Alzheimer's disease (AD) causes progressive hippocampus dysfunctions leading to the impairment of learning and memory ability and low level of uptake rate of glucose in hippocampus."],
    "26118731": ["Amongst these, degenerative diseases involving hippocampus like Alzheimer's disease (AD) and temporal lobe epilepsy (TLE) are ranked higher as it is vulnerable to excitotoxicity induced neuronal dysfunction and death resulting in cognitive impairment."],
    "26275910": ["In a mouse model of AD, C5a-peptide vaccines reduce microglia activation and thus neuroinflammation, which is supposed to lead to reduced neuronal dysfunction and AD symptomatic decline."],
    "26484912": ["The major symptom of AD is progressive dementia that eventually results in dysfunction of daily life."],
    "26487830": ["Alzheimer's disease is a progressive neurodegenerative disorder, characterized by deposition of amyloid beta, neurofibrillary tangles, astrogliosis and microgliosis, leading to neuronal dysfunction and loss in the brain."],
    "26529297": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid plaques and neurofibrillary tangles, as well as microglial and astroglial activation, and, finally, leading to neuronal dysfunction and death."],
    "27199641": ["We review current work suggesting that neuronal differentiation is defective in Alzheimer's disease, leading to dysfunction of the dentate gyrus."],
    "27430312": ["BACKGROUND: Amyloid-beta (Abeta) accumulation is a hallmark of Alzheimer's disease (AD) that can lead to neuronal dysfunction and apoptosis."],
    "27748454": ["This study confirms earlier reports on an association between increased brain iron-burden and risk for neurocognitive dysfunction due to AD, and indicates that disease-progression is conferred by spatial colocalization of brain iron deposits with Abeta-plaques."],
    "27897204": ["In the mitochondria-mediated vicious cycle of Alzheimer's disease (AD), intracellular amyloid beta (Abeta) induces mitochondrial dysfunction and reactive oxygen species, which further accelerate Abeta accumulation."],
    "27910888": ["In Alzheimer's disease, the microtubule cytoskeleton is compromised, leading to neuronal dysfunction and eventually cell death."],
    "28081713": ["BACKGROUND: Deposition of aggregated amyloid beta (A?) protein is hallmark of Alzheimer's disease, leading to dysfunction and apoptosis of neurons."],
    "28208063": ["Data suggest that the contribution of WML to the dysfunction of the cholinergic system in MCI due to AD depends on WML distribution."],
    "28869759": ["Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive deposition of amyloid beta (Abeta) and dysregulation of neurotrophic signaling, causing synaptic dysfunction, loss of memory, and cell death."],
    "28988799": ["The same genetic factors that cause or increase AD risk are also direct causes of endosomal-lysosomal dysfunction, underscoring the essential partnership between this dysfunction and APP metabolites in AD pathogenesis.", "Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease."],
    "29116174": ["In early stages of Alzheimer's disease (AD), neuronal hyperexcitability leads to network dysfunction observed in cortical regions such as the hippocampus."],
    "29156571": ["Studies for Improving a Rat Model of Alzheimer's Disease: Icv Administration of Well-Characterized beta-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory."],
    "29274876": ["Moreover, LC neurodegeneration is not only a consequence of AD, but also drives clinical and pathological manifestations of AD, such as microglial dysregulation, sleep disturbance, cognitive decline, and neurovascular dysfunction."],
    "29388925": ["The amyloid-beta peptide (Abeta), derived from amyloid precursor protein, is one driver of AD, but how it leads to neuronal dysfunction is not established."],
    "29776894": ["Amyloid plaques with neurofibrillary tangles are a neuropathological hallmark of AD that produces synaptic dysfunction and culminates later in neuronal loss."],
    "30031108": ["In Alzheimer's disease (AD), beta-amyloid (Abeta) protein toxicity increases the formation of reactive oxygen species (ROS) and intracellular calcium levels, resulting in neuronal dysfunction, neurodegenerative disorders, and cell death."],
    "30108498": ["Background: The deposition of beta-sheet rich amyloid in senile plaques is a pathological hallmark of Alzheimer's disease (AD), which is thought to cause neuronal dysfunction."],
    "30166454": ["Emerging studies implicate Tau as an essential mediator of neuronal atrophy and cognitive impairment in Alzheimer's disease (AD), yet the factors that precipitate Tau dysfunction in AD are poorly understood."],
    "30244163": ["Consistently, social deficits sometimes represent the first signs of a number of neuropsychiatric disorders including schizophrenia (SCZ), Alzheimer's disease (AD) and major depressive disorder (MDD) which leads to a progressive social dysfunction."],
    "30474638": ["Alzheimer's disease (AD) is a progressive neurodegenerative condition in which aggregated tau and amyloid proteins accumulate in the brain causing neuronal dysfunction which eventually leads to cognitive decline."],
    "7699466": ["METHODS: Twelve patients with higher cortical dysfunction due to Alzheimer's disease and 18 age-matched controls were examined."],
    "10219973": ["Abnormal processing of amyloid precursor protein (APP), in particular the generation of beta-amyloid (Abeta) peptides, has been implicated in the pathogenesis of Alzheimer's disease."],
    "10589538": ["Genetic evidence strongly supports the view that Abeta amyloid production is central to the cause of Alzheimer's disease."],
    "10670439": ["Further studies are required to determine the clinical significance of these physiological changes in plasma amyloid precursor protein and the implications for Alzheimer's disease pathogenesis.", "The deposition of beta amyloid is a critical event in the pathogenesis of Alzheimer's disease."],
    "10818502": ["The beta-amyloid (A beta) peptide is believed to play a central role in the pathogenesis of AD."],
    "10899442": ["Although there remains controversy as to whether Abeta deposited as classic amyloid or a smaller, aggregated, form causes AD, the relevance of studying the amyloid deposits has certainly been proven."],
    "11019859": ["Chemical and conformational early modifications of the beta-amyloid peptide are critical steps in AD pathogenesis and have been widely investigated."],
    "11145990": ["Converging lines of evidence implicate the beta-amyloid peptide (Ass) as causative in Alzheimer's disease."],
    "11181832": ["A large body of evidence suggests that an increase in the brain beta-amyloid (Abeta) burden contributes to the etiology of Alzheimer's disease (AD)."],
    "11388427": ["Microglial activation induced by beta-amyloid (A beta) is an important cellular response in the pathogenesis of Alzheimer's disease (AD)."],
    "11455613": ["Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease."],
    "11475420": ["Recent studies suggest melatonin, due to its antioxidant and free-radical-scavenging actions, may play a role in the neuroprotection against amyloid, which is implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "11496136": ["The beta-amyloid peptide (A beta) is a key player in the pathogenesis of Alzheimer's disease."],
    "11602326": ["Substantial evidence suggests that the accumulation of beta-amyloid (Abeta)-derived peptides contributes to the aetiology of Alzheimer's disease (AD) by stimulating formation of free radicals."],
    "11701593": ["This was unusually severe CAA reminiscent of the Flemish amyloid precursor protein (A692G) mutation we reported previously, which causes Alzheimer's disease and/or cerebral haemorrhages.", "Nevertheless, in > 90% of cases of Alzheimer's disease amyloid is also deposited in cerebral blood vessel walls (congophilic amyloid angiopathy; CAA) but its role in Alzheimer's disease pathogenesis remains enigmatic."],
    "11818564": ["beta-amyloid (A beta), derived form the beta-amyloid precursor protein (APP), is important for the pathogenesis of Alzheimer's disease (AD), which is characterized by progressive decline of cognitive functions, formation of A beta plaques and neurofibrillary tangles, and loss of neurons."],
    "11848621": ["Investigation of the interactions of nerve cells with human apolipoprotein E (apoE), beta-amyloid (Abeta), and their complex, which are known to be included in senile plaques, is necessary to clarify the functional role of apoE in the pathogenesis of Alzheimer's disease."],
    "11886820": ["Aggregation of amyloid peptide (Abeta) has been identified as a major feature of the pathogenesis of Alzheimer's disease."],
    "11967228": ["Moreover, our findings indicate that beta-sheet breaker peptides provide a valuable tool for evaluating further the importance of amyloid in the etiology of AD and suggest that these peptides or some of their derivatives might be good candidates for AD treatment."],
    "12119153": ["The amyloid and tangle cascade hypothesis is the dominant explanation for the pathogenesis of Alzheimer's disease (AD)."],
    "12214051": ["The biogenesis and degradation/clearance of Abeta amyloid lies at the centre of the pathogenesis of Alzheimer's disease."],
    "12423367": ["While BACE1 processes the amyloid precursor protein (APP) at a key step in generating the beta-amyloid peptide and presumably causes Alzheimer's disease (AD), BACE2 has not been demonstrated to be directly involved in APP processing, and its physiological functions remain to be determined."],
    "12496118": ["The amyloid precursor protein (APP) is the precursor of the beta-amyloid peptide (Abeta), which is centrally related to the genesis of Alzheimer's disease (AD)."],
    "12598899": ["Amyloid precursor protein (APP) processing and the generation of beta-amyloid peptide (Abeta) are important in the pathogenesis of Alzheimer's disease."],
    "12600718": ["Increased formation of the beta-amyloid peptide (Abeta) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "12751917": ["The evidence indicates that abnormal processing and extracellular deposition of the longer form of the beta-amyloid (Abeta) peptide (Abeta(1-42), a proteolytic derivative of the amyloid precursor protein [APP]) is implicated in the pathogenesis of Alzheimer's disease.", "This research strongly supports the notion that abnormal Abeta processing is essential to the pathogenesis of Alzheimer's disease and provides a crucial platform for the development and detailed testing of potential treatments in experimental models before each of these approaches can be proposed as a therapy for Alzheimer's disease."],
    "12821522": ["The accumulation of beta-amyloid (A beta) in neuritic plaques is thought to be causative for the progression of Alzheimer's disease (AD)."],
    "12970358": ["Increased production and deposition of the 40-42-amino acid beta-amyloid peptide (Abeta) is believed to be central to the pathogenesis of Alzheimer's disease."],
    "13130516": ["Current Alzheimer's disease (AD) research has established the fact that excessive genesis of Abeta derived from amyloidogenic processing of beta-amyloid (Abeta) precursor protein is fundamental to AD pathogenesis."],
    "14511676": ["Deposition of amyloid in the brain is important in the pathogenesis of Alzheimer's disease (AD), but it remains to be determined if deposition is due to increased production or decreased clearance of fibrillogenic forms of beta-amyloid (Abeta)."],
    "14640701": ["Deposition of beta-amyloid (Abeta) is considered an important early event in the pathogenesis of Alzheimer's disease (AD)."],
    "14713297": ["Beta-amyloid (Abeta) peptide has been suggested to play important roles in the pathogenesis of Alzheimer's disease (AD)."],
    "15071107": ["Multiple lines of evidence implicate beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD), but the mechanisms whereby Abeta is involved remain unclear."],
    "15099019": ["The formation of amyloid-containing senile plaques and tau-rich neurofibrillary tangles are central events in Alzheimer disease (AD) pathogenesis."],
    "15181252": ["We will continue to investigate the effect of apoE isoform and Abeta conformation on the structural and functional interactions between these two proteins in relation to the pathogenesis of AD."],
    "15189029": ["Recent studies have indicated that the most important role of beta-amyloid peptide (Abeta) in the etiology of Alzheimer's disease may not be in plaque formation but in the formation of soluble, metastable Abeta(1-42) neurotoxic intermediates (called ADDLs)."],
    "15240683": ["Human formyl peptide receptor-like 1 and its mouse homologue formyl peptide receptor 2 (FPR2) are G protein-coupled receptors used by a number of exogenous and host-derived chemotactic peptides, including the 42 aa form of beta amyloid peptide, a causative factor of Alzheimer's disease."],
    "15340356": ["Cerebral accumulation of beta-amyloid peptide (A beta) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "15452193": ["gamma-Secretase inhibitors reduce brain beta-amyloid peptide (Abeta), which is believed to be a major contributor in the etiology of AD."],
    "15474359": ["Understanding the molecular mechanism of beta-amyloid (Abeta) generation is crucial for Alzheimer's disease pathogenesis as well as for normal APP function."],
    "15565529": ["According to the beta-amyloid cascade hypothesis, the accumulation of beta-amyloid (Abeta) deposits as amyloid plaques in the patient's brain is the primary event in the pathogenesis of Alzheimer's disease (AD)."],
    "15974916": ["Previous studies from our lab also showed that TGF-beta1 can reduce accumulation of beta-amyloid peptide (Abeta), which appears to be central to Alzheimer's disease (AD) pathogenesis, and we therefore initiated a search for small molecule chemical compounds that could mimic this effect."],
    "16170650": ["Genetic evidence indicates a central role of cerebral accumulation of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD)."],
    "16271725": ["Polymerization of the soluble beta-amyloid peptide into highly ordered fibrils is hypothesized to be a causative event in the development of Alzheimer's disease."],
    "16289381": ["Accumulation of the beta-amyloid peptide (Abeta) is a primary event in the pathogenesis of Alzheimer's disease (AD)."],
    "16420415": ["Considering the deleterious role of beta-amyloid (Abeta) in the aetiology of Alzheimer's disease (AD), we investigated green and black tea extracts and flavan-3-ols (present as monomers and dimers in green and black forms, respectively) against toxicity induced by Abeta-derived peptides using primary cultures of rat hippocampal cells as model."],
    "16539391": ["Activation of alpha-secretase upon PKC stimulation by ligands causes increased degradation of the amyloid precursor protein (APP), resulting in enhanced secretion of sAPPalpha and reduced deposition of beta-amyloid peptide (Abeta), which is implicated in the pathogenesis of Alzheimer's disease."],
    "16542055": ["The amyloid hypothesis, which states that beta-amyloid (Abeta) aggregates cause the onset and progression of Alzheimer's disease (AD), is a leading proposal to explain AD aetiology."],
    "16581185": ["Production and accumulation of beta-amyloid peptide (Abeta) is central to the pathogenesis of AD."],
    "16624948": ["Increasing evidence links intraneuronal beta-amyloid (Abeta42) accumulation with the pathogenesis of Alzheimer's disease (AD)."],
    "16626708": ["In addition to the role of beta-amyloid peptide (Abeta) in the pathogenesis of AD, reduced glucose oxidative metabolism and decreased mitochondrial activity have been suggested as associated factors."],
    "1669714": ["Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function."],
    "16723396": ["beta-Amyloid (Abeta) polypeptide plays a critical role in the pathogenesis of Alzheimer's disease (AD), which is characterized by progressive decline of cognitive functions, formation of Abeta deposits and neurofibrillary tangles, and loss of neurons."],
    "16762454": ["beta-Amyloid (Abeta) is a hydrophobic peptide that drives the pathogenesis of Alzheimer's disease (AD) due to its aberrant aggregation."],
    "16822591": ["Cerebral accumulation of beta-amyloid peptide (Abeta) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "16908985": ["The accumulation of the beta-amyloid peptide (Abeta) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "16945610": ["BACKGROUND: Growing evidence suggests that oxidative damage caused by the beta-amyloid peptide in the pathogenesis of Alzheimer's disease may be hydrogen peroxide mediated."],
    "16962711": ["Recent studies indicate that the deposition of beta-amyloid (Abeta) is related in the pathogenesis of Alzheimer's disease (AD), but the underlying mechanism is still not clear."],
    "17013614": ["A contributing factor to the pathology of Alzheimer's disease is the generation of reactive oxygen species, most probably a consequence of the beta-amyloid (Abeta) peptide coordinating copper ions."],
    "17050537": ["Understanding the intracellular transport of the beta-amyloid precursor protein (APP) is a major key to elucidate the regulation of APP processing and thus beta-amyloid peptide generation in Alzheimer disease pathogenesis."],
    "17086547": ["Based on the central dogma of beta-amyloid (Abeta) as a key seeding event in the pathogenesis of Alzheimer disease (AD), immunoneutralization strategies have been actively pursued both in AD and in models of AD as a potential means for treating AD."],
    "17287054": ["Beta-amyloid peptide (AbetaP) aggregation, an essentially early event in Alzheimer's disease (AD) pathogenesis, became a target for therapeutics."],
    "17374949": ["Evidence supports an important role for beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD)."],
    "17517969": ["Subcutaneous administration of G-CSF into two different beta-amyloid (Abeta)-induced AD mouse models substantially rescued their cognitive/memory functions."],
    "17531157": ["The involvement of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD) has been well documented."],
    "17553417": ["BACE initiates the production of beta-amyloid (Abeta), the likely cause of Alzheimer's disease (AD)."],
    "17566645": ["Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is a key protease in the generation of beta-amyloid, an important trigger protein in the pathogenesis of AD."],
    "17620492": ["BACKGROUND: Deposition of the beta-amyloid peptide Abeta(42) is thought to be an important initial step in the pathogenesis of Alzheimer disease (AD)."],
    "17650113": ["The beta amyloid (Abeta) cascade has been at the forefront of the hypothesis used to describe the pathogenesis of Alzheimer's disease (AD)."],
    "17722071": ["To elucidate whether myricetin could counter the progress of AD, we examined the effects of myricetin on neurotoxicity induced by beta-amyloid (A beta), a component of senile plaques in the AD brain."],
    "17907956": ["The ageing brain becomes increasingly less able to destroy or eject toxic amyloid (A) beta42 peptide byproducts of normal neuronal activity that consequently accumulate to induce Alzheimer's disease (AD)."],
    "18167346": ["Amyloid formation may mediate aberrant protein interactions that culminate in neurodegeneration in Alzheimer, Huntington, and Parkinson diseases and in prion encephalopathies."],
    "18304698": ["The amyloid precursor protein (APP) is the source of beta-amyloid, a pivotal peptide in the pathogenesis of Alzheimer's disease (AD)."],
    "18357680": ["While such amyloid mechanism contributes to Alzheimer's pathological conditions, recent studies from a number of laboratories suggest that defective axonal transport may represent an early stage in AD pathogenesis because axonal swellings and reduced axonal transport were observed before apparent AD hallmarks."],
    "18395981": ["Amyloid precursor protein (APP) is a precursor protein for beta-amyloid, an important trigger protein in the pathogenesis of AD."],
    "18413473": ["Most of these mutations may also cause cognitive impairment, but the Arctic APP mutation is the only known intra-beta-amyloid mutation to date causing the more typical clinical picture of Alzheimer disease."],
    "18422968": ["The interaction of the beta-amyloid peptide (Abeta) with neuronal membranes could play a key role in the pathogenesis of Alzheimer's disease."],
    "18452319": ["Extracellular beta-amyloid (A beta) deposit is considered as one of the primary factors that induce Alzheimer's disease (AD)."],
    "18473932": ["Beta-amyloid (Abeta)likely plays a pivotal role in the etiology of Alzheimer's disease (AD)."],
    "18855672": ["In line with the growing body of evidence of the pivotal role of the beta-amyloid peptide (Abeta) in the pathogenesis of AD, alternative classes of drugs targeting mainly the formation or the aggregation of Abeta are actively pursued by the pharmaceutical industry, as they could positively modify the course of AD, stopping or slowing down disease progression."],
    "19270530": ["Extracellular accumulation of beta-amyloid peptide has been reported to be a major cause of Alzheimer disease (AD) and large numbers of autophagic vacuoles accumulate in the brain of AD patient."],
    "19360426": ["Beta-amyloid (Abeta) is thought to be a key contributor to the pathogenesis of Alzheimer disease (AD) in the general population and in adults with Down syndrome (DS)."],
    "19572401": ["Deposition of beta-amyloid (A beta) is considered as an important early event in the pathogenesis of Alzheimer's Disease (AD), and reduction of A beta levels by various therapeutic approaches is actively being pursued."],
    "19594760": ["BACKGROUND AND PURPOSE: Orally administered withanoside IV (a compound isolated from the roots of Withania somnifera) improved memory deficits in mice with a model of Alzheimer's disease induced by the amyloid peptide Abeta(25-35)."],
    "19610108": ["The significance of intracellular beta-amyloid (Abeta(42)) accumulation is increasingly recognized in Alzheimer's disease (AD) pathogenesis."],
    "19631265": ["The role of beta-amyloid (A beta) in the pathogenesis of Alzheimer's disease (AD) is frequently reported in the literature."],
    "19634775": ["A wide range of diseases are associated with amyloidosis such as Alzheimer's disease, multiple myeloma, other plasma cell disorders, and chronic inflammation, either as a cause, or result, of amyloid production."],
    "19657023": ["Recent evidence supports an important role for intraneuronal beta-amyloid in the pathogenesis of Alzheimer's disease."],
    "19678545": ["The neurotoxicity induced by beta-amyloid (Abeta), which is one of the major causes of Alzheimer's disease (AD), leads to synaptic loss and subsequent neuronal death."],
    "19699263": ["The neurotoxicity of aggregated beta-amyloid (Abeta) has been implicated as a critical cause in the pathogenesis of Alzheimer's disease (AD)."],
    "19794916": ["In Alzheimer's disease tauopathy is considered secondary to amyloid, and the duality obscures their relation and the definition of their respective contributions."],
    "19827625": ["Anomalous accumulation of beta-amyloid peptide in cerebral neurons plays central role in pathogenesis of Alzheimer's disease (AD)."],
    "19843960": ["The beta-amyloid (Abeta) peptide is associated with the pathogenesis of Alzheimer's disease (AD)."],
    "19903023": ["Genetic and biological studies provide strong support for the hypothesis that accumulation of beta amyloid peptide (Abeta) contributes to the etiology of Alzheimer's disease (AD)."],
    "19957250": ["Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease."],
    "20074226": ["Beta-amyloid (Abeta) peptides are thought to play a major role in the pathogenesis of Alzheimer's disease."],
    "20101562": ["Increased beta-amyloid (Abeta) production and its aggregation to the oligomeric state is considered to be a major cause of Alzheimer's disease (AD)."],
    "20101719": ["The design of future immunomodulatory approaches that are more focused is dependent on addressing a number of questions, including when is the best time to start immunization, what are the most appropriate targets for vaccination, and is amyloid central to the pathogenesis of Alzheimer's disease or is it critical to target tau-related pathology also."],
    "20164555": ["Controversy still exists about the amyloid pathway as the initiating mechanism or a mere consequence of the events leading to AD."],
    "2025422": ["Hypothesis regarding amyloid and zinc in the pathogenesis of Alzheimer disease: potential for preventive intervention."],
    "20306540": ["Although Alzheimer's disease (AD) is characterized by the extracellular deposition of fibrillar aggregates of beta-amyloid (Abeta), transient oligomeric species of Abeta are increasingly implicated in the pathogenesis of AD."],
    "20348021": ["Research in genetics, pathology, epidemiology, biochemistry, and cell biology, as well as in animal models, suggests that cholesterol, its transporter in the brain, apolipoprotein E, amyloid precursor protein, and amyloid-beta all interact in AD pathogenesis."],
    "20362424": ["Beta-amyloid (Abeta) aggregation, believed to be responsible for Alzheimer's disease, is monitored using its intrinsic fluorescence decay."],
    "20429609": ["Deposition of beta-amyloid (Abeta) is considered an important early event in the pathogenesis of Alzheimer's disease (AD), and reduction of Abeta levels in the brain could be a viable therapeutic approach."],
    "20456003": ["Presenilin 1 (PS1) is a key component of the gamma-secretase complex in the generation of beta-amyloid (Abeta), an important trigger protein in the pathogenesis of AD."],
    "20583856": ["Inhibiting the PAS is desirable for prevention of aggregation of the amyloid peptide Abeta, a major causative factor in the progression of Alzheimer's disease (AD)."],
    "20637185": ["In AD, activated microglia may facilitate the clearance of beta-amyloid (Abeta), a neurotoxic component in AD pathogenesis."],
    "20665950": ["Galantamine, which is currently used in the treatment of patients with Alzheimer's disease (AD), has been shown to have a neuroprotective effect against beta-amyloid (Abeta) peptide-induced toxicity, which is involved in the pathogenesis of AD."],
    "20674676": ["The neurotoxicity of aggregated beta-amyloid (Abeta) has been implicated as a critical cause in the pathogenesis of Alzheimer's disease (AD)."],
    "20675873": ["[Involvement of beta-amyloid in the etiology of Alzheimer's disease]."],
    "20972410": ["Accumulation of the beta-amyloid peptide (Abeta) is generally believed to be central to the induction of Alzheimer's disease, but the relevant mechanism(s) of toxicity are still unclear."],
    "21222605": ["Proteolytic processing of APP to generate beta-amyloid, the principle component of amyloid plaques, can occur in membrane rafts, implicating them in the pathogenesis of Alzheimer's disease (AD)."],
    "21233670": ["The first article on Alzheimer's disease (AD) outlines the major evidence available to date that links Abeta-amyloid peptide as a proximal cause of AD."],
    "21270904": ["beta-Amyloid (Abeta) over-expression and tau hyperphosphorylation are considered to be the central events in the pathogenesis of Alzheimer's disease (AD)."],
    "21315759": ["Metabolism of beta-amyloid peptide (Abeta) is closely associated with the pathology and etiology of Alzheimer's disease (AD)."],
    "21318523": ["A large body of evidence suggests a causative role of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (reviewed in refs. 1 and 2)."],
    "21395066": ["[Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases]."],
    "21472290": ["Excessive accumulation of beta-amyloid (Abeta) has been proposed as a pivotal event in the pathogenesis of Alzheimer's disease."],
    "21476939": ["The beta-amyloid (Abeta) peptide, which plays a crucial role in the pathogenesis of Alzheimer's disease, alters hippocampal-dependent synaptic plasticity and memory and mediates synapse loss through the CREB signaling pathway."],
    "21480689": ["The production of beta-amyloid is thought to be a major and early contributor to the pathogenesis of AD."],
    "21504387": ["Solanezumab is a monoclonal antibody that binds to beta-amyloid (Abeta), a protein that plays a key role in the pathogenesis of AD."],
    "21706413": ["beta-amyloid (Abeta) and copper play important roles in the pathogenesis of Alzheimer's disease (AD)."],
    "21839813": ["It is recognized that the main trigger of Alzheimer disease related neurodegeneration is beta-amyloid peptide, which subsequently generates different metabolic disorders in neuron and finally leads to neuronal death."],
    "21897007": ["These results support the idea that a link between glucose dysmetabolism and the amyloid pathway may exist in the pathogenesis of AD."],
    "21961303": ["Excess production and accumulation of beta-amyloid peptide (betaAP) are central for pathogenesis of Alzheimer's disease."],
    "22031884": ["Impaired beta-amyloid secretion in Alzheimer's disease pathogenesis."],
    "22042506": ["Beta-amyloid peptide (Abeta), a major protein component of senile plaques, has been considered as a critical cause in the pathogenesis of Alzheimer's disease (AD)."],
    "22202113": ["Generation of Amyloid peptide (Abeta) is at the beginning of a cascade that leads to Alzheimer's disease."],
    "22288451": ["Solanezumab (LY2062430) is a humanized monoclonal antibody that binds to the central region of beta-amyloid, a peptide believed to play a key role in the pathogenesis of Alzheimer's disease (AD)."],
    "22342932": ["It has been more than a century since the first evidence linking the process of amyloid formation to the pathogenesis of Alzheimer's disease."],
    "22351073": ["Generation of amyloid peptide (Abeta) is at the beginning of a cascade that leads to Alzheimer's disease (AD)."],
    "22702727": ["beta-Amyloid peptide (1) (Abeta) aggregates are toxic to neuron and the main cause of Alzheimer's disease (AD)."],
    "22727791": ["AIMS: Multiple lines of evidence have implicated beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD)."],
    "22833976": ["BACKGROUND: Excessive accumulation of beta-amyloid (Abeta) has been proposed as a pivotal event in the pathogenesis of Alzheimer's disease."],
    "23036978": ["The abnormal production and accumulation of beta-amyloid peptide (Abeta), which is produced from amyloid precursor protein (APP) by the sequential actions of beta-secretase and gamma-secretase, are thought to be the initial causative events in the development of Alzheimer's disease (AD)."],
    "23134284": ["CONTEXT: The beta-amyloid (Abeta) peptide aggregation with accompanying oxidative stress plays the major role in the pathogenesis of Alzheimer's disease (AD)."],
    "23300647": ["Beta-amyloid (Abeta ) neurotoxicity is important in Alzheimer's disease (AD) pathogenesis."],
    "23383341": ["Unraveling the normal physiologic role of beta-amyloid is likely crucial to understanding the pathogenesis of Alzheimer's disease."],
    "23420027": ["IMPORTANCE: Current hypothetical models emphasize the importance of beta-amyloid in Alzheimer disease (AD) pathogenesis, although amyloid alone is not sufficient to account for the dementia syndrome."],
    "23512986": ["The extracellular accumulation of beta-amyloid peptide is a key trigger in the pathogenesis of Alzheimer's disease (AD)."],
    "23516302": ["Alzheimer's disease is thought to be caused by beta-amyloid peptide (Abeta)-dependent synaptic dysfunction."],
    "23662474": ["At current review we represented state-of-art views on the processes of production and aggregation of betaAP in organism, cellular and molecular mechanisms of betaAP influence on physiological functions of excitable cells, the role of betaAP in pathogenesis of neurodegenerative diseases (Alzheimer's disease and others), as well as the results of our own studies in this field."],
    "23794448": ["Amylin amyloid formation in the wall of cerebral blood vessels may also induce failure of elimination of Abeta from the brain, thus contributing to the etiology of AD."],
    "23942088": ["BACKGROUND: Beta-amyloid (Abeta) protein is a key factor in the pathogenesis of Alzheimer's disease (AD) and it has been reported that mitochondria is involved in the biochemical pathway by which Abeta can lead to neuronal dysfunction."],
    "24162852": ["Notably, CD36 is also a receptor for modified lipoproteins and beta-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer's disease."],
    "24277156": ["The current study was carried out to investigate the effects of chronic administration of pioglitazone, a PPAR-gamma agonist, on cognitive impairment in an animal model of Alzheimer's disease induced by beta-amyloid."],
    "24287378": ["The toxicity of amyloid beta-peptide (Abeta) has been implicated as a critical cause in the development of AD, and Abeta-amyloid-induced toxicity is typically associated with apoptosis."],
    "24491999": ["Many evidences are starting to cast doubt on Abeta as the primary causative factor in AD.", "The dark sides of amyloid in Alzheimer's disease pathogenesis."],
    "24985739": ["The disruption of Abeta homeostasis, which results in the accumulation of neurotoxic amyloids, is the fundamental cause of Alzheimer's disease (AD)."],
    "25066110": ["Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in beta-amyloid induced Alzheimer's disease."],
    "25108368": ["Aberrant accumulation of beta-amyloid (Abeta) is thought to be an early event in a biological cascade that eventually leads to Alzheimer's disease (AD)."],
    "25639816": ["An interesting target is the beta-amyloid peptide (Abeta), whose accumulation and progressive deposition into amyloid plaques are key events in AD aetiology."],
    "25686760": ["Even in Alzheimer disease, which is thought to be primarily caused by amyloid, vascular pathology, such as small vessel disease, may be of greater importance than amyloid itself in terms of influencing the disease course, especially in older individuals."],
    "25686800": ["Extracellular beta-amyloid peptide accumulation is reported as a major cause in Alzheimer's disease (AD) pathogenesis; large numbers of autophagic vacuoles accumulate in patients' brains."],
    "25714795": ["Alzheimer's disease (AD) and Parkinson's disease (PD) are caused by beta-amyloid (Abeta) and alpha-synuclein (alphaS), respectively."],
    "26073444": ["Aggregation of beta-amyloid (Abeta) is central to the pathogenesis of Alzheimer's disease (AD)."],
    "26244661": ["Autophagy is a vital pathway for the removal of beta-amyloid peptide (Abeta) and the aggregated proteins that cause Alzheimer's disease (AD)."],
    "26411291": ["Although amyloids are best known for their role in the etiology of diseases such as Alzheimer's, Parkinson's, and diabetes by forming toxic protein aggregates, our findings show that cells can utilize amyloid-like protein aggregates to function as central regulators of gametogenesis."],
    "26440073": ["The accumulation of extracellular beta-amyloid (Abeta) is crucial in AD pathogenesis, and Abeta-initiated secondary pathological processes could independently lead to neuronal degeneration and pathogenesis in AD."],
    "26594145": ["Strong evidence showed neurotoxic properties of beta amyloid (Abeta) and its pivotal role in the Alzheimer's disease (AD) pathogenesis."],
    "26618706": ["OBJECTIVE: To assess the role attributed to amyloid in AD pathogenesis by Italian dementia experts, and whether this modulates the impact of amyloid PET results in their diagnostic workup.", "RESULTS: 55% of the experts assigned a dominant role to amyloid, and 32% attributed a similar role to amyloid and tau in AD pathogenesis."],
    "26786779": ["Accumulation of oxidized proteins, and especially beta-amyloid (Abeta), is thought to be one of the common causes of Alzheimer's disease (AD)."],
    "26883101": ["The processing of amyloid beta precursor protein (APP) to beta-amyloid peptide (Abeta) is one of the critical events in the pathogenesis of AD."],
    "27018282": ["beta-Amyloid (Abeta) oligomers may play an important role in the early pathogenesis of Alzheimer's disease: cognitive impairment caused by synaptic dysfunction."],
    "27071404": ["Protein misfolding, aggregation and deposition in the brain, in the form of amyloid, are implicated in the etiology of several neurodegenerative disorders, such as Alzheimer's, Parkinson's and prion diseases."],
    "27072891": ["The processing of amyloid precursor protein (APP) into beta-amyloid peptide (Abeta) is a key step in the pathogenesis of Alzheimer's disease (AD), and trafficking dysregulations of APP and its secretases contribute significantly to altered APP processing."],
    "27072999": ["Because of the increased lifetime of phosphorylated beta-amyloid aggregates, phosphorylation can promote the spreading of beta-amyloid in Alzheimer pathogenesis."],
    "27106205": ["Several lines of evidence indicate that beta amyloid (beta-A) production, neurofibrillary tangles and neuroinflammation are interrelated in the pathogenesis of Alzheimer's disease (AD)."],
    "27303604": ["INTRODUCTION: To study the effect of gallic acid (GA) on hippocampal long-term potentiation (LTP) and histological changes in animal model of Alzheimer disease (AD) induced by beta-amyloid (Abeta)."],
    "27318146": ["The misfolding and accumulation of the protein fragment beta-amyloid (Abeta) is an early and essential event in the pathogenesis of Alzheimer's disease (AD)."],
    "27481595": ["Given its role in the formation of amyloids leading to Alzheimer's disease, it has been a major therapeutic target for intervention and has been a challenge in the past and the progress has been very slow."],
    "27634977": ["This review examines the possible role of the gut in the dissemination of amyloids, the role of the gut microbiota in the regulation of the gut-brain axis, the potential amyloidogenic properties of gut bacteria, and the possible impact of nutrients on modulation of microbiota composition and amyloid formation in relation to the pathogenesis of Alzheimer disease."],
    "27710900": ["Misfolded beta-sheet-rich protein aggregates termed amyloid, deposit in vivo leading to debilitating diseases such as Alzheimer's, prion and renal amyloidosis diseases etc."],
    "27867033": ["The prevailing beta-amyloid (Abeta)-cascade hypothesis is the most classical Alzheimer's disease (AD) pathogenesis."],
    "27922847": ["The objective of this article is to review the recent findings about the metabolism of apolipoprotein E (ApoE) and amyloid beta and other possible mechanisms by which ApoE contributes to the pathogenesis of Alzheimer's disease."],
    "28261990": ["AIMS: Axonal degeneration is a pathological symbol in the early stage of Alzheimer's disease (AD), which can be triggered by amyloid-?"],
    "28271324": ["Beta-amyloid peptide (Abeta) induced neurotoxicity is considered as a hallmark of the pathogenesis of Alzheimer's disease (AD)."],
    "28320296": ["Here we (i) highlight the latest data on mechanisms of amyloid formation and further discuss a hypothesis on the amyloid cascade as a primary mechanism of AD pathogenesis and (ii) review the evolutionary aspects of amyloidosis, which allow new insight on human-specific mechanisms of dementia development."],
    "28352309": ["The present study aimed to investigate the effects of asiaticoside (AS) on the pathology and associated mechanisms of beta-amyloid (Abeta)-induced Alzheimer's disease (AD) in rats.", "According to the findings of the observed study, AS has a marked protective effect on Abeta-induced AD pathology, and the underlying mechanism may be associated with the alleviation of the mitochondrial injuries, the anti-inflammatory activities, and the influence on the expression levels of apoptosis-associated proteins."],
    "28509380": ["OBJECTIVE: The aim of this study is to examine the hypotheses stating the importance of amyloid or of its oligomers in the pathogenesis of Alzheimer's disease (AD).", "RESULTS: The importance of amyloid in the pathogenesis of AD is well established, yet accepting it as the main cause for AD is problematic, because amyloid-centric treatments have provided no clinical benefit and about one-third of cognitively normal, older persons have cerebral amyloid plaques."],
    "28592267": ["BACKGROUND: ?-Amyloid peptide (A?) oligomers are initial factors used to induce Alzheimer's disease (AD) development, and A? monomers have normal physiological function."],
    "28756148": ["Excessive accumulation of beta-amyloid (Abeta) has been proposed as a pivotal event in the pathogenesis of AD."],
    "28774853": ["Maintenance of normal biochemical levels in brain tissue demonstrated the potential of these coated MWCNTs in reducing beta-amyloid induced AD."],
    "28815614": ["The amyloid hypothesis suggests that the progressive accumulation and deposition of central nervous system (CNS) amyloid with aging is the proximate cause of Alzheimer's disease (AD)."],
    "28866757": ["Experimental data suggest that the cerebrospinal fluid (CSF) dynamic is involved in the clearance of beta-amyloid, a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "28900376": ["Also, various experimental and clinical studies are in progress to prove exercise role in the beta-amyloid (Abeta) pathology as a most prevailing hypothesis explaining AD pathogenesis."],
    "2890206": ["Furthermore, no significant allelic association was detected between AD and any of the loci, including the amyloid and SODI genes, providing no support for the hypothesis that defects in these specific genes are the primary cause of AD."],
    "28993924": ["The role of beta-amyloid (Abeta) in the pathogenesis of Alzheimer's disease (AD) is still considered crucial."],
    "29158049": ["We therefore evaluated the effects of tanshinone IIA (TIIA) and cryptotanshinone (CRY) (the two major lipophilic compounds of Danshen) in a non-genetic mouse model of beta-amyloid (Abeta)-induced AD, which is mainly characterized by reactive gliosis and neuro-inflammation in the brain."],
    "29191087": ["Deranged beta-amyloid (Abeta) trafficking across the blood-brain barrier is known to be a critical element in the pathogenesis of AD."],
    "29311595": ["Excessive accumulation of beta-amyloid (Abeta) is thought to be a major causative factor in the pathogenesis of Alzheimer's disease (AD)."],
    "29427089": ["However, the role of ER stress in beta-amyloid (Abeta)-induced AD pathology remains elusive, and data obtained from different animal models and under different experimental conditions are sometimes controversial."],
    "29444819": ["BACE1 initiates the generation of the beta-amyloid peptide, which likely causes Alzheimer's disease (AD) when accumulated abnormally."],
    "29966723": ["beta-Amyloid (Abeta) plays an important role in the early pathogenesis of Alzheimer's disease (AD)."],
    "30126231": ["Increasing evidence suggests that amyloid formation, i.e., self-assembly of proteins and the resulting conformational changes, is linked with the pathogenesis of various neurodegenerative disorders such as Alzheimer's disease, prion diseases, and Lewy body diseases."],
    "30127003": ["Amyloid peptide-related inflammation is thought to be an important aspect of AD pathogenesis."],
    "30220236": ["In light of recent evidence that the cascade is driven by the misfolding and templated aggregation of Abeta and tau, we believe that an empirically grounded Standard Model of Alzheimer's pathogenesis is within reach.", "By affirming markers of abnormal Abeta and tau proteins as the essential pathobiological signature of Alzheimer's disease, the Framework tacitly reinforces the amyloid (Abeta) cascade as the leading theory of Alzheimer pathogenesis."],
    "30232325": ["In Alzheimer's disease (AD), the canonical Wnt inhibitor Dickkopf-1 (Dkk1) is induced by beta-amyloid (Abeta) and shifts the balance from canonical towards non-canonical Wnt signalling."],
    "30483749": ["Cytotoxicity of beta-Amyloid (Abeta) is a major contributor to the pathogenesis of Alzheimer's disease."],
    "30572184": ["beta-Amyloid (Abeta) accumulation is an early event of Alzheimer's disease (AD) pathogenesis."],
    "30723404": ["Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of beta-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer's Disease."],
    "30786665": ["Alzheimer's disease neuropathologic change (ADNC) in the form of ?-amyloid (A?) deposits is important not only in the pathogenesis of Alzheimer's disease (AD) and Down's syndrome (DS) but also as a 'co-pathology' in disorders such as dementia with Lewy bodies (DLB), corticobasal degeneration (CBD), and chronic traumatic encephalopathy (CTE)."],
    "30868421": ["Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?"],
    "30936829": ["Literary evidence depicts that aggregated beta-amyloid (Abeta) leads to the pathogenesis of Alzheimer's disease (AD)."],
    "30946834": ["Beta-amyloid (Abeta) has pivotal functions in the pathogenesis of Alzheimer's Disease (AD)."],
    "30959405": ["beta-amyloid (Abeta) plays an essential role in the pathogenesis of Alzheimer's disease (AD)."],
    "31095505": ["Accumulation of beta-amyloid peptide (Abeta) is regarded as a primary cause of Alzheimer's disease (AD)."],
    "31108937": ["beta-site APP-cleaving enzyme 1 (BACE1) initiates amyloid precursor protein (APP) cleavage and beta-amyloid (Abeta) production, a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "31164812": ["Alzheimer's disease (AD) is one of the most common neurodegenerative diseases, and beta-amyloid (Abeta) plays a leading role in the pathogenesis of AD."],
    "31193333": ["They are infectious such as prions or noninfectious such as beta-amyloid (Abeta) fibrils causing Alzheimer's disease (AD)."],
    "31211853": ["The abnormal accumulation of beta-amyloid peptide (Abeta) is recognized as a central component in the pathogenesis of Alzheimer disease."],
    "31299145": ["Tracing the GSAP-APP C-99 Interaction Site in the beta-Amyloid Pathway Leading to Alzheimer's Disease."],
    "31301179": ["Pretreatment with QCR potentiates the action of Sita in Abeta induced AD in rats.", "Activation of Nrf2 signaling by sitagliptin and quercetin combination against beta-amyloid induced Alzheimer's disease in rats."],
    "31332160": ["Beta-amyloid (Abeta) peptide accumulation is considered as a primary cause of AD pathogenesis, with defective autophagy in patients' brains."],
    "31458243": ["During the early stages of beta amyloid (Ab) peptide aggregation, toxic oligomers form which have been recognized as a likely cause of Alzheimer's disease."],
    "31482248": ["Beta amyloid (Abeta) peptide aggregation and phosphorylated tau protein accumulation are considered as one of the causes for AD."],
    "31629115": ["Beta-amyloid (Abeta) peptide accumulation has long been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "31639294": ["Previous studies have shown that fascaplysin might act on acetylcholinesterase and beta-amyloid (Abeta) to produce anti-AD properties."],
    "31722781": ["Both amyloid and tau pathologies have an impact upon mitochondria through physical interaction or indirect signaling pathways, resulting in the disruption of mitochondrial function and dynamics which can trigger AD."],
    "31876283": ["Zinc ions and glycosaminoglycans (GAGs) are found in amyloid deposits and are known to modulate the beta-amyloid peptide (Abeta) aggregation, which is thought to be a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "32035959": ["Sodium tanshinone IIA sulfonate protects against Abeta     1-42      -induced cellular toxicity by modulating Abeta-degrading enzymes in HT22 cells.beta-Amyloid (Abeta) plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "32046518": ["This study investigated the mechanism which postulates that intraneuronal accumulation of amyloid aggregates for pathogenesis of AD."],
    "32350803": ["CONCLUSIONS: The current ATN model of AD does not specify the subtype of beta-amyloid to be considered, which may be overlooking the differential roles that these two subtypes serve in the pathogenesis of AD."],
    "32353422": ["The fibrillar peptide beta-amyloid (Abeta) has a chief function in the pathogenesis of AD."],
    "32508629": ["Emerging evidence reveals that an aberrant accumulation of beta-amyloid (Abeta) is the main reason of Alzheimer's disease (AD) pathogenesis."],
    "32831200": ["Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.BACKGROUND: Previous studies suggest that Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in amyloid-induced toxicity and hence Alzheimer's disease (AD)."],
    "3288032": ["Theories pertinent to the origins of brain amyloid and its role in the pathogenesis of Alzheimer disease are discussed in relation to theories of the cause of this dementia."],
    "32907613": ["Peroxiredoxin 6 mediates protective function of astrocytes in Abeta proteostasis.BACKGROUND: Disruption of beta-amyloid (Abeta) homeostasis is the initial culprit in Alzheimer's disease (AD) pathogenesis."],
    "33092519": ["Amyloid-beta peptides slightly affect lifespan or antimicrobial peptide gene expression in Drosophila melanogaster.BACKGROUND: Beta-amyloid peptide (Abeta) is the key protein in the pathogenesis of Alzheimer's disease, the most common age-related neurodegenerative disorder in humans."],
    "33186671": ["With this viewpoint article, we aim to challenge the traditional view of amyloid as the leading cause of AD."],
    "33480241": ["Injection of ?-amyloid peptide (A?1-42) into the lateral ventricle was used to induce AD in rats."],
    "33509204": ["Despite extensive research on the amyloid-based mechanism of AD pathogenesis, the underlying cause of AD is not fully understood."],
    "34123738": ["Amyloid and tau protein abnormalities have been identified as the main causes of Alzheimer's disease but exact mechanisms remain to be revealed."],
    "34299592": ["Beta (beta)-amyloid (Abeta) is a causative protein of Alzheimer's disease (AD)."],
    "34488020": ["These three amyloidogenic proteins forming amyloids under physiological conditions (pH 7.4 and 37C) served as model and are thought to be the causative proteins of AD, type 2 diabetes, and insulin-derived amyloidosis, respectively."],
    "34520451": ["Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype."],
    "35109309": ["BACKGROUND: The amyloid channel theory readily explains primary molecular damage induced by beta-amyloid (Abeta) but cannot interpret multiple major phenomena associated with Alzheimer's Disease such as autophagy failure and decreased metabolism."],
    "36420978": ["Betaeta-amyloid (Abeta) is a neurotoxic protein that deposits early in the pathogenesis of preclinical Alzheimer's disease."],
    "36856252": ["Effect of silibinin and trans-chalcone in an Alzheimer's disease-like model generated by insulin amyloids."],
    "37774681": ["Our integrative analysis provides an organizing framework for targeting circuit dysfunction, neuroinflammation, and amyloid production early in AD pathogenesis."],
    "38352874": ["Methods: Here, we evaluated the    in vivo     role of microglia-selective and full body inflammasome signalling in several mouse models of ss-amyloid-induced AD neuropathology."],
    "38473975": ["New data suggest that the aggregation of misfolded native proteins initiates and drives the pathogenic cascade that leads to Alzheimer's disease (AD) and other age-related neurodegenerative disorders.", "Understanding the distinct roles of soluble and insoluble amyloid aggregates on AD pathogenesis has been the key missing piece of the Alzheimer's puzzle."],
    "7491048": ["Our study suggests that the size of cortical area affected by beta-amyloid deposition is an important factor in the clinical manifestation of dementia, and lends support to the possibility that beta-amyloid is central to the aetiology of AD."],
    "7565212": ["Amyloid, aluminium and the aetiology of Alzheimer's disease."],
    "7708775": ["Normal control fibroblasts exposed to 10 nM beta-amyloid, the same concentration that induced AD-like K+ changes in control fibroblasts, showed a similar decrease in Cp20."],
    "7750567": ["The non-enzymatic glycosylation of beta-amyloid is implicated in the aetiology of Alzheimer's disease."],
    "7763339": ["Consequences of the molecular mechanism of amyloid formation for the understanding of the pathogenesis of Alzheimer's disease and the development of therapeutic strategies."],
    "7812796": ["These observations have direct consequences for the interpretation of Alz-50 staining in diagnostic usage and for the assessment of Alzheimer's disease-like changes induced by beta-amyloid in experimental animal brains."],
    "7822152": ["PURPOSE: Increased immunoreactivity (IR) of beta-amyloid and the amyloid-associated proteins tau and amyloid precursor protein (APP) in the brain have been linked to the pathogenesis of neurodegenerative disorders such as Alzheimer's disease."],
    "8131745": ["Accumulation of the amyloid A beta peptide, which is derived from a larger precursor protein (APP), and the formation of plaques, are major events believed to be involved in the etiology of Alzheimer's disease."],
    "8146663": ["Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels."],
    "8159255": ["We probed serial and near serial sections of cerebellum from 13 Alzheimer's disease (AD), 10 older Down's syndrome (DS) patients, and 9 age-matched, non-AD controls, using single and double labeling immunohistochemistry to investigate the pathologic consequences of beta-amyloid or A4 (A beta) deposits in cerebellum and their relationship to Purkinje cells (PCs)."],
    "8185566": ["Besides the neurotoxic properties of beta-amyloid (beta A4), apolipoprotein E polymorphism seems to play an important role in the pathogenesis of sporadic Alzheimer's disease (AD)."],
    "8489324": ["CONCLUSION: The results of the study indicate the importance of neurofibrillary degeneration, not the deposition of amyloid, in the pathogenesis of Alzheimer's disease."],
    "8604204": ["Amyloid, aluminum and the aetiology of Alzheimer's disease."],
    "8606673": ["Amyloid, aluminium and the aetiology of Alzheimer's disease."],
    "8706841": ["The overproduction of beta-amyloid (A beta) appears to be a primary cause of Alzheimer's disease (AD)."],
    "8740984": ["The occurrence and effects of the mutations in APP and the fact that the epsilon 4 allele of ApoE are genetic risk factors point to the hypothesis that the extracellular deposition of beta-amyloid is the key initiating event in the pathogenesis of AD.", "Four genes have thus far been implicated in the etiology of Alzheimer's disease (AD)."],
    "8761337": ["Soluble beta-amyloid induces Alzheimer's disease features in human fibroblasts and in neuronal tissues."],
    "8997415": ["The importance of the beta-amyloid peptide in the pathogenesis of AD has been strengthened by the identification of pathogenic mutations in the APP gene on chromosome 21."],
    "9116244": ["Since administration of anti-inflammatory drugs has been reported to possibly slow the progression of Alzheimer's disease, an effort was made to define effector functions induced by beta-amyloid (A beta) which may be inhibited by these drugs."],
    "9168112": ["Although most of the molecular mechanisms involving beta-amyloid and APP in the aetiology of Alzheimer's disease are still unclear, changes in APP metabolism may be important in the pathogenesis of the disease."],
    "9348103": ["Since the identification in 1984 of the amyloid beta protein (Abeta) as the major component of senile plaques and cerebrovascular amyloid in Alzheimer's disease (AD) brains, it is well accepted that the production of this protein is a crucial factor in the pathogenesis of AD."],
    "9399697": ["These findings indicate that changes in cerebral betaA4 levels contribute to temporal lobe atrophy in AD and support the possibility that betaA4 is central to the etiology of AD."],
    "9630681": ["Experimental evidence increasingly implicates the beta-amyloid peptide in the pathogenesis of Alzheimer's disease."],
    "9683325": ["Formation of beta-amyloid and neurofibrillary tangles in the brain due to genetic or other factors is the most frequent cause of Alzheimer's disease."],
    "9794144": ["The particular contribution of muscarinic receptors, beta-amyloid and tau proteins in the pathogenesis of Alzheimer's disease remains still unclear."],
    "9865931": ["An increased beta-amyloid (Abeta) peptide is believed to play a central role in the pathogenesis of AD."],
    "9928821": ["Strong genetic evidence has been accumulated in favor of a central role of beta-amyloid precursor protein (APP) and beta-amyloid peptide (betaA4) in the pathogenesis of Alzheimer's disease (AD)."],
    "31949779": ["The abnormal accumulation and deposition of amyloid-beta peptide (Abeta) in senile plaques and cerebral vasculature is widely recognized to be the most likely culprit in the pathogenesis of AD."],
    "31991578": ["AD mutations contribute to the generation of toxic amyloid beta (Abeta) peptides and the formation of cerebral plaques, leading to the formulation of the amyloid cascade hypothesis for AD pathogenesis."],
    "32028683": ["Amyloid-beta (Abeta) peptides play a crucial role in the pathogenesis of Alzheimer's disease (AD)."],
    "32046252": ["Interaction of Abeta42 with Membranes Triggers the Self-Assembly into Oligomers.The self-assembly of amyloid beta (Abeta) proteins into oligomers is the major pathogenic event leading to Alzheimer's disease (AD)."],
    "32142821": ["Abeta-ganglioside interactions in the pathogenesis of Alzheimer's disease.It is widely accepted that the abnormal self-association of amyloid beta-protein (Abeta) is central to the pathogenesis of Alzheimer's disease, the most common form of dementia."],
    "32210564": ["Purpose: Amyloid-beta protein (Abeta) is one of the causative proteins of Alzheimer's disease."],
    "32272441": ["Multiple lines of evidence indicate that amyloid beta (Abeta) peptide is responsible for the pathological devastation caused in Alzheimer's disease (AD)."],
    "32307772": ["Identification of calcium and integrin-binding protein 1 as a novel regulator of production of amyloid beta peptide using CRISPR/Cas9-based screening system.The aberrant metabolism of amyloid beta peptide (Abeta) has been implicated in the etiology of Alzheimer disease (AD)."],
    "32354467": ["Successive cleavage of beta-amyloid precursor protein by gamma-secretase.gamma-Secretase is a multimeric aspartyl protease that cleaves the membrane-spanning region of the beta-carboxyl terminal fragment (betaCTF) generated from beta-amyloid precursor protein. gamma-Secretase defines the generated molecular species of amyloid beta-protein (Abeta), a critical molecule in the pathogenesis of Alzheimer's disease (AD)."],
    "32372339": ["BACKGROUND: Acetylcholine deficiencies in hippocampus and cortex, aggregation of beta-amyloid, and beta-secretase over activity have been introduced as main reasons in pathogenesis of Alzheimer's disease."],
    "32444869": ["Amyloidogenic processing of Alzheimer's disease beta-amyloid precursor protein induces cellular iron retention.The proteolytic cleavage of beta-amyloid precursor protein (APP) to form the amyloid beta (Abeta) peptide is related to the pathogenesis of Alzheimer's disease (AD) because APP mutations that influence this processing either induce familial AD or mitigate the risk of AD."],
    "32580638": ["Salt bridges for the APOE correct folding are missing in APOE4, resulting in an increased deposition of the amyloid-beta peptide, compared to APOE3, which can lead to the AD."],
    "32683653": ["Amyloid-beta (Abeta) peptides play a significant role in the pathogenesis of Alzheimer's disease (AD)."],
    "32733240": ["The Neuroprotective Action of Amidated-Kyotorphin on Amyloid beta Peptide-Induced Alzheimer's Disease Pathophysiology."],
    "32848600": ["Major efforts in AD drug were devoted to the interference with the production and accumulation of amyloid-beta peptide (Abeta), which plays a causal role in the pathogenesis of AD."],
    "32973471": ["Studies focused on nonpharmacological treatment for AD have been developed to act on brain plasticity and minimize the neurotoxicity caused by the amyloid-beta (Abeta) peptide."],
    "32975365": ["Evidence that in Down syndrome (DS), a population markedly predisposed to develop early onset AD, increased APP gene dose is necessary for both AD neuropathology and dementia points to normalization of the levels of the amyloid precursor protein (APP) and its products as a route to further define AD pathogenesis and discovering novel treatments.", "NEW/UPDATED HYPOTHESIS: We hypothesize that the increase in APP gene dose in DS initiates a process in which increased levels of full-length APP (fl-APP) and its products, including beta-CTF and possibly Abeta peptides (Abeta42 and Abeta40), drive AD pathogenesis through an endosome-dependent mechanism(s), which compromises transport of neurotrophic signals."],
    "32990912": ["Amyloid beta protein (Abeta) deposition is the main pathogenesis of AD, and many studies have shown that Abeta accumulation is toxic to neurons, leading to the inflammatory reaction, neuronal apoptosis, and neurofibrillary tangles."],
    "33010207": ["Aggregation, fibril formation, and deposition of amyloid beta (Abeta) protein are believed to be the central pathogeneses of Alzheimer's disease (AD)."],
    "33066971": ["This study investigated whether early-life and chronic exposure to DEHP affects AD via the toxicity of amyloid-beta (Abeta), which has been implicated in the pathogenesis of AD, using Caenorhabditis elegans AD models (strains CL4176 and CL2006)."],
    "33074279": ["Excess aggregation of amyloid beta peptide (Abeta) is a fatal cause of Alzheimer's disease (AD), which leads to physiological toxicity."],
    "33132896": ["Accumulation of amyloid beta is a key event in Alzheimer's disease pathogenesis."],
    "33189440": ["Further spatial memory assays in Abeta-induced AD model showed that 22 enhanced the ability of learning and memory."],
    "33208229": ["The accumulation and aggregation of amyloid-beta (Abeta) are critical factors in the pathogenesis of Alzheimer's disease (AD)."],
    "33224974": ["Particularly, the aggregation of misfolded amyloid-   beta     and hyperphosphorylated tau and    alpha    -synuclein are linked to the pathogenesis of AD and PD, respectively."],
    "33225679": ["The accumulation and deposition of beta-amyloid (Abeta) is one postulated cause of Alzheimer's disease (AD)."],
    "33238667": ["[Roles of amyloid-beta in the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease should be clarified]."],
    "33258115": ["A variety of findings from in vitro experiments and animal models support the hypothesis that one contribution to pathogenesis in Alzheimer's disease (AD) is enhanced phosphorylation of tau protein, which may be triggered by amyloid beta (Abeta) and mediated by impaired activity of the PI3K/Akt signaling pathway."],
    "33279620": ["The amyloid beta protein cascade hypothesis places the formation of amyloid beta protein aggregates on the first position in the complex pathological cascade leading to neurodegeneration, and therefore AD might be considered to be a protein-misfolding disease."],
    "33310049": ["In the present study, we tested whether pinoresinol reduces learning and memory and excitatory synaptic deficits in an amyloid beta (Abeta)-induced AD-like mouse model."],
    "33353018": ["We evaluated the effects of a grain diet rich in anthocyanins in a mouse model of Alzheimer's disease induced by amyloid-beta (Abeta) and a transgenic mouse model of Parkinson's disease (PD) with overexpression of human alpha-synuclein."],
    "33359145": ["Accumulating evidences suggest that amyloid beta (Abeta)-peptide plays a key role in pathogenesis of Alzheimer's disease (AD) through aggregation and deposition into plaques in neuronal cells."],
    "33386802": ["Such stress provides the activation energy needed to induce conformational changes of both Abeta and tau within the lower brain and brainstem region, producing unique neurotoxic oligomer molecule conformations that induce AD."],
    "33400522": ["Cu, Zn, and amyloid-beta (Abeta) peptides play an important role in the etiology of Alzheimer's disease (AD)."],
    "33401892": ["Cu     2+      -mediated amyloid beta-protein (Abeta) aggregation is implicated in the pathogenesis of Alzheimer's disease, so it is of significance to understand Cu     2+      -mediated conformational transitions of Abeta."],
    "33414705": ["Misfolding and extracellular aggregation of Amyloid-beta (Abeta) peptides are recognized as the main cause of AD progression, leading to the formation of toxic Abeta oligomers and to the deposition of beta-amyloid plaques in the brain, representing the hallmarks of AD."],
    "33426095": ["Amyloid beta peptides (A   beta    1-42) have been found to be associated with the cause of Alzheimer's disease (AD) and dementia."],
    "33495810": ["The generation of beta-amyloid protein (Abeta) is considered a key step in the pathogenesis of Alzheimer's disease (AD) and the regulation of its production is an important therapeutic strategy."],
    "33503934": ["Aggregation of amyloid-beta (abeta) peptides into toxic oligomers, fibrils, and plaques is central in the molecular pathogenesis of Alzheimer's disease (AD) and is the primary focus of AD diagnostics."],
    "33508037": ["Intraneuronal rise of amyloid beta in its oligomeric forms (iAbetaOs), has been linked to the pathogenesis of AD by disrupting cytosolic Ca2+ homeostasis."],
    "33535469": ["Amyloid beta (Abeta) peptide is an important pathological factor that triggers the progression of AD through accumulation and aggregation, which leads to AD-related pathologies that consequently affect cognitive functions."],
    "33560154": ["Areas covered    : Considering the significance of Abeta and Tau in AD pathogenesis, these proteins have currently been adopted as the core biomarkers of AD, and their quantification has provided precise diagnostic information to develop next-generation AD therapeutic approaches."],
    "33571523": ["Beta-amyloid (Abeta) has been recognized as an early trigger in the pathogenesis of Alzheimer's disease (AD) leading to synaptic and cognitive impairments."],
    "33571524": ["gamma-secretase is responsible for the proteolysis of amyloid precursor protein (APP) into amyloid-beta (Abeta) peptides, which are centrally implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "33624157": ["METHODS: For the induction of Alzheimer's disease, amyloid beta (Abeta) 1-42 was injected in the CA1 region of the hippocampus."],
    "33716668": ["(Dys)regulation of Synaptic Activity and Neurotransmitter Release by beta-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis."],
    "33727592": ["Amyloid plaques are small (~ 50 MUm), highly-dense aggregates of amyloid beta (Abeta) protein in brain tissue, supposed to play a key role in pathogenesis of Alzheimer's disease (AD)."],
    "33750486": ["Ovariectomized Sprague-Dawley rats were fed high-fat(H-F) or H-P diets for two weeks, and then they had a hippocampal infusion of beta-amyloid(25-35) for 4 weeks to induce AD and an injection of monoidoacetate(MIA) into the articular cartilage to induce osteoarthritis."],
    "33785017": ["BACKGROUND: Alzheimer's disease (AD), an age-related neurodegenerative disorder and a serious public health concern, is mainly caused by beta-amyloid (Abeta)-induced toxicity."],
    "33803769": ["The aggregation of amyloid beta (Abeta) peptides and deposition of amyloid plaques are implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "33828600": ["AD was induced by amyloid-beta (Abeta     1-42      ) (10 MUg/2 MUL, intracerebroventricular injection, icv) and then BVS at 20, 40, and 80 mg/kg were injected intraperitoneally (ip) in six equal intervals over 21 days."],
    "33845371": ["Here, we review novel findings that have shifted our understanding of the role of Abeta in the pathogenesis of Alzheimer's disease."],
    "33848635": ["The imbalance between production and clearance of amyloid beta (Abeta) peptides and their resulting accumulation in the brain is an early and crucial step in the pathogenesis of Alzheimer's disease (AD)."],
    "33851209": ["Amyloid formation and the deposition of the amyloid-beta peptide are hallmarks of Alzheimer's disease pathogenesis."],
    "33875089": ["Recent studies found that the cellular uptake of extracellular amyloid beta (Abeta) peptides can lead to a build-up of intracellular Abeta in certain neuronal cells, which consequently lead to the onset of AD pathogenesis."],
    "33876786": ["A comparative study of the effects of phosphatidylserine rich in DHA and EPA on Abeta-induced Alzheimer's disease using cell models."],
    "33898246": ["In the present study, we report that SST has preventive effects on memory impairment and neuronal cell changes in an Abeta-induced AD-like mouse model.", "Korean traditional herbal formula Soshiho-tang attenuates memory impairment and neuronal damage in mice with amyloid-beta-induced Alzheimer's disease."],
    "33908427": ["The accumulation of toxic soluble oligomers of the amyloid-beta peptide (Abeta) is a key step in the pathogenesis of Alzheimer's disease."],
    "33935701": ["Leaves Ameliorate Cognitive Deficit and Neuronal Damage in a Mouse Model of Amyloid-beta-Induced Alzheimer's Disease.", "Here, we investigated the neuroprotective effects of    F. erecta     Thunb. against cognitive deficit and neuronal damage in a mouse model of amyloid-beta (Abeta)-induced AD."],
    "33967797": ["Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and accumulating evidences suggest a key role of amyloid-beta (Abeta) peptide in the pathogenesis of AD."],
    "33976546": ["The amyloid cascade hypothesis, claiming that excess production or reduced clearance of amyloid-beta (Abeta) and its aggregation into amyloid plaques, was accepted for a long time as the main cause of AD."],
    "33977265": ["Accumulation of amyloid beta peptides is thought to initiate the pathogenesis of Alzheimer's disease."],
    "34006557": ["As amyloid-beta (Abeta) is regarded as the core pathological change and the trigger mechanism of AD, anti-Abeta therapy may be an effective therapy."],
    "34051062": ["Based on existing literature, as a signaling molecule, Abeta is proposed to modulate its own turnover and synaptic plasticity through what is currently believed to be the cause of AD: the transient formation of pore-like oligomers.", "The link between Abeta-mediated synaptic plasticity and Abeta trafficking is central for understanding AD pathogenesis and remains a perplexing relationship.", "An emerging concept is that the amyloid-beta (Abeta) peptide, which was until recently deemed a major player in the cause of AD, may instead modulate synaptic plasticity and protect against excitotoxicity."],
    "34053209": ["Treadmill Running Improves Spatial Learning Memory Through Inactivation of Nuclear Factor Kappa B/Mitogen-Activated Protein Kinase Signaling Pathway in Amyloid-beta-Induced Alzheimer Disease Rats."],
    "34078792": ["Amyloid beta (Abeta) is one of the causative proteins of AD."],
    "34080759": ["The relationship between neuronal loss and Abeta deposits is one of the fundamental questions in the pathogenesis of AD."],
    "34084446": ["The excessive production and deposition of amyloid-beta (Abeta) is one of the most important etiologies of Alzheimer's disease (AD)."],
    "34086399": ["The aggregation and deposition of amyloid beta (Abeta) peptide onto neuronal cells, with consequent cellular membrane perturbation, are central to the pathogenesis of Alzheimer's disease (AD)."],
    "34099032": ["BACKGROUND: The aggregation of amyloid beta (Abeta) is central in the pathogenesis of Alzheimer's disease (AD)."],
    "34133880": ["The aggregation of amyloid beta (Abeta) peptide with subsequent formation of fibrils which deposit in senile plaques is considered one of the key triggers of Alzheimer's disease (AD)."],
    "34151790": ["Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model."],
    "34280181": ["Oligomers of the amyloid beta-protein (Abeta) have been implicated in the pathogenesis of Alzheimer's disease (AD) through their toxicity towards neurons."],
    "34285489": ["Purpose: Amyloid-beta (Abeta) is a brain protein that causes Alzheimer's disease."],
    "34286787": ["Additionally, they were able to inhibit the aggregation of amyloid-beta, one of the hallmarks in AD pathogenesis, and to exhibit considerable antioxidant capacity."],
    "34294676": ["Failures of clinical trials targeting amyloid-beta protein (Abeta), a key trigger of AD, have been explained by drug inefficiency regardless of the mechanisms of amyloid neurotoxicity, which are very difficult to address by available technologies."],
    "34299316": ["In addition, since toxic aggregates of amyloid-beta (Abeta) have been proposed as one of the major causes of the disease, the mechanism of clearing Abeta is also required to be investigated to reveal the etiology of AD clearly."],
    "34343891": ["The accumulation of amyloid beta (Abeta) peptides in the human brain leads to AD."],
    "34407949": ["Synapse loss at early stages of Alzheimer's disease is thought to be induced by beta-amyloid (Abeta) pathology."],
    "34411643": ["Chemical inhibition of sEH by TPPU, a selective sEH inhibitor, alleviated spatial learning and memory deficits, and elevated levels of neurotransmitters in Abeta-induced AD mice.", "The results showed that the sEH expression and activity were remarkably increased in the hippocampus of Abeta-induced AD mice.", "In this study, we evaluated the vital role of sEH in amyloid beta (Abeta)-induced AD mice, and revealed a possible molecular mechanism for inhibition of sEH in the treatment of AD."],
    "34446574": ["Using mixed gender human temporal cortex and cultured hippocampal neurons from rats we further show that this balance is perturbed during Alzheimer's disease (AD) because of amyloid beta (Abeta)-driven reduction in Ly6h, with severe reduction leading to increased phosphorylated tau and alpha7-mediated neurotoxicity."],
    "34502282": ["To investigate its therapeutic effects on AD pathology, we administered aripiprazole to 5xFAD AD model mice and examined beta-amyloid (betaA)-induced AD-like phenotypes, including betaA production, neuroinflammation, and cerebral glucose metabolism."],
    "34628876": ["BACKGROUND: Alzheimer's disease (AD) is a progressive dementia, and beta-amyloid (Abeta) accumulation is widely regarded as the primary pathogenesis of AD."],
    "34654465": ["METHODS: We examined relationships between CSF p-Tau/Abeta     40      , and CSF Abeta     42      /Abeta     40      , Abeta PET, and white matter hyperintensities (WMH) as well as vascular risk factors in 149 cognitively unimpaired and 52 impaired individuals who were presumably not on the Alzheimer's disease (AD) pathway due to negative Abeta status on both CSF and PET."],
    "34669098": ["Moreover, plant-based foods containing flavonoids were previously reported to show neuroprotective effects by modulating self-aggregation of amyloid-beta (Abeta)/or tau peptide into oligomers and fibrils, associated with the pathogenesis of AD."],
    "34671708": ["According to the glymphatic hypothesis, in physiological conditions, cerebrospinal fluid flows primarily during sleep and serves to remove metabolic wastes like the amyloid-beta and tau proteins whose accumulation is believed to cause Alzheimer's disease."],
    "34677321": ["Abnormal amyloid beta protein (Abeta) accumulation is believed to be the most common cause of AD."],
    "34695393": ["This study explored the effects of chronic stimulation of 5-HT4R on cognition, memory, long-term potentiation (LTP), paired-pulse ratio (PPR), and neuronal apoptosis in a rat model of amyloid-beta (Abeta)-induced AD."],
    "34715093": ["Here we investigate the potential of concurrent exercise to prevent recognition memory deficits in an Alzheimer's disease-like model induced by the hippocampal beta-amyloid (Abeta) injection in Wistar rats."],
    "34733055": ["Background: Alzheimer's disease (AD), a prevalent neurodegenerative disease with progressive dementia and neurotransmission (NT)-dysfunction-related complications in older adults, is known to be caused by abnormal Amyloid-beta (Abeta) peptide and associated amyloid plaques in the brain."],
    "34789556": ["Erratum: Medeiros et al., \\Connecting TNF-alpha Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid beta Protein\\."],
    "34798299": ["Coenzyme Q10, which scavenges FA, was shown to ameliorate Abeta-induced AD pathological phenotypes, thus suggesting a causative relation between FA toxicity and AD."],
    "34801648": ["In our study, our established 3D gelatin scaffold model and a well characterized in vivo (APP/PS1) murine model of AD were used to directly investigate the molecular, biochemical and behavioural effects of neuronal stem cell exposure to Abeta to improve understanding of the in vivo etiology of AD."],
    "34832029": ["Amyloid beta (Abeta) is a transmembrane protein known to play a major role in the pathogenesis of AD."],
    "34838849": ["MAIN METHODS: Neuroblastoma cell line SH-SY5Y was treated with beta-amyloid (Abeta) to induce AD-like pathological changes, which serves as Alzheimer's disease model."],
    "34856900": ["However, given the well-described role of misfolding peptides, particularly beta-amyloid (Abeta), in the pathogenesis of AD, the need for a broad-based conceptualization of AD, coalescing different theories into a single harmonized explanation emerges as a viable alternative."],
    "34861133": ["Mounting evidence suggests that amyloid-beta (Abeta) and vascular etiologies are intertwined in the pathogenesis of Alzheimer's disease (AD)."],
    "34867177": ["Amyloid beta (Abeta) and alpha-synuclein are two of the most investigated proteins, whose pathological aggregation and spreading are crucial to the pathogenesis of AD and PD, respectively."],
    "34878807": ["The main pathological phenomena of AD are the accumulation of beta-amyloid (Abeta), neurofibrillary tangles, and neuroinflammation, however, the specific molecular mechanism of pathogenesis of AD is not fully clear."],
    "34943094": ["The abnormal extracellular accumulation and deposition of the peptide amyloid-beta (Abeta) is considered as an early toxic event in AD pathogenesis, which initiates a series of events leading to neuronal dysfunction and death."],
    "34971171": ["Fibroblast Growth Factor 21 and Autophagy Modulation Ameliorates Amyloid beta-Induced Alzheimer Disease Pathology in Rats."],
    "35013124": ["All together, these findings suggest that L1-70 contributes to the clearance of Abeta in AD, thereby adding a novel perspective in understanding AD pathogenesis."],
    "35019536": ["Two major amyloid-beta peptide (Abeta) variants, Abeta     42       and Abeta     40      , play a pivotal role in the etiology of AD and the concentration ratio of which (i.e., Abeta     42      %) has been suggested to be the superior biomarker for AD."],
    "35043380": ["Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease.", "Amyloid-beta-induced Alzheimer's disease (AD) and its further complications are well-established models in preclinical studies and demonstrated by many researchers."],
    "35108926": ["Transport across the BBB is an important mediator of beta-amyloid (Abeta) accumulation in the brain and a contributing factor in the pathogenesis of Alzheimer's disease (AD)."],
    "35109138": ["Microglia, specialized phagocytic cells of the brain, likewise play a critical role in the clearance of cellular debris, particularly amyloid beta, which is involved in the pathogenesis of Alzheimer's disease."],
    "35109187": ["Increasing activity of post-synaptic kinase p38gamma that targets T205 in tau reduced memory deficits in symptomatic Abeta-induced AD models."],
    "35122611": ["Optimal Formula of Angelica sinensis Ameliorates Memory Deficits in beta-amyloid Protein-induced Alzheimer's Disease Rat Model."],
    "35134462": ["PINK1 regulates mitochondrial fission/fusion and neuroinflammation in beta-amyloid-induced Alzheimer's disease models."],
    "35148068": ["Abnormal aggregation and subsequent fibrillogenesis of amyloid-beta protein (Abeta) can cause Alzheimer's disease (AD)."],
    "35156141": ["For the purpose of discovering potential inhibitors of beta-amyloid (BACE1), which is a crucial element in Alzheimer's disease (AD) pathogenesis, an in silico study of naturally occurring compounds was performed using precise computational approaches."],
    "35212149": ["Here, we aim to refocus the amyloid cascade hypothesis on its original premise that the accumulation of amyloid beta (Abeta) peptide is the primary and earliest event in AD pathogenesis as based on current evidence, initiating several pathological events and ultimately leading to AD dementia."],
    "35214143": ["Neurofibrillary tangles (NFTs) composed of tau rather than senile plaques composed of Abeta are correlated with AD pathogenesis."],
    "35281253": ["The aggregation of beta-amyloid peptide (Abeta) is one potential cause for Alzheimer's disease (AD)."],
    "35294796": ["INTRODUCTION: Amyloid beta (Abeta) is a brain protein that causes Alzheimer's disease (AD)."],
    "35306343": ["Here, we analyzed the process of aggregation and accumulation of amyloid beta (Abeta), which causes the development of Alzheimer's disease (AD), by real-time 3D imaging under physiological conditions using a quantum dot nanoprobe that we previously developed."],
    "35372522": ["The cytotoxic self-aggregation of beta-amyloid (Abeta) peptide and islet amyloid polypeptide (IAPP) is implicated in the pathogenesis of Alzheimer's disease (AD) and Type 2 diabetes (T2D), respectively."],
    "35443153": ["Amyloid-beta and tau are key molecules in the pathogenesis of Alzheimer's disease, but it remains unclear how these proteins interact to promote disease."],
    "35443198": ["The present study was aimed to evaluate the effect of HIIT exercise and ecdy consumption synergistically on the changes in learning and memory functions, activities of hippocampal antioxidant enzymes, and neuronal population after AD induced by Abeta in male rats."],
    "35459147": ["These observations have given rise to the theory that Abeta is the primary trigger of AD, and induces proinflammatory activation of immune brain cells (i.e., microglia), which culminates in neuronal damage and cognitive decline."],
    "35474400": ["The accumulation of amyloid-beta at the neuronal sites is a major pathological hallmark involved in the etiology of Alzheimer's disease."],
    "35531555": ["The development of hQC inhibitors could prevent the self-aggregation of Abeta peptides, resulting in impeding AD."],
    "35631608": ["Subsequently, beta-amyloid (Abeta) was added into the brain-on-a-chip system to generate an AD-on-a-chip model, and toxic effects on neurons and the degeneration of synapses were observed."],
    "35656096": ["While AD research is dominated by protein/peptide-centric research based on the amyloid hypothesis, a theory that designates dysfunction in beta-amyloid production, accumulation, or disposal as the primary cause of AD, many studies focus on metabolomics as a means of understanding the biological processes behind AD progression."],
    "35663520": ["In this paper, we follow up with our preliminary biological studies that showed that Repeated electromagnetic field stimulation (REMFS) decreased the toxic amyloid-beta (A   beta    ) levels, which is considered to be the cause of Alzheimer's disease (AD)."],
    "35666692": ["These studies will enhance the physicochemical understanding of the structural changes of Abeta at the heterogeneous interfaces and the mechanism of Alzheimer's disease pathogenesis."],
    "35741166": ["Accumulation of aggregated amyloid-beta (Abeta) in the brain is considered the first pathological event within the pathogenesis of Alzheimer's disease (AD)."],
    "35742862": ["Disposition of amyloid beta (Abeta) into the perivascular space of the cerebral cortex has been recently suggested as a major source of its clearance, and its disturbance may be involved in the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease."],
    "35759136": ["Alzheimer's disease (AD) is a type of dementia characterized by the deposition of amyloid beta, a causative protein of AD, in the brain."],
    "35762411": ["Excessive accumulation of amyloid-beta (Abeta) is the leading cause of Alzheimer's disease (AD)."],
    "35928227": ["C99 is the immediate precursor for amyloid beta (Abeta) and therefore is a central intermediate in the pathway that is believed to result in Alzheimer's disease (AD)."],
    "35956985": ["In this study, the neuroprotective effects of 4-(4-(heptyloxy)phenyl)-2,4-dihydro-3   H    -1,2,4-triazol-3-one (W112) against beta-amyloid (Abeta)-induced AD pathology and its possible mechanism were explored both in vitro and in vivo.", "The results showed that W112 exhibits a neuroprotective role against Abeta-induced cytotoxicity in PC12 cells and improves the learning and memory abilities of Abeta-induced AD-like rats.", "Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3   H    -1,2,4-triazol-3-one via Repression of MAPK/NF-kappaB Signaling Pathways in beta-Amyloid-Induced Alzheimer's Disease Models."],
    "36015135": ["Pretreatment with the KBD formula for 14 days significantly improved the short- and long-term memory performance of Abeta-induced AD rats as assessed by the Morris Water Maze (MWM) and object-recognition tests.", "The main purpose of the present study was to determine the protective effect and mechanism of KBD in amyloid beta (Abeta)-induced AD rats and its toxicity profiles."],
    "36044812": ["Due to the hugely important roles of neurotransmitter acetylcholine (ACh) and amyloid-beta (Abeta) in the pathogenesis of Alzheimer's disease (AD), the development of multi-target directed ligands (MTDLs) focused on cholinesterase (ChE) and Abeta becomes one of the most attractive strategies for combating AD."],
    "36058175": ["CONCLUSIONS: Our findings indicate that Abeta peptide induces AD-like molecular changes at certain doses, and these changes could be detected by evaluating brain oscillations."],
    "36084891": ["The present study was designed to investigate the potential protective effects of minocycline against beta-amyloid (Abeta)-induced Alzheimer's disease (AD), recognition memory decline, and the possible involved anti-apoptotic mechanisms."],
    "36093396": ["Herpes Simplex Virus Infection Increases Beta-Amyloid Production and Induces the Development of Alzheimer's Disease."],
    "36120782": ["BACKGROUND: Amyloid-beta (Abeta) and tau protein accumulation in the brain is thought to be one of the causes of Alzheimer's disease (AD)."],
    "36144245": ["The transitional expression and aggregation of amyloid beta (Abeta) are the most important causative factors leading to the deterioration of Alzheimer's disease (AD), a commonly occurring metabolic disease among older people."],
    "36155521": ["The amyloid cascade hypothesis attributes a vital role to amyloid-beta protein (Abeta) in the pathogenesis of AD."],
    "36214002": ["BACKGROUND: Amyloid-beta (Abeta) is important in the etiology of Alzheimer's disease (AD)."],
    "36221865": ["Since Abeta plays an important role in the etiology of AD, therefore Abeta-linked pathways are mainly targeted in order to develop potential AD therapies."],
    "36284704": ["Amyloid beta-peptide (Abeta) misfolding into beta-sheet structures triggers neurotoxicity inducing Alzheimer's disease (AD)."],
    "36361906": ["Amyloid beta (Abeta) peptide is suspected to be a major cause of AD, and therefore, simultaneously blocking its formation and aggregation by inhibition of the enzymes BACE-1 (beta-secretase) and AChE (acetylcholinesterase) by a single inhibitor may be an effective therapeutic approach, as compared to blocking one of these targets or by combining two drugs, one for each of these targets."],
    "36362046": ["This study could reveal the role of a highly toxic Abeta on AD pathogenesis, thereby contributing to the development of a novel therapeutic strategy targeting the toxic conformer."],
    "36422822": ["New therapies under development include agents that target amyloid-beta (Abeta), a key component in AD pathogenesis."],
    "36438603": ["Given the promising data on the additive effect of combination therapy with donepezil (Aricept), an acetylcholinesterase inhibitor (AChEI), and regarding the similar neuronal mechanisms through which donepezil (DON) and environmental enrichment (EE) exert their enhancing effects on cognition; we asked whether simultaneous treatment with two paradigms in amyloid-beta-induced AD rats may lead to greater protection against the cognitive impairments than either treatment individually."],
    "36510132": ["Our findings revealed that LOTUS may be a promising therapeutic agent in counteracting Abeta-induced AD pathologies.", "PirB deletion has been shown to suppress Abeta-induced synaptic dysfunction and behavioral deficits in AD model mice, implying that PirB mediates Abeta-induced AD pathology."],
    "36544574": ["Oligomers of amyloid beta (Abeta) represent an early aggregative form that causes neurotoxicity in the pathogenesis of Alzheimer's disease (AD)."],
    "36549596": ["Naringin enhances long-term potentiation and recovers learning and memory deficits of amyloid-beta induced Alzheimer's disease-like behavioral rat model.", "However, the effect of naringin in AD caused by Abeta has not been clearly studied, and there are few studies on the electrophysiological aspect."],
    "36596482": ["The production of amyloid beta peptide (Abeta) is an important process relating to the pathogenesis of Alzheimer disease (AD)."],
    "36610160": ["Esculentoside A (EsA), isolated from Phytolacca esculenta, exhibits pharmacotherapeutic efficacy in mice with amyloid beta-induced AD."],
    "36623626": ["Hesperidin methylchalcone (HMC) hinders amyloid-beta induced Alzheimer's disease by attenuating cholinesterase activity, macromolecular damages, oxidative stress and apoptosis via regulating NF-kappaB and Nrf2/HO-1 pathways."],
    "36630532": ["Impact of nanoparticles on amyloid beta-induced Alzheimer's disease, tuberculosis, leprosy and cancer: A systematic review."],
    "36651694": ["Oxidative stress due to Cu     2+      -triggered aggregation of beta-amyloid protein (Abeta) and reactive oxygen species (ROS) overexpression in the brain is an important hallmark of early stages of Alzheimer's disease (AD) pathogenesis."],
    "36674792": ["Alzheimer's disease (AD) is known to be caused by amyloid beta-peptide (Abeta) misfolded into beta-sheets, but this knowledge has not yet led to treatments to prevent AD."],
    "36680733": ["Intriguingly, PCO treatment improved all the above-mentioned neuropathological changes in the Abeta-induced AD rats."],
    "36704637": ["Overproduction and accumulation of beta-amyloid and its improper clearance can cause neurotoxicity leading to Alzheimer's disease."],
    "36803816": ["The amyloid hypothesis, that established amyloid-beta (Abeta) peptide as the primary cause of Alzheimer's disease (AD) and related dementia, has driven the development of treatments for neurodegeneration for 30 years."],
    "36816173": ["This study is going on to examine the effect of ghrelin on antioxidant status in the rat's model of AD induced by Abeta.", "The effect of ghrelin on antioxidant status in the rat's model of Alzheimer's disease induced by amyloid-beta."],
    "36866639": ["It is proven that protein aggregation like amyloid beta (Abeta) is one of the critical factors causing AD and, its diagnosis in the early stages of the disease is important for the treatment or prevention of AD."],
    "36868776": ["The \\amyloid cascade hypothesis\\ stablishes that the aggregation of the beta-amyloid protein (Abeta     42      ) is the first event that subsequently triggers AD development."],
    "36878848": ["Mounting evidence suggests that the accumulation and aggregation of amyloid-beta peptides (Abeta), which constitute amyloid plaques in the brain, is critical for initiating and accelerating AD pathogenesis."],
    "36889654": ["However, it has been suggested that rather than the fibrillary amyloid beta (Abeta) deposits, it is smaller, soluble Abeta aggregates that exert a neurotoxic effect and trigger AD pathogenesis."],
    "36945328": ["Our preliminary biological studies showed that Repeated Electromagnetic Field Stimulation (REFMS) applying an EM frequency of 64 MHz and a specific absorption rate (SAR) of 0.4 - 0.9 W/kg decrease the level of amyloid-   beta     peptides (A   beta    ), which is the most likely etiology of AD."],
    "36945751": ["In this review, we first discuss the importance of Abeta in the pathogenesis of AD, then summarize the latest progress of Abeta-related targets and compounds."],
    "36978955": ["The current study aims to investigate the effect of baicalein in combination with memantine in beta-amyloid-induced AD in albino Wistar rats.", "The Combination of Baicalein and Memantine Reduces Oxidative Stress and Protects against beta-amyloid-Induced Alzheimer's Disease in Rat Model."],
    "37068195": ["Brain-targeted lycopene-loaded microemulsion modulates neuroinflammation, oxidative stress, apoptosis and synaptic plasticity in beta-amyloid-induced Alzheimer's disease mice."],
    "37101809": ["Polymerization of soluble amyloid beta (Abeta) peptide into protease-stable insoluble fibrillary aggregates is a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "37105250": ["Administraction of HPS ameliorated age-related symptoms such as imbalanced intestinal homeostasis, sleep disturbances, and beta-amyloid (Abeta) induced Alzheimer's disease (AD) in flies, but did not modulate neurobehavioral deficits in the AD model of tauopathy and the Parkinson's disease (PD) model of Pink1 mutation."],
    "37173803": ["Remarkably, hIAPP has structural similarity with amyloid beta (Abeta) and can engage in the pathogenesis of T2DM and Alzheimer's disease (AD)."],
    "37179042": ["Minocycline effects on memory and learning impairment in the beta-amyloid-induced Alzheimer's disease model in male rats using behavioral, biochemical, and histological methods.", "This study investigated the effect of minocycline on the changes in learning and memory functions, activities of blood serum antioxidant enzymes, neuronal loss, and the number of Abeta plaques after AD induced by Abeta in male rats."],
    "37212117": ["The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-beta-Induced Alzheimer's Disease.", "Interestingly, pretreatment with CoQ10, HIIT, or both, could markedly improve the oxidative status and cognitive decline in the MWM and NOR tests, and hinder neuronal loss in the hippocampus of Abeta-induced AD rats.", "OBJECTIVE: This study was done to determine the protective effects of coenzyme Q10 (CoQ10) and high-intensity interval training (HIIT) alone and in combination for eight continuous weeks, on oxidative status, cognitive functions, and histological changes in the hippocampus in amyloid-beta (Abeta)-induced AD rats."],
    "37239068": ["Emerging evidence over the past few decades supports the critical role of Abeta and tau in AD pathogenesis and the participation of glial cells in different molecular and cellular pathways."],
    "37245024": ["CONCLUSIONS: Together, these findings indicate the protective functions of the N-terminal Abeta fragments extend to reactive gliosis and gliotoxicity induced by Abeta, by preventing or reversing glial reactive states indicative of neuroinflammation and synaptic loss central to AD pathogenesis."],
    "37263123": ["This study provides basic data for the effects of Abeta and donepezil on plasma and urine metabolites in Abeta-induced AD rat models.", "Effects of donepezil treatment on plasma and urine metabolites in amyloid beta-induced Alzheimer's disease rats."],
    "37307834": ["Decades of research have demonstrated an incontrovertible role of amyloid-beta (Abeta) in the etiology of Alzheimer's disease (AD)."],
    "37348174": ["This study aimed to evaluate whether preconditioning MSCs with dimethyl fumarate (DMF), a Nrf2 inducer, could enhance MSC therapeutic efficacy in an amyloid-beta (Abeta     1-42      )-induced AD rat model."],
    "37506558": ["The abnormal accumulation of amyloid beta protein (Abeta) is one of the most important causes of Alzheimer's disease (AD) and is usually a detecting biomarker."],
    "37607046": ["Recent studies have found that beta-amyloid (Abeta) oligomers may play much more important roles than amyloid plaques in the pathogenesis of Alzheimer's disease (AD)."],
    "37609338": ["Microglial cGAS deletion protects against amyloid-beta induced Alzheimer's disease pathogenesis."],
    "37619312": ["Dose-dependent neuroprotective effects of adipose-derived mesenchymal stem cells on amyloid beta-induced Alzheimer's disease in rats."],
    "37626631": ["Amyloid-beta (Abeta) is one of the causes of Alzheimer's disease (AD), damaging nerve membranes and inducing neurotoxicity."],
    "37628913": ["In conclusion, this study demonstrates the neuroprotective effects of NACA against beta-amyloid induced AD-like pathology."],
    "37654789": ["The question of how Abeta relates to neurovascular function and which is the trigger for AD has recently come into sharp focus."],
    "37663321": ["Aggregation of amyloid-beta peptide (Abeta) is hypothesized to be the primary cause of Alzheimer's disease (AD) progression."],
    "37667395": ["However, it is still a challenge to understand the DNs of specific neurons that are vulnerable to Abeta in the pathogenesis of AD."],
    "37718800": ["Probabilistic and parsimony-based arguments regarding available genetics data are used to propose that Hardy and Higgin's amyloid cascade hypothesis is valid but is commonly interpreted too narrowly to support, incorrectly, the primacy of the amyloid-beta peptide (Abeta) in driving Alzheimer's disease pathogenesis."],
    "37728399": ["The accumulation of amyloid-beta (Abeta) into senile plaques and the resulting continuous oxidative stress are major pathogenic mechanisms in Alzheimer's disease (AD)."],
    "37758932": ["This study aimed to assess the defensive properties of rosavin against Alzheimer's disease induced by amyloid-beta, utilizing experimental models."],
    "37853914": ["Sequential proteolysis of the amyloid precursor protein (APP) by gamma-secretases generates amyloid-beta (Abeta) peptides and defines the proportion of short-to-long Abeta peptides, which is tightly connected to Alzheimer's disease (AD) pathogenesis."],
    "37905874": ["ABSTRACT: The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to play key roles in Alzheimer's disease pathogenesis and are considered the main pathological hallmarks of this devastating disease."],
    "37921143": ["METHODS: The present study reviews the arsenic role in the generation of amyloid-beta from its precursor that leads to Alzheimer's disease through the published article from Pubmed and Scopus."],
    "37935338": ["Although the validation of the long standing amyloid cascade hypothesis would seem to be at hand, what remains is the puzzling issue of why - if Abeta indeed causes AD - does removing it from the brain not stop the disease entirely."],
    "37976283": ["Oligomers formed from monomers of the amyloid beta-protein (Abeta) are thought to be central to the pathogenesis of Alzheimer's disease (AD)."],
    "37983764": ["Amyloid-beta (Abeta) and its assemblies play important roles in the pathogenesis of Alzheimer's disease (AD)."],
    "38053635": ["Oligomeric amyloid beta (oAbeta) is considered a major synaptotoxic trigger for AD."],
    "38071408": ["AD was induced using amyloid beta (Abeta) and confirmed through the Morris water maze (MWM) behavioural test and Congo red staining."],
    "38143280": ["Amelioration of Amyloid-beta Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK-3beta/Wnt/beta-Catenin Signaling."],
    "38163326": ["Amyloid-beta (Abeta) forms heterogeneous oligomers, which are implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "38188833": ["Retracted: Herpes Simplex Virus Infection Increases Beta-Amyloid Production and Induces the Development of Alzheimer's Disease."],
    "38194817": ["Abnormal aggregation and fibrillogenesis of amyloid-beta protein (Abeta) can cause Alzheimer's disease (AD)."],
    "38211684": ["Potential links between platelets and amyloid-beta in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies."],
    "38242524": ["The undifferentiated OE-MSCs were transplanted either by intranasal (IN) or intrahippocampal (IH) injection to rat models of AD, which were induced by injecting amyloid-beta (Abeta) intrahippocampally."],
    "38287166": ["Compelling genetic and biomarker evidence supports Abeta as the root cause of AD."],
    "38344035": ["Aggregates of amyloid-beta (Abeta) peptides are thought to cause Alzheimer's disease."],
    "38455162": ["Accumulation of beta-amyloid peptide (Abeta) induces neurotoxicity, which is the primary risk factor in the pathogenesis of Alzheimer's disease (AD)."],
    "38473727": ["The perivascular space has been proposed as a clearance pathway for degradation products in the brain, including amyloid beta, the accumulation of which may induce Alzheimer's disease."],
    "38475929": ["BACKGROUND: Although abnormal accumulation of amyloid beta (Abeta) protein is thought to be the main cause of Alzheimer's disease (AD), emerging evidence suggests a pivotal vascular contribution to AD."],
    "38497073": ["The beta-amyloid (Abeta) accumulation triggers AD pathogenesis, though clinical trials lowering Abeta have not altered disease outcomes suggesting other interacting factors to be identified for drug design of AD."],
    "38534427": ["One of the most accepted theories in AD, the amyloid beta (Abeta) hypothesis, assumes that the buildup of the peptide Abeta is the root cause of AD."],
    "38615460": ["This review summarizes the research on beta-hairpins in Abeta peptides and discusses the relevance of this conformation in AD pathogenesis and drug development."],
    "10195200": ["Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide, are important for the pathogenesis of Alzheimer's dementia."],
    "10206645": ["This cleavage occurs within the predicted transmembrane domain, releasing the Notch intracellular domain (NICD), and is reminiscent of gamma-secretase-mediated cleavage of beta-amyloid precursor protein (APP), a critical event in the pathogenesis of Alzheimer's disease."],
    "10379578": ["Endocytosis of full-length beta-amyloid precursor protein (APP) from the plasma membrane contributes to beta-amyloid peptide (Abeta) secretion, and, hence, potentially contributes to the molecular pathogenesis of Alzheimer's disease."],
    "10479682": ["Although abnormal processing of beta-amyloid precursor protein (APP) has been implicated in the pathogenic cascade leading to Alzheimer's disease, the normal function of this protein is poorly understood."],
    "10632583": ["Both LRP and several of its ligands, including tissue plasminogen activator (tPA), apolipoprotein E/lipoproteins, alpha(2)-macroglobulin, and the beta-amyloid precursor protein, have been implicated in various neuronal functions and in the pathogenesis of Alzheimer's disease."],
    "10878808": ["The beta-amyloid precursor protein (beta-APP), which is involved in the pathogenesis of Alzheimer's disease, and the Notch receptor, which is responsible for critical signalling events during development, both undergo unusual proteolysis within their transmembrane domains by unknown gamma-secretases."],
    "10933822": ["These results indicate that oxidatively damaged phospholipid membranes promote beta-sheet formation by amyloid beta-proteins, and they suggest a possible role for lipid peroxidation in the pathogenesis of Alzheimer's Disease."],
    "10944232": ["Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide (Abeta), play a critical role in the pathogenesis of Alzheimer's dementia."],
    "10959033": ["Cerebral accumulation of the amyloid beta-protein (Abeta) is an early and invariant event in the pathogenesis of Alzheimer's disease (AD)."],
    "10978191": ["The final step in the generation of the amyloid-beta protein (Abeta), implicated in the etiology of Alzheimer's disease, is proteolysis within the transmembrane region of the amyloid precursor protein (APP) by gamma-secretase."],
    "11099491": ["The abnormal accumulation of the amyloid beta protein (Abeta) has been implicated as an early and critical event in the etiology and pathogenesis of Alzheimer's disease (AD)."],
    "11140685": ["Much evidence indicates that abnormal processing and extracellular deposition of amyloid-beta peptide (A beta), a proteolytic derivative of the beta-amyloid precursor protein (betaAPP), is central to the pathogenesis of Alzheimer's disease (reviewed in ref. 1).", "Evidence that A beta immunization also reduces cognitive dysfunction in murine models of Alzheimer's disease would support the hypothesis that abnormal A beta processing is essential to the pathogenesis of Alzheimer's disease, and would encourage the development of other strategies directed at the 'amyloid cascade'."],
    "11193150": ["The amyloid-beta protein (A beta), strongly implicated in the etiology of Alzheimer's disease (AD), is formed from the amyloid-beta precursor protein (APP) through sequential proteolysis by beta- and gamma-secretases."],
    "11227137": ["Recent findings have underlined the significance of beta-amyloid protein (betaA4) in the etiology of Alzheimer's disease (AD)."],
    "11378243": ["Processing of the beta-amyloid precursor protein (APP) in the endoplasmic reticulum and the Golgi apparatus may be critical in generating the beta-amyloid molecules linked to the pathogenesis of Alzheimer's disease."],
    "11549733": ["Interactions between amyloid beta-protein (Abeta) and lipids have been suggested to play important roles in the pathogenesis of Alzheimer's disease."],
    "12052174": ["A considerable body of evidence has accumulated in recent years implicating the beta-amyloid protein (Abeta) in the etiology of Alzheimer s disease (AD)."],
    "12153480": ["Aberrant production of amyloid-beta peptides by processing of the beta-amyloid precursor protein leads to the formation of characteristic extracellular protein deposits which are thought to be the cause of Alzheimer's disease."],
    "12196135": ["Despite extensive genetic and animal modelling data that support a central role for the amyloid beta-protein (A beta) in the genesis of Alzheimer's disease, the specific form(s) of A beta which causes injury to neurons in vivo has not been identified."],
    "12740129": ["Amyloid beta-protein (Abeta) is believed to be a primary cause of Alzheimer's disease (AD)."],
    "12740439": ["gamma-Secretase catalyzes the intramembrane proteolysis of Notch, beta-amyloid precursor protein, and other substrates as part of a new signaling paradigm and as a key step in the pathogenesis of Alzheimer's disease."],
    "12937642": ["Experimental results have suggested that abnormalities in the processing of the beta-amyloid precursor protein (beta APP) are central to the pathogenesis of Alzheimer's disease (AD).", "Given the important role that abnormal processing of beta APP plays in the genesis of AD, most current efforts are directed at either modulating A beta peptide production or inhibiting its ability to aggregate into fibrils and cause neurotoxicity."],
    "1418219": ["Although the precise functional role of PN-II/APP is not clear, the accumulation of amyloid beta-protein within the neuropil appears to be one of the earliest events in the pathogenesis of Alzheimer's disease (AD)."],
    "14522007": ["Impaired efflux has been suggested as a mechanism by which AbetaP can accumulate in the CNS and so lead to Alzheimer's disease (AD)."],
    "1461350": ["Cell culture systems for evaluating the biological effects of the beta-amyloid protein are potentially important tools in the study of the pathogenesis of Alzheimer's disease."],
    "14659572": ["Amyloid beta protein (Abeta) fibrillogenesis is considered one of the crucial steps of Alzheimer's disease (AD) pathogenesis."],
    "15286183": ["Mutations in the amyloid precursor protein (APP) gene inducing abnormal processing and deposition of beta-amyloid protein in the brain have been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "15363895": ["Secretion and progressive cerebral accumulation of beta-amyloid peptides (A beta), which derive by endoproteolytic ('amyloidogenic') processing of beta-amyloid precursor protein (APP), are felt to represent collectively an early and necessary event in the pathogenesis of Alzheimer's disease."],
    "15485850": ["Gamma-secretase cleavage of beta-amyloid precursor protein (APP) is crucial in the pathogenesis of Alzheimer disease, because it is the decisive step in the formation of the C terminus of beta-amyloid protein (Abeta)."],
    "15850663": ["Although beta-amyloid precursor protein (APP) and Abeta have a central role in the etiology of AD, it is not clear which forms of APP or Abeta are responsible for the neuronal vulnerability in AD brain."],
    "15944381": ["Beta-amyloid precursor protein (APP) is a conserved and ubiquitous transmembrane glycoprotein strongly implicated in the pathogenesis of Alzheimer's disease but whose normal biological function is unknown."],
    "15975058": ["Alzheimer's disease (AD) is a common cause of dementia, resulting from accumulated beta-amyloid protein deposits in the brain."],
    "15975082": ["Despite considerable progress in defining the role of the beta-amyloid protein (Abeta) in the pathogenesis of Alzheimer's disease (AD), the mechanism by which accumulation of Abeta causes dementia remains elusive."],
    "16324726": ["Continuous intracerebroventricular infusion of beta-amyloid peptide 1-40 (Abeta(1-40)) in animal models induces learning and memory impairment associated with dysfunction of the cholinergic neuronal system, which has been considered to be a pathological model of Alzheimer's disease [Nitta, A., Itoh, A., Hasegawa, T., Nabeshima, T., 1994. Beta-amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.]."],
    "16364890": ["Accumulation of beta-amyloid protein (Abeta) in the extracellular space of the brain has been hypothesized to be a culprit in the pathogenesis of Alzheimer's disease."],
    "16597736": ["Gamma-secretase is a multisubunit aspartyl protease complex that catalyzes intramembrane cleavage of beta-amyloid precursor protein (APP), a substrate key to Alzheimer's disease pathogenesis, and of Notch, a substrate crucial for cell differentiation."],
    "16650774": ["The aggregation of the beta-amyloid protein (Abeta) is an important step in the pathogenesis of Alzheimer's disease."],
    "16752395": ["The aggregation of the amyloid-beta-protein (Abeta) is an important step in the pathogenesis of Alzheimer's disease."],
    "16771827": ["Beta amyloid protein (Abeta) and acetylcholinesterase (AChE) have been shown to be closely implicated in the pathogenesis of Alzheimer's disease."],
    "17069749": ["The aggregation (fibril formation) of amyloid beta-protein (Abeta) is considered to be a crucial step in the etiology of Alzheimer's disease (AD)."],
    "17073707": ["Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease."],
    "17076655": ["The central role of the beta-amyloid protein (Abeta) in the pathogenesis of AD and the relationship between plaque and tangle pathology is now much better understood."],
    "17108166": ["Accumulation of amyloid beta protein (Abeta) aggregates is hypothesized to trigger a pathological cascade that causes Alzheimer's disease (AD)."],
    "17286590": ["Converging lines of evidence suggest that progressive accumulation of the amyloid beta-protein (A beta) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that A beta had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects."],
    "17331655": ["Cerebral microvascular amyloid beta protein (Abeta) deposition and associated neuroinflammation are increasingly recognized as an important component leading to cognitive impairment in Alzheimer's disease and related cerebral amyloid angiopathy (CAA) disorders."],
    "17376966": ["Cerebral microvascular amyloid beta protein (Abeta) deposition and associated neuroinflammation is increasingly recognized as an important component leading to cognitive impairment in Alzheimer's disease and related cerebral amyloid angiopathy disorders."],
    "17507561": ["Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein."],
    "17767011": ["Amyloid-beta peptides (Abeta), generated by proteolysis of the beta-amyloid precursor protein (APP) by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease (AD).", "Inflammation is also believed to be integral to the pathogenesis of AD."],
    "18275940": ["Secretion and progressive cerebral accumulation of beta-amyloid peptides (Abeta) derived by endoproteolytic (\\amyloidogenic\\) processing of beta-amyloid precursor protein (APP) represent collectively an early and necessary event in the pathogenesis of Alzheimer's disease."],
    "18359102": ["During the last 25 years, neuropathological, biochemical, genetic, cell biological and even therapeutic studies in humans have all supported the hypothesis that the gradual cerebral accumulation of soluble and insoluble assemblies of the amyloid beta-protein (Abeta) in limbic and association cortices triggers a cascade of biochemical and cellular alterations that produce the clinical phenotype of Alzheimer's disease (AD)."],
    "18400214": ["The role of amyloid-beta protein (Abeta) in the pathogenesis of Alzheimer's disease (AD) has been widely investigated and amyloid aggregates are considered a major cause of neuronal dysfunction."],
    "18404827": ["Conformational changes of Alzheimer's beta-amyloid protein (AbetaP) enhance its neurotoxicity, and finally lead to Alzheimer's pathogenesis."],
    "18515070": ["Here, we further test whether FP may exhibit 'amyloid-like' characteristics, by contrasting its structural and functional properties with those of Abeta(26-42), a 17-residue peptide from the C-terminus of the amyloid-beta protein responsible for Alzheimer's."],
    "18537546": ["The amyloid beta-protein (Abeta), which is believed to cause Alzheimer's disease (AD), is considered an archetypal amyloidogenic protein."],
    "18554321": ["The beta-amyloid precursor protein (APP) is central to the pathogenesis of Alzheimer's disease, but its normal functions in the brain are poorly understood."],
    "18650433": ["The generation and aggregation of amyloid beta-protein in the brain are believed to be a primary cause of Alzheimer disease pathogenesis, and indeed, early onset Alzheimer disease is genetically linked to APP and also to presenilins 1 and 2, which are components of gamma-secretase."],
    "18728806": ["The neurotoxicity of beta-amyloid protein (AbetaP) is implicated in the etiology of Alzheimer's disease."],
    "19167357": ["Beta-amyloid peptide (Abeta) is generated via the sequential proteolysis of beta-amyloid precursor protein (APP) by beta- and gamma-secretases, and plays a crucial role in the pathogenesis of Alzheimer's disease (AD)."],
    "1933692": ["The precursor protein is processed constitutively within the beta-amyloid domain, leading to the release of the large N-terminal portion into the extracellular medium. beta-amyloid protein may be toxic to certain neuronal cell types and its early deposition may be an important event in the pathogenesis of Alzheimer's disease."],
    "19337829": ["The accumulation of oligomeric species of beta-amyloid protein in the brain is considered to be a key factor that causes Alzheimer's disease (AD)."],
    "19384407": ["BACKGROUND: Hypocatabolism of the amyloid beta-protein (Abeta) by insulin-degrading enzyme (IDE) is implicated in the pathogenesis of Alzheimer disease (AD), making pharmacological activation of IDE an attractive therapeutic strategy."],
    "19402778": ["Neurotoxicity of Alzheimer's beta-amyloid protein (AbetaP) is central to the pathogenesis of Alzheimer's disease (AD)."],
    "19407341": ["Amyloid-beta (Abeta) peptides, generated by the proteolysis of beta-amyloid precursor protein by beta- and gamma-secretases, play an important role in the pathogenesis of Alzheimer disease."],
    "19710311": ["The 42-aa-long beta-amyloid protein--Abeta(1-42)--is thought to play a central role in the pathogenesis of Alzheimer's disease (AD) (Walsh and Selkoe, 2007)."],
    "19786811": ["The beta-amyloid precursor protein (APP) is a type I transmembrane protein whose functions and metabolic processing have been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "19890727": ["The overexpression of these genes has been associated to a greater production of the beta-amyloid protein which, in turns, is the major factor that leads to Alzheimer's disease, and to the development of brain-tumors, respectively."],
    "19930651": ["Extensive multi-disciplinary research has implicated the amyloid beta-protein (Abeta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of Abeta are mediators of synaptic compromise."],
    "20097446": ["Extensive research has implicated the amyloid-beta protein (Abeta) in the aetiology of Alzheimer's disease (AD)."],
    "20129098": ["The amyloid beta protein with 42 amino acid residues (Abeta), which is a causative protein of Alzheimer's disease (AD), forms the complex with copper (II) to induce the cholesterol oxidase-like activity by the proton transfer from the cholesterol."],
    "20348104": ["Pathogenic generation of the 42-amino acid variant of the amyloid beta-peptide (Abeta) by beta- and gamma-secretase cleavage of the beta-amyloid precursor protein (APP) is believed to be causative for Alzheimer disease (AD)."],
    "20558149": ["The amyloid beta-protein (Abeta)-induced complement system activation plays an important role in Alzheimer's disease (AD)."],
    "20586699": ["Extensive literature exists supporting a causative role of mitochondrial dysfunction and amyloid-beta protein in the pathogenesis of Alzheimer's disease (AD)."],
    "20600609": ["Amyloid-beta peptides (Abeta) generated by proteolysis of the beta-amyloid precursor protein (APP) by beta- and gamma-secretases play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "20616783": ["Amyloid beta-protein (Abeta) is central to AD pathogenesis."],
    "20659435": ["Diffusible oligomeric assemblies of the amyloid beta-protein (Abeta) could be the primary factor in the pathogenic pathway leading to Alzheimer's disease (AD)."],
    "21197086": ["Among the various theories that have been put forth to explain the pathophysiology of AD, the oxidative stress induced by amyloid beta-protein (Abeta) deposition has received great attention."],
    "21375783": ["Alzheimer's Disease (AD) is the most common neurodegenerative disorder leading to dementia and deposition of amyloid beta protein (Abeta) is the pathological feature of AD pathogenesis."],
    "21423554": ["Mounting evidence has suggested that significance of oligomerization of beta-amyloid protein and neurotoxicity in the molecular mechanism of AD pathogenesis."],
    "21487536": ["Genetic studies of early-onset familial Alzheimer's disease cases revealed causative mutations in the genes encoding beta-amyloid precursor protein and the gamma-secretase-complex components presenilin-1 and presenilin-2, supporting an important role of beta-amyloid in the pathogenesis of Alzheimer's disease."],
    "21924918": ["Aggregation of 42-residue amyloid beta-protein (Abeta42) plays a pivotal role in the etiology of Alzheimer's disease (AD)."],
    "22086139": ["Transgenic rodent models over-expressing human beta-amyloid precursor protein (beta-APP) and mutant forms of tau have become precious tools to study and understand the pathogenesis of AD at the molecular, cellular and behavioural levels, and to test new therapeutic agents."],
    "22285195": ["The central role of Abeta protein in the AD etiology is well-established, and its increased deposition in AD brain is attributed to its decreased clearance from the brain."],
    "22543851": ["AD is caused by amyloid-beta protein (Abeta) accumulation."],
    "23041348": ["Antioxidant role of amyloid beta protein in cell-free and biological systems: implication for the pathogenesis of Alzheimer disease."],
    "23182244": ["Aggregation of the amyloid beta-protein (Abeta) is believed to play a central role in initiating the molecular cascade that culminates in Alzheimer-type dementia (AD), a disease which in its early stage is characterized by synaptic loss and impairment of episodic memory."],
    "23427404": ["OBJECTIVE: To investigate the effect of Bushenyisui Formula on cell apoptosis and positive B cell lymphoma (Bcl-2) in the Brain of rat models of Alzheimer's disease (AD) induced by beta-amyloid protein (Abeta) and the mechanism underlying the effect."],
    "23789343": ["[Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease]."],
    "23844122": ["Amyloid beta (abeta) protein assembles into larger protein aggregates during the pathogenesis of Alzheimer's disease (AD) and there is increasing evidence that soluble abeta oligomers are a critical pathologic species."],
    "23991168": ["The aggregation of amyloid beta protein (Abeta) is a key step in the pathogenesis of Alzheimer's disease (AD), and therefore inhibitory substances for Abeta aggregation may have preventive and/or therapeutic potential for AD."],
    "24052108": ["It proposes that abnormal production of beta amyloid protein (Abeta) is the cause of AD and that the neurotoxicity is due to Abeta itself or its oligomeric forms."],
    "24566726": ["beta-amyloid precursor protein (beta-APP), also known as Abeta peptide, has a key role in the pathogenesis of Alzheimer's disease, and is also likely to be involved in the development of refractory epilepsy."],
    "24680748": ["Neurotoxic amyloid beta-protein (Abeta) is believed to play a causative role in the development of AD."],
    "24823497": ["The longer and neurotoxic species of amyloid-beta protein (Abeta), Abeta42 and Abeta43, contribute to Abeta accumulation in Alzheimer's disease (AD) pathogenesis and are considered to be the primary cause of the disease."],
    "24840308": ["Evidence for a central role of amyloid beta-protein (Abeta) in the genesis of Alzheimer's disease (AD) has led to advanced human trials of Abeta-lowering agents."],
    "24936619": ["Changes in spatial learning ability and memory and induction of AD-like pathogenesis were not detected by in vivo brain imaging for amyloid-beta peptide accumulation and by immunohistochemical staining of amyloid precursor protein, amyloid-beta protein, tau, and phosphorylated tau protein."],
    "24962158": ["We investigated the effects of cerebral arterial microemboli on amyloid beta protein (Abeta) deposition in the hippocampal region of amyloid precursor protein/presenilin 1 (APP/PS1) double transgenic mice and evaluated the role of cerebral arterial microemboli in Alzheimer's disease (AD) pathogenesis."],
    "25169677": ["Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis."],
    "25655625": ["UNLABELLED: Pathologic deposition of amyloid beta (Abeta) protein is a key component in the pathogenesis of Alzheimer disease (AD) but not a feature of frontotemporal dementia (FTD)."],
    "25881896": ["The amyloid beta-protein (Abeta) is believed to play a causative role in the development of Alzheimer's disease (AD)."],
    "26394756": ["Strong evidence exists for a central role of amyloid beta-protein (Abeta) oligomers in the pathogenesis of Alzheimer's disease."],
    "26401936": ["It is believed that the amyloid beta-protein (Abeta) plays a causative role in the development of Alzheimer's disease (AD)."],
    "26463138": ["The aged brain may be used as a tool to investigate altered metabolism of amyloid beta protein (Abeta42) that may have implications in the pathogenesis of Alzheimer's disease (AD)."],
    "26496862": ["The accumulation of amyloid-beta protein (Abeta) is significant in the pathogenesis of Alzheimer's disease."],
    "26614753": ["Although the amyloid-beta protein associated with the Alzheimer's disease plaque has been detectable in living people for over a decade, its importance in the pathogenesis of Alzheimer's disease is still debated."],
    "26839237": ["Evidence suggests that oligomers of the 42-residue form of the amyloid beta-protein (Abeta), Abeta42, play a critical role in the etiology of Alzheimer's disease (AD)."],
    "27406082": ["Deposition of amyloid beta protein (Abeta) is a key component in the pathogenesis of Alzheimer's disease (AD)."],
    "27543203": ["Tau aggregation and amyloid beta protein (Abeta) deposition are the main causes of Alzheimer's disease (AD)."],
    "27546887": ["Alzheimer's disease (AD) is a complex, progressive neurological disorder characterized by the formation of extracellular amyloid plaques composed of beta-amyloid protein (Abeta), the key component in pathogenesis of AD."],
    "27641666": ["Microglia-mediated clearance of amyloid beta-protein (Abeta) via Toll-like receptor 4 (TLR4) signaling may play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "27873937": ["Extensive evidence supports an important role for soluble oligomers of the amyloid beta-protein (Abeta) in Alzheimer's Disease pathogenesis."],
    "27940601": ["Further study of Abeta binding proteins will define the molecular basis of this crucial step in AD pathogenesis."],
    "28131834": ["Increasing evidence has shown that beta-amyloid protein (Abeta) production is the key pathological cause of AD."],
    "28371680": ["Aggregation of amyloid beta-proteins (Abeta) induced by Cu2+ is a crucial element in the pathogenesis of Alzheimer's disease (AD), and cerebral acidosis is a common complication of AD."],
    "28567323": ["Aggregation of amyloid beta protein (Abeta) and phosphorylated tau (p-Tau) plays critical roles in pathogenesis of Alzheimer's disease (AD)."],
    "29056865": ["The early oligomerization of amyloid beta-protein (Abeta) is a crucial step in the etiology of Alzheimer's disease (AD), in which soluble and highly neurotoxic oligomers are produced and accumulated inside neurons."],
    "2907602": ["It is thus very tempting to speculate that a defect (or defects) of the amyloid beta protein gene is the cause of Alzheimer's disease."],
    "29086767": ["The amyloid-beta protein (Abeta) protein plays a pivotal role in the pathogenesis of Alzheimer's disease (AD)."],
    "29165985": ["Amyloid beta-protein (Abeta) oligomers are emerging as potent neurotoxic species in Alzheimer's disease pathogenesis."],
    "29214278": ["The extracellular accumulation of amyloid beta protein (Abeta), reactive gliosis and cerebral amyloid angiopathy (CAA) play critical roles in the pathogenesis of Alzheimer's disease (AD)."],
    "29478851": ["The beta-amyloid precursor protein (APP) plays a central role in the etiology of Alzheimer's disease (AD)."],
    "29549749": ["Amyloid beta-protein (Abeta) aggregation is crucial for the pathogenesis of Alzheimer's disease, and surface charge of nanoparticles (NPs) has been recognized as an important factor influencing Abeta aggregation."],
    "30346704": ["The abnormal aggregation of amyloid beta-protein (Abeta) is considered central in the pathogenesis of Alzheimer's disease."],
    "30448407": ["Endocytic membrane trafficking system is altered in the brains of early-stage Alzheimer disease (AD) patients, and endocytic disturbance affects the metabolism of beta-amyloid protein (Abeta), a key molecule in AD pathogenesis."],
    "30532948": ["Progressive cerebral accumulation of Abeta protein was widely proposed to explain the cause of Alzheimer's disease, for which one promising direction of the preclinical study is to convert the preformed beta-sheet structure of Abeta aggregates into innocent structures."],
    "31349027": ["MATERIALS AND METHODS: Intracerebroventricular injection of Abeta was used to induce Alzheimer's disease-like pathology.", "The fruit of Crataegus pinnatifida ameliorates memory deficits in beta-amyloid protein-induced Alzheimer's disease mouse model."],
    "31478183": ["beta-amyloid protein (Abeta) is thought to be the primary cause of the pathogenesis of Alzheimer's disease (AD)."],
    "7650762": ["The beta-amyloid precursor protein (APP) has been implicated in the etiology of Alzheimer's disease (Kang et al.:"],
    "7695621": ["In this study we sought to understand the role that ApoE protein could play in the pathogenesis of AD.", "These findings suggest that the interaction of ApoE with tau and amyloid-beta proteins in AD could play a important role in the formation of NFT and SP, respectively, contributing to the pathogenesis of AD."],
    "7777509": ["The beta-amyloid precursor protein (beta-APP), from which the beta-A4 peptide is derived, is considered to be central to the pathogenesis of Alzheimer disease (AD)."],
    "8033965": ["The role of beta-amyloid protein and its precursor protein is a central question in the pathogenesis of Alzheimer's disease."],
    "8084515": ["Cerebral deposition of amyloid-beta protein (A beta) is central to the pathogenesis of Alzheimer's disease (AD)."],
    "8086012": ["beta-Amyloid protein-induced Alzheimer's disease animal model."],
    "8239276": ["The suspected involvement of the beta-amyloid precursor protein (beta APP) in the etiology of Alzheimer's disease (AD) has been strengthened by recent genetic evidence, but pursuit of the mechanisms involved will initially require basic cell biology approaches."],
    "8239277": ["Amyloid beta protein (A beta P) is the 40-42 residue polypeptide implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "8321160": ["Amyloid beta-protein is a major focus in efforts to understand the etiology of Alzheimer disease yet there is little known about the mechanism of its deposition in plaques."],
    "8380642": ["Amyloid beta protein (A beta P) is the 40- to 42-residue polypeptide implicated in the pathogenesis of Alzheimer disease."],
    "8636108": ["Aggregation of physiologically produced soluble amyloid beta protein (Abeta) to insoluble, neurotoxic fibrils is a crucial step in the pathogenesis of Alzheimer's disease."],
    "9007411": ["Neuropathological observations, supported by genetic and biochemical studies, indicate the central role of amyloid-beta protein deposits in the pathogenesis of Alzheimer's disease."],
    "9799084": ["As a prelude to further investigations of the role of FE65 in the metabolism of betaPP and in the pathogenesis of DAT, we have determined the entire genomic structure and sequence of human FE65 and have discovered several polymorphisms in this gene."],
    "9830016": ["Excessive cerebral accumulation of the 42-residue amyloid beta-protein (Abeta) is an early and invariant step in the pathogenesis of Alzheimer's disease."],
    "9844014": ["Genetic evidence has implicated three proteins, the beta-amyloid precursor protein (beta-APP) and the two homologous presenilins (PS-1 and PS-2), in the etiology of Alzheimer's disease (AD)."],
    "10215996": ["In this review, we concentrate on the biology of amyloid precursor protein, and on the central role of amyloid in the pathogenesis of Alzheimer's disease."],
    "10329382": ["The identification of a novel protein kinase that phosphorylates Ser655 will hopefully contribute to our understanding of the metabolism and/or function of APP in the pathogenesis of Alzheimer's disease (AD)."],
    "10466897": ["N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease."],
    "10591213": ["Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease."],
    "10607841": ["Since the secretase activities that process APP are localized in different intracellular compartments, it is likely that membrane transport is a key factor in the pathogenesis of AD."],
    "10727079": ["Several lines of evidence indicate that particular isoform(s) of APP may contribute to the etiology of AD."],
    "10742146": ["The amyloid beta-protein precursor gives rise to the amyloid beta-protein, the principal constituent of senile plaques and a cytotoxic fragment involved in the pathogenesis of Alzheimer disease."],
    "10997291": ["The enzymatic cleavage of the amyloid-precursor-protein or the hyperphosphorylation of tau as well as the subsequent aggregation of the resulting products are further targets for drugs intended to delay the neuropathological destruction observed in AD."],
    "11004129": ["Several mutations in the amyloid precursor protein (APP) gene may lead to either Alzheimer's disease or cerebral haemorrhage due to congophilic amyloid angiopathy (CAA)."],
    "11029529": ["The cleavage of the amyloid precursor protein (APP) into amyloidogenic components (Abeta) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "11099780": ["Since both a decreased level of APP secretion and a low activity and level of PKC may be involved in the pathogenesis of AD, it is concluded that the administration of AChE inhibitors to AD patients may facilitate the memory processes and exert a neuroprotective effect."],
    "11238726": ["Genetic studies have implicated amyloid precursor protein (APP) in the pathogenesis of Alzheimer's disease."],
    "11277983": ["Several mutations have been discovered in APP, which are causative of early-onset, familial, neurological disease, including Alzheimer's disease (FAD)."],
    "11432978": ["These suggest that CT-APP may participate in Alzheimer's pathogenesis through MAPKs- and NF-kappaB-dependent astrocytosis and iNOS induction."],
    "11528419": ["The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.", "Here we present studies of a pathogenic amyloid precursor protein (APP) mutation, located within the Abeta sequence at codon 693 (E693G), that causes AD in a Swedish family."],
    "11536196": ["While the amyloidogenic processing of APP in neurons is linked to the pathogenesis of Alzheimer's disease (AD), the expression of TACE in neurons has not yet been examined."],
    "11536323": ["In the present study, we investigated effects of estrogen on cell death induced by carboxy-terminal fragment of amyloid precursor protein (CT), a candidate causative substance in the pathogenesis of Alzheimer's disease."],
    "11706973": ["We report that endocytic pathway abnormalities are present not only in neurons, but in cerebral endothelia in Alzheimer's disease caused by certain APP mutations."],
    "11741910": ["This aspartic protease cleaves the amyloid precursor protein at the beta-secretase site, a critical step in the Alzheimer's disease pathogenesis."],
    "11840170": ["The Alzheimer amyloid precursor protein (APP) is a transmembrane protein whose abnormal processing is associated with the pathogenesis of Alzheimer's disease."],
    "11851430": ["Proteolytic processing of the transmembrane domain of the amyloid precursor protein (APP) is a key component of Alzheimer's disease pathogenesis."],
    "11935293": ["Proteolytic processing of the Alzheimer amyloid precursor protein (APP) results in the generation of at least two distinct classes of biologically relevant peptides: (1) the amyloid beta peptides which are believed to be involved in the pathogenesis of Alzheimer's disease and (2) the soluble N-terminal ectodomain (sAPP) which exhibits a protective but as yet ill-defined effect on neurons and epithelial cells."],
    "12011466": ["The cleavage of APP by gamma-secretase releases amyloid-beta peptides, which have been implicated in the pathogenesis of Alzheimer's disease, and the APP intracellular domain (AID), for which the function is not yet well understood."],
    "12213230": ["The amyloid precursor protein (APP) and presenilin-1 (PS-1) are not only of importance for the normal functioning of the various neurons, but also play central roles in the pathogenesis of Alzheimer's disease (AD)."],
    "12214125": ["It is highly likely that studies on the normal functions of APP will shed further light on aspects of the pathogenesis of AD."],
    "12223532": ["This review covers the trafficking and processing of APP, amyloid cascade hypothesis in AD pathogenesis, physiological and pathological roles of presenilins, molecular characteristics of alpha-synuclein, their interactions, and therapeutic strategies for AD."],
    "12463910": ["We were able to obtain functional information about two proteins, Amyloid Precursor Protein and Prion Protein, that have been implicated in the etiology of Alzheimer's Disease and Creutzfeldt-Jakob Disease, respectively."],
    "12473667": ["BACE1 is a membrane-bound aspartic protease that cleaves the amyloid precursor protein (APP) at the beta-secretase site, a critical step in the Alzheimer disease pathogenesis."],
    "12540236": ["Abnormal processing of APP through the action of the beta- and gamma-secretases leads to the production of the 39-43 amino acid Abeta fragment, which is neurotoxic and which is believed to play an important role in the etiology of Alzheimer's disease."],
    "12670422": ["A large body of evidence has implicated Abeta peptides and other derivatives of the amyloid precursor protein (APP) as central to the pathogenesis of Alzheimer's disease (AD)."],
    "12694406": ["Our data provide the first in vivo evidence that ASPP2 is a negative regulator of the neddylation pathway through specific interaction with APP-BP1 and suggest that dysfunction of the APP-BP1 interaction with APP may be one cause of Alzheimer's disease."],
    "12749853": ["The amyloid precursor protein (APP) is a transmembrane protein whose abnormal processing is associated with the pathogenesis of Alzheimer's disease."],
    "12948653": ["The discovery of a novel endogenous modulator of alpha-secretase-mediated, in preference to beta-secretase-mediated, cleavage of APP implicates sumoylation in the etiology of AD, and offers a new therapeutic target for intervention in APP processing."],
    "1415269": ["These studies show that APP mutations account for AD in only a small fraction of FAD kindreds."],
    "14507929": ["The aspartyl protease BACE1 cleaves the amyloid precursor protein and the sialyltransferase ST6Gal I and is important in the pathogenesis of Alzheimer's disease."],
    "14598315": ["Analysis of betaCTF (or C99), the amyloid precursor protein (APP) product of BACE cleavage that is the direct precursor to Abeta, shows it is also elevated in AD, underlying the importance of beta-secretase cleavage in AD pathogenesis."],
    "14973371": ["Alzheimer's beta-secretase (BACE1) is a membrane-bound protease that cleaves the amyloid precursor protein (APP) in the trans-Golgi network, an initial step in the pathogenesis of Alzheimer's disease."],
    "15035625": ["These include the amyloid precursor protein, which is central to Alzheimer's disease pathogenesis, as well as N-cadherin and Notch, which regulate transcription."],
    "15067372": ["Estrogen influences the processing of the amyloid beta precursor protein (APP) in the pathogenesis of Alzheimer's disease, and this effect is mediated by estrogen receptors (ERs) in activating mitogen-activated protein kinase (MAPK)-signaling pathway."],
    "15114629": ["Taken together, these results suggest that the transgenic APP, or its derivatives, produces the age-dependent pathophysiology of the AD-like brain and that the progressive cognitive impairment and anxiety induction can proceed in the absence of visible Abeta-plaque deposition."],
    "15171563": ["This review covers the trafficking and processing of APP, the amyloid cascade hypothesis in AD pathogenesis, the mutations in the genes encoding APP, PS1 and PS2 of early-onset and late-onset AD."],
    "15197738": ["Amyloid precursor protein (AbetaPP), a precursor of amyloid beta (Abeta) peptide, is one of the molecules involved in the pathogenesis of Alzheimer's disease (AD)."],
    "15207262": ["The metabolism of amyloid precursor protein (APP) is central to Alzheimer's disease pathogenesis."],
    "1521868": ["Mutations at codon 717 of the beta-amyloid precursor protein gene are a cause of Alzheimer's disease."],
    "15268750": ["A huge amount of evidence has implicated amyloid beta (A beta) peptides and other derivatives of the amyloid precursor protein (beta APP) as central to the pathogenesis of Alzheimer's disease (AD)."],
    "15274612": ["Cleavage of amyloid-beta precursor protein (APP) by site-specific proteases generates amyloid-beta peptides (Abetas), which are thought to induce Alzheimer's disease."],
    "15689559": ["Biochemical and genetic studies place the amyloid precursor protein (APP) at the center stage of Alzheimer's disease (AD) pathogenesis."],
    "15824102": ["Sequential processing of amyloid precursor protein (APP) by membrane-bound proteases, BACE1 and gamma-secretase, plays a crucial role in the pathogenesis of Alzheimer disease."],
    "15955598": ["Abeta peptides and other derivatives of the amyloid precursor protein (APP) have been implicated as central to the pathogenesis of AD."],
    "15989509": ["Mismetabolism of amyloid precursor proteins (APPs) may induce AD."],
    "16140161": ["A large body of evidence implicates beta-amyloid peptide (betaAP) and other derivatives of the evolutionarily highly conserved amyloid precursor protein (APP) in the pathogenesis of Alzheimer's disease."],
    "16252002": ["Proteolytic processing of the amyloid-beta precursor protein (APP) generates the Abeta amyloid peptide of Alzheimer's disease."],
    "16375745": ["The poorly soluble 40-42 amino acid peptide, formed from the cleavage of the Abeta precursor protein (APP) by two proteases, is believed to play a central role in the pathogenesis of AD."],
    "16446073": ["Ectodomain shedding of the amyloid precursor protein (APP) is a key regulatory step in the generation of the amyloid beta peptide (Abeta), which is thought to provoke the pathogenesis of Alzheimer's disease."],
    "16822978": ["The amyloid precursor protein (APP) is critical in the pathogenesis of Alzheimer's disease."],
    "16930452": ["The amyloid precursor protein (APP) takes a central position in Alzheimer's disease (AD) pathogenesis: APP processing generates the beta-amyloid (Abeta) peptides, which are deposited as the amyloid plaques in brains of AD individuals; Point mutations and duplications of APP are causal for a subset of early onset of familial Alzheimer's disease (FAD)."],
    "17119293": ["This cell-cell interaction is required to trigger off a cascade of processes that lead to the production of amyloid-beta (Abeta) from AbetaPP, leading to AD."],
    "17239395": ["Amyloid beta peptide (Abeta), generated by proteolytic cleavage of the amyloid precursor protein (APP), is central to AD pathogenesis."],
    "17303345": ["Misprocessing of beta-amyloid precursor protein (APP) leading to the formation of elevated quantities of beta-amyloid peptide (Abeta), derived by a cleavage at the beta-secretase site (N-671/673aa) and by a cleavage at the gamma-secretase site (C-711/713aa) of APP, is considered a key event in the pathogenesis of Alzheimer disease (AD)."],
    "17307738": ["Ectodomain shedding and intramembrane proteolysis of the amyloid precursor protein (APP) by alpha-, beta- and gamma-secretase are involved in the pathogenesis of Alzheimer disease (AD)."],
    "17319802": ["Alzheimer amyloid precursor protein (APP) is the precursor for the Abeta peptide involved in pathogenesis of Alzheimer's disease."],
    "17360920": ["These findings, in combination with evidence for cell cycle regulation of amyloid precursor protein and tau, has led to the hypothesis that reentry into the cell cycle underlies AD pathogenesis."],
    "17405930": ["Altered metabolism of the Alzheimer's amyloid precursor protein (APP) appears to be a key event in the pathogenesis of Alzheimer's disease (AD), and both altered phosphorylation and oxidative stress appear to affect the production of the toxic Abeta fragment."],
    "17490685": ["It is remarkable that amyloid precursor protein (APP) mutations can cause the typical pathological changes of AD as well as amyloid deposition around blood vessels."],
    "17536333": ["Existing evidence indicates that abnormal processing and extracellular deposition of the longer form of the amyloid peptide Abeta(1-42), a proteolytic derivative of the amyloid precursor protein (APP), is a key step in the pathogenesis of AD."],
    "17596704": ["To date the most relevant role for the amyloid precursor protein (APP) and for the presenilins (PSs) on Alzheimer's disease (AD) genesis is linked to the 'amyloid hypothesis', which considers an aberrant formation of amyloid-beta peptides the cause of neurodegeneration."],
    "17620134": ["BACKGROUND: The generation of the amyloid-beta peptide (Abeta) through the proteolytic processing of the amyloid precursor protein (APP) is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "17961921": ["Proteolytic cleavage of amyloid beta-peptide (Abeta) from amyloid precursor protein (APP) is a key event in the pathogenesis of Alzheimer's disease."],
    "18237744": ["Amyloid-beta (A beta) peptide, generated by proteolytic cleavage of the amyloid precursor protein, is central to AD pathogenesis."],
    "18266116": ["Three recent papers highlight the potential importance of presenilin and APP signaling in the etiology of AD."],
    "18468996": ["Production of the amyloid beta-peptide (Abeta) via sequential proteolytic cleavage of the amyloid precursor protein by beta- and gamma-secretases is strongly implicated in the pathogenesis of Alzheimer disease."],
    "18538664": ["Beta amyloid peptide is generated from amyloid precursor protein (APP) by proteolytic cleavage of beta- and gamma-secretases, and plays a critical role in the pathogenesis of Alzheimer's disease."],
    "18599481": ["Numb endocytic adapter proteins regulate the transport and processing of the amyloid precursor protein in an isoform-dependent manner: implications for Alzheimer disease pathogenesis."],
    "18776243": ["Accumulation of insoluble aggregates of beta-amyloid peptide, a cleavage product of amyloid precursor protein, is thought to be a central step in the pathogenesis of Alzheimer's disease."],
    "18781290": ["Gene analysis revealed amyloid precursor protein (APP) locus duplication as the cause of hereditary Alzheimer's dementia."],
    "18833287": ["Cleavage of the amyloid precursor protein (APP) is a crucial event in Alzheimer disease pathogenesis that creates the amyloid-beta peptide (Abeta) and liberates the carboxy-terminal APP intracellular domain (AICD) into the cytosol."],
    "18953033": ["Expression of amyloid precursor protein (APP) is critical to the etiology of Alzheimer's disease (AD)."],
    "18996484": ["Evidence indicates that abnormal processing and extracellular deposition of the beta-amyloid42 peptide, the longer form of proteolytic derivative of the transmembrane glycoprotein-amyloid precursor protein (APP), is a key step in the pathogenesis of AD."],
    "19075758": ["These observations that the common enzyme, gamma-secretase, modulates proteolysis and the turnover of possible signaling molecules have led to the attractive hypothesis that mechanisms similar to the Notch-Delta signaling pathway may widely contribute to gamma-secretase-regulated signaling pathways, including APP signaling which leads to Alzheimer's disease."],
    "19130181": ["These data suggest that the overproduction of APP after TBI inhibits astrocyte activity and reduces neural cell survival around the damaged brain region, which speculatively may be related to the induction of Alzheimer disease-type dementia after TBI."],
    "19239106": ["It is assumed that impaired cellular functions of APP and secretion of Abeta independently contribute to the pathogenesis of AD."],
    "19433918": ["They also regulate the metabolism of the amyloid precursor protein on multiple levels, implicating them in the pathogenesis of Alzheimer's disease."],
    "19544621": ["Growing evidence suggests a causative role for intracellular accumulation of amyloid precursor protein (APP) and its proteolytic products in the pathogenesis of AD.", "Mitochondrial dysfunction is one of the key characteristics of AD pathogenesis."],
    "19619643": ["In addition to aging, oxidative stress and mitochondrial DNA mutations, recent studies have implicated a role for the mitochondrial accumulation of proteins such as plasma membrane associated amyloid precursor protein (APP) and cytosolic alpha synuclein in the pathogenesis of mitochondrial dysfunction in Alzheimer's disease (AD) and Parkinson's disease (PD), respectively."],
    "19699790": ["APP is the key player in AD pathogenesis, and platelets contain all the enzymatic machinery to its processing, thus being the ideal candidate where to study AD pathogenetic mechanisms."],
    "20016085": ["Multiple recent reports implicate amyloid precursor protein (APP) signaling in the pathogenesis of Alzheimer's disease, but the APP-dependent signaling network involved has not been defined."],
    "20053918": ["Previous studies suggested that cleavage of the amyloid precursor protein (APP) at aspartate residue 664 by caspases may play a key role in the pathogenesis of Alzheimer's disease."],
    "20140888": ["Despite the well-established key role of APP for AD pathogenesis, the physiological function of APP and its close homologues APLP1 and APLP2 remains poorly understood."],
    "20167227": ["Amyloid beta (Abeta) peptides derived from proteolytic cleavage of amyloid precursor protein (APP) are thought to be a pivotal toxic species in the pathogenesis of Alzheimer's disease (AD)."],
    "20395961": ["We have proposed a more complete definition of the NGF trophic action that should also include its newly discovered property of inhibiting the amyloidogenic processing of amyloid precursor protein (APP), which is among the first hypothesized primary trigger of Alzheimer's disease (AD) pathogenesis."],
    "20703260": ["Increased levels of brain amyloid-beta, a secreted peptide cleavage product of amyloid precursor protein (APP), is believed to be critical in the aetiology of Alzheimer's disease."],
    "21034527": ["Amyloid precursor protein (APP), which is critically involved in the pathogenesis of Alzheimer's disease (AD), is cleaved by gamma/epsilon-secretase activity and results in the generation of different lengths of the APP Intracellular C-terminal Domain (AICD)."],
    "21034535": ["Swedish mutation within amyloid precursor protein modulates global gene expression towards the pathogenesis of Alzheimer's disease."],
    "2113416": ["The possible role of matrix associated ABPP in the pathogenesis of Alzheimer's disease is discussed."],
    "2115075": ["Overproduction or aberrant catabolism of the predicted amyloid beta-protein precursor (APP) is suspected as the cause of amyloid deposition in Alzheimer's disease and Down's syndrome brains."],
    "21331224": ["Amyloid Precursor Protein (APP) and its proteolytic product amyloid beta (Abeta) are critical in the pathogenesis of Alzheimer's Disease (AD)."],
    "21516353": ["Here, we review the possibility of gamma-secretase-regulated signaling, including APP signaling, which leads to AD.", "gamma-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease."],
    "21605029": ["Because of the pivotal role of APP and Abeta in AD pathogenesis, it is essential to understand how APP and Abeta modulate synaptic function."],
    "21626267": ["Amyloid beta (Abeta) precursor protein (APP) is a key protein in the pathogenesis of Alzheimer's disease (AD)."],
    "21785276": ["Furthermore, it was demonstrated recently that microRNA could function to regulate APP expression, APP processing, Abeta accumulation and subsequently influence neurotoxicity and neurogenesis related to APP, which was implicated to AD pathogenesis, especially for sporadic AD."],
    "21798242": ["Amyloid precursor protein (APP), a key protein in pathogenesis of Alzheimer's disease (AD), is a type I transmembrane protein which can be cleaved by beta- and gamma-secretase to release the amyloidogenic beta-amyloid peptides (Abeta) and the APP intracellular domain (AICD)."],
    "22120156": ["Since amyloid plaques are also a prominent feature of sporadic Alzheimer's disease (AD), abnormal proteolysis of APP and the generation of amyloid beta (Abeta) are key events in the pathogenesis of AD."],
    "22166205": ["BACE1, which cleaves the amyloid precursor protein, is the rate-limiting enzyme for beta-amyloid peptide production, leading to the pathogenesis of Alzheimer's disease (AD)."],
    "22303960": ["beta-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is the transmembrane aspartyl protease that catalyzes the first cleavage step in the proteolysis of the APP to the amyloid beta-protein (Abeta), a process involved in the pathogenesis of Alzheimer disease."],
    "22494386": ["Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease."],
    "22510281": ["Amyloid precursor-like protein 2 (APLP2), a homologue of APP, is also suggested to participate in AD pathogenesis."],
    "22734645": ["CONCLUSIONS: The present study identified LRP10 as a novel APP sorting receptor that protects APP from amyloidogenic processing, suggesting that a decrease in LRP10 function may contribute to the pathogenesis of Alzheimer's disease."],
    "22940630": ["Proteolytic cleavage of the amyloid precursor protein (APP) by the two proteases alpha- and beta-secretases controls the generation of the amyloid beta peptide (Abeta), a key player in Alzheimer's disease pathogenesis."],
    "22952038": ["Amyloid precursor protein (APP) is a type I transmembrane protein associated with the pathogenesis of Alzheimer's disease (AD)."],
    "22973448": ["Homodimerization of Amyloid Precursor Protein (APP), a key mechanism in the etiology of Alzheimer's disease, was measured on this original set-up."],
    "23289174": ["This finding, in accordance with the similar results in APP and MAPK-1 expression, underlines the significance of cytoskeletal alterations in AD pathogenesis."],
    "23365231": ["Proteolysis of APP leads to the formation of the APP intracellular domain (AICD) and amyloid beta that is crucially involved in the pathogenesis of Alzheimer's disease."],
    "23368879": ["Protein sequence mutations of the Abeta precursor protein (APP) account for a small proportion of AD cases, suggesting that regulation of the associated gene (APP) may play a more important role in AD etiology."],
    "23475515": ["The amyloid precursor protein (APP), presenilin1 (PSEN1), and presenilin2 (PSEN2) genes were identified as causative genes in a small number of families with autosomal dominant early-onset forms of AD (ADEOAD)."],
    "23585889": ["Dysregulation of the proteolytic processing of amyloid precursor protein by gamma-secretase and the ensuing generation of amyloid-beta is associated with the pathogenesis of Alzheimer's disease."],
    "23613819": ["Collectively, these data demonstrate that mOS does not modify BACE1 expression but alters BACE1 subcellular compartmentalization to favour the amyloidogenic processing of APP, and thus offer new insight in the early molecular events of AD pathogenesis."],
    "23691241": ["Amyloid precursor protein (APP), a transmembrane glycoprotein, is well known for its involvement in the pathogenesis of Alzheimer disease of the aging brain, but its normal function is unclear."],
    "23863461": ["The processing of amyloid precursor protein (APP) is a key event in the pathogenesis of Alzheimer's disease."],
    "23899629": ["Noise can induce tau hyperphosphorylation, formation of neurofibrillary tangles (NFT) and increase beta-amyloid (Abeta) and amyloid precursor protein (APP) and thus could be pivotal to AD pathogenesis and progression."],
    "23907250": ["Pathological amino-acid substitutions in the amyloid precursor protein (APP) and chemical gamma-secretase modulators affect the processing of APP by the gamma-secretase complex and the production of the amyloid-beta peptide Abeta42, the accumulation of which is considered causative of Alzheimer's disease."],
    "23926111": ["Increased processing of amyloid precursor protein (APP) and accumulation of neurotoxic amyloid beta peptide (Abeta) in the brain is central to the pathogenesis of Alzheimer's disease (AD)."],
    "24009040": ["Functional interaction between amyloid-beta precursor protein and peripherin neurofilaments: a shared pathway leading to Alzheimer's disease and amyotrophic lateral sclerosis?"],
    "24086147": ["To gain insights into the role of DSCR1 in AD, we explored the functional interaction between DSCR1 and the amyloid precursor protein (APP), which is known to cause AD when duplicated or upregulated in DS."],
    "24305823": ["Accumulation, aggregation, and deposition of amyloid-beta (Abeta) peptides generated through proteolytic cleavage of amyloid precursor protein (APP) are likely initiating events in the pathogenesis of AD."],
    "24361736": ["The amyloid precursor protein (APP) and amyloid-beta (Abeta) peptide play central roles in the pathology and etiology of Alzheimer's disease."],
    "24466315": ["Proteolytic processing of the amyloid precursor protein (APP) by the beta- and gamma-secretases releases the amyloid-beta peptide (Abeta), which deposits in senile plaques and contributes to the etiology of Alzheimer's disease (AD)."],
    "24556009": ["The beta secretase, widely known as beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), initiates the production of the toxic amyloid beta (Abeta) that plays a crucial early part in Alzheimer's disease pathogenesis."],
    "24748914": ["More recently, an implication of T-type calcium channel in the processing of Amyloid Precursor Protein was documented, with possible implication in the pathogenesis of Alzheimer's disease."],
    "24827165": ["Amyloid precursor protein (APP) and beta-site APP cleaving enzyme (BACE-1) play important roles in the pathogenesis of Alzheimer's disease (AD)."],
    "24859793": ["The amyloid precursor protein (APP) and its cellular processing are believed to be centrally involved in the etiology of Alzheimer's disease (AD)."],
    "24880964": ["Rare coding and fully penetrant variants in amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the only causative mutations reported for autosomal dominant AD."],
    "25043039": ["Aberrant cleavage of the amyloid precursor protein (APP) results in aggregation of amyloid-beta, which accumulates in the brain and consequently causes Alzheimer's disease."],
    "25101540": ["Substantial evidence suggests that cerebral deposition of the neurotoxic fibrillar form of amyloid precursor protein, beta-amyloid (Abeta), plays a critical role in the pathogenesis of Alzheimer's disease (AD)."],
    "25126078": ["Amyloid beta (Abeta) accumulation, which occurs as a result of the amyloidogenic processing of amyloid precursor protein (APP), is thought to initiate the pathogenesis of AD, eventually leading to neuronal cell death."],
    "2514387": ["Thus, the normal and abnormal proteolysis of ABPP may be directly relevant to AD pathogenesis."],
    "25194880": ["Our study demonstrates a novel mechanism by which overexpression of APP and RCAN1 causes neurodegeneration and AD pathogenesis in DS, and it provides new insights into the potential of targeting APP-induced proteasomal impairment and RCAN1 accumulation for AD and DS treatment."],
    "25528641": ["The amyloid precursor protein (APP) and its proteolytic cleavage product Abeta are widely believed to be central to the etiology of Alzheimer's disease (AD)."],
    "25534782": ["The amyloid beta precursor protein (APP) and its neurotoxic cleavage product amyloid beta (Abeta) are a cause of Alzheimer's disease and appear essential for neuronal development and cell homeostasis."],
    "25740230": ["While extensive studies have been focused on APP, which is implicated in the pathogenesis of Alzheimer's disease, the functions of APLP1 remain largely elusive."],
    "25740315": ["APP is an integral membrane protein, and plays a key role in the pathogenesis of AD; however, the biological function of APP is still unclear."],
    "25951880": ["The amyloid precursor protein (APP) is a membrane protein implicated in the pathogenesis of Alzheimer's disease."],
    "26007212": ["The core of this hypothesis is that it is pathological accumulations of amyloid-beta, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis."],
    "26070242": ["The production of amyloid beta (Abeta) in the brain from Abeta precursor protein (APP) through gamma-secretase is important for the pathogenesis of Alzheimer's disease (AD)."],
    "26145164": ["Fully penetrant variants in amyloid precursor protein, presenilin 1 (PSEN1), and presenilin 2 are the only causative mutations reported for autosomal dominant AD."],
    "26188042": ["Genetic and biochemical research indicate that the excessive generation of amyloid-beta peptide (Abeta) from amyloid precursor protein (APP), is a major part of AD pathogenesis."],
    "26312828": ["It started from the discovery of fully penetrant mutations in Amyloid precursor protein, Presenilin 1, and Presenilin 2 as a cause of autosomal dominant AD, the identification of the E4 allele of Apolipoprotein E as a strong genetic risk factor for both early-onset and late-onset AD, and evolved to the more recent detection of at least 21 additional genetic risk loci for the genetically complex form of AD emerging from genome-wide association studies and massive parallel resequencing efforts."],
    "26597721": ["Loss of Polo ameliorates APP-induced Alzheimer's disease-like symptoms in Drosophila."],
    "26614345": ["Excessive accumulation of amyloid-beta (Abeta) caused by cleavage of amyloid precursor protein (APP) is thought to be the primary cause of Alzheimer's disease (AD)."],
    "26623517": ["Aberrant cleavage of Notch is implicated in cancer, while abnormalities in cutting amyloid precursor protein lead to Alzheimer's disease."],
    "26814888": ["The amyloid precursor protein (APP) is a causal agent in the pathogenesis of Alzheimer's disease and is a transmembrane protein that associates with membrane-limited organelles."],
    "26862204": ["Our recent work has surprisingly identified the amyloid precursor protein (APP), the central molecule in Alzheimer's disease aetiology, as a novel interaction partner of a subunit of the PIKfyve complex, Vac14."],
    "27062894": ["The amyloid precursor protein (APP) and acetylcholinesterase (AChE) are multi-faceted proteins with a wide range of vital functions, both crucially linked with the pathogenesis of Alzheimer's disease (AD)."],
    "27079722": ["This is a reasonable assumption because amyloid-beta peptide (Abeta) accumulation and tau hyperphosphorylation are the defining histological features in AD, and because AbetaPP and tau mutations can cause AD in humans or AD-like features in animal models.", "Alzheimer's disease (AD) has long been viewed as a pathology that must be caused either by aberrant amyloid-beta protein precursor (AbetaPP) processing, dysfunctional tau protein processing, or a combination of these two factors."],
    "27094130": ["Extracellular deposition of amyloid-beta (Abeta) peptide, a metabolite of sequential cleavage of amyloid precursor protein (APP), is a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "27133790": ["Aberrant cleavage of APP can lead to Alzheimer's disease, so much research has been done to better understand GS structure and function in hopes of developing therapeutics for Alzheimer's."],
    "27303258": ["Second, molecules, such as amyloid precursor protein (APP) and presenilin-1 are common to both AD etiology and neurogenic development."],
    "28360418": ["Amyloid precursor protein (APP) gives rise to the amyloid-beta peptide and thus has a key role in the pathogenesis of Alzheimer disease."],
    "28371615": ["A thorough characterization of eta-processing of APP is critical for a better understanding of AD pathogenesis and insights into results of clinical trials of AD."],
    "28595039": ["Novel metabolic processing events such as delta-secretase and eta-secretase have been revealed that generate previously uncharacterized APP metabolic fragments with the potential to participate in AD pathogenesis."],
    "28941357": ["Aberrant cleavage of amyloid precursor protein and accumulation of Abeta in the form of the plaque or neurofibrillary tangles are the known primary culprits of AD pathogenesis and target for various regulatory mechanisms."],
    "28946017": ["The cleavage of amyloid precursor protein (APP) by beta-site APP cleaving enzyme 1 (BACE1) is the rate-limiting step in beta amyloid generation during Alzheimer's disease (AD) pathogenesis."],
    "28963516": ["Excessive generation of amyloid-beta peptide (Abeta) by aberrant proteolysis of amyloid precursor protein (APP) is a key event in Alzheimer's disease (AD) pathogenesis."],
    "28966576": ["Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease."],
    "29052089": ["Abnormal processing of amyloid precursor protein (APP) and aggregation of the Abeta peptide are known to play a key role in the pathogenesis of Alzheimer disease, but the function of endogenous APP under normal physiological conditions remains poorly understood."],
    "29080748": ["Abnormal production of amyloid-beta peptides (Abeta) by proteolytic processing of amyloid precursor protein (APP) is thought to be central to the pathogenesis of Alzheimer's disease (AD)."],
    "29090690": ["Considerable evidence has suggested that amyloid beta (Abeta), a secreted proteolytic derivative of amyloid precursor protein, appears to be a critical factor in the early 'synaptic failure' that is observed in Alzheimer's disease pathogenesis."],
    "29101243": ["Our findings indicate a role for APP in AD pathogenesis beyond the generation of Abeta and suggest modulation of APP expression as a therapy for AD.SIGNIFICANCE STATEMENT Here, we report on the plasticity-disrupting effects of amyloid beta-protein (Abeta) isolated from Alzheimer's disease (AD) brain and the requirement of amyloid precursor protein (APP) for these effects."],
    "29106038": ["The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis."],
    "29546477": ["Abeta is a peptide derived from the sequential cleavage of amyloid precursor protein, and is part of the pathogenesis of AD."],
    "29661886": ["Increasing evidence suggests that synaptic functions of the amyloid precursor protein (APP), which is key to Alzheimer pathogenesis, may be carried out by its secreted ectodomain (APPs)."],
    "29687167": ["Considering that all genes responsible for familial AD are amyloid protein precursor (APP) or APP metabolizing enzymes, surely aberrant APP metabolism is crucial to pathogenesis of AD."],
    "29984654": ["BACKGROUND: Mice co-expressing human amyloid precursor protein with the Swedish mutation (APPswe) and exon-9-deleted presenilin (PS1dE9) has become one of the most widely used mouse models for studying Alzheimer's disease (AD) pathogenesis and preclinical studies of AD therapeutic approaches."],
    "30207230": ["Lipids participate in Amyloid Precursor Protein (APP) trafficking and processing - important factors in the initiation of Alzheimer's disease (AD) pathogenesis and influence the formation of neurotoxic beta-amyloid (Abeta) peptides."],
    "30630900": ["Amyloid-beta precursor protein (APP) is central to the pathogenesis of Alzheimer's disease, yet its physiological function remains unresolved."],
    "30951743": ["Osthole attenuates APP-induced Alzheimer's disease through up-regulating miRNA-101a-3p."],
    "31011484": ["Nonetheless, single pathogenic mutations in amyloid precursor protein (APP) or presenilin 1 or 2 can cause AD with almost all of the clinical and neuropathological features, and therefore, we believe an important mechanism of pathogenesis in AD could be revealed from examining pathogenic APP missense mutations."],
    "31143098": ["In addition, impaired processing of Amyloid precursor protein (APP) leading to toxic amyloid beta (Abeta) aggregation is also implicated in the pathogenesis of AD."],
    "31204041": ["APP is believed to play a central role in the pathogenesis of Alzheimer's disease (AD)."],
    "31453210": ["Though amyloid precursor protein (APP) has been implicated in the pathogenesis of AD, the exact role of APP and its underlying mechanism in AD progression have remained largely elusive."],
    "31597094": ["The amyloid precursor protein (APP) is central to AD pathogenesis, and we recently showed that its intracellular domain (AICD) could modify synaptic signal integration."],
    "31779518": ["The Amyloid Precursor Protein (APP) is infamous for its proposed pivotal role in the pathogenesis of Alzheimer's disease (AD)."],
    "31806024": ["The mechanisms that regulate axonal transport of APP are therefore directly relevant to Alzheimer's disease pathogenesis."],
    "31915254": ["Significance Statement:Familial forms of Alzheimer's Disease (AD) are tied to mutations in the amyloid precursor protein, but the cellular mechanisms that cause AD remain unclear.", "Familial forms of Alzheimer's Disease (AD) are tied to mutations in the amyloid precursor protein, but the cellular mechanisms that cause AD remain unclear."],
    "31960113": ["While a lot of studies are focusing on the role played by APP in the pathogenesis of Alzheimer's disease, sAPPalpha is reported to have numerous neuroprotective effects and it is being suggested as a candidate with possible therapeutic potential against Alzheimer's disease."],
    "32105841": ["Neurotoxic amyloid-beta peptide (Abeta) 42/43 species generated by beta-secretase and gamma-secretase from the beta-amyloid precursor protein (APP) are believed to trigger Alzheimer's disease (AD)."],
    "32219307": ["Amyloid-beta precursor protein (APP) is central to the pathogenesis of Alzheimer's disease, yet its physiological functions remain incompletely understood."],
    "32331992": ["By cleaving a C-terminal fragment of the beta-amyloid precursor protein (APP), gamma-secretase generates several amyloid beta-peptide (Abeta) species including longer, neurotoxic forms such as Abeta42 that are a widely believed to trigger AD."],
    "32342327": ["Heterozygous amyloid precursor protein (APP) mutations cause hereditary cerebral amyloid angiopathy (CAA) and autosomal dominant Alzheimer's disease (AD)."],
    "32471175": ["Amyloid beta (Abeta) is a peptide fragment of the amyloid precursor protein that triggers the progression of Alzheimer's Disease (AD)."],
    "32588983": ["An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis.OBJECTIVE: To reassess the role of amyloid beta (Abeta) and the amyloid precursor protein (APP) system in the pathogenesis of Alzheimer's disease (AD)."],
    "32711019": ["Amyloid-beta (Abeta) cleaved from amyloid precursor protein (APP) has been proposed to play a central and causative role in the aetiology of Alzheimer's disease (AD)."],
    "32921309": ["METHODS: To further elucidate the roles of APP and its metabolites in AD pathogenesis, we analyzed transgenic mice overexpressing wildtype human APP (hAPP) or hAPP carrying mutations that cause autosomal dominant familial AD (FAD), as well as App knock-in mice that do not overexpress hAPP but have two mouse App alleles with FAD mutations and a humanized Abeta sequence."],
    "33309748": ["Microglia activation induced by maternal separation in combination with the APP mutation may impair the vascular system, leading to AD progression."],
    "33380425": ["This correlates with enhanced amyloidogenic cleavage of APP, a hallmark of AD pathogenesis."],
    "33551786": ["McGill-R-Thy1-APP transgenic (Tg) rat expresses the human amyloid precursor protein (APP751) with the Swedish and Indiana mutations (of familial AD), leading to an AD-like slow-progressing brain amyloid pathology."],
    "34058678": ["Amyloid precursor protein (APP) is key to AD pathogenesis, and whether APP and its secretase processing are involved in Mn-induced cognitive impairment remains unknown."],
    "34229070": ["BACKGROUND: The aberrant proteolytic processing of amyloid precursor protein (APP) into amyloid beta peptide (Abeta) in brain is a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "34366358": ["BACKGROUND: Processing of the amyloid-beta protein precursor (AbetaPP) is neurophysiologically important due to the resulting fragments that regulate synapse biology, as well as potentially harmful due to generation of the 42 amino acid long amyloid beta-peptide (Abeta 42), which is a key player in Alzheimer's disease."],
    "34532568": ["Discussion: Increased copy number of    APP     is sufficient to cause AD and CAA, with likely earlier onset in case of triplication compared with duplication."],
    "34830236": ["A comprehensive literature review of all reported cases of AD due to APP mutations was performed in PubMed and Web of Science databases."],
    "35120450": ["Mutations in the tau gene (MAPT) lead to frontotemporal dementia (FTD), whereas mutations in the genes for the amyloid-beta precursor protein (APP) and the presenilins (PSEN1, PSEN2) cause early-onset, dominantly inherited forms of Alzheimer's disease (AD)."],
    "35377629": ["The membrane-embedded gamma-secretase complex processively cleaves within the transmembrane domain of amyloid precursor protein (APP) to produce 37-to-43-residue amyloid beta-peptides (Abeta) of Alzheimer's disease (AD)."],
    "35453040": ["Amyloid beta peptide (Abeta) is produced through the proteolytic processing of amyloid precursor protein (APP), and Abeta accumulation in the brain is proposed to be an early toxic event in the pathogenesis of AD."],
    "35543350": ["Amyloid precursor protein (APP) is the core of the pathogenesis of Alzheimer's disease (AD)."],
    "35579846": ["However, the absolute focus on the single APP metabolite Abeta as the cause for AD has resulted in APP and its other fragments that possess toxic propensity, to be overlooked as targets for treatment.", "The decades of evidence that showcase the role of amyloid precursor protein (APP), and its fragment amyloidbeta (Abeta), in Alzheimer's disease (AD) pathogenesis are irrefutable."],
    "35882892": ["Amyloid precursor protein (APP) is a transmembrane protein that plays critical role in the pathogenesis of Alzheimer's disease (AD)."],
    "36412210": ["In this study, we investigated the potential role of AP2S1 in intracellular processing of amyloid precursor protein (APP), which contributes to the pathogenesis of Alzheimer's disease (AD) by generating the toxic beta-amyloid peptide (Abeta)."],
    "36442651": ["The amyloid precursor protein (APP) is critical for the pathogenesis of Alzheimer's disease (AD)."],
    "36579387": ["The formation of amyloid-beta results due to proteolytic cleavage of amyloid precursor protein (APP) by beta-site amyloid precursor protein cleaving enzyme (BACE1) shown as the amyloid hypothesis, a prevalent theory for AD pathogenesis."],
    "36717226": ["The amyloid precursor protein (APP) is linked to the genetics and pathogenesis of Alzheimer's disease (AD)."],
    "36966431": ["Given the vital role of Chol in the central nervous system, the functional connection between APP and Chol bears important implications in the pathogenesis of AD."],
    "37183375": ["Depletion of ESCRT ameliorates APP-induced AD-like symptoms in Drosophila."],
    "37240173": ["Although the exact cause and treatment methods for these diseases are not yet known, research suggests that Alzheimer's disease is caused by amyloid precursor protein, while alpha-synuclein acts as a causative agent in Parkinson's disease."],
    "37387352": ["Amyloid precursor protein (APP) is a key molecule in the pathogenesis of Alzheimer's disease (AD) as the pathogenic amyloid-beta peptide is derived from it."],
    "37830617": ["The amyloid precursor protein (APP) is a key molecular component of Alzheimer's disease (AD) pathogenesis."],
    "38311171": ["Identidying mechanisms underlying APP protein regulation is crucial for understanding AD pathogenesis."],
    "7536093": ["These functional properties of APP may be relevant to the pathogenesis of Alzheimer's disease."],
    "7758106": ["This finding implicates APP in the pathogenesis of Alzheimer's disease in these individuals."],
    "7845465": ["These mice support a primary role for APP/A beta in the genesis of AD and could provide a preclinical model for testing therapeutic drugs."],
    "7897394": ["Transgenic mice overexpressing the three major neuronal isoforms of the human amyloid precursor protein (APP), APP695, APP751, APP770 may provide an animal model for the analysis of the mechanisms and risk factors leading to amyloid deposition in Alzheimer's disease (AD) and Downs syndrome (DS)."],
    "7898047": ["An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease."],
    "7950974": ["Possible mechanisms whereby the APP mutations cause Alzheimer's disease are considered here against the background of current understanding of the physiological role and processing of APP."],
    "7952845": ["The discovery of pathogenic mutations in the amyloid precursor protein gene in families with Alzheimer's disease is a major advance in the understanding of the pathogenesis of Alzheimer's disease."],
    "8028788": ["Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family."],
    "8117426": ["Genetic evidence shows that other genes than the APP are also involved in the aetiology of AD."],
    "8251141": ["The prediction that this second genetic locus will produce a protein intimately involved in the metabolism of the amyloid precursor protein is reiterated, together with the prediction that all causes of Alzheimer's disease will directly involve this process.", "The genetic data implicating mutations framing the beta-amyloid segment of the amyloid precursor protein as causes of Alzheimer's disease are reviewed and integrated with information on the normal processing of the amyloid precursor protein."],
    "8648890": ["[Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia]."],
    "8787835": ["This provides further evidence that chloroquine-induced myopathy in rats provides a suitable model to understand APP processing into A beta, and the role of APP in terms of the pathogenesis of AD."],
    "9295226": ["This experimental model is considered to be a suitable neural model to understand retinal pathology and the processing of APP in terms of the pathogenesis of AD, whereas chloroquine-induced myopathy is a useful extra neuronal model."],
    "9438067": ["The A beta is formed by proteolysis of APP, and its deposition leading to the formation of senile plaques in the brain is considered to be a key step in the pathogenesis of Alzheimer's disease."],
    "9574821": ["The amyloid precursor protein (APP) is a member of a family of proteins found in the central nervous system with a fundamental role in the pathogenesis of Alzheimer's disease."],
    "9582384": ["Several LRP ligands, including apolipoprotein E/lipoproteins and amyloid precursor protein, have been shown to participate either in Alzheimer's disease pathogenesis or pathology."],
    "9593752": ["The amyloid precursor protein (APP) can be cleaved by a beta-secretase to generate a beta-amyloid peptide, which has been implicated in the pathogenesis of Alzheimer's disease."],
    "9811864": ["The importance of the amyloid precursor protein (APP) in the pathogenesis of Alzheimer's disease (AD) became apparent through the identification of distinct mutations in the APP gene, causing early onset familial AD with the accumulation of a 4-kDa peptide fragment (betaA4) in amyloid plaques and vascular deposits."],
    "9839536": ["The localization of the C-terminal tail of APP within the brain tissue of AD patients underscores the likely importance of the C-terminus in the pathogenesis of AD."],
    "9869322": ["The mismetabolism of amyloid precursor protein (APP), favouring the production of A beta, is considered to be central to the pathogenesis of Alzheimer's disease (AD)."],
    "9930726": ["It is hoped that identification of proteins that interact with the cytoplasmic domain will provide new insights into the physiological function of APP and, in turn, into the pathogenesis of Alzheimer's disease."],
    "10420066": ["More specifically, it seems undisputed that the APOE*4 allele plays an important role in the pathogenesis of AD."],
    "10655544": ["Our human apoE4 knock-in mice will be useful in clarifying the role of apoE in the etiologies of AD and cardiovascular diseases in relation to cholesterol and lipid metabolism."],
    "10775884": ["Apolipoprotein E (protein: apo E; gene: APOE) plays an important role in the multifactorial etiology of both Alzheimer's disease (AD) and lipid level concentrations."],
    "10818522": ["Our data suggest that ApoE modulates the outcome following cerebral ischemia via molecular events in common with AD pathogenesis.", "We propose that ischemic-reperfusion processes in brain are the fountain-head of a cycle of molecular and cellular events that have neurodegenerative consequences which finally lead to AD."],
    "10899434": ["This review summarizes part of an experimental approach to identify biological pathways influenced by the different APOE polymorphisms that are relevant to the pathogenesis of AD."],
    "11005255": ["While the relevance of these proposed functions to the etiology of AD remains a mystery, these and other hypotheses will be tested as the field of apoE neurobiology grows, adding relevant new data to the functions of apoE in health and in the pathogenic mechanisms leading to AD."],
    "11145984": ["To further investigate the potential interaction between apoE and A beta in the pathogenesis of AD, we have determined the effect of apoE isoforms on the neurotoxicity of non-fibrillar A beta peptides."],
    "11165374": ["Apolipoprotein E (apoE) is a lipid transport molecule, which has been linked to the pathogenesis of Alzheimer's disease."],
    "11212354": ["However, no clear explanation of the pathogenesis of apoE-induced AD has been provided."],
    "11980062": ["Hypotheses about apolipoprotein E function that may lead to Alzheimer's disease are also discussed."],
    "12214015": ["Since inheritance of different alleles of the apolipoprotein (apo) E gene is a risk factor for AD and apoE is the major lipoprotein trafficking molecule in brain, we hypothesized that apoE may modify the pathogenesis of AD by directing the delivery of oxidized CSF lipoproteins to neurons."],
    "12355988": ["Many of these are controversial and studies have shown conflicting results, but apoE polymorphism seems to be only one of the possible genetic factors suggested to play a role in the multifactoral pathogenesis of AD."],
    "12573540": ["Recent evidence strongly suggests a role for cholesterol and apolipoprotein E in the etiology of Alzheimer's disease."],
    "12661900": ["Understanding how apoE participates in the formation of senile plaques is necessary to clarify the pathogenesis of AD; however, the mechanism remains unknown."],
    "14511323": ["Consequently, NSAID-induced increases in apoE protein may enhance apoE-mediated immunosuppression and compensatory synaptic plasticity, potentially resulting in decreased AD risk and delay of disease onset."],
    "14757931": ["These results suggest that apoE and transferrin may be part of a complex mechanism in the pathogenesis of Alzheimer's disease."],
    "15159602": ["In particular, polymorphisms within the ApoE and alpha1-ACT gene have been implicated in the aetiology of AD and s-IBM."],
    "15634227": ["Accumulating evidence suggests that genetic factors such as apolipoprotein E (APOE), can act in different ways in the pathogenesis of cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD)."],
    "15716586": ["This review examines the current evidence for diet, lipid homeostasis, and apoE in the pathogenesis of AD."],
    "16198584": ["The mechanism of action of APOE in the etiology of AD remains unclear."],
    "16641890": ["Presenilins and apolipoprotein E are other neurotoxic agents involved in the pathogenesis of AD."],
    "17166269": ["Since apoE is important in the pathogenesis of Alzheimer's disease (AD), we tested whether apoE treatment of neurons affected molecules important to phosphorylation of tau, such as GSK 3beta, P35, and CDK5, and the phosphorylation of tau itself."],
    "17854398": ["Apolipoprotein E (ApoE), encoded by the apolipoprotein E gene (APOE), plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "18205697": ["This large body of evidence suggest that apoE is a key player in the pathogenesis of AD."],
    "18430993": ["Further investigation of the genetic influence of these loci on apoE expression levels in the central nervous system is likely to provide new insight into apoE regulation as well as AD pathogenesis."],
    "18580587": ["These findings suggest that small HC limits educational attainment only among individuals who have greater risk of AD owing to their APOE genotype or who are destined to develop this illness later in life."],
    "19116777": ["These studies show that the lipid binding capacity of apoE is a major mechanism of its function in the pathogenesis of AD, and suggest that increasing apoE lipidation may be of therapeutic importance for this devastating disease.", "However, exactly how apoE functions in the pathogenesis of AD remains to be fully determined."],
    "19472365": ["Although apolipoprotein E (apoE) is the most common genetic risk factor for Alzheimer's Disease (AD), how apoE participates in AD pathogenesis remains incompletely understood."],
    "20538374": ["The findings suggest that abnormally high levels of ApoE may play a causative role in the pathological events of AD, particularly those involving the early cholinergic deficit in the AD brain, through modulation of cholinesterases activities, hence disturbing the acetylcholine-dependent activity of neurons and nonexcitable cells such as glial cells."],
    "21676498": ["Despite the considerable converging evidence that implicates ApoE and LRP in the pathogenesis of AD, the precise mechanism by which ApoE and LRP modulate the risk for AD remains elusive."],
    "22482075": ["Three genes, SORL1, APP, and APOE, are suspected to cause Alzheimer's whereas the other 21 genes are related to other diseases but may also be found to be associated with Alzheimer's, and these are TMEM59, CCT4, IGF2R, SFPQ, PRDX3, RNF14, IDS, SSBP1, SYNE2, TXNL4A, STXBP3, SMARCB1, ULK2, AGTPBP1, FABP7, CALB1, H2AFY, COPA, SAP18, ATIC and SYNCRIP."],
    "22502767": ["This 'double whammy' result opens up a new direction for studies aimed at elucidating the relevant neurobiological activities of APOE isoforms in the pathogenesis of AD."],
    "22883744": ["While apoE isoforms differentially interact with amyloid beta (Abeta), a pleiotropic neurotoxin key to AD etiology, more recent work has focused on immune regulation in AD pathogenesis and on the mechanisms of innate immunomodulatory effects associated with inheritance of different APOE alleles."],
    "23541982": ["Analysis of side chain oxysterols in the CSF is likely to provided useful information about cholesterol metabolism and ApoE function in the pathogenesis of AD."],
    "24154541": ["To directly determine the effects of APOE genotype on intraneuronal accumulation of Abeta1-42 at the onset of AD pathogenesis, we introduced lentiviral Abeta1-42 into the cortex of APOE targeted replacement (TR) mice at the age of 8-9 months."],
    "24894353": ["Evidence suggests that the ApoE protein, a major lipid transporter, plays a key role in the pathogenesis of AD, and its role in both normal and aberrant lipid metabolism warrants further extensive investigation."],
    "24971061": ["In this review we will summarize the evidence supporting a role for metals in the function of ApoE and its consequent role in the pathogenesis of AD."],
    "26401939": ["BACKGROUND/OBJECTIVE: Apolipoprotein E (ApoE) has an active part in the pathogenesis of Alzheimer's disease (AD)."],
    "26413387": ["Among those factors, altered circulating cholesterol homeostasis, independent of the APOE genotype, continues to be implicated in brain deposition of amyloid beta protein (Abeta) and the pathogenesis of AD."],
    "26582899": ["Apolipoprotein E (ApoE) is an important modifier of Alzheimer's disease (AD) pathogenesis, and its abundance has been linked to the clearance of beta-amyloid (Abeta) in the brain."],
    "27104063": ["The Role of Upregulated APOE in Alzheimer's Disease Etiology."],
    "28218653": ["The role of different genotypes of apolipoprotein E (apoE) in the etiology of Alzheimer's disease is widely recognized."],
    "29376871": ["This suggests a vicious cycle between inflammation, RA signaling, and ApoE homeostasis in AD pathogenesis."],
    "30032423": ["Regardless of widespread indispensable studies, the appropriate function of APOE in AD etiology stays ambiguous.", "This review also highlighted utmost ApoE targeting therapeutic tactics that are crucial for controlling Alzheimer's pathogenesis.", "Existing proof recommends that the disparate outcomes of ApoE isoforms on Abeta accretion and clearance have a distinct function in AD pathogenesis."],
    "30140051": ["Here, we review the rapidly growing literature on the role of disease-associated microglia, TREM2 and APOE in the pathogenesis of Alzheimer disease and present an integrated view of innate immune function in Alzheimer disease."],
    "30194628": ["Herein, (1) we identified the aggregation prone sequence in Abeta40 and Abeta42 as 'HHQKLVFFAE' and 'SGYEVHHQKLVFFAEDVG/KGAIIGLMVGGV' respectively with critical lysine (K) at 16 and 28 for stabilizing the aggregates; (2) elucidated the interaction pattern of AbetaPP with other Alzheimer's related proteins BACE1, APOE, SNCA, APBB1, CASP8, NAE1, ADAM10, and PSEN1 to describe the pathophysiology; (3) found APOE as commonly interacting factor between amyloid beta and Tau for governing AD pathogenesis; (4) reported K224, K351, K363, K377, K601, K662, K751, and K763 as potential putative lysine for facilitating AbetaPP clearance through ubiquitination thereby arresting Abeta formation; and (5) observed conserved glutamine (Q), glutamic acid (E), and alpha-helical conformation as few crucial factors for lysine selectivity in the ubiquitination of AbetaPP."],
    "30804776": ["APOE in the brain is primarily expressed by astrocytes and microglia, cell types that are now widely appreciated to play key roles in the pathogenesis of AD; thus, a picture is emerging wherein APOE4 disrupts normal glial cell biology, intersecting with changes that occur during normal aging to ultimately cause neurodegeneration and cognitive dysfunction."],
    "31062326": ["The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.", "In this chapter, we discuss the roles of ApoE, lipids, and glucose in the pathogenesis of AD by considering their potential interactions."],
    "31623648": ["However, the specific contributions of different apoE pools to AD pathogenesis remain unknown."],
    "32027932": ["Here we review the critical role of APOE in the pathogenesis of AD and some of the most promising therapeutic approaches that focus on the APOE-Abeta interaction."],
    "35639372": ["However, the mechanisms linking APOE to AD-particularly the apoE protein's role in AD pathogenesis and how this is affected by APOE variants-remain poorly understood."],
    "7615568": ["These findings, together with the strong genetic association between late onset AD and the E4 allele of apoE, have strengthened the hypothesis that apoE may have a central role in the pathogenesis of AD by modulating A beta cerebral accumulation."],
    "7619525": ["Thus, we conclude that A beta-apoE complexes are principal components of AD-associated brain amyloid and that the data presented here support a role for apoE in the pathogenesis of AD."],
    "7761390": ["These and other isoform-specific interactions of apoE give rise to testable hypotheses for the mechanism(s) of pathogenesis of Alzheimer disease."],
    "8809843": ["We suggest that microglia might be one of the sources of apoE in the brain, and that apoE synthesized in microglia might be closely related to the pathogenesis of AD."],
    "8813351": ["However, apoE levels vary in different brain regions, and local factors related to the synthesis and metabolism of apoE may be crucial in the pathogenesis of AD."],
    "8832646": ["Apolipoprotein E (Apo E), one of the major structural and functional apolipoproteins, has recently been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "9073026": ["To evaluate the usefulness of apoE concentration in pathogenesis of AD, we measured the cerebrospinal fluid (CSF) levels of apoE."],
    "9307253": ["In the 162 patients for whom autopsy and ApoE genotype data were available, the clinical diagnosis of AD was verified as the primary cause of dementia in 139 cases (139 of 162, or 86%)."],
    "9326451": ["Apolipoprotein E (apoE) and certain peptides derived from it have been shown to exert neurotoxic effects in vitro, and apoE has been linked to the etiology of Alzheimer's disease."],
    "9523562": ["To further investigate the potential interaction of apoE and A beta in the pathogenesis of AD, we have determined the binding, internalization, and degradation of human apoE isoforms in the presence and absence of A beta peptides to rat primary hippocampal neurons."],
    "9700208": ["These data indicate that in addition to the qualitative effect of the APOE epsilon2/epsilon3/epsilon4 polymorphisms on the AD occurrence, the quantitative variation of expression of these alleles due to functional APOE promoter mutations, is a key determinant of AD development."],
    "9740234": ["ApoE might play an important part in the etiology of Alzheimer's disease by functioning as a \\pathologic chaperone\\ to promote the formation of amyloid filaments."],
    "9751198": ["In parallel, we determined the concentrations of apolipoprotein E (apoE), another apolipoprotein also implicated in nerve regeneration and in the etiology of AD."],
    "9844032": ["This patient group was thought to be separable from those with Alzheimer's disease based on the results of ApoE allele analysis in addition to the substantial absence of amyloid beta deposits and has been designated as senile dementia of the tangle type (SDT)."],
    "10561592": ["The accumulation of Abeta in the brain is an important step in the pathogenesis of AD."],
    "10653285": ["Moreover, the differences between secretory and intracellular Abeta production might hold the clues for brain specificity and cellular mechanisms of AD pathogenesis."],
    "10704308": ["Recent studies have suggested that non-fibrillar soluble forms of Abeta peptides possess neurotoxic properties and may therefore play a role in the molecular pathogenesis of Alzheimer's disease."],
    "10869810": ["Alzheimer's disease (AD) is characterized by the presence of beta-amyloid (Abeta) protein deposits in the brain and increased Abeta (1-42) peptide production is thought to be one of the early events in the pathogenesis of AD that leads to progressive neurodegenerative processes and dementia."],
    "10956426": ["Here we compared the effects of huperzine A (HupA) and tacrine, two acetylcholinesterase (AChE) inhibitors available for AD, on Abeta-induced cell lesion, level of lipid peroxidation, and antioxidant enzyme activities in rat PC12 and primary cultured cortical neurons."],
    "11150636": ["Abeta has been implicated as a cause of Alzheimer's disease (AD)."],
    "11467851": ["Deposition of plaques containing Abeta is considered important in the pathogenesis of Alzheimer's disease."],
    "11513577": ["Since the accumulation of Abeta in the brain is a key event in the pathogenesis of Alzheimer's disease, memapsin 2 is an important target for the design of inhibitory drugs."],
    "11590033": ["The basis for therapeutic strategies targeting the amyloid-beta protein (Abeta) has come from studies showing that accumulation and aggregation of the Abeta within the brain is likely to cause Alzheimer's disease (AD)."],
    "11595492": ["It is now thought that Abeta is pivotal in the pathogenesis of Alzheimer's disease, and that reducing brain Abeta levels may help to treat or prevent the disease."],
    "11684351": ["We hypothesized that over-activity of BACE might lead to the overproduction of Abeta, hence causing Alzheimer's disease (AD)."],
    "11899259": ["One leading theory is that the Abeta in plaques leads to AD because Abeta is directly toxic to the adjacent neurons.", "Mutations of the APP gene lead to AD by influencing APP metabolism."],
    "11906199": ["This findings suggest that the direct generation of Abeta from the complex may play an important role in the pathogenesis of Alzheimer's disease."],
    "12025858": ["Our data show that Abeta can impair cortical neurogenesis, and suggest that this adverse effect of Abeta contributes to the depletion of neurons and the resulting olfactory and cognitive deficits in AD.", "We now report that amyloid beta-peptide (Abeta), a self-aggregating neurotoxic protein thought to cause AD, can impair neurogenesis in the SVZ/cerebral cortex of adult mice and in human cortical NPC in culture."],
    "12034808": ["An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala)."],
    "12128086": ["This work is of obvious relevance to AD and provides a coupling between the centrality of Abeta(1-42) in the pathogenesis of AD and the oxidative stress under which the AD brain exists."],
    "12165357": ["Additionally, large depositions of amyloid beta-peptide (Abeta) are observed, and many researchers opine that Abeta is central to the pathogenesis of AD."],
    "12214126": ["The presence of mutations around the A beta sequence in APP provides strong argument for the involvement of APP, and A beta in particular, in pathogenesis of Alzheimer's disease (AD)."],
    "12235837": ["Genetic and cell biological evidence strongly suggests that mutations in beta APP or presenilin (PS) 1 and 2 genes cause AD through increase in production of A beta 42.", "PS1 and PS2 are shown to be the catalytic subunits of gamma-secretase that cleaves the intramembrane segments of beta APP and Notch. beta-amyloid hypothesis that emphasizes the primacy of A beta in the pathogenesis of AD is currently being verified by the new experimental therapeutic approaches, e.g., A beta vaccine therapy or administration of inhibitors of beta- or gamma-secretases."],
    "12384498": ["Because the Abeta peptide is important in Alzheimer's disease pathogenesis, we examined whether ABCA1 induction altered Abeta levels."],
    "12450704": ["Previous studies have shown that in various mouse models of Alzheimer's disease (AD), amyloid beta-protein (Abeta) antibodies generated by Abeta peptide immunization resulted in the prevention of Abeta plaque formation in brains of young mice, decreased Abeta plaque burdens in older mice and improved cognition."],
    "12453675": ["The existence of pathogenic mutations in beta-APP and the presenilin genes provides strong support for the hypothesis that Abeta production and deposition contribute to the etiology of Alzheimer's disease (AD)."],
    "12491772": ["Genetic and cell biological evidence strongly suggest that mutations in beta APP or presenilin (PS) 1 and 2 genes cause AD through increase in production of A beta 42.", "Recently, PS1 and PS2 are shown to be the catalytic subunits of gamma-secretase that cleaves the intramembrane segments of beta APP and Notch. beta-amyloid hypothesis that emphasizes the primacy of A beta in the pathogenesis of AD is currently being verified by the new experimental therapeutic approaches, e.g., A beta vaccine therapy or administration of inhibitors of beta- or gamma-secretases."],
    "12600720": ["However, there is no information on the effect of intracellular Abeta on endothelial cell biology, although recent studies indicate that neuronal Abeta drives Alzheimer's disease pathogenesis."],
    "12794314": ["It is argued that APP/Abeta is upstream of tau/tangle in the Alzheimer pathogenesis, and that the relationship between the pathologies are promiscuous in two ways: first, APP/Abeta can equally be seen to be upstream of synuclein/Lewy bodies in cell death pathways, and second, tau pathology can be initiated by genetic lesions in other pathways."],
    "12835512": ["These findings reveal a novel action of Abeta on the propagation of intercellular calcium signals in astrocytes, and also suggests a role for altered astrocyte calcium-signaling in the pathogenesis of AD."],
    "12944403": ["Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease."],
    "12972166": ["Coordinate regulation of cerebral Abeta level is important in the pathogenesis of AD since either increased production of Abeta from amyloid precursor protein or decreased degradation causes elevated levels of Abeta, leading to accumulation of cerebral plaque formation or amyloid angiopathy."],
    "15094512": ["Recent evidence suggests oligomeric Abeta may be more relevant to AD etiology."],
    "15181249": ["Hence, factors that influence IDE expression or IDE activity toward Abeta are potentially relevant to the etiology of AD."],
    "15223066": ["Hence, these findings suggest a role for ceramide in iNOS induction and NO production in Abeta-induced AD pathobiology and provide a possible explanation for the beneficial effects of vitamin E therapy."],
    "15234966": ["The significance underlying Abeta-(11-40/42) in Alzheimer's disease pathogenesis has remained to be experimentally elucidated, but increased production of Abeta-(1-40/42) has been broadly demonstrated to contribute to amyloid depositions in senile plaques."],
    "15294135": ["This result supports a primary role for Abeta in AD etiology."],
    "15364896": ["The data collectively suggest that caspase cleavage of APP leads to increased production and deposition of Abeta5-40/42 in the AD brain, and highlight the significance of amino-truncated Abeta in the pathogenesis of AD."],
    "15364953": ["beta-Site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a membrane-bound aspartic protease that cleaves amyloid precursor protein to produce a neurotoxic peptide, Abeta, and is implicated in triggering the pathogenesis of Alzheimer disease."],
    "15365148": ["This indicates that the A713T mutation of the APP gene, lying at the gamma-secretase cleavage site, can be responsible for AD with symptomatic cerebral amyloid angiopathy."],
    "15519283": ["The neurotoxicity and proteasome inhibition by Abeta, a main cause of AD pathogenesis, are mediated by increased E2-25K/Hip-2 in the brains of patients with AD."],
    "15615644": ["Whether Abeta or tau filaments cause AD is still an open question, as a wide variety of proteins and pathways have been implicated in the initiation and advancement of the disease--processes such as apoptosis, oxidative stress, and protein degradation."],
    "15668631": ["To confirm this correlation and its relation to the presence of a human APP mutation, known to definitely cause AD, hairs were examined from AD patients, pregnant women known to have an increase in plasma beta amyloid and transgenic mice carrying a mutated human APP gene."],
    "15672443": ["Identification of such proteins could contribute to our understanding of not only the role of Abeta(1-42) in the pathogenesis of AD, but also provide insight into the mechanisms of neurodegeneration at the protein level in AD."],
    "16054018": ["This fact led us to the notion that an age-related decrease in Abeta catabolism may contribute to the molecular pathogenesis of AD, providing a rationale for seeking proteolytic enzymes that degrade Abeta in the brain."],
    "16226718": ["Exposure to pre-aggregated forms of Abeta(42) caused both the formation of AD-like tau-containing filaments and a decreased solubility of tau, both of which were prevented by mutating the S422 phospho-epitope of tau."],
    "16289870": ["According to the amyloid cascade hypothesis, deposition of Abeta is an initial and essential step in the pathogenesis of AD, and formation of NFT has been proposed to be caused by increased Abeta levels."],
    "16377636": ["Accumulating evidence shows that PS1 is involved in gamma-secretase activity and that FAD-associated mutations of PS1 commonly accelerate Abeta(1-42) production, which causes Alzheimer disease (AD)."],
    "16472119": ["Increased cerebral levels of Abeta(42) peptide, either as soluble or aggregated forms, are suggested to play a key role in the pathogenesis of Alzheimer's disease (AD)."],
    "16472155": ["Genetic and biological studies provide evidence that the production and deposition of Abeta contribute to the etiology of AD."],
    "16539675": ["A progressive neurodegeneration and cognitive decline occurs during the course of the disease, and Abeta is believed to be central for the molecular pathogenesis of AD."],
    "16645451": ["Because altered processing of APP leading to accumulation of Abeta is a key event in the pathogenesis of Alzheimer disease, these findings may have implications for use of this anesthetic agent in individuals with excessive levels of cerebral Abeta and elderly patients at increased risk for postoperative cognitive dysfunction."],
    "16651627": ["The compromised activity of MnSOD, a primary antioxidant enzyme protecting mitochondria, may explain mitochondrial dysfunction and provide the missing link between Abeta-induced oxidative stress and Alzheimer's disease."],
    "16786033": ["ApoE has roles in cholesterol metabolism and Abeta clearance, both of which are thought to be significant in AD pathogenesis."],
    "16794858": ["The present study showed that the ischemic neuronal insults increased the production of Abeta by influencing APP metabolism, which may link the role of ischemic insults to the pathogenesis of AD."],
    "16865398": ["The detection of Abeta11-42 in young DS brain suggests an early role for this N-terminally truncated Abeta peptide in the pathogenesis of SPs in AD and DS."],
    "16954700": ["While a commonly accepted model argues that Abeta peptides are the cause of onset and early pathogenesis of Alzheimer's disease, recent discussions challenge this 'Abeta hypothesis' and suggest a direct role for APP in this neurodegenerative disease.", "The amyloid precursor protein (APP) is a widely expressed transmembrane protein that is cleaved to generate Abeta peptides in the central nervous system and is a key player in the pathogenesis of Alzheimer's disease."],
    "16979587": ["The accumulation and deposition of fibrillar Abeta is thought to be the primary cause of Alzheimer's disease."],
    "17055579": ["The amyloid Abeta-peptide (Abeta) is suspected to play a critical role in the cascade leading to AD as the pathogen that causes neuronal and synaptic dysfunction and, eventually, cell death."],
    "17080204": ["Heparan sulfate, a heterogeneously sulfated glycosaminoglycan, has been identified as the first naturally occurring inhibitor of beta secretase, the rate-limiting step in the formation of Abeta, the peptide core of the amyloid plaques that cause Alzheimer's disease."],
    "17194489": ["These results indicate strain differences in the susceptibility to Abeta(1-40)-induced changes in the GSH-dependent antioxidant defences in mice, which should be taken into account in further studies using the Abeta model of AD in mice."],
    "17316541": ["BACE cleavage of the APP leads to formation of the Abeta peptide, a key event that leads to Alzheimer's disease."],
    "17393484": ["Swedish double mutation (KM670/671NL) of amyloid precursor protein (Swe-APP), a prevailing cause of familial Alzheimer's disease (FAD), is known to increase in Abeta production both in vitro and in vivo, but its underlying molecular basis leading to Alzheimer's disease (AD) pathogenesis remains to be elucidated, especially for the early phase of disease."],
    "17493709": ["These findings indicate that alpha7 nAChR may play a significant neuroprotective role by enhancing cleavage of APP by alpha-secretase, regulating signal transduction, improving antioxidant defenses and inhibiting the toxicity of Abeta, which is connected with the pathogenesis of AD."],
    "17521225": ["It is a widely accepted theory that aggregation of Abeta into plaques is an initial event in the pathogenesis of Alzheimer's disease, driving neurodegeneration."],
    "17687040": ["Recent studies have suggested that highly amyloidogenic Abeta(1-42) is a cause of neuronal damage leading to AD pathogenesis and that monomeric Abeta(1-40) has less neurotoxicity than Abeta(1-42)."],
    "17827153": ["Gamma-secretase, a unique aspartyl protease, is required for the regulated intramembrane proteolysis of Notch and APP, pathways that are implicated, respectively, in the pathogenesis of cancer and Alzheimer disease."],
    "18053791": ["Because the amyloid beta-peptide (Abeta) functions as approximately half of the transmembrane domain of the amyloid precursor protein and interaction of Abeta with membranes is proposed to result in neurotoxicity, the association of Abeta with membranes likely is important in the etiology of Alzheimer's disease."],
    "18056412": ["Abnormal processing of APP by gamma-secretase produces a fragment, Abeta(42), that may be responsible for Alzheimer's disease (AD)."],
    "18245849": ["Our data offer insight into the toxicity of Abeta and open new areas for further study into AD pathogenesis."],
    "18252750": ["Although it is not yet established, whether the resulting Abeta aggregates are the causative agent or just a result of the disease progression, polymerization of Abeta has been identified as a major feature during AD pathogenesis.", "The 'amyloid cascade hypothesis' assigns the amyloid-beta-peptide (Abeta) a central role in the pathogenesis of AD."],
    "18393801": ["The accumulation and deposition of fibrillar Abeta is thought the primary cause of Alzheimer's disease (AD)."],
    "18509986": ["CONCLUSION: The findings indicate that alpha7 nAChR may play a significant neuroprotective role by enhancing cleavage of APP, improving antioxidant defenses and limiting the toxicity of Abeta, which has been implied in the pathogenesis of AD."],
    "18537540": ["All converging lines of evidence suggest that progressive accumulation of the Abeta plays a central role in the genesis of Alzheimer's disease and it was long understood that Abeta had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects."],
    "18571334": ["These data establish hMMEL as a mediator of Abeta catabolism and raise the possibility of its involvement in the etiology of AD and as a target for intervention."],
    "18571499": ["Hereby the interaction between Abeta and nanoparticles may contribute to AD etiology."],
    "18590917": ["Thus, while melatonin may be a potential therapeutic agent in the prevention of oxidative stress associated with Abeta and AD, it can also prevent dopamine turnover induced by Abeta."],
    "18606218": ["FZS modulated the impaired cellular functions, and attenuated the damage caused by beta-amyloid protein, dose-dependently regulated and ameliorated the cholinergic functions of the Abeta(25-35)-induced AD-model mice."],
    "18650431": ["Abeta fulfills a central role in AD pathogenesis, and reduction of Abeta levels should prove beneficial for AD treatment."],
    "18723506": ["Recognition of the importance of Abeta degradation to the overall economy of Abeta has revised our thinking about the mechanistic basis of AD pathogenesis and identified a novel class of enzymes that may serve as both therapeutic targets and therapeutic agents."],
    "18760331": ["A therapeutic target for AD is to block the cascade reaction induced by Abeta."],
    "18835787": ["We therefore hypothesize that a peripheral increase in Abeta may result in corresponding increase of sCD40 and sCD40L further contributing to AD pathogenesis."],
    "18847222": ["Our studies add significant weight to a modified amyloid cascade hypothesis in which sporadic AD is the result of Abeta being upregulated as a response to oxidative stress."],
    "18926803": ["Consequently, the discrepant effects of P and PS on Abeta peptide toxicity may provide insight on the pathogenesis of Alzheimer's disease."],
    "18956886": ["Two conformers of aggregated Abeta, i.e., fibrils and oligomers, have been deemed important in the pathogenesis of Alzheimer's disease."],
    "19026087": ["Oligomers of Abeta peptides are suspected as the underlying cause of Alzheimer disease."],
    "19081767": ["Longitudinal evaluation of blood Abeta in this cohort will provide a better understanding of the significance of this association in AD etiology."],
    "19094587": ["CONCLUSIONS: The expression inhibition of alpha 3 nAChR as a result of recombinant alpha 3 nAChR siRNA can induce oxidative stress and improve the toxicity of Abeta on SH-SY5Y cells, indicating that alpha 3 nAChR may play a significant neuroprotective role in the pathogenesis of Alzheimer disease."],
    "19124085": ["A view that Abeta is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies."],
    "19221413": ["These proteases are targets for the development of therapeutic compounds to downregulate Abeta production. gamma-secretase has received more attention 1) because it generates the C-terminus of Abeta, which is important in the pathogenesis of AD because the longer Abeta species are more amyloidogenic, and 2) because it cleaves AbetaPP within its transmembrane domain."],
    "19222911": ["The steady-state levels of Abeta are determined by the metabolic balance between anabolic and catabolic activity and the dysregulation of this activity leads to Alzheimer's disease."],
    "19275251": ["Abeta peptide is an essential protein in the pathogenesis of Alzheimer's disease and is derived from amyloid precursor protein (APP) in the membrane by beta- and gamma-secretase cleavage."],
    "19295161": ["The proposed role of APP as a vesicle receptor for the microtubule motor kinesin-1 has relevance for the pathogenesis of Alzheimer's disease."],
    "19501112": ["The choroid plexus, a barrier between the blood and cerebrospinal fluid (CSF), is known to accumulate lead (Pb) and also possibly function to maintain brain's homeostasis of Abeta, an important peptide in the etiology of Alzheimer's disease."],
    "19515914": ["The processing of amyloid precursor protein (APP) to Abeta is an important event in the pathogenesis of Alzheimer's disease, but the physiological function of APP is not well understood."],
    "19725915": ["Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis."],
    "19774677": ["Abeta (1-42) conceivably is critical to the pathogenesis of MCI and AD, including the oxidative stress under which brain in both conditions exist."],
    "20045708": ["Intraperitoneal administration of l-thyroxine (L-T4) into Abeta-induced AD model mice prevented their cognitive impairment and improved their memory function."],
    "20135308": ["The aggregation of Abeta(1-42) plays a causative role in the development of Alzheimer's disease."],
    "20153835": ["INTRODUCTION: The amyloid hypothesis states that Abeta is the main trigger for Alzheimer's disease."],
    "20478062": ["Soluble oligomeric Abeta (oAbeta) has recently emerged to be as a likely proximal cause of AD."],
    "20684593": ["The aggregation of Abeta is a crucial step in the etiology of Alzheimer's disease."],
    "20704753": ["Neurons are likely to be exposed to chronic, sublethal doses of Abeta over an extended time during the pathogenesis of AD, however most studies published to date using in vitro models have focussed on acute studies."],
    "20720123": ["We discovered a nonpeptidic compound, TAK-070, that inhibited BACE1, a rate-limiting protease for the generation of Abeta peptides that are considered causative for Alzheimer's disease (AD), in a noncompetitive manner."],
    "20732423": ["APLP2, belonging to the APP gene family, undergoes secretase and caspase cleavages and has been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "20824130": ["Abeta peptide accumulation is thought to be the primary event in the pathogenesis of Alzheimer's disease (AD), with downstream neurotoxic effects including the hyperphosphorylation of tau protein."],
    "20855613": ["Whereas Abeta is viewed as critical for Alzheimer's disease pathogenesis, the role of other APP processing products remains enigmatic."],
    "21166677": ["Recent findings suggest that 'aged garlic extract' (AGE) may be a therapeutic agent for AD because of its antioxidant and Abeta lowering properties."],
    "21214928": ["Multiple lines of evidence demonstrate that overproduction/aggregation of Abeta in the brain is a primary cause of AD and inhibition of Abeta generation has become a hot topic in AD research."],
    "21274428": ["Furthermore, dysregulation of PKC-MAPK signaling is known to increase Abeta levels in the brain, which results in AD phenotypes."],
    "21318512": ["This, combined with the observation that these peptides are differentially deposited in senile plaques (SPs) in vivo, suggests that differential production of Abeta(1)-(40) and Abeta(1)_(42) may be crucially important in the pathogenesis of AD."],
    "21348837": ["Accumulation of soluble and insoluble assemblies of Abeta in the brain is a crucial event in AD pathogenesis and the presence of amyloid plaques in the brain is required for definitive identification of AD."],
    "21350608": ["However, there is now sufficient strong evidence indicating that accumulation of Abeta inside neurons plays an important role in the pathogenesis of Alzheimer's disease."],
    "21442216": ["Apoptogenic interactions of plasmalemmal type-1 VDAC and Abeta peptides via GxxxG motifs induce Alzheimer's disease - a basic model of apoptosis?"],
    "21446542": ["The Abeta peptide is a key molecule in the pathogenesis of Alzheimer's disease and an important marker for early diagnosis."],
    "21464905": ["Overall, these results led us to conclude that calcium ions stimulate the formation of oligomers of Abeta(1-40), that have been implicated in the pathogenesis of AD."],
    "21502851": ["Little is known regarding factors associated with soluble amyloid beta peptide (Abeta) concentrations in humans at late midlife, when Abeta is likely most critical to Alzheimer disease pathogenesis."],
    "21527912": ["Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.", "However, mechanisms that increase the aggregation of wild-type Abeta and cause the much more common sporadic forms of AD are largely unknown."],
    "21740063": ["The latter could represent a two-dimensional (2D) seeding template for the formation of toxic oligomeric Abeta in the pathogenesis of AD.", "Interactions of beta-amyloid (Abeta) peptides with neuronal membranes have been associated with the pathogenesis of Alzheimer's disease (AD); however, the molecular details remain unclear."],
    "21896486": ["Because Abeta(42) is widely believed to trigger AD pathogenesis, gamma-secretase is a key AD drug target."],
    "21944886": ["The evidence that is derived from several sources--genetic, among them--suggests that the Abeta participates in the pathogenesis of Alzheimer's Disease (AD)."],
    "22288403": ["The Abeta and tau proteins, two key players in the pathogenesis of Alzheimer's disease (AD), are highly homologous among primates."],
    "22300406": ["In this review we discuss latent early- life associated regulation (LEARn), where apparently temporary changes, induced by environmental agents, become latent and present themselves again at maturity or senescence to increase production of Abeta that may cause AD."],
    "22327103": ["Thus, quantification of Abeta in several different types of samples from brain is fundamental for understanding AD pathogenesis."],
    "22407769": ["Progressive cerebral deposition of Abeta in the brain is a seminal event in the pathogenesis of Alzheimer's disease (AD)."],
    "22468783": ["In addition, the behavioral deficits accompanying Abeta(1-40)-induced AD were attenuated by inhalation of EOCO.", "OBJECTIVE: The aggregation and formation of beta-amyloid peptides (Abeta) into fibrils are central events in the pathogenesis of Alzheimer's disease (AD), and overproduction and aggregation of Abeta into oligomers have been known to trigger neurotoxicity."],
    "22540007": ["Furthermore, DG significantly decreased the escape latency and search distance and increased the target crossing times of Abeta(1-42)-induced AD mice in the Morris water maze test.", "In addition, DG could alleviate lipid peroxidation and partially restore the mitochondrial function in Abeta(1-42)-induced AD mice."],
    "22545812": ["Understanding the structural basis of neuronal binding and uptake of Abeta might lead to potential therapeutic targets that could block this binding and the subsequent neurodegeneration that leads to the pathogenesis of AD."],
    "22613765": ["Abeta has been widely believed to initiate pathogenic cascades culminating in Alzheimer's disease (AD)."],
    "22660329": ["Our results raise the possibility that Abeta(3(pE)-42) acts similarly at a primary step in Alzheimer's disease pathogenesis.", "Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-beta are strongly associated with Alzheimer's disease, are more toxic than amyloid-beta, residues 1-42 (Abeta(1-42)) and Abeta(1-40), and have been proposed as initiators of Alzheimer's disease pathogenesis.", "Here we report a mechanism by which pE-Abeta may trigger Alzheimer's disease."],
    "22675658": ["Although the role of Abeta as a key molecular factor in the etiology of Alzheimer disease remains controversial, clinical trials of amyloid-lowering agents, reviewed elsewhere in this book, are poised to resolve the question of its pathogenic primacy."],
    "22727994": ["APP mutations cause Alzheimer disease (AD) with virtually complete penetrance."],
    "22840746": ["As evidence suggests that Abeta is critical to Alzheimer pathogenesis, gamma-secretase is considered a key target for the development of disease-modifying therapeutics."],
    "22891248": ["Increasing evidence implicates Abeta peptides self-assembly and fibril formation as crucial events in the pathogenesis of Alzheimer disease."],
    "23143229": ["Abeta is the main component of amyloid deposits in Alzheimer disease (AD) and its aggregation into oligomers, protofibrils and fibrils is considered a seminal event in the pathogenesis of AD."],
    "23279783": ["CONCLUSIONS: DG protects Abeta(1-42) -induced AD models in vitro and in vivo through reducing activation of microglia and inflammation, which may be involved in MAPK and NF-kappaB pathways."],
    "23279943": ["Potential prevention and treatment of maifanite for Alzheimer's disease based on behavior test, oxidative stress assay, and trace element analysis in hippocampus of Abeta(25-35)-induced AD rats."],
    "23324234": ["CONCLUSIONS: An inhibited alpha7 nAChR mRNA induced by siRNA may markedly stimulate the production of Abeta through the mechanism of increased expression of BACE1 and inhibited expression of BACE2, which may be related to the pathogenesis of AD."],
    "23436150": ["A common hypothesis suggests that Alzheimer's disease (AD) is caused by Abeta peptides or their products."],
    "23474291": ["Lowering the production and accumulation of Abeta has been explored as treatment for Alzheimer's disease (AD), because Abeta is postulated to play an important role in the pathogenesis of AD."],
    "23582659": ["Identifying genes that undergo significant epigenetic alterations in response to Abeta could aid in the understanding of the pathogenesis of AD, as well as suggesting possible new treatment strategies."],
    "23651610": ["In the present study we firstly investigated whether Neu-P11 and melatonin enhance memory performance in the novel object recognition (NOR) task in rats, and then assessed whether Neu-P11 and melatonin improve neuronal and cognitive impairment in a rat model of Alzheimer' disease (AD) induced by intrahippocampal Abeta(1-42) injection."],
    "23713771": ["These results uncover a novel molecular property of the Abeta and IAPP sequences, i.e. their ability to form hetero-fibrils, and offer mechanistic support to a model linking Abeta and IAPP hetero-association to their cytotoxic self-association pathways and thus likely to the pathogenesis of AD and T2D."],
    "23756182": ["The present findings demonstrate an improvement of memory and neurobehavioral function with GCSF in Abeta-induced Alzheimer's disease model in rats."],
    "24130920": ["A series of studies on Abeta clearance mechanism provide new insight into the pathogenesis of AD at the molecular level and suggest a new target for the development of novel therapeutics."],
    "24148205": ["The genetics of FAD together with biochemical and cell biological data, led to the formulation of the amyloid hypothesis, stating that accumulation and aggregation of Abeta is the primary event in the pathogenesis of AD, while tau might mediate its toxicity and neurodegeneration.The generation of Abeta involves sequential proteolytic cleavages of the amyloid precursor protein (APP) by enzymes called beta-and gamma-secretases."],
    "24418687": ["Although there are some studies indicating that a single dose of Abeta induces AD-like learning and memory impairment, this model is not usually reproducible especially in rat."],
    "24529520": ["The proximal cause of such resistance in AD dementia and amnestic mild cognitive impairment (aMCI) appears to be serine inhibition of IRS-1, a phenomenon likely due to microglial release of inflammatory cytokines triggered by oligomeric Abeta."],
    "24747018": ["Should Abeta prove to be the underlying cause of AD, our results strongly suggest that IVIG could be beneficial in the therapy for AD by inducing efflux of Abeta from the brain through the LRP1 in the BCB."],
    "24803005": ["The complex dynamics of Abeta contributes to the causative role of Abeta in the pathogenesis of AD."],
    "24900405": ["Compound 14 was finally identified as an effective agent with comparable in vivo efficacy to the marketed drug donepezil in counteracting spatial learning and working memory impairment in an Abeta-induced Alzheimer's mouse model."],
    "25108425": ["Although impaired cerebral blood flow (CBF) has been implicated in faulty Abeta transport and clearance, and cerebral hypoperfusion can exist in the pre-clinical phase of Alzheimer's disease (AD), it is still unclear whether it is one of the causal factors for AD pathogenesis, or an early consequence of a multi-factor condition that would lead to AD at late stage."],
    "25152012": ["Multiple lines of evidence demonstrate that over-production/aggregation of Abeta in the brain is a primary cause of AD and attenuation of Abeta generation has become a topic of extreme interest in AD research."],
    "25193466": ["Although recent genetic evidences strongly argue for a causative role of Abeta in AD onset and progression (Jonsson et al., 2012), its role in AD etiology remains a matter of debate."],
    "25391447": ["However, the mechanism(s) by which HN exerts its neuroprotection against Abeta-induced AD-like pathological changes and memory deficits are yet to be completely defined."],
    "25465238": ["This review summarizes the characters of these prominent receptors and how the bindings of them with Abeta inhibit the LTP, decrease the number of dendritic spine, damage the neurons, and so on in AD pathogenesis."],
    "25815792": ["Self-assembly of Abeta peptides into amyloid aggregates has been suggested as the major cause of Alzheimer's disease (AD)."],
    "25856695": ["CONTEXT: Results from various studies indicate that the presence of certain heavy metals such as aluminum (Al), arsenic (As), copper (Cu), lead (Pb), and mercury (Hg) may enhance the aggregation of Abeta and oxidative stress levels leading to neuronal toxicity and Alzheimer's disease (AD)."],
    "25858471": ["In this study, we aimed to investigate if the Futokadsura stem extract could protect the neuron in the brain of an Abeta-induced Alzheimer's Disease (AD)-like rat model by improving the learning and memory ability of the rats.", "Neuroprotective effects of an aqueous extract of Futokadsura stem in an Abeta-induced Alzheimer's disease-like rat model."],
    "25908557": ["Recent reports have shown that the association of Abeta with membranes containing ganglioside GM1 (GM1) plays a pivotal role in amyloid deposition and the pathogenesis of AD."],
    "26007213": ["We conclude that Abeta likely is the key initiator of a complex pathogenic cascade that causes AD."],
    "26071020": ["Accumulation of Abeta peptides in the brain has been suggested as the cause of AD (amyloid cascade hypothesis); however, the mechanism for the abnormal accumulation of Abeta in the brains of AD patients remains unclear."],
    "26104317": ["RESULTS: The results showed that EsA attenuated memory deficits in Abeta(1-42)-induced AD mice.", "Esculentoside A decreased the pro-inflammatory factors and microglia and astrocyte activation in the hippocampi of Abeta(1-42)-induced AD mice."],
    "26168900": ["The misfolding and aggregation of the Abeta peptide - a fundamental event in the pathogenesis of Alzheimer's disease - can be instigated in the brains of experimental animals by the intracranial infusion of brain extracts that are rich in aggregated Abeta."],
    "26230612": ["Further, declined or impaired sAPPalpha production, or reduced heterodimerization with Abeta, would cause a deficiency in Abeta clearance and thus accelerate the pathogenesis of AD."],
    "26235069": ["The Abeta peptide is widely considered a major cause of Alzheimer's disease since it causes neuronal death in an oligomerisation-dependent manner."],
    "26314631": ["Even if further studies are needed to better understand and validate these mechanisms, we believe that to deepen the role of Abeta in physiological conditions might represent the keystone to elucidate important aspects of AD pathogenesis."],
    "26316988": ["Even though a number of cholesterol modulating agents have been shown to affect Abeta generation, the role of cholesterol in the pathogenesis of AD is not clear yet."],
    "26403946": ["Cleavage produces various Abeta peptides that are linked to the etiology of Alzheimer's disease."],
    "26444772": ["Although N-truncated Abeta peptides and Abeta x-42 species appear to be the crucial players in AD etiology, the Abeta 2-x isoforms did not receive much attention yet."],
    "26515666": ["The aggregation of Abeta peptides is a crucial factor leading to Alzheimer's disease (AD)."],
    "26529393": ["Although N-truncated Abeta peptides and Abetax-42 species appear to be the crucial players in AD etiology, the Abeta2-X isoforms did not receive much attention yet."],
    "26606631": ["Numerous experimental studies indicate that amyloid beta protein (Abeta) oligomers as small as dimers trigger Alzheimer's disease."],
    "26642316": ["Previously it has been demonstrated that polyunsaturated fatty acids (PUFAs), especially docosahexaenoic acid (DHA), are associated with a reduced risk of AD caused by decreased Abeta production.", "To investigate whether lipid peroxidation is only a consequence or might also influence the processes leading to AD, we analyzed 7 different oxidized lipid species including 5 oxidized DHA derivatives and the lipid peroxidation products of omega-3 and omega-6 PUFAs, HNE and 4-hydroxy-hexenal, in human neuroblastoma cells and mouse mixed cortical neurons."],
    "26818522": ["UNLABELLED: gamma-Secretase is an intramembrane-cleaving protease that produces amyloid-beta peptide 42 (Abeta42), which is the toxic and aggregation-prone species of Abeta that causes Alzheimer's disease."],
    "26861514": ["Rats fed a HFD were injected with Abeta to induce AD, allowed to recover, and treated with Met for 8 weeks."],
    "26896721": ["Abeta protein is a highly noticeable protein which causes Alzheimer's disease."],
    "27157482": ["To date, all available evidence strongly supports the notion that an imbalance between the production and removal of Abeta leading to its progressive accumulation is central to the pathogenesis of AD."],
    "27418961": ["Due to the linkage of Abeta to the potential cause of AD, extensive discovery and development efforts have been directed towards potent BACE1 inhibitors for AD therapy."],
    "27420352": ["In the current study, we evaluated the effect of puerarin on Alzheimer's disease induced by Abeta and explored the potential mechanisms underlying this effect."],
    "27554967": ["To reveal its molecular mechanisms on p65, we cultured astrocytes, built Abeta-induced AD model, treated astrocytes with HupA at different concentrations, assayed cell viability with MTT, and detected p65 expression by immunohistochemistry and PCR."],
    "27630262": ["Abeta peptides play a central role in the etiology of Alzheimer disease (AD) by exerting cellular toxicity correlated with aggregate formation."],
    "27665848": ["In the present study, we examined the effect of an irreversible tTG inhibitor, NTU283, on Abeta mimic-induced AD pathogenesis in SH-SY5Y cells."],
    "27806872": ["Our results showed that LPS treatment (500MUg/kg/day) for 7days disturbed memory, enhanced systemic NO production, NOS2 and Abeta 1-42 cerebral expression and generated an Alzheimer's disease (AD)-like neuronal degeneration."],
    "28082052": ["Recent studies revealed the decreased clearance of Abeta in sporadic AD patients, suggesting the importance of the catabolic mechanism in the pathogenesis of AD."],
    "28183246": ["The production of Abeta and its propensity to aggregation to form oligomers and fibrils are believed to initiate a sequence of events that lead to AD dementia."],
    "28231543": ["These results demonstrate that DSE may have beneficial effects in the prevention of Abeta-induced Alzheimer in a rat model."],
    "28411131": ["The purpose of this study was to evaluate the protective effect of N-acetyl cysteine (NAC) on learning and memory in an Abeta-induced Alzheimer's disease model in adult male rats, using behavioral and electrophysiological methods Thirty-five rats were divided into five groups: control, sham-operated, Abeta, Abeta+NAC (1-14days), and Abeta+NAC (14-28days)."],
    "28413720": ["The formation of cytotoxic oligomers consisting of Abeta peptide is widely accepted as being one of the main key events triggering the development of Alzheimer's disease."],
    "28502705": ["The beta-site APP-cleaving enzyme 1 (BACE1) is essential for Abeta generation and dysregulation of BACE1 expression may lead to AD pathogenesis."],
    "28582770": ["The purpose of the current study was to explore the effects of the water extracts of Epimedii Folium and Curculiginis Rhizoma (EX) on Abeta-induced Alzheimer's disease."],
    "28657440": ["Extensive evidence from in vitro and in vivo studies indicates that misfolded and aggregated Abeta peptide, which is the probable molecular trigger for Alzheimer's disease, manifests all of the key characteristics of canonical mammalian prions."],
    "28711595": ["In spite of the numerous studies focusing in Abeta, the relevance of N- and C-terminal truncated species for AD pathogenesis remains largely understudied."],
    "28826585": ["Those may either integrate amyloid pathology or will propose pathogenetic routes independent of Abeta in the search for the causes of AD."],
    "28846851": ["These findings indicated that L-T4 increased BDNF and reelin protein expression by regulation of serum THs and TSH level in Abeta-induced AD rats."],
    "29124171": ["Aggregation of Abeta peptides into amyloid plaques is considered to trigger the Alzheimer's disease (AD), however the mechanism behind the AD onset has remained elusive."],
    "29260173": ["These results suggested that fucoidan might exert its protective effects against Abeta-induced toxicity in transgenic AD C. elegans by reducing the accumulation of toxic Abeta and decreasing Abeta-induced production of ROS, thus ameliorating the progression of the AD phenotype."],
    "29332044": ["In particular, we focused on the Abeta and neurofibrillary tangles formation pathways, which are crucial to AD pathogenesis."],
    "29495486": ["Moreover, despite understanding of potential physiological roles of Abeta, this peptide has been linked to the pathogenesis of Alzheimer disease, and its pathogenic roles remain controversial."],
    "29544432": ["Studies of the process of amyloid formation by Abeta peptide have been topical due to the critical role of this peptide in the pathogenesis of Alzheimer's disease."],
    "29568268": ["Both peptides show enhanced aggregation and neurotoxicity in comparison to full-length Abeta, suggesting that these amyloid peptides may play an important role in the pathogenesis of AD."],
    "29702072": ["The 99 amino acid C-terminal fragment of Amyloid Precursor Protein APP-C99 (C99) is cleaved by gamma-secretase to form Abeta peptide, which plays a critical role in the etiology of Alzheimer's Disease (AD)."],
    "29733614": ["Accumulation of Abeta peptides is a hallmark of Alzheimer's disease (AD) and is considered a causal factor in the pathogenesis of AD."],
    "29849984": ["To elucidate the therapeutic mechanisms of lavender, serum metabolic fingerprint of Abeta-induced rat Alzheimer's models was investigated through nuclear magnetic resonance spectrometry."],
    "29886524": ["Using these approaches, we developed conditions under which Abeta42, the Abeta variant most strongly linked to the aetiology of AD, assembles into an oligomer that inserts into lipid bilayers as a well-defined pore and adopts a specific structure with characteristics of a beta-barrel arrangement."],
    "29887142": ["Although aberrant Abeta appears to be the prime mover of Alzheimer disease pathogenesis, once set in motion by Abeta, the prion-like propagation of tauopathy may proceed independently of Abeta; if so, Abeta might be solely targeted as an early preventive measure, but optimal treatment of Alzheimer disease at later stages of the cascade could require intervention in both pathways."],
    "29945247": ["This indicates that triplication of chromosome 21 genes other than APP is likely to have an important role to play in Alzheimer's disease pathogenesis in individuals who have Down syndrome."],
    "30021335": ["In conclusion, 4-PSQ protected against learning and memory impairment and anxiety in a mouse model of AD induced by Abeta, and anticholinesterase and antioxidant actions are involved in the pharmacological effect of the compound."],
    "30087609": ["These findings led to the \\beta-amyloid hypothesis\\ that proposes that Abeta is the major cause of AD."],
    "30185465": ["Our findings suggest that FcgammaRIIb2 is essential for neuropathic uptake of Abeta in AD.SIGNIFICANCE STATEMENT Accumulating evidences suggest that intraneuronal Abeta is found in the early step of AD brain and is implicated in the pathogenesis of AD."],
    "30257562": ["Abeta is central to the development of Alzheimer's disease (AD) and has been studied extensively to determine the molecular mechanisms of Abeta-induced cellular dysfunctions underlying the pathogenesis of AD."],
    "30318785": ["While we cannot identify the exact mechanism underlying the observed alterations in EC structure and network function, considering the relevance of Abeta in ABCA7 related AD pathogenesis, the results of our study may reflect the synergistic reinforcement between amyloid and tau pathology in the EC, which significantly increases tau-induced neuronal loss and accelerates synaptic alterations."],
    "30322673": ["CONCLUSION: This study demonstrate that KXS significantly improved cognitive function of transgenic mice of AD, repaired the damage caused by Abeta, regulated amino acid metabolism and lipid metabolism abnormalities and determined the effective material basis of KXS treating AD."],
    "30542277": ["According to this hypothesis, the accumulation of Abeta in the brain is the primary factor initiating the pathogenesis of AD."],
    "30564549": ["Moreover, exercise helps to maintain a cerebral microenvironment that facilitates synaptic plasticity by enhancing the clearance of Abeta, one of the main culprits of AD pathogenesis."],
    "30579679": ["The beta-amyloid (Abeta) cascade hypothesis is the most widely accepted and proposes that the accumulation of Abeta in the brain is one potential mechanism for AD pathogenesis."],
    "30622228": ["The amyloid hypothesis states that Abeta initiates the cascade of events that result in AD."],
    "30713632": ["The self-assembly of Abeta to beta-sheet-rich neurotoxic oligomers is a main pathological event leading to Alzheimer's disease (AD)."],
    "30814820": ["Conclusion: Aerobic and resistance exercise could improve recognition memory and decrease AChE activity in Abeta-induced AD in rats."],
    "30842555": ["Excess Abeta production by the key protease BACE1, results in Abeta aggregation, forming amyloid plaques, all of which contribute to the pathogenesis of Alzheimer's disease."],
    "30911686": ["While the accumulation of Abeta is pivotal to the etiology of AD, both the microtubule-associated protein tau (MAPT) and the F-actin severing protein cofilin are necessary for the deleterious effects of Abeta."],
    "30950339": ["The collection of Abeta in the brain is an early poisonous occasion in the pathogenesis of Alzheimer's disease, which is the most widely recognized type of dementia correlated with plaques and tangles within the brain."],
    "31093882": ["Binding between Prion Protein and Abeta Oligomers Contributes to the Pathogenesis of Alzheimer's Disease."],
    "31171765": ["These data reveal an important role of Abeta in oligodendrocyte lineage function and maturation, which may be relevant to AD pathogenesis."],
    "31325011": ["According to the widely accepted amyloid cascade hypothesis, misfolding and aggregation of Abeta peptides is the principal cause of Alzheimer's disease."],
    "31403945": ["However, Cdk5 gene silencing exhibited a neuroprotective effect in the Abeta-induced AD neuron model by effectively inhibiting the Abeta-induced neuronal apoptosis, PPARgamma phosphorylation, PPARgamma expression downregulation, and PPARgamma target gene expression changes, and reducing Abeta levels."],
    "31524157": ["This finding provides further evidence for a mechanistic connection between Abeta and tau at seminal stages of AD pathogenesis."],
    "31625272": ["We have reported earlier that late long-term potentiation (late LTP) and its associative mechanisms such as synaptic tagging and capture (STC) were impaired in Abeta (1-42)-induced AD condition."],
    "31642314": ["Our findings offer insights into interactions between insulin and Abeta42 that are relevant to understanding the molecular basis of intranasal insulin as a therapy against Abeta-induced AD pathology, thereby elucidating a plausible mechanism underlying the observed correlations between AD and T2D."],
    "31647947": ["Therefore, the purpose of this study was to investigate the effect of progesterone on the glucose metabolism of neurons in amyloid precursor protein (APP)/presenilin 1 (PS1) mice and Abeta-induced AD cell model."],
    "34453977": ["Here, we hypothesized that the alpha7nAChR deletion blocks Abeta physiological function and promotes a compensatory increase in Abeta levels that, in turn, triggers an AD-like pathology."],
    "35491248": ["In addition to the extremely rare and fully penetrant pathogenic variants of the PSEN1, PSEN2 or APP genes causing autosomal dominant AD, a large spectrum of risk factors have been identified in complex forms, including the common risk factor APOEE4, which is associated with a moderate-to-high risk, common polymorphisms associated with a modest individual risk, and a plethora of rare variants in genes like SORL1, TREM2 or ABCA7 with moderate to high-magnitude effect."],
    "8766821": ["The discovery of pathogenic mutations in the APP gene provides strong evidence for the hypothesis that APP metabolism is involved in the etiology of AD."],
    "9065490": ["Although considerable genetic evidence implicates Abeta in the pathogenesis of AD, a direct causal link remains to be established."],
    "10212241": ["Polymerization of the amyloid beta (Abeta) peptide into protease-resistant fibrils is a significant step in the pathogenesis of Alzheimer's disease."],
    "10729621": ["Brain deposition of the amyloid beta-peptide (Abeta) is a critical step in the pathogenesis of Alzheimer's disease (AD) and human cerebral amyloid angiopathy (CAA)."],
    "10880853": ["The amyloid beta-peptide (A beta), a hallmark in the pathogenesis of AD and the main component of senile plaques, generates free radicals in a metal-catalyzed reaction inducing neuronal cell death by a reactive oxygen species mediated process which damage neuronal membrane lipids, proteins and nucleic acids."],
    "10899433": ["Polymerization of the amyloid beta-peptide (Abeta) has been identified as a major feature of the pathogenesis of Alzheimer's disease (AD)."],
    "10949910": ["BACKGROUND: The amyloid beta (Abeta) peptide is a key molecule in the pathogenesis of Alzheimer's disease."],
    "11483961": ["The former process (termed gamma-secretase cleavage) generates amyloid beta-peptide (Abeta), which is involved in the pathogenesis of Alzheimer's disease."],
    "11588612": ["The formation, aggregation and deposition of amyloid beta peptide (Abeta) is implicated in the aetiology of Alzheimer's disease."],
    "11786314": ["The amyloid beta peptide as the major culprit of Alzheimer's disease pathogenesis entered the research arena about a decade ago."],
    "11815632": ["Extracellular amyloid beta peptides (Abetas) have long been thought to be a primary cause of Alzheimer's disease (AD)."],
    "11912198": ["Amyloid plaques formed by aggregation of the amyloid beta-peptide (Abeta) are an intrinsic component of Alzheimer disease pathogenesis."],
    "12025816": ["Increased production of neurotoxic forms of amyloid beta-peptide (Abeta) and abnormalities in neuronal calcium homeostasis play central roles in the pathogenesis of Alzheimer's disease (AD)."],
    "12063304": ["The amyloid-beta (A beta) peptide, which is derived from the amyloid precursor protein (APP), is involved in the pathogenesis of Alzheimer's dementia and impairs endothelium-dependent vasodilation in cerebral vessels."],
    "12074840": ["Metabolism of amyloid-beta peptide (Abeta) is closely associated with the pathology and etiology of Alzheimer's disease (AD)."],
    "12176077": ["Over the past several years, experiments with synthetic amyloid-beta peptide (Abeta) and animal models have strongly suggested that pathogenesis of Alzheimer's disease (AD) involves soluble assemblies of Abeta peptides (Trends Neurosci. 24 (2001) 219)."],
    "12359256": ["Polymerization of the amyloid beta-peptide (Abeta) has been identified as a major feature of the pathogenesis of Alzheimer's disease (AD)."],
    "12391610": ["Metabolism of amyloid-beta peptide (A beta) is closely associated with the pathology and etiology of Alzheimer's disease (AD)."],
    "12392766": ["Amyloid beta-peptide [Abeta(1-42)] is central to the pathogenesis of Alzheimer's disease (AD), and the AD brain is under intense oxidative stress, including membrane lipid peroxidation."],
    "12446966": ["It is generally accepted that amyloid beta peptides (Abeta) play a significant role in the etiology of Alzheimer's disease."],
    "12446972": ["Over-production and/or altered metabolism of AbetaPP, resulting in increased amyloid beta-peptide (Abeta), appear pivotal in the pathogenesis of AD."],
    "12493601": ["The amyloid precursor protein (APP) and its proteolytic cleavage products, the amyloid beta peptides, have been implicated as a cause of Alzheimer's disease."],
    "12607822": ["Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD."],
    "12846562": ["Cellular release and subsequent aggregation of the amyloid-beta peptide is thought to be causative for the pathogenesis of Alzheimer's disease."],
    "14646594": ["Amyloid beta-peptide (Abeta), a causative molecule in the pathogenesis of Alzheimer's disease and the main component of senile plaques, is known to be neurotoxic in vitro and in vivo."],
    "14698294": ["Extensive data suggest that the conversion of the amyloid-beta (Abeta) peptide from soluble to insoluble forms is a key factor in the pathogenesis of Alzheimer's disease (AD)."],
    "14732699": ["Amyloid-beta peptide (Abeta) is central to the pathogenesis of Alzheimer's disease, and the low-density lipoprotein receptor-related protein (LRP) has been shown to alter Abeta metabolism in vitro."],
    "15065253": ["The cerebral deposition of amyloid beta-peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms."],
    "15267231": ["Gamma-secretase is the second of two proteolytic enzymes responsible for the release of the amyloid beta-peptide implicated in the etiology of Alzheimer's disease."],
    "15304503": ["Because Abeta peptides are thought to be causative for Alzheimer's disease, inhibiting gamma-secretase represents a potential treatment for this neurodegenerative condition."],
    "15341515": ["Gamma-secretase performs the final processing step in the generation of amyloid-beta (Abeta) peptides, which are believed to be causative for Alzheimer's disease."],
    "15347683": ["The deposition of the amyloid beta (Abeta) peptide in neuritic plaques plays a critical role in the pathogenesis of Alzheimer's disease (AD)."],
    "15502844": ["The Arctic mutation within the amyloid-beta (Abeta) peptide causes Alzheimer disease."],
    "15633014": ["A second example is the cleavage of amyloid beta-peptide by IgM and IgG from aged humans, a phenomenon that may represent a specific proteolytic response to a neurotoxic endogenous peptide implicated in the pathogenesis of Alzheimer's disease."],
    "15880461": ["The potential neurotoxicity of soluble forms of amyloid beta peptide (Abeta) as a key factor in early pathogenesis of Alzheimer's disease is being recognized."],
    "15882358": ["In this review, the case is made that amyloid-beta peptide in the brain of patients with Alzheimer's disease is a primary cause of the disease and that immunotherapy directed against this peptide has the potential to halt and/or reverse disease progression."],
    "15955457": ["Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease."],
    "15959937": ["LRP also binds the amyloid precursor protein (APP) and its proteolytic fragment, the amyloid-beta peptide (Abeta), which are major players in the pathogenesis of AD."],
    "15975052": ["The amyloid beta-peptide (Abeta) plays an early and critical role in the pathogenic cascade leading to Alzheimer's disease (AD)."],
    "16255678": ["Aberrant production or decreased clearance of amyloid-beta peptides is widely accepted to be causative for AD."],
    "16364896": ["Aggregation of the amyloid-beta (Abeta) peptide in the extracellular space of the brain is central to Alzheimer's disease pathogenesis."],
    "16595673": ["Amyloid-beta peptide (Abeta) is pivotal to the pathogenesis of Alzheimer disease."],
    "16696577": ["Genetic and experimental evidence points to amyloid-beta (Abeta) peptide as the culprit in Alzheimer's disease pathogenesis."],
    "16781151": ["The interaction of amyloid beta peptide (Abeta) and Abeta-binding alcohol dehydrogenase (ABAD) was recently implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "16817891": ["The amyloid beta peptide (A beta) is crucial for the pathogenesis of Alzheimer's disease."],
    "16893185": ["Aggregation of the 40-42 residue amyloid beta-peptide (Abeta) into amyloid plaques is a central event in Alzheimer's disease (AD) pathogenesis."],
    "16897184": ["Deposition of amyloid beta-peptide (Abeta) and neurofibrillary tangles in the brain are hallmarks of Alzheimer's disease (AD) pathogenesis."],
    "16946102": ["Accumulation of amyloid beta-peptide (Abeta) is considered a key step in the etiology of Alzheimer's disease."],
    "17035538": ["Aberrant processing of the amyloid precursor protein (APP) and the subsequent accumulation of amyloid beta (Abeta) peptide has been widely established as a central event in Alzheimer's disease (AD) pathogenesis."],
    "17054909": ["Amyloid beta-peptide (Abeta) and glutamate are generally believed to be closely related to the pathogenesis of Alzheimer's disease and cerebrovascular disease, respectively."],
    "17169612": ["Data accumulated during the past two decades place amyloid beta-peptide (Abeta) at center stage as the main perpetrator in initiating the pathological cascade that eventually leads to Alzheimer's disease."],
    "17177887": ["We have found that a quartz-crystal microbalance is a facile and useful tool for detecting the specific aggregation of the amyloid-beta peptides responsible for Alzheimer's disease."],
    "17382287": ["The aggregation and deposition onto neuronal cells of amyloid beta-peptide (Abeta) is central to the pathogenesis of Alzheimer's disease."],
    "17404210": ["The conformational change in amyloid beta (Abeta) peptide from its monomeric form to aggregates is crucial in the pathogenesis of Alzheimer's disease (AD)."],
    "17428603": ["Alternative proteolytic processing of APP releases potentially neurotoxic species, including the amyloid-beta (Abeta) peptide that is centrally implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "17471072": ["Accumulating evidence suggests that amyloid beta-peptide (1-42) plays an important role in the etiology of Alzheimer's disease."],
    "17495608": ["Intracellular cholesterol levels influence the generation of amyloid-beta peptides, the toxic species thought to be a primary cause of Alzheimer's disease."],
    "17511455": ["Dysfunctional interactions of metal ions, especially Cu, Zn, and Fe, with the amyloid-beta (A beta) peptide are hypothesized to play an important role in the etiology of Alzheimer's disease (AD)."],
    "17551018": ["Aggregation of the amyloid-beta (Abeta) peptide in the extracellular space of the brain is critical in the pathogenesis of Alzheimer's disease."],
    "17606418": ["The amyloid cascade hypothesis assigns the amyloid-beta peptide (Abeta) a central role in the pathogenesis of Alzheimer's disease (AD)."],
    "17876751": ["Amyloid beta peptide (Abeta) fibril formation is widely believed to be the causative event of Alzheimer's disease pathogenesis."],
    "17897958": ["BACE1 (beta-site amyloid precursor protein-cleaving enzyme-1) is a membrane-bound aspartic protease that cleaves amyloid precursor protein to produce a neurotoxic peptide, amyloid beta-peptide, and has been implicated in triggering the pathogenesis of Alzheimer disease."],
    "17997700": ["Amyloid-beta peptide (Abeta), a major peptide deposited in neuritic plaques, has been considered as an important initiating molecule in the pathogenesis of AD."],
    "18063474": ["Alzheimer's disease (AD) is a neurodegenerative disorder, due to excess amyloid-beta peptide (Abeta)."],
    "18258258": ["Aggregation of the amyloid beta (A beta) peptide plays a key role in the molecular etiology of Alzheimer's disease."],
    "18385378": ["beta-Site APP-cleaving enzyme 1 (BACE1) is required for the penultimate cleavage of the amyloid-beta precursor protein (APP) leading to the generation of amyloid-beta peptides that is central to the pathogenesis of Alzheimer's disease."],
    "18387708": ["Amyloid-beta peptide (Abeta) has been proposed to be the primary cause of AD."],
    "18400162": ["Aggregation of amyloid-beta (Abeta) peptide into soluble and insoluble forms within the brain extracellular space is central to the pathogenesis of Alzheimer's disease."],
    "18411275": ["The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis."],
    "18471993": ["The aggregation of amyloid beta-peptide (Abeta) into beta-sheet-rich aggregates is a crucial step in the etiology of Alzheimer's disease."],
    "18625450": ["The 4-kDa amyloid beta-peptide (Abeta) is strongly implicated the pathogenesis of Alzheimer's disease (AD), and this peptide is cut out of the amyloid beta-protein precursor (APP) by the sequential action of beta- and gamma-secretases. gamma-Secretase is a membrane-embedded protease complex that cleaves the transmembrane region of APP to produce Abeta, and this protease is a top target for developing AD therapeutics."],
    "18930548": ["Neurotoxic oligomers of amyloid beta (Abeta) peptide have been incriminated in the pathogenesis of Alzheimer's disease."],
    "18957217": ["Impaired degradation of amyloid beta (Abeta) peptides could lead to Abeta accumulation, an early trigger of Alzheimer's disease (AD)."],
    "19057576": ["Amyloid beta-peptide (Abeta) accumulation leads to neurodegeneration and Alzheimer disease; however, amyloid metabolism is a dynamic process and enzymic mechanisms exist for Abeta removal."],
    "19075706": ["Extracellular deposition of amyloid beta-peptide (Abeta) has been implicated as a critical step in the pathogenesis of AD."],
    "19122666": ["Amyloid-beta (Abeta) peptides, widely presumed to cause Alzheimer's disease, increased mouse neuronal expression of collagen VI through a mechanism involving transforming growth factor signaling."],
    "19198114": ["Genetic and biological studies provide evidence that the production and deposition of amyloid-beta peptides (Abeta) contribute to the etiology of Alzheimer's disease."],
    "19277012": ["Accumulation of aggregated amyloid-beta (Abeta) peptide was studied as an initial step for Alzheimer's disease (AD) pathogenesis."],
    "19352532": ["Dysfunctional interactions of metal ions, especially those of Cu, Zn, and Fe, with the amyloid-beta (Abeta) peptide are hypothesised to play an important role in the aetiology of AD, and disruption of these aberrant metal-peptide interactions via chelation therapy holds considerable promise as a therapeutic strategy."],
    "19402777": ["Genetic and biological studies provide strong evidence that the deposition of amyloid-beta peptide (Abeta) contributes to the etiology of Alzheimer's disease (AD)."],
    "19450545": ["The overproduction and extracellular buildup of amyloid-beta peptide (Abeta) is a critical step in the etiology of Alzheimer's disease."],
    "19469700": ["Most disease-modifying therapeutic approaches in Alzheimer's disease (AD) aim to reduce the accumulation of neurotoxic amyloid-beta (Abeta) peptides as a hallmark of AD pathogenesis."],
    "19558683": ["Extensive genetic, biochemical, and histological evidence has implicated the amyloid-beta peptide (Abeta) in Alzheimer's disease pathogenesis, and several mechanisms have been suggested, such as metal binding, reactive oxygen species production, and membrane pore formation."],
    "19646546": ["The neurotoxic amyloid-beta-peptide (Abeta) is important in the pathogenesis of Alzheimer's disease (AD)."],
    "19751725": ["Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35)."],
    "19782682": ["Alzheimer's disease (AD) is the principal cause of dementia in older people, and accumulation of amyloid-beta (Abeta) peptide is a crucial event in AD pathogenesis."],
    "19837693": ["The hypothesis that amyloid-beta (Abeta) peptides are the primary cause of Alzheimer's disease (AD) remains the best supported theory of AD pathogenesis."],
    "19841277": ["Accumulation of amyloid beta-peptide (Abeta) and tau aggregates, possibly linked to age-associated deficiencies in protein homeostasis, appear to cause Alzheimer's disease."],
    "19862643": ["Recent evidence has been provided that neuronal IGF1-R increases during aging leading to activation of a signaling pathway that causes an increased production of amyloid beta-peptide, the principal event in the pathogenesis of Alzheimer's disease."],
    "19906677": ["Microglia are critical for amyloid-beta peptide (Abeta)-mediated neuronal perturbation relevant to Alzheimer's disease (AD) pathogenesis."],
    "19926793": ["The amyloid-beta (Abeta) peptide, widely known as the causative molecule of Alzheimer disease (AD), is generated by the sequential cleavage of amyloid precursor protein (APP) by the aspartyl proteases BACE1/beta-secretase and presenilin/gamma-secretase."],
    "19928820": ["The adsorption and aggregation of the amyloid-beta (Abeta) peptides on the cell membrane plays a causal role in the pathogenesis of Alzheimer's disease."],
    "20008660": ["BACKGROUND: Supported by compelling genetic data regarding early-onset familial Alzheimer disease (AD), the amyloid beta-peptide (Abeta)-centric theory holds that Abeta is involved in the pathogenesis of sporadic AD."],
    "20014755": ["Amyloid-beta (Abeta) peptides exhibit many distinct structural morphology at the early aggregate stage, some of which are biological relevant to the pathogenesis of Alzheimer's disease (AD)."],
    "20021564": ["The protease not only releases small peptides, such as the amyloid-beta peptide, which drives Alzheimer's disease pathogenesis, but also intracellular domains, which can have critical functions in nuclear signaling."],
    "20026079": ["Aggregation of the amyloid-beta (Abeta) peptide is considered a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "20030227": ["Several lines of evidence indicate that the production and deposition of amyloid-beta peptides (Abeta) contribute to the etiology of Alzheimer's disease."],
    "20088802": ["Overwhelming evidence supports a central role for the amyloid beta-peptide (Abeta) in the pathogenesis of Alzheimer's disease (AD), and the proteases that produce Abeta from its precursor protein APP are top targets for therapeutic intervention."],
    "20157254": ["Misfolding, oligomerization, and aggregation of the amyloid-beta (Abeta) peptide is widely recognized as a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "20447471": ["We recently reported that amyloid-beta peptide, thought to be a key mediator of AD pathogenesis, engenders S-nitrosylation and thus hyperactivation of the mitochondrial fission protein Drp1."],
    "20456731": ["The abnormal processing of amyloid-beta peptide (A beta) and resultant formation of fibrillar A beta (fA beta) are major events in the pathogenesis of Alzheimer disease (AD)."],
    "20483339": ["The amphipathicity of the natively unstructured amyloid-beta (Abeta40) peptide may play an important role in its aggregation into beta-sheet rich fibrils, which is linked to the pathogenesis of Alzheimer's disease."],
    "20514639": ["At present, it is rather accepted that amyloid-beta peptide acts in parallel with other factors causing Alzheimer's disease that should be also considered at the time of designing useful therapeutic strategies."],
    "20590832": ["The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease."],
    "20596738": ["At relatively early ages, Down syndrome patients develop progressive formation and extracellular aggregation of amyloid-beta peptide, considered as one of the causal factors for the pathogenesis of Alzheimer's disease."],
    "20643087": ["Amyloid-beta (Abeta) peptides and other amyloidogenic proteins can form a wide range of soluble oligomers of varied morphologies at the early aggregation stage, and some of these oligomers are biologically relevant to the pathogenesis of Alzheimer's disease."],
    "20674685": ["The amyloid beta-peptide (Abeta), which is thought to be the major cause of Alzheimer's disease (AD), is known to be capable of aggregating in different states: soluble monomers and oligomers, and insoluble aggregates."],
    "20691893": ["The axonal protein tau and amyloid beta-peptide (Abeta) are key players in the pathogenesis of Alzheimer's disease, and tau mediates Abeta toxicity, but it is not clear how."],
    "20721410": ["It is well known that oligomeric/aggregated amyloid beta peptides are a key player in the pathogenesis of Alzheimer's disease and that different nanoparticles influence oligomerization/aggregation processes in experiments in vitro."],
    "20858952": ["Laboratory research on anesthetic-induced structural changes of amyloid beta (Abeta) peptide, from normal monomeric alpha-helix to the micro-aggregated form, has generated much interest in the scientific community as Abeta oligomerization is considered a key step in Alzheimer disease pathogenesis."],
    "20974113": ["Amyloid-beta peptide (Abeta) is shown to be toxic to the mitochondria and implicates this organelle in the pathogenesis of Alzheimer's disease."],
    "21068297": ["Nonetheless, a growing body of evidence shows that Abeta peptides are unlikely to be the sole factor in AD etiology."],
    "21223993": ["Among the pathological factors known to be associated with Alzheimer disease (AD), oxidative stress induced by the amyloid-beta peptide (Abeta) has been demonstrated to play a key role in human brain and animal models of AD."],
    "21297277": ["Amyloid-beta peptide (Abeta) is recognized by many as the leading cause of Alzheimer's disease (AD), and Abeta oligomers play a major role in the early-onset form of AD."],
    "21491887": ["The interaction of amyloid-beta (Abeta) peptide with Cu(II) appears to play an important role in the etiology of Alzheimer's disease."],
    "21513747": ["Amyloid-beta peptide (Abeta) is believed to be central in the pathogenesis of Alzheimer's disease (AD) characterized by cognitive deficits."],
    "21559427": ["Amyloid beta-peptide (Abeta) accumulation leads to neurodegeneration and Alzheimer's disease (AD)."],
    "21629967": ["The calcium homeostasis modulator 1 (CALHM1) gene codes for a novel cerebral calcium channel controlling intracellular calcium homeostasis and amyloid-beta (Abeta) peptide metabolism, a key event in the etiology of Alzheimer's disease (AD)."],
    "21712440": ["The proteolytic processing of human amyloid precursor protein (APP) into shorter aggregating amyloid beta (Abeta)-peptides, e.g., Abeta1-42, is considered a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "21858698": ["Substantial evidence suggests that the aggregation of amyloid-beta (Abeta) peptide into fibrillar structures that is rich in beta-sheets is implicated as the cause of Alzheimer's disease."],
    "21958962": ["Extracellular deposition of amyloid beta peptide (Abeta) has been implicated as a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "22044482": ["Amyloid-beta peptide (Abeta), which is generated by the beta- and gamma-secretase-mediated proteolysis of beta-amyloid precursor protein (APP), plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "22090477": ["According to the amyloid cascade hypothesis, cerebral deposition of amyloid-beta peptide (Abeta) is critical for Alzheimer's disease (AD) pathogenesis."],
    "22102917": ["The accumulation of the amyloid-beta peptide (Abeta) into amyloid plaques, an essential event in Alzheimer's disease (AD) pathogenesis, has caused researchers to seek compounds that physiologically bind Abeta and modulate its aggregation and neurotoxicity."],
    "22202057": ["RAGE is an important cellular cofactor for amyloid beta-peptide (Abeta)-mediated cellular perturbation relevant to the pathogenesis of Alzheimer's disease (AD)."],
    "22267726": ["Pyroglutamate-modified Abeta peptides at amino acid position three (Abeta(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD)."],
    "22279212": ["An early role of amyloid-beta peptide (Abeta) aggregation in Alzheimer's disease pathogenesis is well established."],
    "22332002": ["The 42-mer amyloid beta (Abeta42) peptide is thought to be a culprit in the pathogenesis of Alzheimer's disease (AD)."],
    "22384101": ["Here we report for the first time that tacrine-6-ferulic acid (T6FA), one of these compounds, can prevent amyloid-beta peptide (Abeta)-induced AD-associated pathological changes in vitro and in vivo."],
    "22514691": ["Amyloid beta (Abeta) peptide is the key molecule in AD pathogenesis, and has been highlighted in the implication of mitochondrial abnormality during the disease progress."],
    "22528098": ["Neurotoxicity in Alzheimer's disease (AD) is associated to dishomeostasis of intracellular Ca(2+) induced by amyloid beta peptide (Abeta) species."],
    "22544746": ["Aggregates of amyloid-beta (Abeta) peptides have been implicated in the etiology of Alzheimer disease."],
    "22551668": ["Cholesterol accumulation in Niemann-Pick type C disease (NPC) causes increased levels of the amyloid-precursor-protein C-terminal fragments (APP-CTFs) and intracellular amyloid-beta peptide (Abeta), the two central molecules in Alzheimer's disease (AD) pathogenesis."],
    "22570624": ["The aggregation or oligomerization of amyloid-beta (Abeta) peptide is thought to be the primary causative event in the pathogenesis of Alzheimer's disease (AD)."],
    "22621900": ["Proteolytic processing of the amyloid-beta precursor protein (APP) and generation of amyloid-beta peptide (Abeta) are key events in Alzheimer's disease (AD) pathogenesis."],
    "22735675": ["Amyloid-beta peptide (Abeta) is considered a key protein in the pathogenesis of Alzheimer's disease (AD) because of its neurotoxicity and capacity to form characteristic insoluble deposits known as senile plaques."],
    "22834820": ["Amyloid beta peptides, causative factors for AD, potentiate the influx of Ca(2+) into neurons via L-VDCCs."],
    "22879596": ["The amyloid beta (Abeta) peptide, which is abundantly found in the brains of patients suffering from Alzheimer disease, is central in the pathogenesis of this disease."],
    "22886024": ["The Chinese hamster ovary cell line 7PA2, stably transfected with the 751 amino acid isoform of amyloid-beta protein precursor (AbetaPP) containing the Val -> Phe mutation at residue 717, is one of the most used models to study the biochemistry and toxicity of secreted amyloid-beta (Abeta) peptides, particularly Abeta oligomers, which are considered to be of relevance to the pathogenesis of Alzheimer's disease."],
    "22988239": ["In this study, we investigated the effects of two different crowding polymers (dextran and Ficoll) and two different experimental conditions (with and without shaking) on the fibrilization of amyloid-beta peptide, a major player in AD pathogenesis."],
    "23023105": ["beta-Site amyloid precursor protein cleaving enzyme-1 (BACE-1) is a transmembrane aspartic protease that mediates the initial cleavage of the amyloid precursor protein (APP), leading to the generation of amyloid-beta (Abeta) peptides that are thought to be causative of Alzheimer's disease (AD)."],
    "23092134": ["The biogenesis and clearance of the amyloid beta peptide (A beta ), the main component of the lesions, lie at the center of the pathogenesis of AD."],
    "23196551": ["Genetic and biological studies provide strong evidence that the deposition of amyloid-beta peptide (Abeta) contributes to the etiology of Alzheimer's disease (AD)."],
    "23232068": ["In Alzheimer's disease, amyloid beta (Abeta) peptides and their aggregation are believed to be at least partially responsible for the etiology of Alzheimer's disease."],
    "23237322": ["gamma-Secretase plays a central role in the generation of the Alzheimer disease-causing amyloid beta-peptide (Abeta) from the beta-amyloid precursor protein (APP) and is thus a major Alzheimer's disease drug target."],
    "23249207": ["Copper(II) binding to the amyloid-beta peptide has been proposed to be a key event in the cascade leading to Alzheimer's disease."],
    "23270374": ["Deposition of amyloid-beta (Abeta) peptides in the brain is a central event in the pathogenesis of Alzheimer's disease (AD), which makes Abeta peptides a crucial target for therapeutic intervention."],
    "23387074": ["Tyrosinase is a key enzyme related to skin pigmentation disorders of elderly people, while self-aggregation of the amyloid-beta peptide, Abeta42, has been considered as a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "23420419": ["The accumulation of extracellular amyloid-beta peptide (Abeta) has been considered as one of the important causes of Alzheimer's disease (AD), the most prevalent form of dementia."],
    "23456036": ["The selenium-deficiency could possibly promote the onset and/or progression of Alzheimer's disease (AD) dementia, if the Abeta peptides initiate a sequence of events that lead to AD dementia."],
    "23461850": ["In the present study, we investigated whether SalB has neuroprotective effects in an amyloid beta (Abeta) peptide-induced Alzheimer's disease mouse model."],
    "23509904": ["The amyloid hypothesis asserts that excess production or reduced clearance of the amyloid-beta (Abeta) peptides in the brain initiates a sequence of events that ultimately lead to Alzheimer's disease and dementia."],
    "23525279": ["The accumulation of amyloid-beta (Abeta) peptide is thought to be a major causative mechanism of Alzheimer's disease."],
    "23565721": ["INTRODUCTION: Alzheimer's disease (AD), which is characterized by progressive intellectual deterioration, is the most common cause of dementia. beta-Secretase (or BACE1) expression is a trigger for amyloid beta peptide formation, a cause of AD, and thus is a molecular target for the development of drugs against AD."],
    "23585568": ["Presenilin comprises the catalytic subunit of gamma-secretase, a protease responsible for the generation of amyloid-beta peptides causative of Alzheimer disease."],
    "23659495": ["In addition to amyloid-beta (Abeta) peptide and phosphorylated tau, lipid dysregulation is suggested to participate in AD pathogenesis."],
    "23708585": ["Aggregation of amyloid beta (Abeta) peptides into fibrils has been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "23714261": ["Abundant evidence suggests a central role for the amyloid-beta (Abeta) peptide in Alzheimer's disease (AD) pathogenesis."],
    "23948943": ["Soluble oligomeric species of amyloid-beta (Abeta) peptide are presumed to be drivers of synaptic impairment, and the resulting cognitive dysfunction in Alzheimer's disease."],
    "24008925": ["BACKGROUND: Generation of amyloid-beta peptide is at the beginning of a cascade that leads to Alzheimer's disease."],
    "24081144": ["A common hypothesis suggests that AD is caused by aggregated Abeta peptides, but treatments with either inhibitors of Abeta production or anti-Abeta antibodies showed no therapeutic value."],
    "24251391": ["Accumulation, aggregation and deposition of the amyloid-beta (Abeta) peptides in the brain are widely accepted as the central events in the pathogenesis of Alzheimer's disease (AD)."],
    "24295810": ["Amyloid beta (Abeta) peptides are key molecules in the pathogenesis of Alzheimer's disease (AD)."],
    "24366271": ["Accumulation of the amyloid-beta (Abeta) peptide in the brain seems to initiate a cascade of key events in the pathogenesis of AD."],
    "24446231": ["Defective clearance of the amyloid-beta peptide (Abeta) from the brain is considered a strong promoter in Alzheimer's disease (AD) pathogenesis."],
    "24494584": ["The amyloid-beta (Abeta) peptide is one key molecule in the pathogenesis of Alzheimer's disease."],
    "24503618": ["Amyloid-beta peptide (Abeta), the cerebral accumulation of which is thought to cause Alzheimer's disease (AD), is produced throughout life."],
    "24503620": ["Since both modifications are increased in Alzheimer's disease (AD) due to amyloid-beta peptide (Abeta) accumulation, we have studied their effect on albumin, the most abundant protein in cerebrospinal fluid and blood."],
    "24512022": ["Amyloid-beta (Abeta) peptide is the original causative factor of Alzheimer's disease (AD) according to the amyloid cascade hypothesis."],
    "24566006": ["Amyloid beta (Abeta) peptides, which are generated from amyloid precursor protein (APP), are thought to play a major role in the pathogenesis of Alzheimer's disease (AD)."],
    "24649396": ["Alzheimer's disease (AD) is widely considered to be caused by amyloid-beta peptide (Abeta) accumulation in the brain."],
    "24815946": ["Neuroinflammatory responses induced by amyloid-beta peptide (Abeta) are important causes in the pathogenesis of Alzheimer's disease (AD)."],
    "24832605": ["Although Abeta peptides have been proposed to be the main cause of AD pathogenesis, the role of AICD has been underappreciated."],
    "25221640": ["Mitochondrial functions can be negatively affected by amyloid beta peptide (Abeta), an important component in Alzheimer's disease (AD) pathogenesis, and Abeta can interact with mitochondria and cause mitochondrial dysfunction."],
    "25456402": ["The cellular prion protein (PrP(C)), a cell surface glycoprotein involved in prion disorders, has been shown to mediate the toxicity of several pathological aggregates, including its own misfolded state and some oligomeric assemblies of the amyloid beta peptide, which are thought to be primarily responsible for the synaptic dysfunction characterizing Alzheimer's disease."],
    "25505877": ["As amyloid-beta peptide (Abeta) is a causative factor for the cognitive impairments of AD, developing a mechanistic understanding of the contribution of Abeta to cognitive impairments may yield important insights into the pathophysiology of AD."],
    "25533654": ["Amyloid-beta peptides generated by proteolysis of the beta-amyloid precursor protein (APP) play an important role in the pathogenesis of Alzheimer's disease."],
    "25553446": ["Amyloid-beta peptide (Abeta) is believed to be a central player in the Alzheimer disease (AD) pathogenesis."],
    "25650940": ["The aggregation of amyloid-beta (Abeta) peptides plays a crucial role in the etiology of Alzheimer's disease (AD)."],
    "25747232": ["The amyloid beta-peptide (Abeta) is suspected to play a central role in the cascade leading to Alzheimer's disease, but the precise mechanisms are still incompletely known."],
    "25818846": ["Abeta is aggregated with Zn(2+) and the aggregation of Abeta-peptides is widely considered to be the critical step in the pathogenesis of AD."],
    "25825723": ["Metal ions have emerged to play a key role in the aggregation process of amyloid beta (Abeta) peptide that is closely related to the pathogenesis of Alzheimer's disease."],
    "25997382": ["In addition, phenolic compounds and hormones (cytokinins) found in coconut may assist in preventing the aggregation of amyloid-beta peptide, potentially inhibiting a key step in the pathogenesis of AD."],
    "26023729": ["The aggregation of the amyloid-beta peptide, Abeta(1-42), is believed to play an important role in the pathogenesis of AD."],
    "26024352": ["Alzheimer's disease (AD)-associated amyloid beta peptide (Abeta) is one of the main actors in AD pathogenesis."],
    "26092626": ["Flavonoids have been found to play a neuroprotective role by inhibiting and/or modifying the self-assembly of the amyloid-beta (Abeta) peptide into oligomers and fibrils, which are linked to the pathogenesis of Alzheimer's disease."],
    "26271894": ["Amyloid beta (Abeta) peptides are identified in cause of neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "26359500": ["Thus, this study suggests that GAPDH aggregates accelerate Abeta amyloidogenesis, subsequently leading to mitochondrial dysfunction and neuronal cell death in the pathogenesis of AD.", "Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by loss of neurons and formation of pathological extracellular deposits induced by amyloid-beta peptide (Abeta)."],
    "26491725": ["Decreased brain clearance of the neurotoxic amyloid-beta (Abeta) peptide is a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "26593432": ["In the present study, we investigated whether these compounds have neuroprotective effects in an amyloid-beta peptide-induced Alzheimer's disease mouse model."],
    "26652010": ["Understanding of the mechanistic progess of amyloid-beta peptide (Abeta) aggregation is critical for elucidating the underlying pathogenesis of Alzheimer's disease (AD)."],
    "26794527": ["We describe a strategy for fluorescent imaging of organelle transport in primary hippocampal neurons treated with amyloid-beta (Abeta) peptides that cause Alzheimer's disease (AD)."],
    "26868929": ["The oligomerization of amyloid beta (Abeta) peptides into soluble non-fibrillar species plays a critical role in the pathogenesis of Alzheimer's disease."],
    "26890786": ["Neurotoxic amyloid-beta (Abeta) peptide causing cognitive function disabilities is one of the most characteristic pathological features in Alzheimer's disease (AD)."],
    "26963025": ["IDE (insulin-degrading enzyme) is one of the major proteases of amyloid beta peptide (Abeta), a presumed causative molecule in Alzheimer disease (AD) pathogenesis."],
    "26981406": ["One of the primary hallmarks of the neuropathological disease is the accretion of amyloid beta peptide in the brain that leads to Alzheimer's disease, but the mechanism is still a mystery."],
    "27030596": ["Accumulation of amyloid-beta (Abeta) peptide in the brain is the first critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "27093940": ["Accumulating evidence points to the amyloid-beta (Abeta) peptide as the culprit in the pathogenesis of Alzheimer's disease (AD)."],
    "27137996": ["Amyloid-beta peptides form polymorphous amyloid fibrils are correlated with the pathogenesis of Alzheimer's disease."],
    "27151330": ["BACKGROUND: The accumulation, aggregation and deposition of amyloid-beta (Abeta) peptides in the brain are central to the pathogenesis of Alzheimer's disease (AD)."],
    "27163800": ["Alzheimer's disease (AD) is thought to be caused by amyloid-beta peptide that triggers tau hyperphosphorylation, which is neurotoxic."],
    "27392871": ["The involvement of Abeta peptides in the etiology of AD remains a subject of debate."],
    "27441457": ["The aggregation of amyloid-beta peptides (Abeta) is considered as the main possible cause of Alzheimer's disease (AD)."],
    "27562438": ["Polyproline-II helices form two interaction sites in the amyloid-beta peptides, which are pivotal for pathogenesis of Alzheimer's disease (AD)."],
    "27580372": ["gamma-secretase is responsible for the proteolysis of amyloid precursor protein (APP) into short, aggregation-prone amyloid-beta (Abeta) peptides, which are centrally implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "27660034": ["Accumulation of amyloid beta (Abeta) peptide and hyperphosphorylated tau protein has been proposed to play roles in neural destruction which induce Alzheimer's disease (AD) progresses, glutamate transporter type 1 (GLT-1) and Glycogen synthase kinase3beta (GSK3beta) may be the pathological links between Abeta and tau pathology."],
    "27663971": ["Amyloid-beta peptide (Abeta) is considered a key protein in the pathogenesis of Alzheimer's disease because of its neurotoxicity, resulting in impaired synaptic function and memory."],
    "27750416": ["Histidine state (deprotonated, neutral, and protonated) is considered an important factor influencing the structural properties and aggregation mechanisms in amyloid beta-peptides (Abeta), which are associated with the pathogenesis of Alzheimer's disease."],
    "27769888": ["Aggregation of amyloid-beta peptide (Abeta) is a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "27777990": ["Accumulation of the amyloid beta (Abeta) peptide in the brain is responsible for debilitating neurodegenerative diseases, such as Alzheimer's disease (AD)."],
    "27796749": ["Oxidative stress is considered a major contributor to the pathogenesis of AD, and accumulating evidence indicates that high levels of reactive oxygen species (ROS) are involved in Abeta-induced neurodegeneration.", "Amyloid-beta peptide (Abeta) is one of the major players in the pathogenesis of Alzheimer's disease (AD)."],
    "27884599": ["The hallmark characteristics of plaque formation and neuronal cell death in Alzheimer's disease (AD) are caused principally by the amyloid beta-peptide (Abeta)."],
    "28017718": ["The toxic amyloid beta-peptide (Abeta) is a key player in Alzheimer Disease (AD) pathogenesis and selective inhibition of the production of this peptide is sought for."],
    "28052060": ["Aggregation of amyloid-beta peptides into fibrils or other self-assembled states is central to the pathogenesis of Alzheimer's disease."],
    "28096459": ["For example, increased intracellular copper or zinc has been linked to a reduction in secreted levels of the AD-causing amyloid-beta peptide (Abeta)."],
    "28260388": ["Oligomer species of amyloid beta (Abeta) peptides are intensively investigated because of their relevance to Alzheimer's disease (AD), and a stable oligomer will be a cause of AD."],
    "28288354": ["The enzyme beta-secretase-1 is responsible for the cleavage of the amyloid precursor protein, a vital step in the process of the formation of amyloid-beta peptides which are known to lead to neurodegeneration causing Alzheimer's disease."],
    "28360830": ["Amyloid fibril formation by the amyloid beta-peptide (Abeta) is considered to be an underlying cause of AD, and strategies designed to reduce Abeta production and/or its toxic effects are being extensively investigated in both laboratory and clinical settings."],
    "28400058": ["Amyloid-beta peptide (Abeta) is believed to be a primary cause of Alzheimer's disease."],
    "28562008": ["The self-assembling of the amyloid beta (Abeta) peptide into neurotoxic aggregates is considered a central event in the pathogenesis of Alzheimer's disease (AD)."],
    "28569090": ["Impaired brain clearance of amyloid-beta peptides (Abeta) 40 and 42 across the blood-brain barrier (BBB) is believed to be one of the pathways responsible for Alzheimer's disease (AD) pathogenesis."],
    "28570778": ["Zinc-induced oligomerization of amyloid-beta peptide (Abeta) produces potentially pathogenic agents of Alzheimer's disease."],
    "28650319": ["The amyloid beta peptide (Abeta) is a key player in the etiology of Alzheimer disease (AD), yet a systematic investigation of its molecular interactions has not been reported."],
    "28670737": ["Brain accumulation of soluble oligomers of the amyloid-beta peptide (AbetaOs) is increasingly considered a key early event in the pathogenesis of Alzheimer's disease (AD)."],
    "28674340": ["The abnormal aggregation of amyloid beta-peptide (Abeta) is central to the pathogenesis of Alzheimer's disease, the major form of dementia."],
    "28687859": ["According to amyloid cascade hypothesis, the deposit of amyloid-beta (Abeta) peptide is the main cause of Alzheimer's disease (AD)."],
    "28861757": ["AD-like pathology was produced by administering AbetaP (1-40) intracerebroventricular (i.c.v.) in the left lateral ventricle (250 ng/10 MUl, once daily) for 4 weeks."],
    "28870815": ["Cerebral accumulation of amyloid beta-peptide (Abeta), which is produced from amyloid precursor protein (APP), is the primary cause of Alzheimer's disease (AD)."],
    "28889204": ["The beta-secretase (BACE1) initiates the generation of toxic amyloid-beta peptide (Abeta) from amyloid-beta precursor protein (APP), which was widely considered to play a key role in the pathogenesis of Alzheimer's disease (AD)."],
    "28941799": ["Amyloid-beta peptides (Abeta) accumulate in cerebral capillaries indicating a central role of the blood-brain barrier (BBB) in the pathogenesis of Alzheimer's disease (AD)."],
    "28985224": ["The accumulation of amyloid beta (Abeta) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of Alzheimer's disease (AD)."],
    "28987946": ["Amyloid-beta peptide (Abeta) ranks as a pivotal cause of Alzheimer's disease (AD), a common devastating dementia form in elderly."],
    "29118109": ["gamma-Secretase is an intramembrane cleaving protease that is responsible for the generation of amyloid-beta peptides, which are linked to the pathogenesis of Alzheimer disease."],
    "29132916": ["While impaired clearance of amyloid beta (Abeta) peptides is considered as one of the major causes of AD, it was recently complemented by a potential role of other toxic amyloidogenic species."],
    "29138762": ["The aggregation of amyloid beta (Abeta) peptides plays a crucial role in the pathology and etiology of Alzheimer's disease."],
    "29161341": ["Accumulation of amyloid-beta peptides is a dominant feature in the pathogenesis of Alzheimer's disease; however, it is not clear how individual amyloid-beta species accumulate and affect other neuropathological and clinical features in the disease."],
    "29192843": ["The amyloid beta (Abeta) peptide is central to the pathogenesis of Alzheimer's disease (AD)."],
    "29199321": ["BACKGROUND: Vanutide Cridificar (ACC-001), a novel investigational immunotherapeutic vaccine designed to elicit antibodies against the N-terminal peptide 1-7 of the amyloid-beta peptide, believed to be important in the pathogenesis of Alzheimer's disease (AD)."],
    "29210443": ["BACKGROUND: ACC-001 is an investigational therapeutic vaccine designed to elicit antibodies against the N-terminal peptide 1-7 of the amyloid-beta peptide, believed to be important in the pathogenesis of Alzheimer's disease."],
    "29224965": ["Compelling evidence suggests a crucial role of amyloid beta peptides (Abeta(1-40/42)) in the etiology of Alzheimer's disease (AD)."],
    "29310862": ["AD is featured with the loss of cholinergic neurons, the amyloid-beta peptide (Abeta) plaques and the neurofibrillary tangles and several hypotheses were established to explain the pathogenesis of AD."],
    "29315574": ["The production and accumulation of amyloid beta peptide (Abeta) is considered the core pathological molecular event in the pathogenesis of AD."],
    "29440986": ["The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or fibrillar amyloid beta (Abeta) peptide is the primary cause of Alzheimer's disease (AD), has been the mainstream concept underlying AD research for over 20 years."],
    "29448601": ["Amyloid beta (Abeta) peptide is considered to be the critical causative factor in the pathogenesis of Alzheimer's disease (AD) because the hydrophilic molecules accumulated outside of the neural cells and results in the formation of highly toxicity amyloid plaque."],
    "29491833": ["Accumulation of amyloid-beta (Abeta) peptides in the brain is a critical early event in the pathogenesis of Alzheimer's disease (AD), the most common age-related neurodegenerative disorder."],
    "29619615": ["Genetics strongly implicate the amyloid beta-peptide (Abeta) in the pathogenesis of Alzheimer's disease."],
    "29648443": ["Senile plaques formed by aggregated amyloid beta peptides are one of the major pathological hallmarks of Alzheimer's disease (AD) which have been suggested to be the primary influence triggering the AD pathogenesis and the rest of the disease process."],
    "29658548": ["The self-association of the amyloid beta (Abeta) peptide into toxic oligomers is implicated in the early events leading to Alzheimer's disease (AD)."],
    "29743204": ["The beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) initiates the production of amyloid-beta peptide (Abeta), which is central to the pathogenesis of Alzheimer's disease (AD)."],
    "29764453": ["BACKGROUND: Extracellular aggregation of the amyloid-beta (Abeta) peptide into toxic multimers is a key event in Alzheimer's disease (AD) pathogenesis."],
    "29781021": ["It is believed that the self-assembly of amyloid beta (Abeta) peptides in the brain is the cause of Alzheimer's disease."],
    "29899186": ["Accumulation and oligomerization of amyloid-beta (Abeta) peptides have been known to be a potent cause of neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "29905953": ["Amyloid-beta peptide (Abeta) accumulation and aggregation have been considered for many years the main cause of Alzheimer's disease (AD), and therefore have been the principal target of investigation as well as of the proposed therapeutic approaches (Grasso [2011] Mass Spectrom Rev."],
    "29906302": ["Probes for monitoring aggregation of amyloid beta (Abeta) peptides are crucial to advance understanding of the molecular pathogenesis of Alzheimer's Disease (AD)."],
    "29927573": ["Accumulating evidence supports the abnormal deposition of amyloid beta-peptide (Abeta) as the main cause of Alzheimer's disease (AD)."],
    "29945719": ["Overt accumulation and aggregation of the amyloid-beta peptide (Abeta) is thought to be the initial causative factor for Alzheimer's disease."],
    "30043821": ["The amyloid plaques are mainly aggregates of amyloid beta-peptide (Abeta), a primary factor contributing to the pathogenesis of AD."],
    "30086173": ["Although the aggregation of amyloid-beta peptide (Abeta) clearly plays a central role in the pathogenesis of Alzheimer's disease (AD), endosomal traffic dysfunction is considered to precede Abeta aggregation and trigger AD pathogenesis."],
    "30214656": ["The soluble oligomeric form of the amyloid beta (Abeta) peptide is the major causative agent in the molecular pathogenesis of Alzheimer's disease (AD)."],
    "30260016": ["INTRODUCTION: Aggregation of amyloid-beta (Abeta) peptides represents a crucial step in the pathogenesis of Alzheimer disease (AD)."],
    "30264333": ["Accumulation of amyloid-beta peptide (Abeta) and massive neuronal death due to apoptosis were the essential steps in the pathogenesis of Alzheimer's disease (AD)."],
    "30268822": ["Dysregulation of the Amyloid Precursor Protein (APP) processing leading to toxic species of amyloid beta peptides (Abeta) is central to Alzheimer's disease (AD) etiology."],
    "30345755": ["Aggregation of amyloid beta-peptide (Abeta) plays a key role in the etiology of AD."],
    "30362029": ["Growing evidence gathered from transgenic animal models of Alzheimer's disease (AD) indicates that the intraneuronal accumulation of amyloid-beta (Abeta) peptides is an early event in the AD pathogenesis, producing cognitive deficits before the deposition of insoluble plaques."],
    "30402707": ["Amyloid beta (Abeta) peptide is a critical causative factor in Alzheimer's disease (AD) and of a variety of fragmented Abeta peptides Abeta1-42 thought to exhibit the most neurotoxic effect."],
    "30426203": ["Brain accumulation and aggregation of amyloid-beta (Abeta) peptides is a critical step in the pathogenesis of Alzheimer's disease (AD)."],
    "30480246": ["Evidence suggests that fibril formation of the amyloid beta-peptide (Abeta) is a major underlying cause of AD, and treatment strategies that reduce the toxic effects of Abeta amyloid are sought for."],
    "30486385": ["The amyloid beta (Abeta) peptide has been implicated in the cause of AD, where the peptides undergo a conformational change and form neurotoxic amyloid oligomers which cause neuronal cell death."],
    "30551397": ["The progressive accumulation of amyloid beta (Abeta) peptide is neurotoxic and leads to Alzheimer's type dementia."],
    "30675620": ["The potential therapeutic effect of puerarin against Alzheimer's disease was screened by in silico methods and confirmed by the amyloid beta-peptide-induced Alzheimer's disease (AD) rat model."],
    "30704515": ["The adipocyte plasma membrane-associated protein APMAP is expressed in the brain where it associates with gamma-secretase, a protease responsible for the generation of the amyloid-beta peptides (Abeta) implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "30794963": ["The aggregation and accumulation of amyloid beta (Abeta) peptide is believed to be the primary cause of Alzheimer's disease (AD) pathogenesis."],
    "30830576": ["Human genetic and clinical studies over the past three decades have indicated that abnormal generation or accumulation of amyloid-beta (Abeta) peptides is a likely culprit in AD pathogenesis."],
    "30900203": ["These pathological protein deposits, including Abeta peptides (which form senile plaques) and hyperphosphorylated tau (which aggregates into NFTs), have been assumed to be 'the cause of AD'."],
    "30911827": ["SORL1 encodes SorLA, a key protein involved in the processing of the amyloid-beta (Abeta) precursor protein (APP) and the secretion of the Abeta peptide, the aggregation of which triggers AD pathophysiology."],
    "30913789": ["Amyloid beta (Abeta) peptide is secreted from the outside of neural cell by a neural signal pathway and it accumulated each other results in the highly toxicity amyloid plaque which is a critical causative factor in the pathogenesis of Alzheimer's Disease (AD)."],
    "30949973": ["The pathological form of amyloid beta (Abeta) peptide is shown to be toxic to the mitochondria and implicates this organelle in the progression and pathogenesis of Alzheimer's disease (AD)."],
    "30964132": ["Aggregation of misfolded oligomeric amyloid-beta (Abeta) peptides on lipid membranes has been identified as a primary event in Alzheimer's pathogenesis."],
    "31048748": ["Aggregates of amyloid-beta (Abeta) peptide are well known to be the causative substance of Alzheimer's disease (AD)."],
    "31164420": ["BACE1 is the rate-limiting enzyme for amyloid-beta peptides (Abeta) generation, a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "31234321": ["Amyloid beta (Abeta) peptide is known to be a major cause of AD pathogenesis."],
    "31247730": ["The variation of amyloid beta peptide (Abeta) concentration and Abeta aggregation are closely associated with the etiology of Alzheimer's diseases (AD)."],
    "31365254": ["Excess of amyloid beta (Abeta) peptides and their aggregation are the basis of the amyloid cascade hypothesis, which attempts to explain the causes of AD."],
    "31367507": ["Amyloid beta-peptides (Abeta) play a major role in the pathogenesis of Alzheimer's disease."],
    "31368868": ["BACKGROUND: Aggregation of Amyloid beta (Abeta) peptide is a crucial feature of Alzheimer disease (AD) pathogenesis."],
    "31369984": ["Thus, the sialic acid-binding site on CD33 is a promising pharmacophore for developing therapeutics that promote clearance of the Abeta peptide that is thought to cause AD."],
    "31595293": ["Amyloid-beta peptides (Abeta) are the major drivers of Alzheimer's disease (AD) pathogenesis, and are formed by successive cleavage of the amyloid precursor protein (APP) by the beta and gamma secretases."],
    "31607898": ["Processing of amyloid beta precursor protein (APP) into amyloid-beta peptide (Abeta) by beta-secretase and gamma-secretase complex is at the heart of the pathogenesis of Alzheimer's disease (AD)."],
    "31796114": ["An impairment of amyloid beta-peptide (Abeta) clearance is suggested to play a key role in the pathogenesis of sporadic Alzheimer's disease (AD)."],
    "31809572": ["The aggregation of amyloid-beta (Abeta) peptides into senile plaques is a hallmark of Alzheimer's disease (AD) and is hypothesized to be the primary cause of AD related neurodegeneration."],
    "31814468": ["Truncated or post-translationally modified Abeta peptides are becoming increasingly recognized as important players in the etiology of AD and a more thorough comprehension of their cellular origin and biochemical peculiarities might break new ground for therapeutic strategies."],
    "7556364": ["There is growing evidence that the amyloid beta-peptide (beta 1-40) is involved in the aetiology of Alzheimer's disease also implicating an altered calcium homeostasis of affected cells."],
    "7777177": ["Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease."],
    "10867221": ["Alzheimer's disease (AD) and cerebrovascular dementia (CVD) are two major causes of senile dementia in elderly individuals."],
    "12480441": ["Different forms of dementia are now distinguished-Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia, and dementia secondary to disease, such as AIDS dementia."],
    "15608634": ["A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia."],
    "16037976": ["These results suggest that the activation of this enzyme occurs early in the course of AD, before the onset of overt dementia, thereby implicating 12/15LOX-mediated lipid peroxidation in the pathogenesis of AD."],
    "16046825": ["They are consistent with the hypothesis that brain hypoperfusion contributes to dementia, possibly to AD pathogenesis, and raise the possibility that the APOE allele epsilon 4 contributes directly to heart valve and myocardial damage."],
    "16092095": ["PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly."],
    "16401890": ["BACKGROUND: Although QOL is an important indicator to assess multiple facets of life, the QOL of Alzheimer's disease (AD) subjects with impaired cognitive ability due to dementia has not yet been fully investigated."],
    "17143085": ["Significant changes in personality are typically associated with frontotemporal lobar degeneration (e.g., slowly progressive sociopathy), Alzheimer's disease, mild cognitive impairment due to incipient dementia or underlying medical illness."],
    "18041446": ["At present, different forms of dementia are distinguished, including Alzheimer's disease (AD), dementia with Lewy bodies, frontotemporal dementia, and dementia secondary to diseases, such as AIDS dementia."],
    "19672571": ["Homonymous visual field disorders, impaired elementary visual capacities (e.g. acuity, contrast sensitivity, convergent fusion, oculomotor disorders), visual neglect, Balint-Holmes syndrome or dementia (e.g. Alzheimer's disease) are the most frequent causes of such disorders."],
    "20596916": ["Various innovative diagnostic methods for Alzheimer's disease (AD) have been developed in view of the increasing prevalence and consequences of later-life dementia."],
    "21542885": ["The clinical and scientific study of dementia in adults with Down syndrome led to the development of the amyloid hypothesis as a fundamental concept in Alzheimer's disease pathogenesis."],
    "22492589": ["The ROSA and four standard instruments -- the Alzheimer's disease Assessment Scale-cognitive (ADAS-cog), Severe Impairment Battery (SIB), Disability Assessment for Dementia (DAD), and the Neuropsychiatric Inventory (NPI) -- were used in an open-label, multicenter, single-arm clinical study to assess treatment-induced changes in cognitive, functional, and behavioral symptoms in patients with AD at different severity stages."],
    "22574282": ["Alzheimer's disease (AD), the most common form of dementia, is an age-dependent progressive neurodegenerative disorder. beta-amyloid, a metabolic product of the amyloid precursor protein (APP), plays an important role in the pathogenesis of AD."],
    "23100439": ["Alzheimer's disease (AD) is the most common progressive neurodegenerative disorder causing dementia."],
    "23338285": ["Dementia in 2012: Further insights into Alzheimer disease pathogenesis."],
    "23707728": ["The clinical syndrome of dementia has several aetiologies of which Alzheimer's disease (AD) is the most common."],
    "23828739": ["Therefore, a disorder primarily affecting structures in medial temporal lobe, with accumulation of amyloid beta and abnormal tau, neuritic plaques and tangles, progressive loss of memory and/or other cognitive deficits, ultimately resulting in dementia should be classified as AD.", "Alzheimer's disease (AD), the most prevalent disorder causing dementia, is considered a neurodegenerative disease."],
    "24505903": ["30 % of the cases are wrongly diagnosed with Alzheimer, being in fact other forms of dementia, or that we deal with several biologic processes, generating rather an Alzheimer's syndrome, meanwhile others are unsatisfied by a poor diagnosed disease and its popular receipt as a part of the normal aging process."],
    "25083748": ["Alzheimer's disease (AD) is the most prevalent form of dementia, and aggregation of amyloid beta-proteins (Abeta) into soluble oligomers and fibrils has been implicated in the pathogenesis of AD."],
    "25435921": ["The aim of this study was to examine the relation between AD pathologies and early death in AD caused by dementia."],
    "2545826": ["The relatively small difference in the prevalence of Lewy bodies between controls and Alzheimer's disease could be explained by the additive effects of Lewy body and tangle pathology causing dementia, rather than a greater than chance association between Parkinson's disease and Alzheimer's disease."],
    "26161148": ["Emerging evidence for the potential co-contributions of small vessel vasculopathy to dementia has resulted in a more nuanced view of Alzheimer's disease (AD) pathogenesis."],
    "26862951": ["Molecular alterations in ITM2B are associated with 2 neurodegenerative diseases, Familial British and Danish dementia, and dysregulation of ITM2B function has been implicated in the pathogenesis of Alzheimer disease (AD)."],
    "26882509": ["BACKGROUND AND AIMS: Caregivers of individuals with neurodegenerative diseases, including frontotemporal dementia (FTD), Lewy body dementia (DLB), and Alzheimer's disease (AD), experience high levels of psychological and physical stress, likely due to behavioral and psychological symptoms of dementia (BPSD)."],
    "27040140": ["AD is a neurodegenerative disorder causing dementia with no cure nor means for definitive diagnosis during life."],
    "27554603": ["Alzheimer's disease (AD) is the general consequence of dementia and is diagnostic neuropathology by the cumulation of amyloid-beta (Abeta) protein aggregates, which are thought to promote mitochondrial dysfunction processes leading to neurodegeneration."],
    "27890830": ["Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia behind Alzheimer's disease (AD) and is a frequent co-morbidity with AD."],
    "28522216": ["DISCUSSION: This large prospective study of French older adults suggests that maintaining adequate vitamin D status in older age could contribute to slow down cognitive decline and to delay or prevent the onset of dementia, especially of AD etiology."],
    "28729192": ["Alzheimer's disease (AD) is the most common neurodegenerative disorder causing dementia."],
    "29226870": ["Despite the wide knowledge on factors influencing dementia risk, little is known on what accounts for AD progression."],
    "29383688": ["APP is involved in the pathology of Alzheimer's disease (AD), the most common neurodegenerative disorder causing dementia."],
    "29389553": ["Alzheimer's disease (AD) is the most common cause of dementia in the elderly. beta-Amyloid (Abeta) has been proposed to play a role in the pathogenesis of AD."],
    "29957266": ["When hospitalizations were classified according to the main diagnosis, chronic skin ulcers, functional impairment and daily urinary incontinence were associated with hospitalization due to infectious diseases; impaired cognitive capacity, Alzheimer's disease or other dementia and polypharmacy (protective effect) were associated with hospitalizations due to dementia; age of >=90 years, congestive heart failure, coronary artery disease and using >=10 drugs with hospitalizations due to heart diseases; and moderate or strong pain with hospitalization due to musculoskeletal disorders."],
    "30424485": ["Hallmarks of Alzheimer's disease (AD), a progressive neurodegenerative disease causing dementia, include protein aggregates such as amyloid beta plaques and tau neurofibrillary tangles in a patient's brain."],
    "30696930": ["Dementia was further categorised into Alzheimer's disease (AD), vascular dementia (VaD), and dementia caused by other diseases (ODs)."],
    "30942758": ["The brain ventricles are surrounded by periventricular structures that are affected by dementia which results in neurodegenerative disorder such as Alzheimer's Disease (AD)."],
    "30949934": ["Dementia is considered as the frequent cause of neurodegenerative mental disorder such as Alzheimer's disease (AD) amongst elderly people."],
    "30998476": ["Mild cognitive impairment (MCI) is the preliminary stage of dementia, which may lead to Alzheimer's disease (AD) in the elderly people."],
    "31182772": ["Alzheimer's disease (AD) is the most common type of neurodegenerative dementia, but the cause of AD remained poorly understood."],
    "31248465": ["METHOD: Data from the initial administration of the MINT were obtained on NACC participants who were cognitively normal (N = 3,981) or diagnosed with mild cognitive impairment (N = 852) or dementia (N = 1,148) with presumed etiology of AD."],
    "31356838": ["BACKGROUND: Alzheimer's disease (AD) is the most common neurodegenerative disease causing dementia in the elderly population."],
    "31486140": ["Recognition of the long-term detrimental consequences of migraines for AD and dementia has implications for migraine management, as well as for our understanding of AD etiology."],
    "32615251": ["Increased GABAergic Development in iPSC-Derived Neurons from Patients with Sporadic Alzheimer's Disease.Alzheimer's disease (AD) is the most common cause of dementia in the elderly, and the underlying molecular mechanisms of this neurodegenerative disorder are still unclear. gamma-aminobutyric acid (GABA) neurons play an essential role in the excitatory/inhibitory (E/I) balance in the brain, and the GABAergic system may contribute to the pathogenesis of AD."],
    "33207563": ["Alzheimer's disease (AD) is a fatal neurodegenerative disorder caused by protein misfolding and aggregation, affecting brain function and causing dementia."],
    "33396415": ["Alzheimer's disease (AD) is the most prevalent neurodegenerative disease causing dementia and poses significant health risks to middle-aged and elderly people."],
    "33472953": ["Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pathology in longitudinal studies of normal aging and dementia, including assessment of the central model of Alzheimer's disease (AD) pathogenesis, according to which TAU pathology begins focally but expands catastrophically under the influence of amyloid-beta (Abeta) pathology to mediate neurodegeneration and cognitive decline."],
    "34237255": ["In 2065, YLDs due to Alzheimer's dementia, vascular dementia, and MCI will account for 48% (1358 per 100,000), 15% (410 per 100,000), and 10% (290 per 100,000), respectively, of total YLDs due to MCI and all-cause dementia.", "In 2065, DALYs due to Alzheimer's dementia, vascular dementia, and MCI will account for 38% (3654 per 100,000), 17% (1654 per 100,000), and 27% (2585 per 100,000) of total DALYs due to MCI and all-cause dementia, respectively.", "In 2016, YLDs due to Alzheimer's dementia, vascular dementia, and MCI composed 37% (177 per 100,000), 18% (85 per 100,000), and 15% (70 per 100,000), respectively, of the total YLDs due to MCI and all-cause dementia.", "In 2016, DALYs attributed to Alzheimer's dementia, vascular dementia, and MCI accounted for 33% (423 per 100,000), 20% (316 per 100,000), and 24% (123 per 100,000), respectively, of the total DALYs due to MCI and all-cause dementia."],
    "35493944": ["Mild Cognitive Impairment (MCI) is an early stage of dementia, which may lead to Alzheimer's disease (AD) in older adults."],
    "36113115": ["Despite early mentions of dementia in the ancient literature and the first patient diagnosed in 1906, the underlying causes of AD are not well understood."],
    "36254682": ["Alzheimer's disease (AD) is the most common form of dementia, and risk-influencing genetics implicates microglia and neuroimmunity in the pathogenesis of AD."],
    "36362376": ["The biological plausibility of the link between high adiposity, insulin resistance, and dementia is central for understanding AD etiology, and to form bases for prevention efforts to decrease the disease burden."],
    "37223834": ["Conclusions: We identified a gap in the literature on the description of the psychotic symptoms of dementia, mainly in those of non-AD etiologies."],
    "37425748": ["ABri plaques are accompanied by tau pathology, neuronal cell death and progressive dementia, with striking parallels to the aetiology and pathogenesis of Alzheimer's disease."],
    "37543811": ["In particular, Alzheimer disease, the most common type causing dementia, remains an incurable disease."],
    "37629545": ["Repurposing Diltiazem for Its Neuroprotective Anti-Dementia Role against Intra-Cerebroventricular Streptozotocin-Induced Sporadic Alzheimer's Disease-Type Rat Model.", "Considering the results obtained, DTZ might have a potential therapeutic role in treating and managing AD and related dementia pathologies due to its anti-dementia activity in SAD-type conditions in rats induced by ICV-STZ.", "In the present study, the neuroprotective anti-dementia effects of DTZ against intra-cerebroventricular-streptozotocin (ICV-STZ)-induced sporadic AD (SAD)-type rat model was investigated."],
    "38491393": ["Alzheimer's disease (AD) is the most prevailing form of dementia, with long-term high-fat diet (HFD) consumption being a pivotal contributor to AD pathogenesis."],
    "8739399": ["This paper summarizes results of the Vienna Longitudinal Study on Dementia obtained during the past few years and presents a critical discussion on the relevance of clinicopathological correlation studies for the pathogenesis of AD."],
    "9058061": ["In spite of this progress, the pathogenetic events that differentiate normal brain aging from the early stages of dementia and may lead eventually to AD are not completely understood."],
    "9625186": ["CONCLUSIONS: In a population aged 75 to 85 years, the presence of an apoE e4 allele is associated with impaired cognitive function, clinical dementia, AD, and excess 5-year mortality resulting from dementia and all causes."],
    "10570621": ["UNLABELLED: BASIC: The loss of verbal fluency in Alzheimer's disease (AD) has been related to the cognitive and functional impairment caused by the disorder."],
    "10879068": ["These novel findings regarding the protein aggregates and causative genes for AD and related disorders will facilitate our understanding of the pathogenesis of AD, as well as development of therapeutic strategies against it."],
    "11006125": ["As NSP-C was also reduced in AD frontal cortex, NSP-C deficits in these disorders may be reflecting neurodegenerative changes rather than a primary and specific finding of DS or AD pathogenesis."],
    "11741391": ["In addition, it has revealed differences in apoC-I expression based on site, genotype, and disease status that may reflect a role for apoC-I in the pathogenesis of AD."],
    "12740808": ["Despite the dramatic progress that has been made in understanding the disease, the exact cause of Alzheimer's disease is still unknown.", "The enigmatic proteases alpha-,beta-, and gamma-secretase are the three executioners of amyloid precursor protein processing, and disruption of their delicate balance is suspected to result in Alzheimer's disease."],
    "14758627": ["For the first time the Alzheimer disease in monkeys was shown to entail a deficit of operative memory due to disorders in the sensory and cognitive components of the memory."],
    "15340159": ["Because enhanced neurogenesis occurs in both AD and an animal model of AD, it seems to be caused by the disease itself and not by confounding clinical factors."],
    "16120299": ["Mitochondrial dysfunction causes dozens of debilitating diseases, and is implicated in the etiology of type 2 diabetes, Parkinson's, and Alzheimer's diseases, among others."],
    "17337008": ["However, evidence from epidemiological, neuropathological, clinical, pharmacological, and functional studies suggest considerable overlap in risk factors and pathological changes suggesting shared common pathogenic mechanisms between these two diseases such that vascular factors play a vital role in the pathogenesis of Alzheimer disease."],
    "17892369": ["The onset of disease is not manifested clinically and little is known regarding the cause of nonfamiliar AD."],
    "17922309": ["Moreover, accumulating evidence that mitochondria failure, reduced glucose utilization and deficient energy metabolism occur already very early in the course of the disease suggests a role of impaired insulin signalling in the pathogenesis of AD."],
    "1976213": ["Disorders in somatostatin metabolism have been proposed to contribute to the pathogenesis of Alzheimer's disease, epilepsy, GI motility disorders, and diabetes."],
    "19777328": ["The markers of oxidative stress have been localized in the brain regions of AD and MCI that show pathological hallmarks of this disease, suggesting the possible role of Abeta in the initiation of the free-radical mediated process and consequently to the build up oxidative stress and AD pathogenesis."],
    "20059701": ["For example, in neurodegenerative diseases such as Alzheimer disease (AD), evidence for abnormal cell cycle re-entry precedes other hallmarks of disease and as such, implicates cell cycle aberrations in the aetiology of AD."],
    "20305996": ["BACKGROUND: During the course of the Alzheimer's disease (AD), many patients need to be hospitalized either due to the direct consequences of the disease itself, or due to associated diseases or life event."],
    "20413848": ["The accumulation of toxic amyloid-beta42 (Abeta42) peptide oligomers and aggregates in AD brain has been proposed to be primarily responsible for the pathology of the disease, an idea dubbed the 'amyloid hypothesis' of AD etiology."],
    "20442493": ["Since its proposal in 1992, the amyloid cascade hypothesis implicates Abeta overproduction as a causative event in disease pathogenesis, and this thinking has predominated the field's understanding of AD pathogenesis and the development of potential therapeutics (i.e., Abeta-reducing agents)."],
    "20552018": ["In neurodegenerative disorders such as Alzheimer's disease (AD), brain miRNA profiles are altered; thus miRNA dysfunction could be both a cause and a consequence of disease."],
    "20601643": ["While partially effective in improving symptoms, currently available treatments approved by the US Food and Drug Administration (FDA) do not halt progression of AD, or address the underlying mechanism of the disease, in part because the etiology of AD is still an active area of investigation."],
    "21391278": ["BACKGROUND: Cerebral small vessel disease (SVD) and hippocampal atrophy are related to verbal memory failures and may ultimately result in Alzheimer's disease."],
    "21504127": ["Mild cognitive impairment (MCI) is recognized as a prodromal phase of dementing disorders, and it has been suggested that oxidative stress may play a role in the pathogenesis of Alzheimer's disease (AD), and in predicting progression of MCI to AD."],
    "22886015": ["While macroscopic stroke can clearly produce cognitive deficits and accelerate Alzheimer's disease, the prevalence and implications of microvascular disease in Alzheimer's disease pathogenesis has been harder to define."],
    "2313044": ["Alzheimer's disease is a major public health problem, yet little is known about the potential oral consequences of the disease."],
    "23811083": ["Some significant novel genes and other variants for various biological processes have been reported as being associated with AD, AG, and other diseases, and these could be implicated in biochemical events leading to AD from AG through pathways, interactions, and associations.", "The present study aimed to identify genes with differential topology and their further association with other biological processes that regulate causative factors for AD, ageing (AG) and other diseases."],
    "24059308": ["Our findings implicate diabetic disorders in the pathogenesis of AD, and provide a basis for future candidate studies based on specific pathways."],
    "24899710": ["Few animal models of AD have been capable of isolating the relative contribution made by soluble and insoluble forms of Abeta to the behavioral symptoms and biochemical consequences of the disease."],
    "25435363": ["Within this group, the top five leading causes of DALYs were: depressive disorders, Alzheimer's disease, migraine, substance-use disorders, and anxiety disorder, which accounted for 70.9% of all DALYs due to neuropsychiatric disorders."],
    "26283893": ["Although no single model of AD is capable of providing the solution to the growing epidemic of the disease, we encourage a comprehensive approach that acknowledges the complex etiology of AD with the goal of enhancing the bidirectional translatability from bench to bedside and vice versa."],
    "26618971": ["Tests of processing speed, working memory, verbal symbolic functions, and visuoperceptual and visuospatial judgment and problem solving are sensitive to the severity of TBI and AD, as well as to the functional consequences of these disorders, including ability to work, financial and medical decision-making capacities, and driving ability."],
    "27094492": ["Mitochondrial dysfunction has been widely associated with the pathology of Alzheimer's disease, but there is no consensus on whether it is a cause or consequence of disease, nor on the precise mechanism(s)."],
    "27313503": ["Whether these changes are an initial cause for the onset of AD or occur as a result of the disease in late stages is still under debate."],
    "27699087": ["Evidence from rodent and cell models show a number of neurotrophic and neuroprotective effects of guanosine preventing deleterious consequences of seizures, spinal cord injury, pain, mood disorders and aging-related diseases, such as ischemia, Parkinson's and Alzheimer's diseases."],
    "28122529": ["Because the burden of AD on patients, families, healthcare providers, and society is substantial and increasing, it is important and necessary to understand the economic burden caused by this disease."],
    "28261376": ["Studying AD from a metabolic perspective provides new insights into AD pathogenesis and may lead to the discovery of dietary metabolite supplements that can partially compensate for alterations of enzymatic function to delay AD or alleviate some of the suffering caused by the disease."],
    "28387677": ["To date, neither any effective treatment nor prevention of Alzheimer's disease (AD), a major dementia causing disorder, are available."],
    "29301530": ["OBJECTIVES: To understand AMD pathogenesis by analogy and suggest ideas for future research, this study summarizes main commonalities in disease pathogenesis of AMD, Alzheimer's disease, atherosclerosis and glomerulonephritis."],
    "2941815": ["The theories put forward to explain the association between these two disorders and their possible significance to the understanding of the aetiology of Alzheimer's disease are discussed."],
    "30546389": ["Although both amyloid beta peptide deposition and neurofibrillary tangle formation in the AD brain have been established as pathological hallmarks of the disease, many other factors contribute in a complex manner to the pathogenesis of AD before clinical symptoms of the disease become apparent."],
    "30740049": ["Nevertheless, the relationships between the morphological and functional changes of dendrodendritic synapses, particularly the local field potentials (LFPs) as a consequence of olfactory disorders in patients with AD have not been investigated."],
    "30937343": ["The identification of the molecular underpinning of the disease not only provided the framework of AD pathogenesis but also targets for therapeutic inventions."],
    "31127574": ["BER deficiency is associated with development of diseases causing neurodegenerative disorders, such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS)."],
    "31228376": ["Despite the fact that this disease is considered, of course, age-associated pathology, which is the main cause of senile dementia, its diagnosis in Russia is exhibited rather rarely compared with dementia, for example, of vascular origin."],
    "31456206": ["Increasing evidence suggests that disorders of metal ion metabolism in the brain are one of the risk factors for the pathogenesis of AD."],
    "31521231": ["Amyloid-beta (Abeta) and alpha-synuclein (alphaS) are two intrinsically disordered proteins (IDPs) at the centers of the pathogenesis of Alzheimer's and Parkinson's diseases, respectively.", "Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases."],
    "31605538": ["While Abeta has been suggested to be critical in inducing and, potentially, driving the disease, the molecular basis of AD pathogenesis is still under debate."],
    "31607780": ["Similar to other complex disorders, the etiology of Alzheimer disease is multifactorial and characterized by an interplay of biological and environmental risk and protective factors."],
    "31894361": ["Knowing the intrinsic disorder status and disorder-based functionality of proteins associated with amyloid cascade signaling pathway may help to untangle the mechanisms of AD pathogenesis and help identify therapeutic targets."],
    "31900899": ["Excitotoxicity is a modern clinical condition included in the pathogenesis of Alzheimer's disease."],
    "32225073": ["Although the exact etiology of the disease remains elusive, accumulating evidence highlights the key role of lipid rafts, as well as the endocytic pathways in amyloidogenic amyloid precursor protein (APP) processing and AD pathogenesis."],
    "32696388": ["Measuring Interactions Between Tau and Aggregation Inducers with Single-Molecule Forster Resonance Energy Transfer.Tau is an intrinsically disordered protein implicated in the pathogenesis of Alzheimer's disease and other neurodegenerative disorders."],
    "33302541": ["AD is considered a multifactorial disease: two main hypotheses were proposed as a cause for AD, cholinergic and amyloid hypotheses."],
    "33457489": ["Models or combinations of new models are needed that incorporate genetics with environmental interactions, timing of disease development, heterogeneous mechanisms and pathways, comorbidities, and other pathologies that lead to AD and related dementias."],
    "33512819": ["Although it has not been possible to determine the origin of this disease, the amyloid hypothesis is one of the most accepted to explain the etiology of AD."],
    "33629978": ["Although it has not been possible to determine the origin of this disease, the amyloid hypothesis is one of the most accepted to explain the etiology of AD."],
    "33806317": ["Identifying the molecular characteristics of the disease is imperative to understanding the pathogenesis of AD."],
    "34439596": ["No drug class was associated with the least severe AD (cluster-1), likely due to lesser antecedent disease."],
    "34609116": ["The progression of AD can be due to the change in DNA methylation of CLOCK gene, followed with worsening of AD by APOE4 gene due to dyslipidaemia condition in T2DM patients."],
    "35463002": ["Background: Recent Alzheimer's disease (AD) hypotheses implicate that hepatic metabolic disorders might contribute to the disease pathogenesis of AD, but the mechanism remains unclear."],
    "35563253": ["As research progresses, it has become known that AD can be caused by diseases that have been experienced over the course of a lifetime, which could also affect other organs."],
    "36430144": ["The identification signatures overlapping for AD, PD, and MS raise the question of whether these reflect a common etiology or rather common consequence of these diseases."],
    "36431219": ["This state of affairs has made neuroscientists suspicious, so much so that for several years the idea has gained ground that AD is not a direct neuropathological consequence taking place downstream of the deposition of the two toxic proteins, but rather a multifactorial disease, including mitochondrial dysfunction as an early event in the pathogenesis of AD, occurring even before clinical symptoms."],
    "36436686": ["Disorders of the cholinergic system are well known to be involved in the pathogenesis of AD, characterized by increased acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) and decreased acetyltransferase (ChAT) enzymatic activities.", "Animal model of Alzheimer's disease induced by streptozotocin: new insights about cholinergic pathway."],
    "37000425": ["Although it is largely unclear whether dysfunctions in sleep and circadian rhythms contribute to the etiology of AD or are a consequence of the disease, there is evidence that these conditions are involved in a complex self-reinforcing bidirectional relationship."],
    "37693644": ["We suggest that Abeta is not a culprit of Alzheimer's disease, but merely a byproduct of autophagy/lysosomal failure resulting from hydroxynonenal-induced Hsp70.1 disorder."],
    "37811614": ["Furthermore, despite the disease hallmarks commonly manifested in all AD cases, considerable evidence suggests complex heterogeneity of AD pathogenesis."],
    "37934647": ["For Alzheimer's Disease, the proposed method demonstrated remarkable performance in predicting the brain ventricle changes induced by the disease, achieving the state-of-the-art result on TADPOLE cross-sectional prediction challenge dataset."],
    "38203429": ["After several years of research in the field of Alzheimer's disease (AD), it is still unclear how amyloid-beta (Abeta) and Tau, two key hallmarks of the disease, mediate the neuropathogenic events that lead to AD."],
    "38549636": ["Background: Increasing evidence suggests that both amyloid-beta metabolism disorders in the liver and cerebral hypoperfusion play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "7542917": ["CONCLUSION: These results indicate that optic nerve degeneration is not a feature of AD and suggest that the visual deficits in the disease result from cortical dysfunction."],
    "8198393": ["Alzheimer's disease (AD), the most common dementing disorder of late life, is a major cause of disability and death in the elderly."],
    "8290042": ["This mutation was present in DNA from all four examined affected individuals and linked to the disease with a lod score of 3.25, and was the most probable cause of AD in this family."],
    "8871938": ["Despite a large amount of evidence that suggests an association between oxidative stress and the pathogenesis of AD, it is not yet known whether oxidative stress is a cause or consequence of the disorder."],
    "8912490": ["Further studies will determine whether this alteration could provide a peripheral biochemical marker of the disorder and whether it could intervene in the pathogenesis of Alzheimer disease."],
    "10737603": ["These results support the hypothesis that cathepsin D links lysosomal dysfunction to the etiology of Alzheimer's disease and suggest a new approach to treating the disease."],
    "10790719": ["Decreased melatonin production with malfunction of REM sleep is proposed to be a cause of sudden infant death syndrome and Alzheimer's disease, because the loss of the antioxidant function of melatonin allows brain injury to occur."],
    "11447838": ["We have hypothesized that AD results from a progressive dysfunction of APP."],
    "12387703": ["Neuronal cell dysfunction and cell death due to oxidative stress may causally contribute to the pathogenesis of progressive neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, as well as acute syndromes of neurodegeneration, such as ischaemic and haemorrhagic stroke."],
    "12453672": ["This raises a question whether Alzheimer's dementia is secondary to vascular dysfunction in the central nervous system (CNS) and, therefore, the neurodegeneration that follows is a consequence of inadequate cerebral blood flow, altered brain metabolism and failure in physiological functions of brain endothelium which represents a site at the blood-brain barrier (BBB)."],
    "12476348": ["The clinical presentation of patients with AD is dominated by cognitive deficits and emotional disturbances that result from dysfunction and degeneration of neurons in the limbic system and cerebral cortex."],
    "1453480": ["Finally, disfunction of the lysosomal system may play a role in the pathogenesis of Alzheimer's disease."],
    "14689635": ["This adaptation in Alzheimer's disease may be caused by dysfunction of the mechanism in adaptation of a quickly recovering central process."],
    "15639790": ["Selective dysfunction of mGlu II receptors may also lead to abnormal protein phosphorylation (i.e., tau phosphorylation), culminating in neurodegenerative disorders (i.e., Alzheimer disease)."],
    "15781969": ["Accumulation of cytoplasmic inclusion bodies in many neurodegenerative diseases, including Alzheimer's disease (AD), might result from dysfunction of the ubiquitin-proteasome system.", "Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction."],
    "15847115": ["CONCLUSIONS: Spectrophotometric enzymatic analyses of respiratory complexes in brain homogenates do not support the primary contribution of mitochondrial RC dysfunction in the pathogenesis of AD."],
    "16002400": ["Synaptic dysfunction is one of the earliest events in the pathogenesis of Alzheimer disease (AD)."],
    "16078048": ["Since mitochondrial dysfunction has been proposed as an underlying cause of AD and a specific haplogroup was found to affect AD susceptibility in Caucasians, we investigated whether inherited mitochondrial haplogroups affect risk of developing AD dementia in Ohio and Indiana Amish communities."],
    "16178023": ["There is strong evidence from genetics and transgenic mouse models that mitochondrial dysfunction results in neurodegeneration and may contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, hereditary spastic paraplegia, and cerebellar degenerations."],
    "16569229": ["BACKGROUND: Alzheimer's disease is a neurodegenerative disorder characterized by a progressive cognitive impairment, the consequence of neuronal dysfunction and ultimately the death of neurons."],
    "16814428": ["A pathological feature of Alzheimer's disease (AD) is an area-specific neuronal loss that may be caused by excitotoxicity-related synaptic dysfunction."],
    "17168642": ["Today, we know that Abeta-degrading proteases are critical regulators of brain Abeta levels in vivo, with evidence accumulating that their dysfunction may play a role in the etiology of AD."],
    "17512984": ["Oxidative stress, bioenergetic failure and mitochondrial dysfunction are all implicated in the etiology of neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "17558294": ["Tau is an axonal microtubule-associated protein, whose dysfunction causes neurodegenerative diseases such as Alzheimer's disease and other tauopathies."],
    "17678440": ["Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease."],
    "17696767": ["This article discusses critical issues of mitochondria causing dysfunction in aging and AD and discusses the strategies to protect neurons caused by mitochondrial dysfunction."],
    "1776729": ["At the cellular level, Alzheimer's disease (AD) must be the result of neuronal dysfunction and degeneration leading to a reduction in synaptic density."],
    "17786024": ["Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer disease."],
    "17911214": ["Growing evidence suggests that mitochondrial dysfunction is one of the key intracellular lesions associated with the pathogenesis of Alzheimer's disease (AD)."],
    "17959149": ["Our results provide a template for the design of curcuminoid-based synthetic small-molecule fold catalysts that accelerate the folding of ER-processed proteins; this assumes significance given that nitrosative stress and dysfunction of the ER-resident oxidoreductase protein disulfide isomerise due to S-nitrosylation are factors associated with the pathogenesis of Alzheimer's and Parkinson's diseases."],
    "17986027": ["The epidemiological finding of an increased risk of dementia in patients with diabetes mellitus has raised the hypothesis that a dysfunction of the insulin receptors plays a role in the pathogenesis of Alzheimer's disease (AD)."],
    "18641892": ["In Alzheimer's disease, pathological and neuroimaging data indicate that apathy is likely due to a dysfunction of the medial prefrontal cortex."],
    "18949251": ["BACKGROUND: Subjects with Alzheimer's disease (AD) have elevated cortisol levels as a result of hypothalamic-pituitary-adrenal (HPA) axis dysfunction."],
    "19182481": ["When AD or DLB patients walk with incongruent visual information, they may increase their postural sway or instability, because of their executive dysfunction."],
    "19389700": ["Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease."],
    "19417214": ["Mitochondrial dysfunction is a hallmark of beta-amyloid (Abeta)-induced neuronal injury in the pathogenesis of Alzheimer's disease."],
    "19496804": ["There is strong evidence that beta-amyloid (Abeta) causes oxidative stress and induces mitochondrial dysfunction in the pathogenesis of Alzheimer's disease."],
    "19519498": ["However, there is growing evidence that early stages of AD may be due to neuronal network dysfunction produced by the actions of soluble forms of Abeta."],
    "19682326": ["The current clinical criteria for diagnosis of AD are focused mostly on cognitive deficits produced by dysfunction of hippocampal and high-order neocortical areas, whereas noncognitive, behavioural and psychological symptoms of dementia such as disturbances in mood, emotion, appetite, and wake-sleep cycle, confusion, agitation and depression have been less considered."],
    "19853658": ["Extensive literature exists supporting a role for mitochondrial dysfunction and oxidative damage in the pathogenesis of Alzheimer's disease.", "Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology."],
    "19907182": ["BACKGROUND/AIM: The contribution of mitochondrial dysfunction and oxidative stress to the pathogenesis of Alzheimer's disease (AD) has previously been described."],
    "20016833": ["Whether mitochondrial dysfunctions are merely a consequence of AD pathology, or are early seminal events in AD pathogenesis remains to be determined."],
    "20061648": ["Although increasing evidence supports a role for mitochondrial dysfunction in the pathogenesis of AD, there have been few studies that simultaneously evaluate changes in multiple mitochondrial proteins."],
    "20107079": ["Alzheimer's disease (AD) is attributable to synapse dysfunction and loss, but the nature and progression of the presynaptic structural and functional changes in AD are essentially unknown."],
    "20127811": ["Recent studies suggest that synaptic dysfunction is one of the earliest events in the pathogenesis of AD."],
    "20463402": ["Increasing evidence is implicating mitochondrial dysfunction as a central factor in the etiology of Alzheimer's disease (AD)."],
    "20512543": ["Cognitive impairment symptoms of AD are induced by limbic system dysfunction, and an early-stage AD brain without dementia has the potential for atrophy in the hippocampal region."],
    "20553766": ["The dysfunction and loss of basal forebrain cholinergic neurons and their cortical projections are among the earliest pathological events in the pathogenesis of Alzheimer's disease (AD)."],
    "20555132": ["Although mitochondrial dysfunction and the resultant oxidative stress are believed to play a major role in the pathogenesis of both early- and late-onset AD, it is conceivable that the altered physiological state of the cells leading to sporadic AD could involve additional mechanisms."],
    "20661404": ["Mitochondrial dysfunction has surfaced as one of the most discussed hypotheses acting as a trigger for the pathogenesis of Alzheimer's disease."],
    "20730022": ["Studies in mice expressing both human amyloid precursor protein and human tau have provided clear evidence that amyloid-beta and tau interact in the pathogenesis of AD.", "A defined effort must be made to develop therapies that directly address the impact of tau dysfunction in the pathogenesis of AD."],
    "20840064": ["We also cover the recent findings on cellular and animal models that highlight mitochondrial dysfunction as a fundamental mechanism in AD pathogenesis."],
    "21046564": ["The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease."],
    "21112383": ["This review proposes the hypothesis that a chronic mild longlasting cerebrovascular dysfunction could initiate a cascade of events leading to AD.", "Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?"],
    "21143177": ["Dysfunction of one or more of these proteins is hypothesized to contribute to the pathogenesis of Alzheimer's disease (AD)."],
    "21244356": ["Mitochondrial dysfunction has been widely implicated in the etiology of Alzheimer's disease (AD)."],
    "21336338": ["The analyses of the similarities and differences of these dysfunctional pathways provide insights into understanding the dynamics of AD progression in six brain regions from a network perspective, which will further shed light on the pathogenesis of AD."],
    "21450370": ["Mitochondrial dysfunction is likely a significant contributing factor to Alzheimer disease pathogenesis, and both amyloid peptide (Abeta) and pathological forms of tau may contribute to this impairment."],
    "21514369": ["Especially in the context that mitochondrial dysfunction is an early and prominent characteristic of Alzheimer's pathogenesis, EMF treatment could have profound value in the disease's prevention and treatment through intervention at the mitochondrial level."],
    "2165009": ["The hypothesis that the symptomatology of Alzheimer's disease is attributable to cholinergic dysfunction is supported by postmortem studies that have demonstrated reduced choline acetyltransferase (ChAT) activity across all areas of cerebral cortex and diminished numbers of perikarya in the basal forebrain nucleus basalis of Meynert."],
    "22024748": ["Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy."],
    "22391273": ["Mitochondrial dysfunction is considered a major causative factor in Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD)."],
    "22539855": ["Oxidative stress, mitochondrial dysfunction, and Ca2+ dysregulation are key factors in the pathogenesis of AD, but the causal relationship between these factors and synaptic dysfunction is not clearly understood.", "Alzheimer's disease (AD) in the early stages is characterized by memory impairment, which may be attributable to synaptic dysfunction."],
    "22751174": ["The evidence that neurovascular dysfunction is an integral part of Alzheimer's disease (AD) pathogenesis has continued to emerge in the last decade."],
    "22833458": ["From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.", "Furthermore, there is cumulating evidence that Abeta formation impairs mitochondrial function and that mitochondrial dysfunction is an early event in the pathogenesis of AD."],
    "22914888": ["Several lines of evidence point to synaptic dysfunction as a cause of AD and that synapse loss is a pathological correlate associated with cognitive decline."],
    "22922216": ["The recognition that G(1)/S checkpoint dysfunctions in Alzheimer's disease (AD) has opened a novel avenue for better understanding the pathogenesis of AD, as well as for searching for new biomarkers for early diagnosis of AD."],
    "22961084": ["Our data indicate that insulin dysfunction in NOD mice leads to AD-like tau hyperphosphorylation in the brain, with molecular mechanisms likely involving a deregulation of PP2A."],
    "22995655": ["Mitochondrial dysfunction and synaptic damage have been described as early events in Alzheimer's disease (AD) pathogenesis."],
    "23107435": ["Increasing evidence demonstrates that amyloid beta (Abeta) elicits mitochondrial dysfunction and oxidative stress, which contributes to the pathogenesis of Alzheimer's disease (AD)."],
    "23126372": ["Thus, deficiency in mural vascular cells may contribute to disrupted vascular barrier properties and resultant neuronal dysfunction during AD pathogenesis."],
    "23151073": ["Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.", "Oxidative damage and mitochondrial dysfunction have been also implicated in the pathogenesis of AD, but the question as to whether they are involved in the onset and progression of the pathology or rather represent a consequence of neurodegeneration is still debated."],
    "23382999": ["Abnormal mitochondrial motility and mitochondrial dysfunction within axons are critical for amyloid beta (Abeta)-induced synaptic stress and the loss of synapses relevant to the pathogenesis of Alzheimer's disease (AD)."],
    "23494712": ["The dysfunction of the Neurovascular Unit (NVU) has been proposed to be causative in AD development, due to an impaired clearance of Abeta from the brain."],
    "23756733": ["Their dysfunction may cause various life-threatening disorders, such as Parkinson's, Alzheimer's, and cardiovascular diseases."],
    "23948929": ["Dysfunction of this signaling process may underlie glia-based aspects of AD pathogenesis."],
    "24171818": ["Here, we provide an overview of current research focused on the relevance of autophagic/lysosomal dysfunction in AD pathogenesis as well as potential therapeutic targets aimed at restoring autophagic/lysosomal pathway function."],
    "24252187": ["As such, NVU/BBB dysfunction, associated to irregularities in cerebral blood flow (CBF), has been proposed to contribute in the pathogenesis of Alzheimer's disease (AD), mainly by impairing cerebral Abeta clearance."],
    "24450113": ["Currently, AD is believed to begin with synaptic dysfunction caused by soluble Abeta oligomers, playing a more important role in the etiology of AD than insoluble Abeta ibrils ('oligomer hypothesis')."],
    "24512632": ["Dysfunction of retromer is a risk factor for the pathogenesis of Parkinson's disease (PD) and Alzheimer's disease (AD), both neuro-degeneration disorders."],
    "24610177": ["Increasing evidence has implicated autophagic dysfunction in the pathogenesis of Alzheimer's disease (AD)."],
    "24664866": ["The brain is more vulnerable than other organs to oxidative stress, and most of the components of neurons (lipids, proteins, and nucleic acids) can be oxidized in AD due to mitochondrial dysfunction, increased metal levels, inflammation, and beta-amyloid (Abeta) peptides."],
    "24684730": ["Synaptic dysfunction and synapse loss are key features of Alzheimer's pathogenesis."],
    "24713000": ["Together, our results support the role of tau and calcineurin as two intermediate signaling molecules between Abeta initiation and eventual synaptic dysfunction early in AD pathogenesis."],
    "24728903": ["Human studies show that besides loss of cognition/learning ability, neuropsychological symptoms such as anxiety and seizures are seen as high as 70 and 17 % respectively in AD patients, suggesting dysfunction of GABAergic neurotransmission contributes to pathogenesis of AD."],
    "24902900": ["Evidence indicates that nitrosative stress and mitochondrial dysfunction participate in the pathogenesis of Alzheimer's disease (AD)."],
    "25045655": ["Since synaptic dysfunction and degeneration are early events during the pathogenesis of AD, we aim to investigate the effects of testosterone on oligomeric Abeta-induced synaptic changes."],
    "25062013": ["Soluble oligomeric amyloid beta (oAbeta) causes synaptic dysfunction and neuronal cell death, which are involved in the pathogenesis of Alzheimer's disease (AD)."],
    "25106114": ["Alzheimer's disease (AD) has historically been considered to arise due to the specific dysfunction and pathology of neurons in brain areas related to cognition."],
    "25322927": ["BACKGROUND: Specific mechanisms behind the role of oxidative/nitrosative stress and mitochondrial dysfunction in Alzheimer's disease (AD) pathogenesis remain elusive."],
    "25400096": ["Although it is well documented that soluble beta amyloid (Abeta) oligomers are critical factors in the pathogenesis of Alzheimer's disease (AD) by causing synaptic dysfunction and neuronal death, the primary mechanisms by which Abeta oligomers trigger neurodegeneration are not entirely understood."],
    "25465240": ["Olfactory dysfunction is a recognized risk factor for the pathogenesis of Alzheimer's disease (AD), while the mechanisms are still not clear."],
    "25511446": ["Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.", "Although pathological hallmarks of AD are senile plaques, neurofibrillary tangles, and neuronal degeneration which are associated with increased oxidative stress, synaptic loss is an early event in the pathogenesis of AD."],
    "25531259": ["This review explores the potential role of mitochondrial epigenetic dysfunction in Alzheimer's disease etiology and discusses some technical issues pertinent to the study of these processes."],
    "25533203": ["INTRODUCTION: Synaptic dysfunction is an early event in Alzheimer's disease (AD) pathogenesis and directly related to cognitive impairment."],
    "25688079": ["Despite widespread recognition of the significance of vascular dysfunction in Alzheimer's disease aetiology and progression, much uncertainty still surrounds the mechanism underlying Alzheimer's disease vascular injury."],
    "26075247": ["Diabetes is associated with various nervous disorders, such as cognitive deficits, depression, and Alzheimer's disease, and that may be caused by neural stem cell dysfunction."],
    "26126792": ["Dysfunction of protein transport contributes to pathogenesis of AD and other neurodegenerative diseases."],
    "26186010": ["Additionally, oxidative damage and the dysfunction of the antioxidant system play important roles in the pathogenesis of osteoporosis and AD."],
    "26311408": ["Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.", "This study reviews the current literature of in vitro and ex vivo studies on endothelium-mediated mechanisms underlying vascular dysfunction in AD pathogenesis, with the aim of presenting a comprehensive overview of the complex network of causative relationships."],
    "26380416": ["[THE ROLE OF beta-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE]."],
    "26440450": ["In Alzheimer's disease (AD), the deposition of beta-amyloid (Abeta) is hypothesized to result in a series of secondary neurodegenerative processes, leading ultimately to synaptic dysfunction and neuronal loss."],
    "26500157": ["This study demonstrates for the first time mitochondrial dysfunction in transgenic mice with a mutation within the Abeta peptide (the Arctic APP mutation), and confirms previous studies suggesting that mitochondrial dysfunction and oxidative stress is an early event in the pathogenesis of Alzheimer disease."],
    "26601965": ["Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most widespread neurological disorders (NDs) characterized by degeneration of cognitive and motor functions due to malfunction and loss of neurons in the central nervous system (CNS)."],
    "26647379": ["This multi-sensor system measured mitochondrial parameters in the brain of transgenic mice that model Alzheimer's disease (AD), because mitochondrial dysfunction is believed to be a primary event in the pathogenesis of AD."],
    "26829765": ["Characterizing the early NVU damage and identifying biomarkers of neurovascular dysfunction may provide a fresh insight into Alzheimer pathogenesis and open opportunities for pediatric neuroprotection."],
    "26869037": ["Mounting evidence has implicated autophagic dysfunction in the pathogenesis of several major neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease and Huntington's disease, where deficient elimination of abnormal and toxic protein aggregates promotes cellular stress, failure and death."],
    "26949964": ["Alzheimer's disease (AD) and Parkinson's disease (PD) are such kind of killer CDs that occur due to dysfunction of cholinergic and dopaminergic neurons."],
    "26976084": ["Its dysfunction and aggregation into insoluble paired helical filaments is involved in the pathogenesis of Alzheimer's disease (AD), constituting, together with accumulated beta-amyloid (Abeta) peptides, a hallmark of the disease."],
    "27073745": ["Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by cognitive impairment and dementia, resulting from progressive synaptic dysfunction, loss and neuronal cell death."],
    "27340665": ["Cellular dysfunctions involving specific subcellular compartments, such as mitochondria and endoplasmic reticulum (ER), are emerging as crucial players in the pathogenesis of AD, as well as increased oxidative stress and dysregulation of calcium homeostasis."],
    "27439966": ["It is well known that cognitive deficit of AD is caused by synaptic dysfunction."],
    "27556379": ["On the other hand, experimental findings and human observations signal that some of the primary degenerative diseases of the CNS, like frontotemporal dementia, Parkinson's disease, Alzheimer's dementia, Huntington's dementia, primary cerebellar ataxias and amyotrophic lateral sclerosis, all of which affect the human species exclusively, may be due to astroglial dysfunction."],
    "27581448": ["UNLABELLED: Microglial dysfunction is increasingly recognized as a key contributor to the pathogenesis of Alzheimer's disease (AD)."],
    "27599716": ["Mitochondrial dysfunction is known as one of causative factors in Alzheimer's disease (AD), inducing neuronal cell death."],
    "27629410": ["These results further implicate endolysosome dysfunction in the pathogenesis of AD and HAND, and by virtue of its ability to prevent and/or block neuropathological features associated with AD and HAND caffeine might find use as an effective adjunctive therapeutic agent."],
    "27634555": ["Mitochondrial dysfunction and ensuing oxidative damage is typically thought to be a primary cause of Huntington's disease, Alzheimer's disease, and Parkinson disease."],
    "27634936": ["Cerebrovascular dysfunction is a critical component of Alzheimer's disease (AD) pathogenesis."],
    "27653553": ["Mitochondrial dysfunction and impaired energy metabolism are important components of AD pathogenesis."],
    "27834780": ["Therefore, to elucidate the causative mechanisms of mitochondrial dysfunction in aging brains is of paramount importance for our understanding of the pathogenesis of AD, in particular its sporadic form."],
    "27987381": ["Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease."],
    "28131207": ["BACKGROUND: Potential role of vascular dysfunction has been suggested in the pathogenesis of Alzheimer's disease (AD)."],
    "28237964": ["Microvascular dysfunction is considered an integral part of Alzheimer disease (AD) pathogenesis, but the possible relationship between amyloid pathology, microvascular dysfunction and cell death is still unclear."],
    "28299814": ["They further support the concept of subtypes of Alzheimer's disease with distinct cognitive profiles due to prominent neocortical dysfunction early in the disease course."],
    "28531191": ["Recent studies have shown that mitochondrial dysfunction is a causative factor of AD."],
    "28934248": ["Dysfunction of retromer is a risk factor for the pathogenesis of Parkinson's disease (PD) and Alzheimer's disease (AD)."],
    "28956268": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder leading to dementia caused by advanced neuronal dysfunction and death."],
    "29089996": ["Alzheimer's disease, a progressive neurodegenerative disease, affects learning and memory resulting from cholinergic dysfunction."],
    "29124106": ["(A?) accumulation and A?-related neural network dysfunction are considered central to the pathogenesis of Alzheimer's disease (AD) at the early stage."],
    "29127191": ["Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated beta-amyloid (Abeta) peptides in the AD brain results from a dysfunction in these cellular clearance systems."],
    "29255835": ["Mitochondrial dysfunction has been found to play an important role in the initiation of both aging and the pathogenesis of Alzheimer's disease."],
    "29320772": ["This article examines the available evidence for a role of mTOR-driven cerebrovascular dysfunction in the pathogenesis of AD and of vascular cognitive impairment and dementia (VCID) and highlights the therapeutic potential of targeting mTOR and/or specific downstream effectors for vasculoprotection in AD, VCID, and other age-associated neurological diseases with cerebrovascular etiology."],
    "29354787": ["We suggest that complex I dysfunction accelerate amyloid toxicity and mitochondrial complex I dysfunction in aging may contribute to the pathogenesis of sporadic AD."],
    "29516292": ["Along with brain amyloid-beta (Abeta) deposits and neurofibrillary tangles, cerebrovascular dysfunction is increasingly recognized as fundamental to the pathogenesis of AD."],
    "29777753": ["Recent studies suggest that neurovascular dysfunction may be an integral part of AD pathogenesis, contributing to the onset and development of AD pathologies such as neuronal death, inflammatory response, and breakdown of blood-brain barrier (BBB)."],
    "29863022": ["These findings indicate that the involvement of early demyelination at 3 months and the oligodendrocyte dysfunction at 6 months in APP/PS1 mice are in association with Alzheimer's disease pathogenesis."],
    "29992725": ["While both Abeta plaques and tau aggregates could in turn enhance the dysfunction of these proteostatic pathways, eventually leading to apoptotic or necrotic neuronal death and pathogenesis of Alzheimer's disease."],
    "30009706": ["Dysfunction of the cholinergic system plays an important role in pathogenesis of AD."],
    "30144541": ["In summary, APOE epsilon4 may affect CSF SNAP levels in MCI patients, suggesting an important role of APOE epsilon4 in synaptic dysfunction leading to AD."],
    "30292394": ["CONCLUSIONS: Our results reveal a role for RPS23RG1 in maintaining synaptic integrity and function and provide a new mechanism for synaptic dysfunction in AD pathogenesis."],
    "30296191": ["CONCLUSION: Endogenous n-3 PUFAs delayed the onset of Alzheimer's disease caused by tau protein dysfunction, alleviating related symptoms and significantly prolonging survival in vivo."],
    "30352630": ["Amyloid beta (Abeta)-mediated synapse dysfunction and spine loss are considered to be early events in Alzheimer's disease (AD) pathogenesis."],
    "30362531": ["Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis."],
    "30472149": ["Overtaken of High-fat, high-glucose or high-cholesterol diet may hasten the incidence of AD in later life, due to the metabolic dysfunction."],
    "30478411": ["Moreover, our findings strongly suggest that mitochondrial dysfunction, NF-kappaB signalling and iNOS signalling are important dysregulated pathways in AD pathogenesis."],
    "30481567": ["Importantly, dysfunction of such postsynaptic receptor trafficking can lead to severe brain diseases such as Alzheimer's Disease, autism spectrum disorder, and intellectual disability, yet underlying mechanisms remain elusive."],
    "3539000": ["Two principal features of Alzheimer's disease (AD) are (1) the occurrence of neurofibrillary tangles (NFTs) and senile plaques, and (2) the loss of cortical cholinergic activity because of dysfunction of neurons in the basal forebrain cholinergic system."],
    "7280699": ["The effects of diffuse cerebral dysfunction on oculomotor reaction time were assessed in patients with dementia of presumed Alzheimer's etiology and in normal age-matched control subjects."],
    "8892355": ["Thus, the decrease we observe in overall PGSH-2 mRNA levels is likely to reflect both the known decline in numbers of neurons in AD as well as a lowered capacity for neuronal synthesis of PGHS-2, perhaps due to dysfunction or a loss of synaptic input."],
    "9452785": ["Hypertension may also give rise to a blood-brain barrier dysfunction, which has been suggested to be involved in the aetiology and pathogenesis of Alzheimer's disease."],
    "10210960": ["Three genes causing early-onset autosomal dominant Alzheimer have so far been described."],
    "10349334": ["Recently another gene on chromosome 12 has been suggested to be involved in the development of late-onset Alzheimer's disease, and identification of the gene on chromosome 12 may bring a new insight into the pathogenesis of Alzheimer's disease.", "Although these data suggest that accumulation of A beta is an essential step in the pathogenesis of Alzheimer's disease, it still remains to be elucidated whether such process is causative for Alzheimer's disease."],
    "10464576": ["The first group consists of genes that appear to cause AD when mutated, and the second category is composed of genes that are statistically associated with AD, depending on the inheritance of specific alleles."],
    "11290552": ["Mutations in the amyloid precursor protein (APP) and presenilin-1 and -2 genes (PS-1, -2) cause Alzheimer's disease (AD)."],
    "12227924": ["In addition, the model estimates that about 0.20% of the population carries genes that cause AD at very early ages, through mechanisms that are not associated with the APOE genotype."],
    "12489805": ["Deposition of the amyloid-beta protein (Abeta) in the form of cerebral plaques is a defining pathological feature of Alzheimer's disease (AD), and all AD-causing genes identified to date affect Abeta production or deposition.", "AD-causing mutations in the presenilin genes alter y-secretase activity, increasing production of the more deleterious 42-residue form of Abeta."],
    "15584876": ["More than 180 genes distributed across the human genome are potentially involved in the pathogenesis of Alzheimer's disease (AD)."],
    "15917099": ["Additional markers in these genes need to be screened to explore their role in the etiology of AD."],
    "18005339": ["Located on chromosome 21 are the genes that encode beta-amyloid (Abeta) precursor protein (APP ), a key protein involved in the pathogenesis of AD, and dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A (DYRK1A ), a proline-directed protein kinase that plays a critical role in neurodevelopment."],
    "18161858": ["The results suggest that, in addition to genes that might directly affect pathways leading to AD, there may be familial/genetic factors not connected to specific pathophysiological processes in AD but instead associated with increased longevity that contribute to the familial aggregation observed in AD."],
    "18165854": ["The interplay of genes and environment in the aetiology of AD needs to be further investigated as well as the role of lifestyle and pharmacological interventions for the prevention of dementia."],
    "19173769": ["Here, we investigated whether dietary vitamin E (VE) depletion may induce adverse effects and supplementation with alpha-tocopherol (alphaT) may result in beneficial effects on redox status and the regulation of genes relevant in the pathogenesis of AD in healthy rats."],
    "19902022": ["The aim of the present feeding trial was to investigate the effects of EGb761 and its major constituents on the expression of genes encoding for proteins involved in the pathogenesis of AD in mouse brain."],
    "19912889": ["Since cytochrome oxidase is important for neuronal function, these findings suggest a possible role for this gene in the pathogenesis of AD."],
    "21440575": ["We therefore examined early cognitive changes in 4-month-old mice over-expressing 2 genes responsible for AD (APPswe/PS1d9 mouse line)."],
    "22618995": ["Although mutations in these genes are rare causes of AD, their discovery had a major impact on our understanding of molecular mechanisms of AD.", "Early work identified mutations in three genes that cause AD: APP, PSEN1 and PSEN2."],
    "23111619": ["The transgene, consisting of a cDNA of the Alzheimer's disease-causing gene PSEN1M146I driven by an enhanced human UbiC promoter, had an expression profile in various tissues similar to that of the GFP marker gene."],
    "23669301": ["Both of these genes are in the cholesterol metabolism pathway leading to AD."],
    "23833557": ["Animal models of Alzheimer disease (AD) are used to study the mechanisms underlying AD pathogenesis, genetic interactions with genes of interest, and environmental risk factors that cause sporadic AD as well as to test the therapeutic effects of AD drug-candidates on neuropathology and cognitive function."],
    "25362032": ["Computationally-derived clusters and modules within the networks indicated strong ties between RORA and genes involved in the AD etiology."],
    "25432889": ["To facilitate novel discoveries in this filed, here, we have integrated information from multiple sources for the better understanding of gene functions in AD pathogenesis."],
    "25845235": ["Probable molecular mechanisms implicated in the relation of genes under study to AD pathogenesis are discussed."],
    "26289409": ["Increasing evidence indicates that many genes including interleukin-6 (IL-6) and alpha 2-macroglobulin (A2M) may contribute to the pathogenesis of AD."],
    "26394601": ["The genes we have identified are in pathways that are strong candidates for involvement in the development of AD pathology and may lead to a better understanding of AD pathogenesis."],
    "26742512": ["The epsilon 4 allele of the apolipoprotein E (ApoE4) gene is the most important risk factor implicated in Alzheimer's disease (AD) etiology."],
    "27345973": ["Skin fibroblasts were obtained from a 48-year-old presymptomatic woman carrying a A79V mutation in the presenilin 1 gene (PSEN1), causing Alzheimer's disease (AD)."],
    "27345998": ["Skin fibroblasts were obtained from a 46-year-old symptomatic man carrying a M146I mutation in the presenilin 1 gene (PSEN1), responsible for causing Alzheimer's disease (AD)."],
    "28666362": ["Although it has been reported that AD is strongly affected by CNVs, most of AD-causing genes with pathogenic CNVs have not been identified yet."],
    "28855300": ["Sequence variations occurring in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2) support an essential function of microglia and innate immunity in the pathogenesis of Alzheimer's disease (AD) and other neurodegenerative disorders."],
    "29262769": ["Analysis of the expression patterns of the genes in different regions of the brain influenced in AD surely contribute for a enhanced comprehension of AD pathogenesis and shed light on the early characterization of the disease."],
    "29675796": ["Eventually, not only a number of genes such as E2F4 and ATF1 related to the pathogenesis of AD have been identified, but also several significant biological processes, such as immunoregulation and neurogenesis, have been found to be associated with AD."],
    "29692703": ["Conclusions: Pathogenic mutations in the Alzheimer disease-causing genes (PSEN1 and PSEN2) are found in sporadic PD patients."],
    "30315455": ["Epigenetics provide a bridge between genes and environment to improve our understanding on the etiology of AD."],
    "30797548": ["Screening for Alzheimer's disease-causing genes is indicated in presenile dementia with an overlapping clinical diagnosis."],
    "31043483": ["Notably, similar endosomal-lysosomal pathobiology emerges early in sporadic AD, where neuronal APP-betaCTF is also elevated, underscoring its importance as a therapeutic target and underscoring the functional and pathogenic interrelationships between the endosomal-lysosomal pathway and genes causing AD."],
    "32019384": ["The study aimed to identify the key differentially expressed genes (DEGs) and pathways in AD pathogenesis and obtain potential biomarkers in AD diagnosis."],
    "32429084": ["Our analyses provided stronger evidence for possible roles of four genes (i.e.,    AIM2    ,    C16orf80    ,    DGUOK    , and    ST14    ) in AD pathogenesis as they were also transcriptionally associated with AD."],
    "32741831": ["Decades after their discovery, the mechanisms by which these genes cause Alzheimer's disease (AD) or promote AD progression are not fully understood."],
    "32804129": ["Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.BACKGROUND: Genetic risk factors play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "33310624": ["Assessment of preclinical individuals with genes causing autosomal dominant AD (ADAD) provides a model for prodromal disease."],
    "33512697": ["Two items (#1: particularly prone to depression; #20: depression can be mistaken for AD) fit to a domain relating to depression, another two items (#2: mental exercise can prevent AD development; #8: benefit of psychotherapy) can be related to potential prevention and improvement, and four items (#12: poor nutrition can make the symptoms worse; #18: high cholesterol may increase the risk of AD; #26: high blood pressure may increase the risk of AD; #27: genes can only partially account for AD development) fit to a risk factor domain."],
    "33712570": ["Genome-wide association studies (GWAS) have identified more than 40 loci associated with Alzheimer's disease (AD), but the causal variants, regulatory elements, genes and pathways remain largely unknown, impeding a mechanistic understanding of AD pathogenesis."],
    "34308907": ["Five of these genes (PFKFB3, DLD, ALDOC, LDHB, LDHC) have significant differences in gene expression between AD and control groups by Alzdata, while three of the genes (HK3, ALDOC, PKLR) are related to the pathogenesis of AD."],
    "34892435": ["Because gene is an important clinical risk factor resulting in AD, genomic studies, such as genome-wide association studies (GWAS), have widely been applied into AD studies."],
    "35045380": ["We studied participants with or known to be at-risk for mutations in genes causing autosomal-dominant Alzheimer's disease (ADAD) with early onset, providing a unique window into the pathogenesis of Alzheimer's largely disentangled from age-related factors."],
    "35108947": ["BACKGROUND: Genome-wide association studies (GWAS) provide a robust approach for discovery of genes involved in the causal chain of events leading to Alzheimer's disease."],
    "35768560": ["CD36 was selected as a gene previously shown to be implicated in the etiology of AD."],
    "35955777": ["We recently reported that glia-specific suppression of the lipolysis-stimulated lipoprotein receptor (LSR) gene leads to Alzheimer's disease-like memory deficits."],
    "37302034": ["The patients with DS develop typical Alzheimer's disease (AD) neuropathology, indicating the role of genes on human chromosome 21 (HSA21) in the pathogenesis of AD."],
    "37796069": ["The established importance of these genes in the pathogenesis of AD suggests that similar changes in their expression profile in cSVD may be one of the conditions for the comorbidity of the two pathologies."],
    "37855447": ["These results point to an overlap between the genes and pathways that leads to AD and those that influence dementia and memory decline in the DS population."],
    "38306048": ["Codon Pattern and Context Analysis in Genes Triggering Alzheimer's Disease and Latent Tau Protein Aggregation Post-Anesthesia Exhibited Unique Molecular Patterns Associated with Functional Aspects."],
    "38343132": ["INTRODUCTION: Genetic studies conducted over the past four decades have provided us with a detailed catalog of genes that play critical roles in the etiology of Alzheimer's disease (AD) and related dementias (ADRDs)."],
    "7845336": ["The classical Mendelian model taught that extreme and rare phenotypes shed light on more frequent ones, hence the definition of genes responsible for hypercholesterolemia, for Alzheimer disease, and for amyotrophic lateral sclerosis."],
    "8220418": ["Overexpression of the gene encoding the beta-amyloid precursor protein (APP) may have a key role in the pathogenesis of both Alzheimer's disease (AD) and Down Syndrome (DS)."],
    "8357032": ["Genetic research may uncover the causes of severe mental disorders, and many projects have been undertaken to locate the genes responsible for schizophrenia, bipolar disorder, and Alzheimer disease."],
    "8787186": ["Recent genetic and biochemical studies have shown the involvement of at least four genes in the pathogenesis of AD."],
    "8904781": ["Missense mutations in the presenilin-1 (PS-1) and presenilin-2 (PS-2) genes have been shown to be causes of autosomal dominant Alzheimer's disease (the AD3 and AD4 loci, respectively)."],
    "9622002": ["Analysis of the PS-1 gene is thought to be useful in clarifying the pathogenesis of AD."],
    "9666901": ["We hypothesized that in some cases of sporadic AD, a somatic mutation in an embryonic cell committed to neuronal development within the amyloid precursor protein (APP), the presenilin 1 (PS-1) or the presenilin 2 (PS-2) genes (genes known to be involved in familial AD) may result in AD phenotype.", "We conclude that the genes that are involved in familial AD do not display somatic mutations in the brains of sporadic AD patients, and that other molecular mechanisms are probably involved in the pathogenesis of sporadic AD."],
    "9772024": ["However, the disease in many familial AD cases cannot be explained by these genes; thus, other genetic factors involved in the etiology of AD should exist."],
    "9851443": ["The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease."],
    "10869806": ["Further, as inflammation is reported to play a prominent role is AD pathogenesis, IL-6, a known mediator of inflammation, is another candidate gene proposed to be associated with the risk of AD."],
    "11715204": ["They could have a role in the neurotoxicity observed in AD because of the inflammatory reaction they generate."],
    "11738475": ["Further, in diseases such as progressive supranuclear palsy, Huntington's, Alzheimer's and Parkinson's diseases, the aberrant activation of TGases may be caused by oxidative stress and inflammation."],
    "11754998": ["The limited number of studies that have investigated chemokine and chemokine receptor expression in Alzheimer's disease (AD) brain and in cell culture models seem to support a role for inflammation in AD pathogenesis."],
    "11755000": ["Biochemical, genetic, and epidemiological evidence indicates that inflammation is an essential part of the pathogenesis of Alzheimer's disease."],
    "12099698": ["Transforming growth factor-beta-1 (TGF-beta), a key regulator of the brain responses to injury and inflammation, has been implicated in upregulating the expression of the Alzheimer amyloid precursor protein (APP) and Alzheimer's disease (AD) pathogenesis."],
    "12973747": ["Moreover, doses leading to similar brain/serum levels provided neuroprotection in animal models relevant for neurodegeneration in AD such as neurotoxicity produced by inflammation in the NBM or beta-amyloid injection to the hippocampus."],
    "15473667": ["Expression of the NF-kappaB-dependent genes responsible for inflammation, such as TNF-alpha, IL-1beta, and nitric oxide synthase (NOS), contributes to chronic inflammation which is a major cause of neurodegenerative diseases (i.e. Alzheimer's disease)."],
    "15644140": ["But simultaneous with the arrival of a more complex view of microglia, evidence that inflammation plays a causal or exacerbating role in AD etiology has been boosted by genetic, physiological, and epidemiological studies."],
    "15665405": ["These then cause a cytokine cascade and microlocalized inflammation in the CNS, that in time results in clinical Alzheimer's disease."],
    "15681802": ["Inflammation is a critical component of the pathogenesis of Alzheimer's disease (AD), consisting of the activation of both microglia and astrocytes."],
    "15748779": ["The importance of the role of inflammation has been suggested in the pathogenesis of Alzheimer's disease (AD)."],
    "16192374": ["Inflammation is a critical component of the pathogenesis of Alzheimer's disease (AD)."],
    "16384684": ["The initial stages of Alzheimer's disease pathology in the neocortex show upregulation of cell cycle proteins, adhesion and inflammation related factors, indicating the early involvement of inflammatory and regenerating pathways in Alzheimer's disease pathogenesis."],
    "16478525": ["Several lines of evidence suggest that enhanced oxidative stress, inflammation, and apoptosis play important roles in the pathogenesis of AD."],
    "16602061": ["DEVELOPMENT: Inflammation is considered an important, although secondary, element in the pathogenesis of AD."],
    "16787834": ["In vivo, doses leading to similar brain/serum levels produce neuroprotection in animal models relevant for neurodegeneration in Alzheimer's disease such as neurotoxicity produced by inflammation in the NBM or beta-amyloid injection to the hippocampus."],
    "17027528": ["Epidemiologic data as well as clinical trial evidence suggest that nonsteroidal anti-inflammatory drug (NSAID) use may decrease the incidence of AD, further supporting a role for inflammation in AD pathogenesis."],
    "17262990": ["The importance of inflammation in the pathogenesis of AD was indirectly confirmed by epidemiological investigations that revealed a decreased incidence of AD in subjects using anti-inflammatory drugs, especially the non-steroidal anti-inflammatory drugs (NSAIDs)."],
    "17949824": ["Increasing evidence supports a propensity towards inflammation in Alzheimer's disease (AD) pathogenesis."],
    "19914323": ["A large body of evidence suggests the importance of inflammation and oxidative or nitrosative stress in Alzheimer's disease (AD) pathogenesis."],
    "20011709": ["The importance of inflammation in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease, is increasingly being recognized."],
    "20160456": ["OBJECTIVES: To show that the interest in inflammation in Alzheimer's disease (AD) is not only an early event in the history of AD but that inflammation is also an early event in the pathogenesis of AD."],
    "20195797": ["How the regulation of inflammation loses its effectiveness during AD pathogenesis remains largely unclear."],
    "20933033": ["The Abeta aggregate-induced neurotoxicity, inflammatory reactions and oxidative stress are linked strongly to the etiology of AD."],
    "21143138": ["This strongly indicates that inflammation plays a central role in the aetiology of AD."],
    "21567187": ["Inflammation including microglial activation may contribute in AD pathogenesis, and biomarkers for this process may thus be of value to study AD pathogenesis and might facilitate development of therapies targeting these cells."],
    "21920632": ["Inflammation is believed to be integral to the pathogenesis of Alzheimer's disease (AD)."],
    "21951392": ["Beta-amyloid (Abeta) plaques and local inflammation are central to the pathogenesis of Alzheimer's disease."],
    "22342162": ["Inflammation within the CNS is part of the pathogenesis of neurodegenerative diseases, in particular Alzheimer's disease, multiple sclerosis and Parkinson's disease."],
    "23046210": ["There is a great deal of evidence suggesting an important role for systemic inflammation in the pathogenesis of Alzheimer's disease."],
    "23533697": ["Although much attention has been devoted concerning the contribution of the microscopic lesions, senile plaques, and neurofibrillary tangles to the disease process, inflammation has long been suspected to play a major role in the etiology of AD."],
    "23566485": ["BACKGROUND: Immune activation and inflammation represent critical factors in the pathogenesis of Alzheimer's disease (AD) and are associated with increased blood concentrations of markers like neopterin and the kynurenine to tryptophan ratio (Kyn/Trp)."],
    "24369524": ["The presence of activated microglia and astrocytes in the vicinity of amyloid plaques in the brains of Alzheimer's disease (AD) patients and mouse models implicates inflammation as a contributor to AD pathogenesis."],
    "24384767": ["Amyloid beta or Abeta plaques and neurofibrillary tangles define AD pathologically but do not fully explain it, because dementia may also be caused by inflammation resulting in neuronal, axonal synaptic loss and dysfunction."],
    "24413537": ["Alzheimer's disease may result from low-grade inflammation of the brain, and the characteristic amyloid beta may be a protective response."],
    "24557039": ["Immune activation and inflammation, likely triggered by amyloid-beta (Abeta) deposition, play a remarkable role in the pathogenesis of Alzheimer's disease (AD), which is the most frequent cause of dementia in the elderly."],
    "24631395": ["The current study was designed to further our understanding of peripheral inflammation-induced AD-like pathology, by administering polyinosinic:polycytidylic acid (poly I:C), a viral mimetic."],
    "25051986": ["BACKGROUND: Aging is characterized by a low-grade systemic inflammation that contributes to the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD)."],
    "25554493": ["In Alzheimer's disease (AD), large populations of endothelial cells undergo angiogenesis due to brain hypoxia and inflammation."],
    "26103884": ["There is relatively little information about inflammation in the DS brain and how the genetics of DS may alter inflammatory responses and modify the course of AD pathogenesis in this disorder."],
    "26587902": ["BACKGROUND: The critical role of neuro-inflammation and oxidative stress in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD) has become evident."],
    "26899953": ["Clusterin (CLU) is recognized as a secreted protein that is related to the processes of inflammation and immunity in the pathogenesis of Alzheimer's disease (AD)."],
    "26910914": ["Neuro-inflammation is associated with activation of astrocyte and amyloid-beta (Abeta) generations that lead to pathogenesis of Alzheimer disease (AD)."],
    "26913031": ["In this article, we consider how current imaging techniques can help to unravel new inflammation mechanisms in the pathogenesis of AD and identify novel therapeutic strategies to treat the disease by interfering with leukocyte trafficking mechanisms."],
    "27010693": ["BACKGROUND: One of the factors that contribute to Alzheimer's disease (AD) is the DNA damage caused by oxidative stress and inflammation that occurs in nerve cells."],
    "27357286": ["Inflammation is becoming increasingly recognized as an important contributor to Alzheimer's disease (AD) pathogenesis."],
    "27412235": ["Inflammation is one of the main causes of Alzheimer's disease (AD)."],
    "27829994": ["In conclusion, astrocytes have been shown to exert a direct role in Abeta clearance and undergo functional impair associated with inflammation in the pathogenesis of AD."],
    "28460142": ["This study suggested that AgNP exposure might cause Abeta deposition and inflammation for subsequent neuronal cell apoptosis to potentially induce AD progression."],
    "28977138": ["Innate immunity and inflammation in Alzheimer's disease pathogenesis."],
    "29249963": ["A working hypothesis links extrinsic inflammation as a secondary cause of AD."],
    "29393440": ["Although the pathologic mechanism remains to be fully elucidated, inflammation has been shown to be critical in the pathogenesis of AD."],
    "29562537": ["The production of soluble amyloid-beta oligomers (AbetaOs) and the activation of inflammation are two important early steps in the pathogenesis of Alzheimer's disease (AD)."],
    "29628886": ["Furthermore, the CCR might be mechanistically linked to inflammation, a critical factor in the AD etiology according to the genetic evidence."],
    "30403186": ["OBJECTIVE: The dysregulation of neuro-inflammation is one of the attributes of the pathogenesis of Alzheimer's disease (AD)."],
    "30564548": ["The cognitive impairment that is a hallmark of AD may be caused by inflammation in the brain triggered and maintained by the presence of Abeta protein, ultimately leading to neuronal dysfunction and loss."],
    "30661858": ["Inflammation increases beta-amyloid burden and is thought to drive Alzheimer's disease pathogenesis."],
    "30777084": ["Given the role played by inflammation in AD pathogenesis and the established efficacy of IFNbeta1a in the treatment of inflammatory diseases of the central nervous system such as multiple sclerosis, its use may be a viable strategy to inhibit the pro-inflammatory cytokine and oxidative stress cascade associated with Abeta deposition in the hippocampus of AD patients."],
    "30929586": ["BACKGROUND: An imbalance of free radicals and antioxidant defense systems in physiological processes can result in protein/DNA damage, inflammation, and cellular apoptosis leading to neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD)."],
    "30968773": ["Evidence also suggests that inflammation may lead to atherosclerosis, Alzheimer's, hypertension, stroke, cysts and cancers."],
    "31233762": ["According to the critical role of inflammation in pathogenesis of AD and memory deficits, a cytokine with anti-inflammatory properties like interferon beta (IFNbeta), currently used to slow down disease progression and protect against cognitive disturbance in multiple sclerosis, might be also an effective treatment in AD condition."],
    "31312547": ["A central role for inflammation has been implicated in the pathogenesis of AD."],
    "31451750": ["Regulator of calcineurin 1 (RCAN1) is a multifunctional protein involved in neurodegeneration, mitochondrial dysfunction, inflammation and protein glycosylation, and plays an important role in the pathogenesis of Down syndrome and Alzheimer's disease."],
    "31680874": ["Accumulating evidences suggest an active role of inflammation in the pathogenesis of AD."],
    "31865964": ["We believe this review will provide new insights into biomarker candidates for the early diagnosis of AD with systemic relevance to inflammation during AD pathogenesis."],
    "31867568": ["Human and animal studies have shown that chronic immune response and inflammation are important factors in the pathogenesis of AD."],
    "32444542": ["Tenuifolin Attenuates Amyloid-beta42-Induced Neuroinflammation in Microglia Through the NF-kappaB Signaling Pathway.BACKGROUND: Inflammation and oxidative stress are believed to play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "32606694": ["Background: beta-Amyloid (Abeta) induces oxidative stress and inflammation of microglial cells, thus leading to Alzheimer's disease."],
    "32765394": ["Thus, ORC may exert a protective role in AD through attenuating the damage caused by inflammation and oxidative stress."],
    "32781098": ["Evidence suggests that hyperglycemia induces oxidative stress, mitochondrial dysfunction, inflammation and excitotoxicity, all of which play important roles in the onset and progression of AD pathogenesis."],
    "32916195": ["Chronic airway allergy induces pro-inflammatory responses in the brain of wildtype mice but not 3xTgAD mice.The effects of systemic inflammation on the pathogenesis of Alzheimer's disease (AD) are not clarified, both beneficial and deleterious effects being reported."],
    "33422142": ["BACKGROUND: Both serotonergic signalling disruption and systemic inflammation have been associated with the pathogenesis of Alzheimer's disease (AD)."],
    "33737171": ["INTRODUCTION: Systemic inflammation has been increasingly implicated in the pathogenesis of Alzheimer's disease (AD), yet the mechanistic and temporal specificity of this relationship is poorly understood."],
    "33881288": ["PURPOSE: Systemic inflammation is characteristic for the pathogenesis of Alzheimer's disease (AD) and is responsible for the accumulation of its disease-specific Tau-protein and beta-amyloid plaques."],
    "33977208": ["Here, we explain how vascular dysfunction mechanistically contributes to thrombosis as well as inflammation and neurodegeneration in AD pathogenesis."],
    "34023945": ["Chronic exposure to metals like aluminium and copper causes accumulation of Abeta plaques, promotes oxidative stress, neuro-inflammation, and degeneration of cholinergic neurons results in AD-like symptoms."],
    "34025357": ["Recent studies have shown that inflammation plays early and perhaps causal roles in the pathogenesis of AD related to NVU damage, possibly in part by overactivating the aspartic acid protease activity of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1), which until now has almost solely been studied in the context of the beta-amyloid cascade."],
    "34032945": ["BACKGROUND: Numerous studies have indicated the role of inflammation in the pathogenesis of Alzheimer's disease (AD)."],
    "34245502": ["It was noted, that the capacities of the tenuigenin to decrease the secretion of beta amyloid and to protect of neurons from damage by already made beta ameloids, to inhibit the processes of the tau proteins' hyperphosphorylation and inflammations in microglia, as well as increase the main synaptic transmission can be used by the development of effective therapeutic drugs aimed to reduce the pathogenesis of Alzheimer's disease."],
    "34260075": ["Inflammation plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "34340010": ["Increasing evidence has placed inflammation and immune dysfunction at the center of the pathogenesis of Alzheimer's disease (AD)."],
    "34384901": ["Although the mechanisms are still not fully elucidated, studies have revealed that these highly conserved ncRNAs are important modulators of gene expression, amyloid-beta production, tau phosphorylation, inflammation, synaptic plasticity and neuronal survival, all features considered central to AD pathogenesis."],
    "34403662": ["CONCLUSION: CircLPAR1 promotes Abeta25-35-induced apoptosis, inflammation, and oxidative stress via miR-212-3p/ZNF217 axis, suggesting a new insight into the pathogenesis of AD."],
    "34856902": ["Inflammation in the CNS - understanding various aspects of the pathogenesis of Alzheimer's disease."],
    "35145898": ["Objective: Sustained inflammation, which could be promoted by Abeta aggregation and tau hyperphosphorylation, is a critical player in Alzheimer's disease (AD) pathogenesis."],
    "35327563": ["Using Alzheimer's disease (AD) as the archetype, the pathological findings include the aggregation of Amyloid Beta (Abeta) peptides, mitochondrial dysfunction, synaptic degradation caused by inflammation, elevated reactive oxygen species (ROS), and cerebrovascular dysregulation."],
    "35601620": ["Background: Inflammation and immune dysfunction play significant roles in the pathogenesis of Alzheimer's disease (AD)-related dementia."],
    "36204826": ["Secondly, we outlined key aspects of glial cell-associated inflammation in Alzheimer's disease pathogenesis and provided the latest evidence on the roles of microglia and astrocytes in Alzheimer's disease pathology."],
    "36340795": ["Combining animal pharmacodynamic experiments with network pharmacology analysis, we confirmed the importance of inflammation in pathogenesis of AD, clarified the pharmacodynamic characteristics of QZZD in treating AD, and proved its neuroprotective effects through the regulation of TNFR1-ERK1/2-NF-kappaBp65 signaling pathway, which might provide reference for studies on treatment of AD in the future."],
    "36675125": ["SIRT3 downregulation leads to mitochondrial dysfunction, neuroinflammation, and inflammation, potentially triggering factors of AD pathogenesis."],
    "36982996": ["Evidence suggests that systemic inflammation, dysregulation of the immune response and the resulting neuroinflammation and neurodegeneration play a significant role in AD pathogenesis."],
    "37251647": ["Recent advances highlight that inflammation is critical to Alzheimer Disease (AD) pathogenesis."],
    "37332353": ["Cumulative studies have shown inflammation as one of the main contributors to the pathogenesis of AD, leading to the recognition of a specific role of neuroinflammation synergic with the Abeta and NFTs cascades."],
    "37337817": ["Specifically, we have shown that acrolein, acting as a diffusive factor of secondary injury, is both critical and sufficient in promoting inflammation (TNF-alpha) and Abeta42 aggregation, two known contributors of AD pathogenesis."],
    "38157740": ["It suggests that the therapeutic effect of nervonic acid on AD is likely to be produced by ameliorating inflammation."],
    "8712791": ["Abundant circumstantial evidence implicates inflammation in the pathogenesis of AD."],
    "8892340": ["The present review addresses these issues by showing that 1) inflammatory molecules and mechanisms are uniquely present or significantly elevated in the AD brain, 2) inflammation may be a necessary component of AD pathogenesis, 3) inflammation may be sufficient to cause AD neurodegeneration, and 4) retrospective and direct clinical trials suggest a therapeutic benefit of conventional antiinflammatory medications in slowing the progress or even delaying the onset of AD."],
    "8892348": ["Recent evidence suggests that inflammation in the central nervous system plays an important role in the pathogenesis of Alzheimer's disease."],
    "8996832": ["Largely this review presents current opinions which support the concept that inflammation and similar immune mechanisms need to be considered as participating in AD pathogenesis."],
    "9545438": ["The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer's disease."],
    "9550286": ["It has been suggested that inflammation may be a possible cause of Alzheimer's disease (AD)."],
    "9651139": ["Several converging lines of evidence suggest that beta-amyloid and inflammation may be linked in the pathogenesis of Alzheimer disease (AD), but the mechanism of beta-amyloid neurotoxicity is unclear."],
    "16262633": ["Abnormal hyperphosphorylation of tau is believed to lead to neurofibrillary degeneration in Alzheimer's disease (AD) and other tauopathies."],
    "16953147": ["Hence, the abnormal hyperphosphorylation of tau appears to be critical to the pathogenesis of AD."],
    "17044033": ["The degradation of aberrantly phosphorylated tau in neurons plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "17077307": ["These studies describe a novel mechanism for MPTP neurotoxicity, namely a MPTP-inducible, strictly alpha-Syn-dependent, increased formation of PHF-1-reactive Tau, suggesting convergent overlapping pathways in the genesis of clinically divergent diseases such as AD and PD."],
    "17361031": ["The positive correlation trend in MCI and the robust correlation in AD between Pin1 activity and phosphorylated tau implies that increasing phosphorylated tau during AD pathogenesis may induce the compensatory activation/up-regulation of Pin1, while the inverse correlation between Pin1 activity and phosphorylated tau in NCI group implies that decreased Pin1 may play a role in the initial accumulation of phosphorylated tau in AD pathogenesis."],
    "17562708": ["A combination of casein kinase 1delta and glycogen synthase kinase-3beta activities could account for over three-quarters of the serine/threonine phosphorylation sites identified in PHF-tau, indicating that casein kinase 1delta may have a role, together with glycogen synthase kinase-3beta, in the pathogenesis of Alzheimer disease."],
    "18583940": ["An altered tau produces cytoskeleton pathology resulting in neurodegenerative diseases such as Alzheimer's disease and tauopathies."],
    "18690834": ["Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies."],
    "19742193": ["The mismetabolism of APP and the defective clearance of beta amyloid generate a cascade of events including hyperphosphorylated tau (tau) mediated breakdown of microtubular assembly and resultant synaptic failure which results in AD."],
    "20422200": ["Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons."],
    "20683187": ["Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings."],
    "20926667": ["Our results strongly support a convergent role for PS and tau in axonal transport and neuronal survival and function and implicate their misregulation as a contributor to AD pathogenesis."],
    "21348938": ["However, given the increasing evidence that pathological forms of tau can compromise neuronal function and that tau is likely an important mediator of Abeta toxicity, there is a growing awareness that tau is a central player in AD pathogenesis."],
    "22401494": ["The misfolding and aggregation of the intrinsically disordered, microtubule-associated tau protein into neurofibrillary tangles is implicated in the pathogenesis of Alzheimer's disease."],
    "22922102": ["Tau, a microtubule-associated protein and substrate for GSK3beta, has been implicated in the pathogenesis of tauopathies such as Alzheimer's disease."],
    "23052602": ["The cerebrospinal fluid (CSF) biomarker profile in Alzheimer's disease (AD) is characterized by decreased beta amyloid (Abeta(1-42)), increased total and hyperphosphorylated tau (t-tau and p-tau, respectively), which is a useful diagnostic tool and gives insight in the pathogenesis of AD."],
    "23517246": ["Both pro-aggregant Tau variants cause Alzheimer-like features, including synapse loss, mis-localization of Tau into the somatodendritic compartment, conformational changes and hyperphosphorylation."],
    "23904623": ["Tau, a microtubule-associated protein, is implicated in the pathogenesis of Alzheimer's Disease (AD) in regard to both neurofibrillary tangle formation and neuronal network hyperexcitability."],
    "24027553": ["Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease."],
    "24076336": ["A role for tau at the synapse in Alzheimer's disease pathogenesis.", "Understanding the role of tau in both normal and degenerating synapses is crucial for the development of therapeutic strategies designed to ameliorate synapse loss and prevent AD pathogenesis."],
    "24493463": ["Therefore, Abeta is upstream of tau in AD pathogenesis and triggers the conversion of tau from a normal to a toxic state, but there is also evidence that toxic tau enhances Abeta toxicity via a feedback loop.", "Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis."],
    "24785461": ["Heat shock protein 90 (Hsp90alpha) is a molecular chaperone which was found to regulate the function of number of client proteins including tau that is involved in the cause of the AD."],
    "25442111": ["The interaction of amyloid-beta (Abeta) and tau in the pathogenesis of Alzheimer's disease is a subject of intense inquiry, with the bulk of evidence indicating that changes in tau are downstream of Abeta."],
    "26563932": ["Accumulation of beta-amyloid (Abeta) and phosphorylated tau in the brain are central events underlying Alzheimer's disease (AD) pathogenesis."],
    "26943044": ["Our findings reveal a novel mechanism underlying the htau-induced neuronal toxicities in AD and other tauopathies."],
    "27034421": ["According to published research, the inverted tau concentration gradient may be one of the reasons leading to AD."],
    "27152883": ["Tau is a microtubule-associated protein implicated in the pathogenesis of Alzheimer's disease and other related tauopathies."],
    "27651066": ["Tau is a microtubule-associated protein that plays an important role in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease."],
    "28186985": ["Hyperphosphorylation of Tau forming neurofibrillary tangles has been considered as a crucial event in the pathogenesis of Alzheimer's disease (AD)."],
    "28420695": ["Cyclin-dependent kinase 5 (Cdk5), which binds to and is activated by p35, phosphorylates multiple substrates and plays an essential role in the development and function of the CNS; however, proteolytic production of p25 from p35 under stress conditions leads to the inappropriate activation of Cdk5 and contributes to hyperphosphorylation of tau and other substrates that are related to the pathogenesis of Alzheimer's disease."],
    "28580182": ["There is growing evidence that in addition to Abeta deposition, accumulation of hyperphosphorylated oligomeric tau contributes significantly to AD etiology."],
    "28655349": ["BACKGROUND: Finding ways to reverse or prevent the consequences of pathogenic tau in the brain is of considerable importance for treatment of Alzheimer's disease and other tauopathies."],
    "29237931": ["OBJECTIVE: To review recent research advances on tau, a major player in Alzheimer's disease (AD) pathogenesis, a biomarker for AD onset, and potential target for AD therapy."],
    "29278891": ["We investigated the CSF levels of Abeta and tau, another pathological hallmark in the AD pathogenesis."],
    "29554190": ["Conclusions and Relevance: Alzheimer disease CSF core biomarkers can be used with high specificity for the in vivo identification of patients with pure FTLD-TDP and FTLD-tau when accounting for comorbid AD and genetic status."],
    "29782836": ["Structural studies show interaction modes of Hsp90 with the intrinsically disordered Alzheimer's disease-causing protein Tau, the kinase Cdk4 in a partially unfolded state and the folded ligand-binding domain of a steroid receptor."],
    "29954063": ["However, the roles of A&beta; and Tau in AD pathology are being questioned and other causes of AD are postulated."],
    "30278184": ["These findings have implications for further studies of tau under the conditions of protein phosphatase downregulation, aiming to explain mechanisms involved in early events leading to AD."],
    "30382187": ["Here we show that the fragments of delta-secretase-cleavage, APP (586-695) and Tau(1-368), additively drive AD pathogenesis and cognitive dysfunctions."],
    "30744518": ["Given that accumulation of hyperphosphorylated MAPT contributes to the pathogenesis of Alzheimer disease and other tauopathies, decreasing endogenous MAPT levels has been shown to be beneficial to neuronal health in models of these diseases."],
    "30864847": ["Recent studies imply that sleep-wake cycles affect brain tau more significantly than Abeta levels, leading to accelerated AD progression and cognitive decline."],
    "31016584": ["As the HIV-infected population is aging, it is becoming increasingly important to understand how HIV-Tat may interact with proteins such as amyloid beta and Tau which accumulate in the aging brain and eventually result in Alzheimer's disease."],
    "31308793": ["Mitochondrial dysfunction is also a prominent feature in AD, and the extracellular Abeta and phosphorylated tau result in the impaired mitochondrial dynamics."],
    "31796124": ["These findings shed light on early PTM changes of tau during AD pathogenesis in human brains."],
    "7532213": ["Several PDPKs can phosphorylate tau in vitro and induce Alzheimer-like epitopes to many phosphorylation-dependent antibodies."],
    "7533559": ["These results suggest that abnormal phosphorylation at Ser-202 of PHF-tau in DNs represents one of the earliest neuropathological changes within the neurites of vulnerable neurons and may have a pivotal role in the initial pathogenesis of AD."],
    "7566354": ["It is unclear whether levels of nuclear tau can be correlated to pathologic events in AD, but its insoluble nature along with reports of intranuclear PHFs warrant further studies of nuclear tau as a molecular candidate in the genesis of AD."],
    "7891887": ["Isoform-specific interactions of apoE with the microtubule-associated proteins MAP2c and tau might affect intracellular maintenance of microtubules and could contribute to a time-dependent pathogenesis of Alzheimer's disease."],
    "8764598": ["The ability of GSK-3beta to phosphorylate APPcyt and tau provides a putative link between the two lesions and indicates a critical role of GSK-3beta in the pathogenesis of Alzheimer's disease."],
    "10037473": ["Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene."],
    "10352866": ["While the discovery of three rare genetic mutations that can cause AD has provided much information about the causes and progression of the disease, a great deal of attention has been focused on apolipoprotein (ApoE) because of its involvement in the more common, later onset form of AD."],
    "10381410": ["Familial forms of Alzheimer's disease are caused by mutations in the genes encoding the presenilins, which are integral membrane proteins."],
    "10448055": ["Mutations in the presenilin 1 (PSEN1) gene are an important cause of autosomal dominant Alzheimer's disease (AD)."],
    "10518543": ["Absence of PS2 does not detectably alter processing of amyloid precursor protein and has little or no effect on physiologically important apoptotic processes, indicating that Alzheimer's disease-causing mutations in PS2, as in PS1, result in gain of function."],
    "10526115": ["Although dietary restriction (DR) can increase lifespan and reduce the incidence of several age-related diseases in rodents, the possibility that DR can modify the pathogenic actions of mutations that cause AD has not been examined.", "Some cases of AD are caused by mutations in presenilin-1 (PS1), an integral membrane protein located in the endoplasmic reticulum."],
    "10624576": ["A hypothesis and model are suggested to explain the interaction between evolutionary, ontogenetic, and epigenetic factors of the development of the central nervous system and the products of genes whose mutations result in AD."],
    "10662826": ["Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene."],
    "10671319": ["The contribution of mutations in the amyloid precursor protein (APP) gene known as Flemish (APP/A692G) and Dutch (APP/E693Q) to the pathogenesis of Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis of the Dutch type, respectively, was studied in transgenic mice that overexpress the mutant APP in brain."],
    "10764737": ["Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene."],
    "10891589": ["Mutations in the presenilin 1 gene have been shown to result in Alzheimer's disease."],
    "10951459": ["Rare forms of autosomal-dominant AD are caused by mutations in the APP and presenilin genes (PS-1 and PS-2)."],
    "11193801": ["The genetics, however, favor a disease process revolving around the APs, principally because mutations in the amyloid precursor protein (A beta PP) are sufficient to cause AD."],
    "11300728": ["Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene."],
    "11321043": ["For example, mutations in the amyloid precursor protein and presenilin genes can cause Alzheimer's disease, while head injury is a risk factor for both Alzheimer's and Parkinson's diseases."],
    "11398010": ["This review is devoted to the relationships between phenotype and genotype of the autosomal dominant forms of Alzheimer's disease caused by mutations of presenilins (PSs) and amyloid precursor protein (APP) genes."],
    "11406330": ["Presenilin 1 mutations are the major cause of autosomal dominant Alzheimer's disease."],
    "11447832": ["Some cases of AD are caused by mutations in the genes encoding presenilin 1 (PS1)."],
    "11466028": ["LOMEDS apparently shares features with myoclonic epilepsy in Alzheimer's disease (AD) and Unverricht-Lundborg disease (ULD) caused by a mutation on chromosome 21."],
    "11684347": ["Presenilin 1 mutations are the major cause of autosomal dominant Alzheimer's disease: here we identify a new missense mutation causing a methionine to valine change at codon 233."],
    "11695101": ["A very small percentage (less than 5%) of all cases of Alzheimer's disease are autosomal dominant inherited and caused by a mutation in the presenilin protein (PS)."],
    "11714100": ["Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease."],
    "11816793": ["Mutations in the presenilins cause Alzheimer's disease (AD) and alter gamma-secretase activity to increase the production of the 42-residue amyloid-beta peptide (Abeta) found disproportionally in the cerebral plaques that characterize the disease."],
    "11851296": ["Mutations in the PS-1 gene at chromosome 14 are by far the most frequent genetic cause of AD."],
    "11876645": ["AD-causing mutations in PS1 and PS2 did not alter de novo generation of PS fragments.", "AD-causing mutations in PS1 and PS2 result in a selective and significant increase in production of the more amyloidogenic Abeta42 peptide."],
    "12068009": ["Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation."],
    "12125371": ["Involvement of superoxide in pathogenic action of mutations that cause Alzheimer's disease."],
    "12185765": ["LOMEDS apparently shares features with myoclonic epilepsy in Alzheimer's disease (AD) and Unverricht-Lundborg disease (ULD) caused by a mutation on chromosome 21."],
    "12230303": ["Some cases of AD are caused by mutations in presenilin-1 (PS1), and it has been shown that PS1 mutations perturb neuronal calcium homeostasis, promote increased production of amyloid beta-peptide (Abeta), and render neurons vulnerable to synaptic dysfunction, excitotoxicity, and apoptosis."],
    "12402229": ["All mutations that known to cause AD are related to an increase production of beta amyloid."],
    "12527416": ["Abnormalities in calcium homeostasis also occur in fibroblasts from Alzheimer's disease (AD) patients and in cells bearing mutations that lead to AD."],
    "12876480": ["These findings provide novel evidence implicating genetic enzymatic alterations of homocysteine metabolic pathways in the pathogenesis of AD."],
    "1303172": ["These data suggest that mutations in APP are a rare cause of familial early onset AD (3/21 families tested) and that within APP most, possibly all, mutations which cause AD are in exon 17."],
    "1365885": ["Despite their rarity, these mutations are important because they represent the first known cause of Alzheimer's disease."],
    "14563691": ["We demonstrate that bradykinin (BK) B2 receptor activation leads to selective Ser phosphorylation of tau in skin fibroblasts from persons who have or will develop AD due to Presenilin 1 mutations or Trisomy 21, but not in skin fibroblasts from normal individuals at any age."],
    "14566063": ["At least some Alzheimer's disease-causing PS mutations reside in proteins possessing low catalytic activity."],
    "15094078": ["(1) In a minority of about 5% or less of all cases, Alzheimer disease is due to mutations of three genes, resulting in the permanent generation of betaA4."],
    "15639313": ["These normal age-related glial changes, likely a response to the normal wear and tear of the aging process, raise the threshold of glial activation and thus may explain the fact that even genetically determined Alzheimer's disease, resulting from genetic mutations such as those in beta-amyloid precursor protein and presenilins or from genetic duplication such as of chromosome 21, only shows the full manifestation of the disease decades after birth."],
    "15722417": ["An aggressive Alzheimer-causing mutation in PS1 strongly reduced photolabeling by a transition-state analogue but not by helical peptides, providing biochemical evidence that the pathological effect of this PS mutation is due to alteration of the active-site topography."],
    "15834426": ["Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production.", "The elevations in Abeta42 by these compounds are comparable to the increases in Abeta42 induced by Alzheimer disease-causing mutations in the genes encoding amyloid beta protein precursor and presenilins, raising the possibility that exogenous compounds or naturally occurring isoprenoids might increase Abeta42 production in humans."],
    "15989638": ["While driving an ever increasing research effort related to the production, deposition and clearance of Abeta peptides, these mutations account for less than 10% of the AD cases reported, indicating that other causative factors, both genetic and environmental, may contribute to the pathophysiology of AD unrelated to familial cohorts."],
    "15992373": ["Concordantly, presenilin-1 mutations that result in Alzheimer's disease also decrease the release of CTFgamma."],
    "16407539": ["Autosomal-dominant, familial forms of AD (FAD) are caused by mutations in genes encoding amyloid precursor protein, presenilin-1 (PS1), and presenilin 2."],
    "16478768": ["Investigation of R406W tau mutation may provide insight into such abnormal tau hyperphosphorylation, since this mutation causes AD-like dementia and tauopathy in humans and because it has the unique ability to reduce tau phosphorylation in vitro and in cultured cells."],
    "1671712": ["This suggests that some cases of AD could be caused by mutations in the APP gene."],
    "16805926": ["Persons known to be at 50% risk for young-onset AD due to presenilin-1 (PSEN1) mutations provide the opportunity to assess which measures on the Mini-mental State Examination (MMSE) are most sensitive to these early changes."],
    "16873960": ["In terms of mitochondria and Alzheimer's, altered function could reflect intrinsic properties of this organelle, potentially due to mutations in mitochondrial DNA, or extrinsic changes secondary to signal transduction mechanisms activated in the cytosol."],
    "16917905": ["Since the first report showing that Alzheimer disease (AD) might be caused by mutations in the amyloid precursor protein gene (APP), 20 different missense mutations have been reported."],
    "16941492": ["Biological effects of four PSEN1 gene mutations causing Alzheimer disease with spastic paraparesis and cotton wool plaques."],
    "17114823": ["Thus, adverse effects of a mutation that causes AD on immune function that involves perturbed calcium regulation and cytokine signaling in lymphocytes, and associated sensitivity of lymphocytes to apoptosis are demonstrated."],
    "17344096": ["Mutations in amyloid precursor protein (APP), tau and apolipoprotein E4 (ApoE4) lead to Alzheimer's disease (AD) or related pathologies."],
    "17366635": ["Our results also suggest that PSEN1 mutations can cause AD with a large range in age of onset, spanning both early- and late-onset AD."],
    "17514900": ["First, genes with mutations causing Alzheimer's Disease (presenilin genes PSI, PS2 and APP) or bearing a risk factor polymorphism (ApoE) for Alzheimer's Disease were described."],
    "17947293": ["The majority of familial Alzheimer's disease (AD) cases are caused by mutations in presenilins, therefore, identifying regulators of presenilins is crucial for understanding AD pathogenesis."],
    "18369390": ["Mutations in three genes (APP, PSEN1, and PSEN2) have been found to cause AD and APOE4 allele increases the risk of the disease."],
    "18675468": ["AD-causing mutations in the beta-amyloid precursor protein and presenilins can compromise these normal proteins in the plasma membrane and endoplasmic reticulum, respectively."],
    "18694898": ["These genetic changes have been proposed to cause AD by elevating levels of amyloid-beta peptides (Abeta), which are thought to be neurotoxic."],
    "18727676": ["BACKGROUND: Mutations in the Presenilin 2 gene (PSEN2) are rare causes of Alzheimer's disease (AD)."],
    "18852354": ["BACKGROUND: Deposits of abnormally hyperphosphorylated tau are a hallmark of several dementias, including Alzheimer disease (AD), and about 10% of familial frontotemporal dementia (FTD) cases are caused by mutations in the tau gene."],
    "1900373": ["Mutation identified as a possible cause of Alzheimer's disease."],
    "19363265": ["Mutations in the amyloid-beta protein precursor (AbetaPP) gene can cause autosomal dominant early-onset Alzheimer's disease, or Alzheimer's disease (AD) associated with cerebral amyloid angiopathy (CAA), cerebral hemorrhage, or both."],
    "19625741": ["Mutations in the progranulin gene (GRN), causative for Frontotemporal Lobar Degeneration with ubiquitin-immunoreactive neuronal inclusions (FTLD-U), could also be associated with Alzheimer's disease (AD)."],
    "19823103": ["Mutations in ALDH genes are the molecular basis of several disease states (e.g. Sjogren-Larsson syndrome, pyridoxine-dependent seizures, and type II hyperprolinemia) and may contribute to the etiology of complex diseases such as cancer and Alzheimer's disease."],
    "19924286": ["Production of longer forms of the Abeta peptide occur in patients with autosomal dominant Alzheimer disease (AD) due to mutations in presenilin."],
    "19932144": ["Presenilin 1 (PS1) is the catalytic subunit of gamma-secretase and PS1 mutations cause Alzheimer's disease, spastic paraplegia and spinal cord atrophy."],
    "20173332": ["Mutations in several causative genes have been linked to monogenic forms of Alzheimer's disease (AD) or Parkinson's disease (PD)."],
    "20452980": ["Mutations in the amyloid beta-protein (Abeta) precursor gene cause autosomal dominant Alzheimer disease in a number of kindreds."],
    "20461595": ["The series of mutations that cause brain cells to spontaneously and randomly die leading to Alzheimer's disease (AD) is modelled."],
    "20523046": ["RESULTS: In 1 family, this mutation was responsible for AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far.", "BACKGROUND/AIMS: Mutations in the amyloid precursor protein gene were the first to be recognized as a cause of Alzheimer's disease (AD)."],
    "20655969": ["Probably the most important target groups for novel treatments are carriers of mutations causing AD, and individuals with minor cognitive impairment representing a pre-dementia stage of the disease."],
    "20678067": ["Only a small proportion of AD is due to mutations in the genome of patients, the large majority of cases being of late onset and sporadic in origin."],
    "20858971": ["In conclusion, anesthetic gases induce changes which may reproduce AD pathology in mice with mutations which produced AD."],
    "21318527": ["More than 40 AD-causing mutations have been identified in PS1, whereas only two mutations have been identified in PS2."],
    "21368062": ["Currently, it is unclear whether mutations in the beta-amyloid precursor protein (APP) and tau are sufficient to cause similar, AD-like attention deficits in mouse models of the disease."],
    "21482412": ["APP sumoylation modulates Abeta peptide levels, suggesting a potential role in Alzheimer's disease, and decreased lamin A sumoylation due to mutations near its SUMO site has been implicated in causing some forms of familial dilated cardiomyopathy."],
    "21501974": ["Mutations in the presenilin-1 gene (PSEN1) on chromosome 14 are the most common cause of autosomal dominant Alzheimer's disease (AD), with around 180 mutations described to date."],
    "21919498": ["Dissociation between the processivity and total activity of gamma-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations."],
    "21971471": ["In one trial, we propose to study AD-causing presenilin 1 [PS1] mutation carriers from the world's largest early-onset AD kindred in Antioquia, Colombia, close to their estimated average age at clinical onset."],
    "22122678": ["Twenty years of Alzheimer's disease-causing mutations."],
    "22153900": ["Mutations in 3 genes (APP, PSEN1, and PSEN2) are known to cause AD, but a large number of familial cases do not harbor mutations in these genes and several unidentified genes that contain disease-causing mutations are thought to exist."],
    "22297172": ["Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells."],
    "22307680": ["There are several familial forms of Alzheimer's disease (AD) most of which             are caused by mutations in the genes that encode the presenilin enzymes involved             in the production of amyloid-beta (Abeta) from the amyloid precursor protein (APP)."],
    "22749011": ["Therefore, NHPs are appropriate models for the study of human diseases, such as neurodegenerative diseases including Parkinson's, Alzheimer's and Huntington's diseases, which occur as a result of genetic mutations."],
    "22944690": ["A competing hypothesis is that the mutations cause AD through a loss of function, by reducing gamma-secretase activity.", "One hypothesis is that these mutations cause AD through a toxic gain of function, changing gamma-secretase activity to increase the proportion of 42-residue Abeta over the more soluble 40-residue form."],
    "23327526": ["In the past 25 years, autosomal dominant forms of AD were found to be primariy attributable to mutations in one of two presenilins, polytopic proteins that contain the catalytic site of the gamma-secretase protease that releases the amyloid beta (Abeta) peptide."],
    "23579031": ["Most of the genes whose mutation leads to AD are involved in synaptic plasticity."],
    "23649480": ["Mutations in the APP gene identified in early-onset AD patients are believed to cause AD."],
    "23761040": ["Autosomal dominant AD (ADAD) caused by mutations in the presenilin (PSEN) gene have been postulated to result from increased production of Abeta42 compared to Abeta40 in the central nervous system (CNS)."],
    "24029002": ["Mutations in PS lead to Alzheimer's disease (AD) by altering gamma-secretase activity to generate pathologic amyloid beta and amyloid plaques in the brain."],
    "24099007": ["The crystal structure also provides a platform for the formulation of specific hypotheses regarding substrate interaction and catalysis as well as the pathogenic mechanism of Alzheimer-causing presenilin mutations."],
    "24409422": ["While the rare early-onset form of AD is due to autosomal dominant genetic mutations, the etiology and pathophysiology of age-dependent, late-onset AD is more complex."],
    "24704512": ["Genetically, AD is caused by a mutation in one of at least 3 genes: presenilin 1 (PS1), presenilin 2 (PS2) and the amyloid precursor protein (APP)."],
    "24773620": ["U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21."],
    "25069482": ["IMPORTANCE: Autosomal dominant Alzheimer disease (ADAD) is caused by rare genetic mutations in 3 specific genes in contrast to late-onset Alzheimer disease (LOAD), which has a more polygenetic risk profile."],
    "25239621": ["The question of whether these mutations result in AD through a gain or a loss of function remains highly controversial.", "Kinetic analysis of five different AD-causing mutations in presenilin-1 revealed that all result in drastic reduction of normal carboxypeptidase function."],
    "2602419": ["It is likely that these Volga German kindreds carry the same genetic mutation leading to Alzheimer's disease; and thus, they are a valuable resource for genetic investigations of AD."],
    "26108876": ["Alzheimer's disease that is caused by mutations in the genes for presenilin 1, presenilin 2 and amyloid precursor protein has an onset under the age of 65 years in most cases."],
    "26146489": ["The reasons for these failures will be discussed, along with recent findings on the mechanism of gamma-secretase and of Alzheimer-causing mutations that may suggest new strategies for targeting this enzyme."],
    "26282939": ["Recent evidence suggests that the development of Alzheimer's disease (AD) and related cognitive loss is due to mutations in the Amyloid Precursor Protein (APP) gene on chromosome 21 and increased activation of eukaryotic translation initiation factor-2alpha (eIF2alpha) phosphorylation."],
    "26350633": ["Presenilin 1 (PSEN1) mutations are the major cause of autosomal dominant Alzheimer's disease (ADAD)."],
    "26756738": ["Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease."],
    "26852951": ["There is no molecular explanation for the many presenilin 1 (PSEN1) mutations causing Alzheimer's disease, but both gain of function relating to amyloid production and loss of isolated PSEN1 function have been implied."],
    "26925509": ["Autosomal dominant Alzheimer's disease (AD) is caused by mutations in amyloid precursor protein, presenilin 1 (PSEN1), and presenilin 2 genes and is mostly associated with early-onset form of AD (EOAD), whereas very few mutations were also found in late-onset AD (LOAD) cases."],
    "27313629": ["While only a few familial AD cases are due to mutations in three causative genes (APP, PSEN1, and PSEN2), the ultimate cause behind the rest of the cases, called sporadic AD, remains unknown."],
    "27325702": ["The amyloid precursor protein (APP), whose mutations cause Alzheimer disease, plays an important in vivo role and facilitates transmitter release."],
    "27498054": ["Presenilin 1 (PSEN1) mutations are the main cause of monogenic Alzheimer's disease."],
    "27557896": ["Mutations in the amyloid precursor protein (APP) may be causative or protective of AD."],
    "28054745": ["The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the \\amyloid cascade hypothesis\\."],
    "28103467": ["Alzheimer disease may be caused by mutations in PSEN1, PSEN2 and APP."],
    "28181072": ["Detailed analysis of these changes in animal and cell models of the AD-causing presenilin mutations reveal robust changes in ryanodine receptors, inositol tris-phosphate receptors, calcium leak channels and store activated calcium entry."],
    "28495961": ["Mutations in the Presenilin genes are the major genetic cause of Alzheimer's disease."],
    "28739993": ["The identification of mutations in APP, PSEN1, and PSEN2 causative for autosomal dominant AD (ADAD) has provided the basis of the \\amyloid cascade\\ hypothesis of the pathogenetic mechanism of AD."],
    "28753424": ["Alzheimer's-Causing Mutations Shift Abeta Length by Destabilizing gamma-Secretase-Abetan Interactions."],
    "28841371": ["gamma-Secretase produces beta-amyloid (Abeta) within its presenilin (PS1) subunit, mutations in which cause Alzheimer's disease, and current therapies thus seek to modulate its activity."],
    "28898051": ["Although sporadic AD is the common form of AD, 2-3% of the AD cases are expected to be due to mutations in the beta region of the amyloid precursor protein, which is referred to as autosomal dominant AD (ADAD)."],
    "29103038": ["Besides familial mutations on the AbetaPP gene, or upon its overexpression, familial forms of AD are often caused by mutations or deletions in presenilin 1 (PSEN1) and 2 (PSEN2) genes: the catalytic components of the proteolytic enzyme gamma-secretase (GS)."],
    "29182052": ["Finally, we apply the proposed methodology to the data of several biomarkers collected by the Dominantly Inherited Alzheimer Network, an international family-clustered registry to study autosomal dominant Alzheimer disease which is a rare form of Alzheimer disease caused by mutations in any of the three genes including the amyloid precursor protein, presenilin 1 and presenilin 2."],
    "29440563": ["CONCLUSIONS: Tau PET shows higher magnitude of binding in MAPT mutation carriers who harbor mutations that are more likely to produce AD-like tau pathology (e.g., in our series, the non-exon 10 families tend to accumulate mixed 3R/4R aggregates)."],
    "29494861": ["Individuals with fully penetrant genetic mutations causing autosomal dominant Alzheimer's disease (ADAD) are essentially certain to develop the disease, providing a unique opportunity to examine biomarkers during the preclinical stage."],
    "29670961": ["Here we present the high pressure NMR characterization of Abeta42 and two Abeta40 variants with Alzheimer-causing mutations E22G and D23N."],
    "29857474": ["The presenilin 1 gene harbors the largest number of AD-causing mutations resulting in the late onset familial form of AD."],
    "29915376": ["A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling."],
    "30021643": ["Mutations in amyloid-beta precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the pathogenic cause of autosomal dominant AD (ADAD)."],
    "30040714": ["OBJECTIVE: We tested whether a theoretically driven three-factor structure would characterize cognitive functioning in individuals who are genetically-determined to develop AD due to a mutation in Presenilin-1 (PSEN1) gene."],
    "30510423": ["Mutations in the amyloid precursor protein (APP) gene were the first to be recognized as the cause of AD."],
    "30626721": ["Alzheimer's-causing mutations in presenilin altered the Abeta42/40 peptide ratio generated by the HMW beta/gamma-secretase complex indistinguishably from that observed in whole cells."],
    "30904577": ["Although the cause of AD is still unknown, a minor percentage of AD cases are produced by genetic mutations in the presenilin-1 (PSEN1) gene."],
    "31109937": ["AD-causing mutations destabilize GSEC-APP/Abetan interactions and thus enhance the production of longer Abetas, which elicit neurotoxic events underlying pathogenesis."],
    "31135820": ["Approximately 3% of EOAD cases carried known AD-causing mutations."],
    "31198028": ["Two new reports of structures of gamma-secretase bound to membrane protein substrates provide great insight into the nature of substrate recognition and how Alzheimer's disease-causing mutations in presenilin might alter substrate binding and processing."],
    "31295475": ["Recent findings addressing substrate recognition and processing will be discussed, including the role of protease subunit nicastrin as a gatekeeper, the effects of Alzheimer-causing mutations in presenilin on processive proteolysis of APP, and evidence that three pockets in the active site (S1', S2', and S3') determine carboxypeptidase cleavage of substrate in intervals of three residues."],
    "31578030": ["APP gene mutations causing Alzheimer disease (AD) segregate in an autosomal dominant pattern."],
    "31697913": ["Computational analysis of Alzheimer-causing mutations in amyloid precursor protein and presenilin 1."],
    "31699328": ["The study of rare genetic mutations that cause FAD should provide insight into the pathogenesis of sporadic Alzheimer's disease."],
    "32216003": ["CONCLUSIONS: Taken together, we have established and characterized the pathological features of an AD patient carrying PS1-S170F mutation using iPSC technology, which will be the first case on this mutation and this iPSC line will serve as a useful resource for studying AD pathogenesis and drug screening in the future."],
    "32241222": ["Mutations in the presenilin-1 gene (PSEN1) on chromosome 14 are the most common cause of autosomal dominant Alzheimer's disease (ADAD), which has a broad clinical phenotype, encompassing not only dementia but a variety of other neurological features."],
    "32894632": ["Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation.BACKGROUND: Mutations in the PSEN1 gene are the most common cause of autosomal-dominant Alzheimer's disease and have been associated with the earliest disease onset."],
    "32925067": ["Individuals with autosomal dominant AD due to a mutation (E280A) in Presenilin-1 (PSEN1) are genetically determined to develop early-onset dementia and thus, have few age-related risk factors for AD that are known to vary by sex (i.e., cardiovascular disease, menopause, life expectancy)."],
    "32954172": ["Impact of Mutations on the Conformational Transition from alpha-Helix to beta-Sheet Structures in Arctic-Type Abeta     40      : Insights from Molecular Dynamics Simulations.The amyloid-beta (Abeta) protein aggregation into toxic oligomers and fibrils has been recognized as a key player in the pathogenesis of Alzheimer's disease."],
    "32966331": ["Familial forms of Alzheimer's disease (AD) are caused by mutations in the presenilin genes or in the gene encoding for the amyloid precursor protein (APP)."],
    "33188256": ["Mutations in PSEN1, PSEN2, or APP genes are known to be causative for autosomal dominant Alzheimer's disease (ADAD)."],
    "33218200": ["Genetic mutations, smoking, and several other factors have been reported as causes of AD, but alterations in glycans have recently been demonstrated to play a role in AD."],
    "33255694": ["These diseases include frontotemporal dementia (FTD) and Alzheimer's disease (AD) and can be sporadic or inherited when caused by mutations in the    MAPT     gene."],
    "33494218": ["Familial forms of AD (FAD) are caused by mutations in amyloid precursor protein (   APP    ), presenilin 1 (   PSEN1    ) and presenilin 2 (   PSEN2    ) genes."],
    "33965374": ["We validated this interaction in human AD, familial frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) caused by mutations in MAPT (R406W & P301L) and corticobasal degeneration (CBD) postmortem brain tissues as well as human cell lines."],
    "34133918": ["Mutations in the sorting receptor-encoding gene SORL1 cause autosomal-dominant Alzheimer's disease, and SORL1 variants increase risk for late-onset AD."],
    "34207526": ["Mutations in the PSEN1 gene are the most common cause of autosomal dominant Alzheimer's disease, and are characterized by a high phenotype variability."],
    "34725778": ["Another process acting as a regulator of mitochondrial function is mitophagy which is involved in the removal of damaged and non-functional mitochondria however this process is also altered in AD due to mutations in Presenilin1 (PS1) and Amyloid Precursor Protein (APP) gene."],
    "35109404": ["A small proportion of AD is familial, due to mutations in APP, PSEN1, and PSEN2 genes."],
    "35421846": ["Alzheimer's disease (AD) is a common neurodegenerative disease characterized by cognitive decline even leading to incapacity, which prevalence estimates that about 5% of AD cases are caused by mutations in genes such as Presenilin-1 (PSEN1)."],
    "35602652": ["Amyloid-beta deposition is one of the hallmark pathologies in both sporadic Alzheimer's disease and autosomal-dominant Alzheimer's disease, the latter of which is caused by mutations in genes involved in amyloid-beta processing."],
    "35850649": ["Novel PSEN1 (P284S) Mutation Causes Alzheimer's Disease with Cerebellar Amyloid beta-protein deposition."],
    "36139715": ["Familial AD (fAD) is an early onset form of AD caused primarily by mutations in the presenilin-encoding genes."],
    "36503128": ["However, the majority of the Juvenile type of Alzheimer's disease occurs at 50-60 years of age, and is usually induced by genetic mutations, such as amyloid beta, and the presenilin 1 or 2 genes."],
    "36704504": ["Although most cases of AD and PD are sporadic, some are caused by genetic mutations that are inherited."],
    "37024647": ["Rare, autosomal dominant forms of AD occur in middle age as a result of highly penetrant genetic mutations, but the most common form of AD occurs later in life."],
    "37357229": ["Mutations, variant genotypes, or downregulation that reduce amyloid clearance or accelerate amyloid accumulation can lead to Alzheimer's disease."],
    "37919079": ["RESULTS: Most of the mutations in the amyloid precursor protein (APP) can lead to the accumulation of APP oligomers in the brain, leading to AD."],
    "37990912": ["METHOD: The SENAS was administered to 202 older adults from the Los Angeles Latino Eye Study (LALES) and 29 adults with (carriers) or without (non-carriers) mutations causing ADAD."],
    "7584064": ["Here we demonstrate that it is comparatively straightforward to introduce pathogenic mutations into such YACs by the use of the 'pop-in, pop-out' procedure, by inserting an Alzheimer-causing mutation (APP717Val-->lle) into an APP-containing YAC which has previously been used as a transgene."],
    "7697197": ["Familial AD displays genetic and phenotypic heterogeneity, meaning that mutations of different genes may cause the AD phenotype, and that different mutations of the same gene may cause phenotypically distinct disorders, including Alzheimer-type dementia and cerebral amyloid angiopathy with cerebral hemorrhages and stroke."],
    "7761987": ["The location of these mutations immediately suggests that they may cause AD by altering beta APP processing in a way that is amyloidogenic."],
    "7763337": ["In some of these rare families, mutations in the amyloid precursor protein (APP) gene on chromosome 21 are responsible for AD."],
    "7937606": ["Although a mutation of the gene coding for the beta A4 peptide appears to be sufficient to induce (or accelerate) Alzheimer's disease, this is undoubtedly an exceptional mechanism."],
    "8215975": ["Progress in the study of the epidemiology of AD, discovery of multiple AD loci, and interpreting how mutations affect and produce the AD phenotype have been the initial keys to unlocking the mysteries of this disease."],
    "8618867": ["Ways in which mutations in either gene could lead to AD are discussed."],
    "8733749": ["We discuss the distribution of mutations and the proportions of autosomal dominant AD with a mean age of onset below 60 years caused by mutations in this gene."],
    "8867023": ["We conclude that these mutations in the APP gene may be a very rare cause of AD in Eastern Finland and thus most Finnish familial AD will likely be due to other gene defects."],
    "8918895": ["To understand the function of this protein and how mutations lead to AD, it is important to determine which cell types in the brain express this gene."],
    "9052714": ["Transgenic mice carrying AD-causing mutations in APP develop spontaneous age-related beta-amyloid (A beta) deposition and memory impairment."],
    "9117566": ["Brain amyloid deposits play a central role in the histopathology of Alzheimer's disease (AD), as evidenced by increased formation of amyloid beta peptides (A beta) in genetic forms of AD that are caused by mutations in the presenilin genes, or the amyloid beta protein precursor (APP) gene."],
    "9562460": ["Thus, mutations in presenilin genes may enhance the production and deposition of Abeta42 in the brains, thereby leading to Alzheimer's disease."],
    "9623986": ["Except in those rare cases of AD caused by a mutation, levels of secreted A beta are not elevated; thus, the secretory pathway may be unaffected, and factors other than the extracellular concentration of A beta may contribute to the aggregation properties of the peptide."],
    "9667817": ["Mutations on this gene may contribute to pathogenesis of AD."],
    "9674758": ["All mutations known to cause AD increase the production of beta-amyloid peptide."],
    "9678319": ["CONCLUSION: Our results differ from the data from AD due to mutations in presenilin 1 and presenilin 2 genes and the amyloid precursor protein and suggest that the APOE epsilon4 genotype mediates increased Abeta deposition by a mechanism that differs from that found in other genetic causes of AD."],
    "9720489": ["Mutations in PS genes cause autosomal dominant Alzheimer disease, with age of onset frequently in the 40s."],
    "9740395": ["Yet, the physiological function of presenilin 1 and the pathological mechanisms of the mutations leading to Alzheimer's disease are still unknown."],
    "9850912": ["The hypothesis that mild cognitive impairment (MCI) represents an early stage of Alzheimer's disease (AD) was investigated by reviewing recent research from three sources: asymptomatic and symptomatic individuals carrying mutations that cause AD, hospital-samples of non-demented patients with MCI at the initial examination that are followed longitudinally, and community-based incident cases of AD."],
    "9920359": ["Although mutations in the known genes are a rare cause of AD they are useful for the purposes of presymptomatic diagnostics in autosomal dominant AD families that segregate these mutations."],
    "10928742": ["As the previous studies have almost always used the visual modality for presentation, they speculate that auditory presentation, especially of nonverbal material, may be compromised in AD because of neural degeneration in auditory areas in the temporal lobes."],
    "11226152": ["Our results demonstrate that in vivo overexpression of GSK-3beta results in neurodegeneration and suggest that these mice can be used as an animal model to study the relevance of GSK-3beta deregulation to the pathogenesis of Alzheimer's disease."],
    "15036597": ["While many studies have addressed the atherogenic or anti-atherogenic potential of this polymorphism, little is known about its effect on neurodegeneration, despite the fact that CETP is expressed in the brain and the disturbance of cholesterol homeostasis appears to be an important factor in the pathogenesis of Alzheimer's disease (AD)."],
    "15197750": ["The most visible and, until very recently, the only hypothesis regarding the involvement of microglial cells in Alzheimer's disease (AD) pathogenesis is centered around the notion that activated microglia are neurotoxin-producing immune effector cells actively involved in causing the neurodegeneration that is the cause for AD dementia."],
    "15704193": ["To elucidate the involvement of protein citrullination in human neuronal degeneration, we examined whether citrullinated proteins are produced during Alzheimer's disease (AD)."],
    "17017913": ["We will review recent findings in in vitro cell models, in vivo mouse models, and post mortem AD brain tissue in view of the effects of different Abeta peptide species on neurodegeneration during AD pathogenesis."],
    "17197420": ["Based on these and other observations, we propose that partial loss of PS function may underlie memory impairment and neurodegeneration in the pathogenesis of AD."],
    "18067990": ["Elucidation of the events that control the transitions from neuroprotection to neurodegeneration should be a critical point toward elucidation of AD pathogenesis."],
    "18157656": ["Amyloid beta (Abeta) deposition and neurodegeneration are the two related events in the pathogenesis of Alzheimer's disease."],
    "18645613": ["The neuroinflammatory response during the course of Alzheimer's disease (AD) is triggered by the neurodegeneration and the deposition of the beta-amyloid peptide in extracellular plaques."],
    "18648646": ["Analysis of postmortem brain tissue from AD patients can provide information on molecular alterations present at the end of the disease process, but cannot discriminate between changes that are specifically involved in AD versus those that are simply a consequence of neuronal degeneration."],
    "19114068": ["Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease."],
    "19264902": ["Together, these data indicate that UPR activation in AD neurons occurs at an early stage of neurofibrillary degeneration and suggest that the prolonged activation of the UPR is involved in both tau phosphorylation and neurodegeneration in AD pathogenesis."],
    "19373562": ["Here, we will review reports of host and viral factors associated with HAND and place these studies in the context of the data employed to support current theories regarding the molecular and cellular mechanisms that lead to HIV-induced neurodegeneration with additional focus on mechanisms common to AD pathogenesis."],
    "19683527": ["Similar type of intraneuronal Abeta accumulation, which precedes senile plaque formation, may link Abeta to tauopathy and neurodegeneration in Alzheimer's disease pathogenesis."],
    "19685437": ["The most prevalent form of neurodegeneration is Alzheimer's disease(AD) reaching a prevalence of over 30 % above age 80.The question is reviewed whether nutrients may protect or slow down the age associated mental decline due to neuronal degeneration."],
    "19801631": ["Evidence from both in vitro and in vivo studies indicates that increased GSK3beta activity contributes to neurodegeneration and to the pathogenesis of Alzheimer disease."],
    "19903025": ["AD usually shows poor prognosis owing to progressive neuronal degeneration, while depression is basically reversible."],
    "20080301": ["The accumulation of toxic amyloid-beta (Abeta) peptide aggregates in AD brain are thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the 'amyloid hypothesis' of AD etiology in both the familal (FAD) and sporadic forms of the disease."],
    "20594619": ["AD is caused by severe neurodegeneration in the hippocampus and neocortical regions of the brain but the cause of this neuronal loss is unclear."],
    "21371450": ["Apoptosis or programmed cell death has been suggested as an important mode of neurodegeneration in Alzheimer's disease pathogenesis."],
    "21547225": ["Oligomerization, conformational changes, and the consequent neurodegeneration of Alzheimer's beta-amyloid protein (AbetaP) play crucial roles in the pathogenesis of Alzheimer's disease (AD)."],
    "21663966": ["The accumulation of toxic amyloid-beta (Abeta) peptide aggregates in AD brain is thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the 'amyloid hypothesis' of AD etiology in both the familal (FAD) and sporadic forms of the disease."],
    "21786197": ["The accumulation of toxic amyloid-beta (Abeta) peptide aggregates in AD brain is thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the 'amyloid hypothesis' of AD etiology in both the familal (FAD) and sporadic forms of the disease."],
    "22232001": ["With regards to Alzheimer's disease (AD) pathogenesis, it is not yet established whether entangled tau represents a cause or a consequence of neurodegeneration."],
    "22266106": ["The result that APP proteins and specifically their soluble alpha-cleaved ectodomains can protect against progressive neurodegeneration in vivo provides support for the hypothesis that a disruption of the physiological function of APP could play a role in the pathogenesis of Alzheimer's Disease."],
    "22505366": ["The lack of differences between AD and controls may result from a relatively advanced neurodegeneration in AD brains."],
    "23701948": ["We argue that the interaction between the APOE-dependent non-pathological vulnerabilities and age-related pathological changes is one mechanism that can trigger neurodegeneration, resulting in AD and other complex phenotypes."],
    "23783773": ["RATIONALE: Acetylcholinesterase inhibitors (AChEIs) are approved to treat the symptoms of mild to moderate Alzheimer's disease by restoring acetylcholine levels at synapses where the neurotransmitter has been depleted due to neurodegeneration."],
    "24514870": ["We highlight how structural network damage caused by axonal injury might interact with neuroinflammation and neurodegeneration in the pathogenesis of Alzheimer disease and chronic traumatic encephalopathy, which are late complications of TBI."],
    "25399848": ["Neurodegeneration is the progressive loss of neuronal structure and function, which ultimately leads to neurological disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis, and Huntington's disease."],
    "25713139": ["Brain accumulation of neurotoxic amyloid beta (Abeta) peptide because of increased processing of amyloid precursor protein (APP), resulting in loss of synapses and neurodegeneration, is central to the pathogenesis of Alzheimer disease (AD)."],
    "26083882": ["Alzheimer's disease (AD) is a clinical syndrome caused by neurodegeneration and characterized by a progressive deterioration in cognitive ability and capacity for independent living."],
    "26555572": ["Despite recent advances criticized the direct role in neurodegeneration of cortical neurons, Abeta is considered responsible for synaptopathy and impairment of neurotransmission and therefore remains the major trigger of AD and future pharmacological treatment remain Abeta oriented."],
    "26557086": ["Here, we review the emerging evidence regarding the roles of lipid and glucose metabolism in the modulation of beta-amyloid, tau, and neurodegeneration during the pathogenesis of AD."],
    "26880859": ["The anxiety status is changed along with memory impairments in intracerebroventricular colchicine injected rat model of Alzheimer Disease (cAD) due to neurodegeneration, which has been indicated to be mediated by inflammation."],
    "26898910": ["Thus, pSer26Abeta could represent a critical species in the neurodegeneration during AD pathogenesis."],
    "27111252": ["OBJECTIVE: Alzheimer's disease (AD) is the result of neurodegeneration, which manifests clinically as deficits in memory, thinking, and behavior."],
    "27776205": ["Neuroinflammatory mechanisms mediated by activated glial and cytokines (TNF-alpha, IL-1beta) might contribute to neuronal degeneration leading to Alzheimer's (AD) and Parkinson's disease (PD)."],
    "27879212": ["Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease causing neural cell degeneration and brain atrophy and is considered to be the most common form of dementia."],
    "28094792": ["Our in silico analysis, suggesting a novel function for APOE4 at the DNA level, offers a potential mechanism for the observed tissue specific neurodegeneration and the role of environmental factors in Alzheimer's disease etiology."],
    "28157684": ["These results were confirmed in an Alzheimer's disease mouse model, which exhibited increased levels and nuclear localization of Foxo3 in hippocampal neurons, which preceded neurodegeneration and Abeta plaque formation, indicating this phenomenon is an early event in Alzheimer's disease pathogenesis."],
    "28861684": ["Amyloid beta (Abeta) peptide deposition is the primary cause of neurodegeneration in Alzheimer's disease (AD) pathogenesis."],
    "29159058": ["The relationships between beta-amyloid (Abeta), tau and neurodegeneration within Alzheimer's Disease pathogenesis are not fully understood."],
    "30041064": ["Seizures have traditionally been related to neuronal loss in the late stages of AD as a consequence of neurodegeneration, however, recent studies indicated that seizures may contribute to the emergence of AD symptoms in early stages of the disease, mainly in familial AD."],
    "30058479": ["Alzheimer's is an age-related disease with a hallmark of progressive loss of memory formation followed by a damage in the brain function due to the neural degeneration and extracellular beta-amyloid (Abeta) plaques accumulation."],
    "30120962": ["Symptoms of AD worsen over time due to progressive neurodegeneration, requiring institutional care at the later stage and resulting in a heavy burden on patients, caregivers, and the public-health system."],
    "30595042": ["Alzheimer's disease (AD) is considered as a potential risk factor for the development of seizure due to neurodegeneration and imbalance between stimulatory and inhibitory circuits in the brain."],
    "31121578": ["AD results from progressive neurodegeneration leading to dysfunctional synaptic transmission in the brain."],
    "31686097": ["BACKGROUND: The National Institute on Aging and Alzheimer's Association (NIA-AA) have proposed a new Research Framework: Towards a biological definition of Alzheimer's disease, which uses a three-biomarker construct: Abeta-amyloid, tau and neurodegeneration AT(N), to generate a biomarker based definition of Alzheimer's disease."],
    "31689310": ["BACKGROUND AND PURPOSE: The loss of retinal ganglion cells observed in Alzheimer's disease (AD) may be attributable to a neurodegeneration of the neuro-retinal structure."],
    "32143546": ["RECENT ADVANCES: Solid recent evidence clearly suggest that metabolic factors, systemic infections, Microbiota dysbiosis, and oxidative stress are implicated, although at different extent, in the development in brain diseases CRITICAL ISSUE: Here, we reviewed the most solid published evidence supporting the implication of the axis systemic inflammation-neuroinflammation-neurodegeneration in the pathogenesis of AD, VAD, PD and MS, highlighting the possible cause of the putative downstream component of the axis."],
    "32183332": ["Alzheimer's disease is an age-related disease characterized by the progressive loss of memory and cognitive function, caused by the unstoppable neurodegeneration and brain atrophy."],
    "32651317": ["Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3*Tg-AD Model Mice.BACKGROUND: The mesencephalic trigeminal nucleus (Vmes) is not only anatomically adjacent to the locus coeruleus (LC) but is also tightly associated with the function of the LC.", "Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3*Tg-AD Model Mice."],
    "32795415": ["Dysregulated microglia are intimately involved in neurodegeneration, including Alzheimer's disease (AD) pathogenesis, but the mechanisms controlling pathogenic microglial gene expression remain poorly understood."],
    "32813239": ["Neurodegeneration leading to Parkinson's disease (PD) and Alzheimer's disease (AD) has become a major health burden globally."],
    "32903806": ["PARP-1 inhibition may also exert a protective effect against neurodegeneration by its action to diminish neuroinflammation and microglial activation which are also implicated in the pathogenesis of AD."],
    "33180216": ["Failure of this machinery and any alterations during mitochondrial biogenesis underlies neurodegeneration resulting in Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD) etc."],
    "33290860": ["In conclusion, we provide clinical trial evidence to confirm that restoration of BMI1 activity through EVOO administration in MCI patients constitutes a potential therapeutic approach against neurodegeneration leading to AD."],
    "33337366": ["BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia caused by irreversible neurodegeneration, with the onset mechanisms elusive."],
    "33459705": ["In the subgroup of 19 AD and 19 NC with ATN results, AD-RAI results matched completely with ATN classification."],
    "33495355": ["Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease.", "Defining the mechanisms underlying molecular neurodegeneration in the EC is crucial to determining its contributions to the pathogenesis of AD."],
    "33788812": ["OBJECTIVE: Alzheimer disease is characterized by progressive decline in cognitive function due to neurodegeneration induced by accumulation of Abeta and hyperphosphorylated tau protein."],
    "34072862": ["Alzheimer's disease (AD) is a mostly sporadic brain disorder characterized by cognitive decline resulting from selective neurodegeneration in the hippocampus and cerebral cortex whereas Huntington's disease (HD) is a monogenic inherited disorder characterized by motor abnormalities and psychiatric disturbances resulting from selective neurodegeneration in the striatum."],
    "34087544": ["One of the major causes of neurodegeneration in the pathogenesis of Alzheimer's disease is the accumulation of cytotoxic amyloid species within the intercellular compartments of the brain."],
    "34100423": ["Therefore, an imbalance caused by mutations in presenilin 1/gamma-secretase might cause aberrant signaling, synaptic dysfunction, memory impairment, and increased Abeta     42      /Abeta     40       ratio, contributing to neurodegeneration during the initial stages of Alzheimer's disease pathogenesis."],
    "34681867": ["Chronic Rhinosinusitis and Alzheimer's Disease-A Possible Role for the Nasal Microbiome in Causing Neurodegeneration in the Elderly."],
    "35283778": ["The ischemic injury in the brain starts a cascade of events that lead to neuronal death, inducing neurodegeneration which could lead to Alzheimer's disease (AD)."],
    "35346299": ["BACKGROUND: Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer's disease (AD) and is considered to result from neurodegeneration."],
    "36012707": ["Neurodegeneration leading to Alzheimer's disease results from a complex interplay of a variety of processes including misfolding and aggregation of amyloid beta and tau proteins, neuroinflammation or oxidative stress."],
    "36091826": ["Disturbed retinoic acid signaling causes inflammatory responses, mitochondrial impairment, oxidative stress, and neurodegeneration, leading to Alzheimer's disease (AD) progression."],
    "37190116": ["While attention has been focused on neurodegeneration in AD pathogenesis, recent decades have provided evidence of the importance of microglia, and resident immune cells in the central nervous system."],
    "37477796": ["Recent studies have shown that, coupled with other environmental factors, aluminium exposure may lead to neurodegeneration resulting in cognitive impairment resembling Alzheimer's disease."],
    "38020769": ["Autophagy acts as a proteostasis process to remove protein clumps, although it progressively weakens with aging and AD, thus facilitating the accumulation of toxic proteins and causing neurodegeneration."],
    "38542219": ["This model, highlighting microglia as a pivotal player in risk factor-mediated neurodegeneration, offers a new point of view on the complex associations of modifiable risk factors and proteinopathy in AD pathogenesis, which may act in parallel to the thoroughly studied amyloid-driven Tau pathology, and strengthens the therapeutic rationale of combining immune modulation with tight control of risk factor-driven insults."],
    "8423065": ["These results suggest that microglial activation in AD may be secondary to neurodegeneration and that, once activated, microglia may participate in a local inflammatory cascade that promotes tissue damage and contributes to amyloid formation."],
    "8620894": ["Alzheimer's disease is a senile dementia caused by progressive neurodegeneration of the central nervous system."],
    "9223085": ["The association of astrocytes with plaques is a well-established feature of Alzheimer's disease (AD) and has generally been interpreted as a secondary reaction to amyloid deposition or neuronal degeneration."],
    "9514829": ["These findings indicate that nNOS expressing neurons are highly susceptible to neurodegeneration and that nNOS might contribute to the pathogenesis of AD."],
    "9700651": ["Alzheimer's disease entails multiple neuronal systems and results from neuronal cytoskeletal degeneration of only a few types of nerve cells."],
    "10507060": ["Oxidative stress and its sequelae are likely related to both necrotic and apoptotic mechanisms of neurotoxicity, and A beta-associated free radical oxidative stress may be of fundamental importance in Alzheimer's disease etiology and pathogenesis."],
    "10568522": ["The provided data appear to be in accordance with the known alteration of GSH levels in central nervous system and strengthen the hypothesis of oxidative stress as an important, possibly crucial mechanism in the pathogenesis of AD."],
    "10681271": ["Many lines of evidence suggest that oxidative stress is important in the pathogenesis of Alzheimer disease."],
    "10850732": ["Because of the proximal role that oxidative stress mechanisms seem to play in the pathogenesis of Alzheimer disease, further investigation in this realm may lead to novel therapeutic strategies."],
    "10867210": ["The relationships shown to exist between hemorheology, blood flow, amyloids, oxidative stress, and cognitive function suggest that these factors may be one of the mechanisms operating in the complex etiology of Alzheimer's disease."],
    "10899439": ["While this suggests that oxidative stress is a proximal event in Alzheimer's disease pathogenesis, the mechanisms by which redox balance is altered in the disease remains elusive.", "Determining which of the proposed sources of free radicals, which include mitochondrial dysfunction, amyloid-beta-mediated processes, transition metal accumulation and genetic factors like apolipoprotein E and presenilins, is responsible for redox imbalance will lead to a better understanding of Alzheimer's disease pathogenesis and novel therapeutic approaches."],
    "11068183": ["The present study may help to explain the pathogenesis of neurodegeneration in AD disorders caused by metal-generated oxidative stress."],
    "11079778": ["To begin to address these issues, we investigated p38 kinase, which is induced by oxidative stress, in the pathogenesis of AD."],
    "11232594": ["Multiple lines of evidence indicate that oxidative stress is an integral component of the pathogenesis of Alzheimer disease (AD)."],
    "11578751": ["On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease."],
    "11640950": ["There are multiple lines of evidence showing that oxidative stress and aberrant mitogenic signaling play an important role in the pathogenesis of Alzheimer disease."],
    "11708617": ["Oxidative stress may contribute to the aetiology of AD by dysregulation of APP metabolism."],
    "11771743": ["An elevation of carbonyl compounds that are biomarkers of and leading to oxidative stress has been demonstrated in Down Syndrome (DS) and Alzheimer's Disease (AD) brains and seems to be the result of a multifactorial process.", "Oxidative stress is considered to be crucial in the pathogenesis of Alzheimer's disease-like neurodegeneration."],
    "11884366": ["In addition, oxidative stress in the mitochondria is associated with the pathogenesis of Alzheimer's disease, Parkinson's disease, prion diseases, and amyotrophic lateral sclerosis (ALS) as well as aging itself."],
    "11890747": ["Oxidative stress and quasi-inflammatory processes recently have been recognized as contributing factors in the pathogenesis of Alzheimer's disease (AD)."],
    "12488575": ["Further investigation into the role that oxidative stress mechanisms seem to play in the pathogenesis of Alzheimer disease may lead to novel clinical interventions."],
    "12870699": ["There is strong evidence that oxidative stress participates in the etiology of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease."],
    "12893008": ["Hopefully, the following discussion will help elucidate the relationship between oxidative stress, protein modification and the pathogenesis of AD."],
    "14656990": ["These results support the hypothesis that oxidative stress is an important early event in AD pathogenesis, and antioxidant therapy may be beneficial only if given at this stage of the disease process."],
    "14661103": ["However, increasing evidence indicates that factors such as oxidative stress and disturbed protein metabolism and their interaction in a vicious cycle are central to AD pathogenesis."],
    "15036353": ["A growing body of evidence supports an important role for oxidative stress in the pathogenesis of Alzheimer's disease."],
    "15039034": ["There are many lines of evidence showing that oxidative stress and aberrant mitogenic changes have important roles in the pathogenesis of Alzheimer's disease (AD)."],
    "15096699": ["Although several studies show the importance of oxidative stress in the pathogenesis of Alzheimer's disease (AD), there are few evidences on the role of free radicals in Mild Cognitive Impairment (MCI)."],
    "15105265": ["Many lines of evidence indicate that oxidative stress is one of the earliest events in the genesis of Alzheimer's disease (AD)."],
    "15120069": ["A growing body of evidence suggests that oxidative stress is a common underlying mechanism in the pathogenesis of neurodegenerative disorders such as Alzheimer's, Huntington's, Creutzfeld-Jakob and Parkinson's diseases."],
    "15141484": ["However, increasing evidence indicates that factors such as oxidative stress and disturbed protein metabolism and their interaction in a vicious cycle are central to AD pathogenesis."],
    "15370876": ["Although the role of oxidative stress in the aetiology of Alzheimer's disease is still not clear, the detection of an increased damage status in the cells of patients could have important therapeutic implications."],
    "15380154": ["There is evidence that oxidative stress, homocysteine-related vitamins, fats, and alcohol have a role in the pathogenesis of AD."],
    "15500684": ["BACKGROUND: An increasing body of evidence implicates both brain inflammation and oxidative stress in the pathogenesis of Alzheimer's disease (AD)."],
    "15614428": ["Oxidative stress has been shown to affect A(beta) generation in the AD pathogenesis and the mechanism of such effect is unknown."],
    "15635602": ["Despite the mounting evidence, however, for the causal role of mitogenic abnormalities and oxidative stress in AD pathogenesis, the effect of the converging relevant pathways due to chronic stimulation in AD remains largely unknown."],
    "15723615": ["Oxidative stress, bioenergetic impairment and mitochondrial failure have all been implicated in the etiology of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), as well as retinal degeneration in glaucoma and retinitis pigmentosa."],
    "15753151": ["Oxidative stress is important in the pathogenesis of Alzheimer's disease (AD)."],
    "16181112": ["Evidence indicates that in the initial phase of Alzheimer's disease development, amyloid-beta deposition and hyperphosphorylated tau are consequences of oxidative stress and function as a primary line of antioxidant defense."],
    "16271804": ["The identification of common oxidized proteins in different brain regions of AD brain suggests a potential role for these oxidized proteins and thereby oxidative stress in the pathogenesis of Alzheimer's disease."],
    "16298240": ["There is a large body of evidence highlighting the importance of oxidative stress in the pathogenesis of Alzheimer's disease (AD)."],
    "16311508": ["Strong evidence indicates oxidative stress in the pathogenesis of Alzheimer's disease (AD)."],
    "16337883": ["These results supported the hypothesis that oxidative stress was an early event in AD pathogenesis and that antioxidant therapy may be beneficial only if given at this stage of the disease process."],
    "16399210": ["Cortical and hippocampal oxidative stress is a very early event in the pathogenesis of sporadic AD and correlates with the development of specific cognitive deficits in this condition.", "We determined whether oxidative stress is an early event in the pathogenesis of sporadic Alzheimer disease (AD), and correlated oxidative stress with neuropsychological functions and neurofibrillary pathology in AD and mild cognitive impairment (MCI)."],
    "16538519": ["Several studies have documented the involvement of oxidative stress represented by lipid peroxidation in the pathogenesis of Alzheimer's disease (AD)."],
    "16703529": ["Glutamatergic excitatory neurotransmission, an important process in learning and memory, is severely disrupted in AD, probably due to the oxidative stress associated with the beta-amyloid peptide (1-42) increase."],
    "16860790": ["Evidence has suggested a critical role for amyloid-beta peptide metabolism and oxidative stress in Alzheimer's disease pathogenesis and progression."],
    "16873963": ["Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification."],
    "16930434": ["This indicates that truncation of tau may precede oxidative stress in the pathogenesis of neurodegenerative diseases such as AD and other tauopathies."],
    "17121373": ["This review will focus on some of the mediators of oxidative stress occurring in AD pathology and their possible role in the AD pathogenesis."],
    "17210195": ["There is substantial evidence implicating increased production of the hydroxyl radical and oxidative stress in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "17279615": ["Although it remains an open question as to whether oxidative stress is a causative factor or a consequence of AD, we show here that 4-HNE, putatively resulting from the peroxidation of lipids, covalently modifies Abeta, triggering its aggregation.", "Recent studies implicating Abeta oligomers and protofibrils in the neurotoxic process that ultimately leads to AD suggest that the Abeta aggregates induced by 4-HNE may be important in the pathogenesis of AD."],
    "17460216": ["Evidence suggests that oxidative stresses are involved in the mechanism of Abeta-induced neurotoxicity and AD pathogenesis."],
    "17664130": ["Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment."],
    "17707551": ["Recent reports on amyloid beta peptide (A beta) binding-alcohol dehydrogenase (ABAD) have revealed the link of A beta with oxidative stress derived from mitochondria in the pathogenesis of Alzheimer's disease (AD)."],
    "17761673": ["There is substantial evidence that oxidative stress elicited by amyloid beta (Abeta) accumulation is a causative factor in the pathogenesis of Alzheimer disease (AD)."],
    "17764625": ["There is evidence that oxidative stress, homo-cysteine-related vitamins, fats, and alcohol have a role in the pathogenesis of AD."],
    "17996678": ["Inflammatory injury and induction of oxidative stress have been implicated as causative factors in neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "18084903": ["Oxidative stress is considered one of the causative pathomechanisms of nervous system diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, stroke and excitotoxicity."],
    "18297609": ["Several studies show the importance of oxidative stress in the pathogenesis of AD."],
    "18427999": ["Glutathione S-transferase omega 1 and 2 (GSTO1 and 2) protect from oxidative stress, a possible pathogenic mechanism underlying the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's disease."],
    "18524497": ["The premise that the event that initiates plaque formation is vascular explains why the risk factors for ALDs and cardiovascular diseases overlap; why drugs and lifestyle changes with vaso-protective effects protect against dementia; and why oxidative stress is prominent early in the genesis of Alzheimer-like dementias."],
    "18539391": ["The expression level of cortical glial fibrillary acidic protein (GFAP) increased in an age-related manner, in particular in 2-month PS cDKO mice, suggesting that the interaction relationship between oxidative stress and inflammatory response may be closely associated with the underlying loss-of-function pathogenesis of AD."],
    "18565274": ["Cross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer's disease."],
    "18662010": ["There is strong evidence that oxidative stress participates in the etiology of neurodegenerative diseases such as Parkinson's, and Alzheimer's diseases."],
    "18762245": ["These results are discussed with reference to the importance of Abeta42-associated oxidative stress in the pathogenesis of AD."],
    "18780972": ["Oxidative stress has been shown to be a triggering event in the pathogenesis of Alzheimer's disease (AD)."],
    "18822368": ["Oxidative stress is one of the hypotheses involved in the etiology of Alzheimer's disease (AD)."],
    "19166318": ["GSH deficiency or a decrease in the GSH/glutathione disulfide ratio manifests itself largely through an increased susceptibility to oxidative stress, and the resulting damage is thought to be involved in diseases, such as cancer, Parkinson's disease, and Alzheimer's disease."],
    "19200343": ["Oxidative stress is one of the earliest events in the pathogenesis of Alzheimer's disease (AD) and can markedly exacerbate amyloid pathology."],
    "19250756": ["The basic pathophysiological difference is that AD is caused by oxidative stress alone, whereas PD is caused by oxidative stress plus failure of energy production."],
    "19345730": ["Oxidative stress has been reported to be a common underlying mechanism in the pathogenesis of many neurodegenerative disorders such as Alzheimer, Huntington, Creutzfeld-Jakob, and Parkinson disease."],
    "19950527": ["CONCLUSION: R. rosea extract can protect rats against cognitive deficits, neuronal injury and oxidative stress induced by intracerebroventricular injection of streptozotocin, and may be used as a potential agent in treatment of neurodegenerative diseases such as AD."],
    "20026169": ["There is significant evidence that oxidative stress is a critical event in the pathogenesis of AD."],
    "20236039": ["Genetic mutations and genetic, acquired and environmental risk factors, particularly neuroinflammation and oxidative stress, are the main causes of AD."],
    "20302830": ["Oxidative stress is known to play a key role in the initiation and promotion of the neurodegeneration that characterizes the pathogenesis of Alzheimer disease (AD)."],
    "20381316": ["There is evidence that malnutrition, oxidative stress, and homocysteine-related vitamins play a role in the pathogenesis of AD."],
    "20541661": ["Metabolic derangements and oxidative stress are early events in Alzheimer's disease pathogenesis."],
    "20564553": ["It is strongly suggested that D-aspartic acid (D-Asp)-containing proteins are spontaneously generated by oxidative stress and would cause many aging-related misfolding diseases, such as cataracts, prion disease, and Alzheimer's disease."],
    "20586698": ["Oxidative stress is an important factor, and one that acts in the earliest stages, of Alzheimer's disease (AD) pathogenesis."],
    "20691758": ["The changes in the levels of homocysteine and DHEA-S in aged rat brain have been related to associated glutathione depletion and oxidative stress and the implications of the results highlighted in the pathogenesis of Alzheimer's disease."],
    "20966918": ["Oxidative stress is an important determinant not only in the pathogenesis of Alzheimer's disease (AD), but also in insulin resistance (InsRes) and diabetic complications."],
    "21357903": ["Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease."],
    "21426072": ["BACKGROUND: beta-amyloidosis and oxidative stress have been implicated as root causes of Alzheimer's disease (AD)."],
    "21463622": ["Increasing evidence indicates that factors such as oxidative-nitrergic stress, glutathione depletion, impaired protein metabolism and cholinergic deficit can interact in a vicious cycle, which is central to Alzheimer's disease pathogenesis."],
    "21551909": ["Moreover, since alpha1-antitrypsin, the principal inhibitor of elastase, is highly susceptible to oxidative stress, our findings suggest a link between proteolytic imbalance and oxidative stress in the pathogenesis of Alzheimer disease."],
    "21605062": ["Oxidative stress is considered one of the earliest events in AD pathogenesis and is thought to contribute largely to neuronal cell death."],
    "21631359": ["Punica granatum protects against oxidative stress in PC12 cells and oxidative stress-induced Alzheimer's symptoms in mice."],
    "22008267": ["The down-regulation of energy metabolism in AD has been considered by many as a consequence of mitochondrion damage due to oxidative stress."],
    "22137893": ["Specific adducts of lipid peroxidation have been demonstrated in intimate association with the pathological lesions of Alzheimer disease (AD), suggesting that oxidative stress is a major component of AD pathogenesis."],
    "22172527": ["In addition, studies from mild cognitive impairment patients suggest that oxidative stress is an early event in the pathogenesis of AD."],
    "22406441": ["Our results confirm a critical role for oxidative stress in AD pathogenesis and progression and suggest the potential usefulness of EUK-207 in AD treatment."],
    "22430645": ["The activation of PARP-1 by oxidative stress seems to be an early and important event in the pathogenesis of AD."],
    "22500616": ["Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis?"],
    "22541290": ["Mitochondrial abnormalities contribute to oxidative stress which is part of AD pathogenesis in DS as well as AD in the general population."],
    "22664577": ["It is well known that oxidative stress is one of the earliest events in Alzheimer's disease pathogenesis, indicating that may play a key role in this disease."],
    "22708607": ["Copper and oxidative stress in the pathogenesis of Alzheimer's disease."],
    "22811764": ["Oxidative stress in the central nervous system is strongly associated with neuronal cell death in the pathogenesis of several neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis."],
    "22998047": ["Consequences of oxidative stress thought to contribute to the development of a wide range of diseases including Alzheimer's disease, Parkinson's disease, diabetes, rheumatoid arthritis, neurodegeneration in motor neuron diseases and many cancer types."],
    "23200807": ["In this review, we focus on changes in mitochondrial DNA and mitochondrial dynamics, two aspects critical to the maintenance of mitochondrial homeostasis and function, in relationship with oxidative stress in the pathogenesis of AD and PD."],
    "23228953": ["There are many evidences suggesting that oxidative stress is one of the earliest events in Alzheimer disease (AD) pathogenesis and plays a key role in the development of the AD pathology."],
    "23254632": ["Oxidative stress is an early event in the pathogenesis of Alzheimer's disease (AD)."],
    "23420079": ["Significant bodies of evidences have shown different mechanisms known to be the etiological cause of Alzheimer's disease (AD) involving amyloid-beta protein accumulation, chronic inflammatory reactions, oxidative stress, proteasome inhibition, and high-cholesterol level, but the presize etiology of AD still remains enigmatic."],
    "23480224": ["BACKGROUND: Oxidative stress represents a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "23849337": ["Another hypothesis proposed by the late Mark Smith and colleagues is that oxidative stress, rather than Abeta, precipitates the pathogenesis of AD."],
    "24372221": ["Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease."],
    "24423585": ["Oxidative stress plays a critical role in the etiology and pathogenesis of Alzheimer's disease (AD), and the molecular mechanisms that control the neuron response to oxidative stress have been extensively studied."],
    "24788773": ["Thus, oxidative stress-induced HRD1 insolubilization might be involved in a vicious cycle of increased amyloid beta production and amyloid beta-induced oxidative stress in Alzheimer's disease pathogenesis."],
    "24846973": ["Aggregation of Abeta induces neurotoxicities manifested by apoptosis, neuroin-flammation, oxidative stress and mitochondrial dysfunction etc., which consequently provoke the pathological progression of AD."],
    "25462645": ["Protein carbonylation is a well-documented and quantifiable consequence of oxidative stress in several neuropathologies, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease."],
    "25620241": ["Oxidative stress and inflammatory response are important elements of Alzheimer's disease (AD) pathogenesis, but the role of redox signaling cascade and its cross-talk with inflammatory mediators have not been elucidated in details in this disorder."],
    "26171115": ["Oxidative stress is a prominent early event in the pathogenesis of AD and is therefore believed to contribute to tau hyperphosphorylation."],
    "26295822": ["These results indicate that JAT may be the potential target to treat AD induced by oxidative stress and apoptosis."],
    "26629876": ["Oxidative stress is considered as an important factor and an early event in the etiology of Alzheimer's disease (AD)."],
    "26890100": ["These changes include chronic astrocytic and microglial gliosis, oxidative stress, and altered metabolism of a number of proteins associated with the pathogenesis of Alzheimer's disease."],
    "27040443": ["CONCLUSION: Recent studies have shown that oxidative stress is the one of the molecular changes underlying the pathogenesis of Alzheimer's disease."],
    "27129593": ["In a novel sporadic mouse model that manifests AD-like pathology caused by accelerated oxidative stress in the absence of any familial AD mutation, oral administration of NMZ attenuated hallmark AD pathology and restored biomarkers of synaptic and neuronal function."],
    "27252059": ["In conclusion, oxidative stress-induced HRD1 insolubilization might be involved in a vicious cycle of increased Abeta production and Abeta-induced oxidative stress in Alzheimer's disease pathogenesis."],
    "27351675": ["Our findings suggest that oxidative stress and inflammatory responses could result in abnormal SET gene expression, contributing to the tauopathy in AD pathogenesis."],
    "27386059": ["BACKGROUND: Recent studies have shown that oxidative stress (OS) is the most important indicator in the pathogenesis of Alzheimer's disease (AD), but the results in previous studies are conflicting."],
    "27498145": ["Evidence suggests that oxidative stress and apoptosis are involved in the mechanism of Abeta-induced neurotoxicity and AD pathogenesis."],
    "27774420": ["At the same time, aggregated Abeta-induced oxidative stress is the trigger in the pathogenesis of Alzheimer's disease (AD)."],
    "28332351": ["Oxidative stress is known to be induced by Abeta and NFTs, and we suggest that oxidative stress caused by metabolic alterations in the body induce brain metabolic alterations, resulting in AD."],
    "28448946": ["INTRODUCTION: There is increasing evidence for the involvement of chronic inflammation and oxidative stress in the pathogenesis of Alzheimer's disease (AD)."],
    "28970897": ["Oxidative stress is linked to the etiology of Alzheimer's disease (AD), the most common cause of dementia in the elderly."],
    "29090409": ["Oxidative stress and cytotoxic damage induced by amyloid beta (Abeta) have been considered pivotal in the pathogenesis of Alzheimer's disease (AD) and may represent a target for treatment."],
    "29109370": ["Our results suggest that olive biophenols potentially serve as agents for the prevention of neurodegenerative diseases such as AD, and other neurodegenerative ailments that are caused by oxidative stress."],
    "29112116": ["Increased evidence suggests neuroinflammation and oxidative stress may cause AD."],
    "29512790": ["Oxidative stress may contribute to the underlying mechanisms causing Alzheimer's disease (AD)."],
    "29574628": ["Increasing evidence indicates that sirtuin 3 (Sirt3) has neuroprotective effects in regulating oxidative stress and energy metabolism, both of which are involved in the pathogenesis of Alzheimer's disease (AD)."],
    "29951441": ["This paper outlines possible protective consequences of LDR in preventing the pathogenesis of AD through mechanisms such as restoring the myelin sheath and preventing neurodegeneration caused by oxidative stress."],
    "30112360": ["Alzheimer's disease (AD) and multiple sclerosis are major neurodegenerative diseases, which are characterized by the accumulation of abnormal pathogenic proteins due to oxidative stress, mitochondrial dysfunction, impaired autophagy, and pathogens, leading to neurodegeneration and behavioral deficits."],
    "30151968": ["Transition-metal-catalyzed oxidative stress is a widespread concern in the pathogenesis of Alzheimer's disease."],
    "30498443": ["Several factors like tau protein hyperphosphorylation, amyloid-beta (Abeta) peptide aggregation, decline in acetyl cholinesterase and oxidative stress might be contributing toward the pathogenesis of AD."],
    "30689517": ["Oxidative stress has also been known as an important cause of AD."],
    "30694418": ["Oxidative stress and the presence of ApoEepsilon4 allele has been reported to play a major role in the pathogenesis of AD, but the contribution of oxidative stress and ApoEepsilon4 in macrophage dysfunction leading to ineffective Abeta phagocytosis needs to be analyzed."],
    "30729451": ["This combinatorial model also exhibited cognitive deficiency which was assessed by Morris water maze and avoidance tests along with enhanced oxidative stress which is thought to be a major player in AD pathogenesis."],
    "30984280": ["For this reason, OS is considered a key factor in Alzheimer's Disease (AD) development and recent evidence correlated oxidative stress with vascular lesion in the pathogenesis of AD, but the mechanism still need to be fully clarified."],
    "31006097": ["Oxidative stress is a key factor of and closely implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "31022822": ["The detrimental effects of oxidative stress and chronic neuroinflammation on neuronal cell death have been implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD)."],
    "31057691": ["In this review, we outline and discuss the mitochondrial and oxidative stress factors causing degenerative diseases, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and Friedreich's ataxia."],
    "31117312": ["It is believed that oxidative stress and cholinergic deficit are the leading causes of AD."],
    "31151322": ["Oxidative stress is believed to be one of the main causes of neurodegenerative diseases such as Alzheimer's disease (AD)."],
    "31165850": ["Cholinergic dysfunction and oxidative stress are the most common causes of Alzheimer's disease (AD)."],
    "31173752": ["The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells."],
    "31247877": ["They indeed impact the aggregation pathways of Abeta and are involved in the catalytic generation of reactive oxygen species (ROS) that participate in oxidative stress, while Abeta aggregation and oxidative stress are regarded as two key events in AD etiology."],
    "31424393": ["Ischemic postconditioning protects against post-ischemic excitotoxicity, oxidative stress, and inflammatory process that have also been implicated in the pathogenesis of AD."],
    "31462605": ["Oxidative stress is closely related to the pathogenesis of AD."],
    "31495239": ["Oxidative stress is implicated in pathogenesis of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases."],
    "31521745": ["These findings support a role for the involvement of mitochondria-derived oxidative stress in the etiology of AD and suggest that mitochondria-targeted antioxidants may lessen symptoms in AD patients."],
    "31585875": ["The pathophysiology involved in AD is intra-neuronal accumulation of hyper-phosphorylated tau protein as neurofibrillary tangle and extra cellular beta amyloid plaque deposition, which is due to oxidative stress."],
    "31607444": ["Dysregulation of the blood brain barrier due to oxidative stress causes neurological disorders, such as Alzheimer's and Parkinson's disease."],
    "31686372": ["Mitochondrial dysfunctions and oxidative stress play important roles in the early pathogenesis of Alzheimer's disease (AD), which also involves the aberrant expression levels of mitochondrial proteins.", "However, the molecular mechanisms underlying the aberrant expression levels of these proteins in the pathogenesis of AD are still not completely understood."],
    "31766696": ["This study presents a literature review of ANTs from different berries and their potential therapeutic value, with particular emphasis on neurodegenerative AD, which owing to oxidative stress."],
    "31939658": ["Oxidative stress is known to play an important role in the pathogenesis of Alzheimer's disease."],
    "31945778": ["The oxidative stress is one of the main causative factors of AD."],
    "32035419": ["Oxidative stress and chronic inflammation have been suggested as causes of AD."],
    "32124703": ["Oxidative stress in the pathogenesis of Alzheimer's disease and cerebrovascular disease with therapeutic implications.The significant gain in life expectancy led to an increase in the incidence and prevalence of dementia.", "Oxidative stress in the pathogenesis of Alzheimer's disease and cerebrovascular disease with therapeutic implications."],
    "32171783": ["Indeed, the burden of amyloid beta (Abeta), neurofibrillary tangles (NFTs), neuroinflammation, oxidative stress, and dysfunction of circadian rhythms may lead to AD."],
    "32180930": ["Moreover, BACE1 was also found to be closely related to AD pathogenesis caused by oxidative stress."],
    "32277437": ["Uric acid and late-onset Alzheimer's disease: results from the ReGAl 2.0 project.BACKGROUND: It has been suggested that oxidative stress may have a role in the pathogenesis of Alzheimer's disease (AD)."],
    "32504391": ["Co-treatment of Zn and Se improved the cognitive performance, mitochondrial dysfunction, and oxidative stress caused by STZ-induced AD.", "Findings of the current study showed that ZnR/GPR39 receptor, mitochondrial dysfunction, and oxidative stress play important roles in the pathogenesis of AD.", "Protective Effects of Co-administration of Zinc and Selenium Against Streptozotocin-Induced Alzheimer's Disease: Behavioral, Mitochondrial Oxidative Stress, and GPR39 Expression Alterations in Rats."],
    "32594052": ["Amyloid beta (Abeta)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "32730855": ["Oxidative stress is considered as one of the pathogenesis of Alzheimer's disease (AD) and plays an important role in the occurrence and development of AD."],
    "32737764": ["Oxidative stress is thought to be central in the pathogenesis of Alzheimer's disease (AD)."],
    "32829453": ["Although a causal relationship between gut dysbiosis and neural dysfunction remains elusive, emerging evidence indicates that gut dysbiosis may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, and insulin resistance in the pathogenesis of Alzheimer's disease (AD)."],
    "32920833": ["It has long been recognized that mitochondrial dysfunction and oxidative stress contribute to the pathogenesis of Alzheimer's disease (AD)."],
    "33052996": ["Oxidative stress and metal dyshomeostasis are considered as crucial factors in the pathogenesis of Alzheimer's disease (AD)."],
    "33081348": ["Several studies have indicated that oxidative stress plays a crucial role in the pathogenesis of AD."],
    "33114450": ["Amongst the dysregulated pathophysiological pathways in AD, oxidative stress seems to play a critical role in the pathogenesis progression of AD, with a dominant role of nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein-1 (Keap1)/antioxidant responsive elements (ARE) pathway."],
    "33239403": ["Abeta accumulation affects mitochondrial redox balance, increasing oxidative stress status, which in turn is proposed as a primary culprit in AD pathogenesis."],
    "33264657": ["Hypoxia causes oxidative stress with severe and detrimental effects on brain function and acts as a critical initiating factor in the pathogenesis of Alzheimer's disease (AD)."],
    "33476985": ["Oxidative stress is a prominent early event in the pathogenesis of AD and is therefore believed to contribute to tau hyperphosphorylation."],
    "33488846": ["beta    -Amyloid (A   beta    ), a strong inducer of oxidative stress, plays a crucial role in the pathogenesis of AD."],
    "33567524": ["Oxidative stress has been implicated in the pathogenesis of Alzheimer's disease, and brains with the disease examined in this study also exhibited higher carbonylated proteins, as well as an increased thiol oxidation state of peroxiredoxin 6 (Prx6)."],
    "33633844": ["Conclusions:     Our findings indicate that oxidative stress, apoptosis, and inflammation/immune system processes likely underlie the pathogenesis of AD and DS."],
    "33679375": ["In this review, we focus on recent progress that highlights the crucial role of alterations in mitochondrial function and oxidative stress in the pathogenesis of AD, emphasizing a framework of existing and potential therapeutic approaches."],
    "33774476": ["Oxidative stress has been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "33811448": ["In addition, oxidative stress is considered as an important factor in the etiology of AD and a multitude of metalloproteins and transporters are affected, leading to metal ion misregulation."],
    "33897425": ["The toxic aggregates of amyloid beta (Abeta) disrupt the cell membrane, induce oxidative stress and mitochondrial dysfunction, and eventually lead to Alzheimer's disease (AD)."],
    "34107282": ["We have found that HSV-1 induces the main neuropathological hallmarks of AD, including the accumulation of intracellular amyloid beta (Abeta), hyperphosphorylated tau protein and autophagic vesicles, that OS exacerbates these effects, and that matrix metalloproteinase 14 (MMP-14) participates in the alterations induced by OS."],
    "34662512": ["Expanding literature suggests that oxidative stress (OS) is a vital factor contributing to the pathogenesis of AD such that biometals (e.g., iron, zinc, copper) are believed to play a crucial role in Abeta formation and neurodegeneration."],
    "34932880": ["Oxidative stress and cholinergic system dysfunction are two widely studied pathogenesis of AD."],
    "35049930": ["As the major clinical indications (CI) of AD are extracellular plaques formed by beta-amyloid (Abeta) protein, intracellular neurofibrillary tangles (NFTs) formed by hyper phosphorylated tau-protein, uncommon inflammatory response and neuron apoptosis and death caused by oxidative stress, alkaloids that may decrease CI, might be used against AD."],
    "35226474": ["Oxidative stress is important for the etiology and pathogenesis of Alzheimer's disease (AD)."],
    "35280979": ["Background/Aim: Apoptosis and oxidative stress have been considered as key events in the pathogenesis of Alzheimer's disease (AD)."],
    "35341471": ["The accumulation of aluminum in brain is reported to be associated with cholinergic dysfunction, oxidative stress and neuronal damage, that may ultimately cause Alzheimer's disease."],
    "35395415": ["Taking oxidative stress as the central point, this review comprehensively expands on the roles of oxidative stress that are involved in the pathogenesis of AD."],
    "35411685": ["Mitochondrial dysfunction and oxidative stress are identified to contribute to the mechanisms responsible for the pathogenesis of Alzheimer's disease (AD)."],
    "35474814": ["Identifying specific interactive effects of MI with cellular antioxidant enzymes would represent an essential step in understanding the oxidative stress-induced AD pathogenicity."],
    "35961386": ["Oxidative stress is an early event during AD pathogenesis and is associated with tau-mediated AD pathology."],
    "36014181": ["The antioxidant, anti-cholinesterase, and anti-diabetic potential of the prepared nanoparticles were high in comparison to other areas of biological potential, indicating that the FeNPs are capable of targeting meditators of oxidative stress leading to diabetes and Alzheimer's disease."],
    "36091821": ["Conclusion:     This study suggests that AOF had the potential to treat AD by suppressing apoptosis induced by oxidative stress via the PI3K/Akt pathway."],
    "36139869": ["Oxidative stress in the brain is highly related to the pathogenesis of Alzheimer's disease (AD)."],
    "36476438": ["These molecules protect neurons against oxidative stress and deposition of amyloid-beta (Abeta) and tau proteins which play a vital role in the pathogenesis of AD."],
    "36587558": ["Although the pathogenesis of AD is unclear, neurotoxicity induced by oxidative stress plays an important role in the progression of AD."],
    "36635346": ["Oxidative stress and neuroinflammation play important roles in the pathogenesis of AD.", "Our study identified 9 key genes associated with oxidative stress and immune reaction in AD pathogenesis."],
    "36744334": ["OBJECTIVE: The goal of the present study was to uncover the oxidative stress mechanisms causing AD, as well as the potential therapeutic targets and neuroprotective drugs against oxidative stress mechanisms."],
    "36999542": ["Oxidative stress is an important contributor to the pathogenesis of Alzheimer's disease (AD)."],
    "37231172": ["Obesity has also been linked to neurological diseases such as cognitive decline, dementia, and Alzheimer's disease (AD), caused by oxidative stress, pro-inflammatory cytokines, and the production of reactive oxygen free radicals (ROS)."],
    "37385075": ["In the present study, we reported a new phosphodiester containing diaminonaphthalene compound, POZL, designed to target the PPI interface using a structure-based design strategy to combat oxidative stress in AD pathogenesis."],
    "37453560": ["Brain acetylcholine deficit and oxidative stress may be considered the key pathogenic causes for AD, even though the basic etiology is still unknown."],
    "37465125": ["Oxidative stress in the brain is considered as one of the contributing factors to the pathogenesis of AD, and thus, antioxidants have attracted much interest as potential therapeutic agents against the disorder."],
    "37516225": ["Amyloid fibrils are associated with various neurodegenerative diseases (ND) such as Alzheimer's disease (AD) and Parkinson's disease (PD), which are caused by oxidative stress and impaired protein homeostasis."],
    "37718506": ["BACKGROUND: Oxidative stress is an early event in the development of Alzheimer's disease (AD) and maybe a pivotal point of interaction governing AD pathogenesis; oxidative stress contributes to metabolism imbalance, protein misfolding, neuroinflammation and apoptosis."],
    "37962427": ["The redox-active metal ions, especially Cu     2+      , are highly correlated to Alzheimer's disease (AD) by causing metal ion-mediated oxidative stress and toxic metal-bound beta-amyloid (Abeta) aggregates."],
    "37979715": ["This study provides evidence to support the essential roles of OS in pathogenesis of AD, and the application of Pls in relieving AD."],
    "38057817": ["A body of evidence suggest that oxidative stress and autophagy are involved in the pathogenesis of AD."],
    "38251163": ["The primary pathological hallmark of Alzheimer's disease (AD) is the formation and accumulation of neurofibrillary tangles and plaques, which result from the aggregation of amyloid-   beta     (A   beta    ) induced by oxidative stress."],
    "38396988": ["Oxidative stress is involved in the impaired clearance of amyloid beta (Abeta), and Abeta-induced oxidative stress causes AD by inducing the formation of neurofibrillary tangles."],
    "38565372": ["Multiple complex pathways, such as oxidative stress, tau and amyloid-beta (Abeta) pathology, and cholinergic dysfunction, are involved in the pathogenesis of Alzheimer's disease."],
    "38571463": ["It is one of the beneficial compounds used to prevent and treat the oxidative stress induced neurological disorders like stress, depression and Alzheimer's disease."],
    "8871940": ["We and other investigators recently demonstrated that several mechanisms related to oxidative stress and free-radical reactions could play a crucial role in the pathogenesis of AD and, specifically, in the formation of senile plaques and neurofibrillary tangles (NFT)."],
    "9562500": ["Recent studies have implicated increased oxidative stress in the pathogenesis of Alzheimer's disease (AD)."],
    "9887447": ["In this review article, we will discuss the evidence suggesting that estrogen may have a protective role against AD, mainly through its action as: a trophic factor for cholinergic neurons, a modulator for the expression of apolipoprotein E (ApoE) in the brain, an antioxidant compound decreasing the neuronal damage caused by oxidative stress, and a promoter of the physiological nonamyloidogenic processing of the amyloid precursor protein (APP), decreasing the production of the amyloid-beta-peptide (A beta), a key factor in the pathogenesis of AD."],
    "10196523": ["Here we review genetic and molecular biological evidence suggesting that the peptide A beta 42 is central to the etiology of AD."],
    "10440895": ["Substantial genetic and biochemical evidence implicates amyloid peptides (Abeta) in the etiology of Alzheimer's Disease (AD)."],
    "10825171": ["beta-(25-35) is a synthetic derivative of beta-amyloid, the peptide that is believed to cause Alzheimer's disease."],
    "10940223": ["beta-Amyloid peptides are the main protein components of neuritic plaques and may be important in the pathogenesis of Alzheimer's Disease."],
    "11409035": ["The extracellular deposition of short amyloid peptides in the brain of patients is thought to be a central event in the pathogenesis of Alzheimer's Disease."],
    "11437372": ["Time-resolved anisotropy measurements (TRAMS) have been used to study the aggregation of the beta-amyloid (Abeta) peptide which is suspected of playing a central role in the pathogenesis of Alzheimer's Disease (AD)."],
    "11544033": ["In the case of amyloid precursor protein, this cleavage contributes to the generation of small, toxic amyloid peptides that trigger the pathological development of Alzheimer's disease."],
    "11606220": ["Beta-amyloid peptides (Abeta) are the main protein components of neuritic plaques and are important in the pathogenesis of Alzheimer's disease."],
    "12182949": ["Here, we demonstrated that PACAP also protected against neuronal toxicity induced by beta-amyloid (Abeta) peptide, aggregation of which is a causative factor for Alzheimer's disease."],
    "12414694": ["Neuronal plasma membranes are thought to be the primary target of the neurotoxic beta-amyloid peptides (Abeta) in the pathogenesis of the Alzheimer's disease."],
    "12435726": ["Presenilins (PS1/PS2) play a critical role in proteolysis of beta-amyloid precursor protein (beta APP) to generate beta-amyloid, a peptide important in the pathogenesis of Alzheimer's disease."],
    "12475558": ["The Abeta(1-42) peptide is widely considered to be of greatest significance in relation to the pathogenesis of Alzheimer's disease."],
    "14766758": ["The proteolytic processing of the precursor of the beta-amyloid peptides (APP) is believed to be a key event in the pathogenesis of Alzheimer's disease."],
    "15126696": ["Data that have accumulated for well over a decade have implicated the beta-amyloid (Abeta) peptide as a central player in the pathogenesis of Alzheimer's disease (AD)."],
    "15211591": ["The beta-amyloid peptides derived by proteolytic cleavage from the amyloid precursor protein (APP) play a major role in the pathogenesis of Alzheimer's disease (AD) by forming aggregated, fibrillary complexes that have been shown to be neurotoxic."],
    "15248287": ["This cleavage is responsible for a key biochemical step in signaling from several different cell-surface receptors, and it is also crucial in generating the neurotoxic amyloid peptides that are central to the pathogenesis of Alzheimer's disease."],
    "15314264": ["Because accumulation of beta-amyloid (Abeta) peptide appears central to AD pathogenesis, large efforts have been directed at understanding and interfering with Abeta production or aggregation."],
    "15326604": ["In the present study the transition from ideal alpha-helical to beta-hairpin conformations is revealed by long timescale molecular dynamics simulations in explicit water solvent, for two well-known amyloidogenic peptides: the H1 peptide from prion protein and the Abeta(12-28) fragment from the Abeta(1-42) peptide responsible for Alzheimer's disease."],
    "15544501": ["These studies together with findings that A beta is neurotoxic in vitro, provide evidence that some aggregates of this peptide are the key to the pathogenesis of AD."],
    "15878503": ["The polymerization of beta-amyloid (A beta) peptides into fibrillary plaques is implicated, in part, in the pathogenesis of Alzheimer's disease."],
    "15909112": ["Peptides derived from proteolytic processing of the amyloid precursor protein (APP) are important for the pathogenesis of Alzheimer's disease (AD)."],
    "16033885": ["Accumulation of beta-amyloid (Abeta) peptides in the cerebral cortex is considered a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "16830133": ["The data are also consistent with the concept that a focally dysfunctional blood-brain barrier (BBB) that is unable to regulate the influx/efflux of neurotoxic amyloid peptides may participate in the pathogenesis of AD lesions."],
    "16880006": ["Beta-amyloid peptides (Abeta) have been genetically implicated as the cause of Alzheimer's disease, but the causality of amyloid deposited as plaques has been challenged."],
    "17276414": ["Disruption of this homeostasis due to aging, injury or toxicant exposure may contribute to accumulation of beta-amyloid peptides in the brain fluids, leading to AD."],
    "17348862": ["Excessive production and/or accumulation of beta-amyloid (Abeta) peptides that are proteolytically derived from the beta-amyloid precursor protein (APP) have been linked to the pathogenesis of AD."],
    "17385278": ["Reportedly, beta-amyloid peptides (Abeta40 and Abeta42) induce the neurodegenerative changes of Alzheimer's disease (AD) both directly by interacting with components of the cell surface to trigger apoptogenic signaling and indirectly by activating astrocytes and microglia to produce excess amounts of inflammatory cytokines."],
    "17559680": ["Mutations in amyloid precursor protein (APP) and presenilins alter APP metabolism resulting in accumulation of Abeta42, a peptide essential for the formation of amyloid deposits and proposed to initiate the cascade leading to AD."],
    "17881287": ["Cellular cholesterol accumulation enhances the deposition of insoluble beta-amyloid peptides, which is considered a hallmark in the pathogenesis of AD."],
    "18220930": ["In particular, a selective reduction of the longer Abeta(1-42) peptide which is widely believed to be causative of AD is currently seen as an attractive approach for a disease-modifying therapy."],
    "18221260": ["AIMS: The deposition of amyloid peptides (A beta) in the cortex and hippocampus is the primary trigger of Alzheimer's disease (AD)."],
    "18232509": ["Extensive studies suggest that the conversion of beta-amyloid (Abeta) peptide from soluble forms into fibrillar structure is a key factor in the pathogenesis of Alzheimer's disease (AD)."],
    "18284028": ["Amyloid beta (Abeta) is a peptide integral in the pathogenesis of AD."],
    "18341423": ["The most studied hypothesis of development of the disease is that of the amyloid cascade, which states that overproduction of amyloid-beta peptide, or failure to clear this peptide, leads to Alzheimer's disease primarily through amyloid deposition, which is presumed to be involved in neurofibrillary tangle formation; these lesions are then associated with cell death, which is reflected in memory impairment, the hallmarks of this dementia."],
    "18544674": ["Increasing evidence suggests that the elevation of beta-amyloid (Abeta) peptides in the brain is central to the pathogenesis of Alzheimer's disease (AD)."],
    "18634756": ["Androgen deprivation increases plasma Abeta levels, which indicate that androgens may reduce the levels of soluble Abeta, the peptide widely implicated in the initiation of AD pathogenesis; however, the underlying mechanisms are still poorly understood."],
    "19237574": ["Insulin modulates metabolism of beta-amyloid precursor protein (APP) in neurons, decreasing the intracellular accumulation of beta-amyloid (Abeta) peptides, which are pivotal in AD pathogenesis."],
    "19238376": ["A peptide with 42 amino acid residues (Abeta42) plays a key role in the pathogenesis of the Alzheimer's disease."],
    "19442147": ["It is believed that the production and accumulation of beta-amyloid (Abeta) peptide is a critical step to the pathogenesis of Alzheimer's disease (AD)."],
    "19509405": ["Excessive production of beta-amyloid (Abeta) peptides from proteolytic cleavage of amyloid precursor protein is believed to play a central role in the pathogenesis of Alzheimer's disease (AD)."],
    "19595795": ["Thus, the aggregation kinetics of these peptides is central to understanding the etiology of AD."],
    "19939231": ["Pathological, genetic, biochemical and pharmacological studies support the hypothesis that brain accumulation of oligomeric species of beta-amyloid (Abeta) peptides may cause Alzheimer's disease (AD)."],
    "20371995": ["Increasing evidence suggests that the elevation of beta-amyloid (Abeta) peptides in the brain is central to AD pathogenesis."],
    "20388523": ["The amyloid cascade hypothesis states that overproduction of amyloid-beta peptide (Abeta/AbetaP) or failure to clear this peptide, leads to Alzheimer's disease (AD) primarily through amyloid deposition, presumed to be involved in neurofibrillary tangle formation; these lesions are then associated with cell death which is reflected in memory impairment, the hallmarks of this dementia."],
    "20418805": ["The anomalous folding and polymerization of the beta-amyloid (Abeta) peptide is thought to initiate the neurodegenerative cascade in Alzheimer's disease pathogenesis(1)."],
    "21383152": ["Amyloid-beta (Abeta), a peptide central to the pathogenesis of AD, has profound vascular effects mediated, for the most part, by reactive oxygen species produced by the enzyme NADPH oxidase."],
    "21813692": ["The concentration of amyloid-beta (Abeta) within the brain extracellular space is one determinant of whether the peptide will aggregate into toxic species that are important in Alzheimer's disease (AD) pathogenesis."],
    "21855336": ["Aggregation and fibril formation of beta-amyloid peptides (Abeta) is the key event in the pathogenesis of Alzheimer's disease."],
    "21889458": ["Assembly of beta-amyloid (Abeta) peptide into toxic oligomers is widely believed to initiate Alzheimer's disease pathogenesis."],
    "21939202": ["The beta amyloid (Abeta) peptide aggregates to form beta-rich structures that are known to trigger Alzheimer's disease."],
    "22206488": ["Alzheimer's disease (AD) is characterized by pathological aggregation of beta-amyloid peptides and MAP-Tau protein. beta-Amyloid (Abeta) is a peptide responsible for extracellular Alzheimer's plaque formation."],
    "22351782": ["Accumulation of the neurotoxic beta-amyloid (Abeta) peptide in the brain is central to the pathogenesis of Alzheimer disease."],
    "22552903": ["One important CSF biomarker is the amyloid beta 42 (Abeta(42)) peptide, a key player in AD pathogenesis."],
    "22610977": ["Aggregated amyloid peptides (AP), major components of senile plaques, have been considered to play a very important and crucial role in the development and neuro-pathogenesis of Alzheimer's disease (AD)."],
    "22711819": ["The aggregation and deposition of amyloid-beta (Abeta) peptides are believed to be central events in the pathogenesis of Alzheimer's disease (AD)."],
    "22947874": ["The amyloid-beta(25-35) peptide plays a key role in the etiology of Alzheimer's disease due to its extreme toxicity even in the absence of aging."],
    "23245572": ["Aggregation and fibril formation of beta-amyloid peptides (Abeta) are central events in the pathogenesis of AD."],
    "23262458": ["Aggregation of amyloid-beta (Abeta) peptides into oligomers and amyloid plaques in the human brain is considered a causative factor in Alzheimer's disease (AD)."],
    "23410038": ["The subsequent release of Abeta (amyloid beta) peptides is thought to be the major cause of the neurodegenerative Alzheimer's disease."],
    "23425062": ["INTRODUCTION: Genetic, physiological, and biochemical data indicate that agglomerates of the 42-amino acid form of the amyloid-beta (Abeta(42)) peptide are strongly linked to Alzheimer's disease (AD) etiology and thus represent a particularly attractive target for the development of an effective disease-modifying approach for AD treatment."],
    "23573456": ["Substantial evidence implicates beta-amyloid (Abeta) peptides in the etiology of Alzheimer's disease (AD)."],
    "23614719": ["Amyloid-beta (Abeta) peptides represent key players in the pathogenesis of Alzheimer's disease (AD), and mounting evidence indicates that soluble Abeta oligomers mediate the toxicity."],
    "23708321": ["Aggregation of the beta-amyloid (Abeta) peptide into toxic oligomers is considered the primary event in the pathogenesis of Alzheimer's disease."],
    "23719722": ["These results, in conjunction with the finding that insulin mitigates hippocampal synapse vulnerability to beta amyloid, a peptide thought to be causative in the development of AD, provide a strong rationale for hypothesizing that pharmacological strategies bolstering brain insulin signaling, such as intranasal administration of insulin, could have significant potential in the treatment and prevention of AD."],
    "24192706": ["BACKGROUND: Accumulation of beta-amyloid peptides (Abeta) and its progressive deposition into amyloid plaques are key events in the aetiology of Alzheimer's disease (AD)."],
    "24410826": ["The beta-amyloid (Abeta) peptide has been postulated to be a key determinant in the pathogenesis of Alzheimer's disease (AD)."],
    "25504599": ["Copper-amyloid peptides are proposed to be the cause of Alzheimer's disease, presumably by oxidative stress."],
    "25621019": ["beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the beta-secretase enzyme required for the production of the neurotoxic beta-amyloid (Abeta) peptide that is widely considered to have a crucial early role in the etiology of Alzheimer's disease (AD)."],
    "25809804": ["A growing body of evidence suggests that beta-amyloid peptides (Abeta) are unlikely to be the only factor involved in Alzheimer's disease (AD) aetiology."],
    "26749845": ["In this study, we first provided evidence that A. arborescens extract protects IMR32, a neuroblastoma human cellular line, from toxicity induced by beta amyloid, the peptide responsible for Alzheimer's disease."],
    "26827638": ["There is a vast literature on the role of beta amyloid (Abeta) peptides in the pathogenesis of Alzheimer's disease."],
    "27030769": ["The accumulation of amyloid-beta (Abeta) peptides cleaved from amyloid precursor protein (APP) in the brain is a key event in AD pathogenesis and we also found that ABCA7 deficit exacerbated brain Abeta deposition in amyloid AD model APP/PS1 mice."],
    "27044452": ["Over the past two decades, many studies have identified significant contributions of toxic beta-amyloid peptides (Abeta) to the etiology of Alzheimer's disease (AD), which is the most common age-dependent neurodegenerative disease."],
    "27118677": ["This is important for understanding the Abeta25-35-Flavonoid (A-F) interaction as a therapeutic strategy to inhibit the neurotoxic effects that this peptide causes in AD, which currently is still considered an ambiguous process."],
    "27565738": ["(A?) peptide, a key protein in Alzheimer's disease pathogenesis."],
    "27721583": ["PURPOSE: This study is aimed at investigating the mechanism of reserpine action, which alleviates the toxicity of amyloid beta (Abeta) (AD-causing peptide) in Caenorhabditis elegans [1, 2]."],
    "27807285": ["beta-Amyloid (Abeta) peptides are thought to be critically involved in the etiology of Alzheimer's disease (AD)."],
    "28145081": ["AIMS: To clarify the correlation between chronic sleep restriction (CSR) and sporadic Alzheimer disease (AD), we determined in wild-type mice the impact of CSR, on cognitive performance, beta-amyloid (A?) peptides, and its feed-forward regulators regarding AD pathogenesis."],
    "28193770": ["Aggregation of the beta-amyloid (Abeta) peptide within the brain is thought to be an initiating event in AD pathogenesis."],
    "28795459": ["The oligomerization and fibrillation of beta-amyloid (Abeta) peptides are important events in the pathogenesis of Alzheimer's disease."],
    "28978359": ["(A?) peptides in plaques in the brain parenchyma and in cerebral blood vessels is considered to be a key event in Alzheimer's disease (AD) pathogenesis."],
    "29337241": ["In conclusion, elevated brain Abeta levels and Abeta42:40 ratio apparent in the early stages of AD could perturb intraneuronal trafficking, augment the anomalous accumulation of amyloid peptides in AD brain, and drive AD pathogenesis."],
    "2950070": ["The following account traces the history of NPY and appraises some of the literature in an attempt to raise some speculation concerning its function; several reviews on this peptide already exist (Emson and de Quidt 1984; Solomon 1985; Allen and Bloom 1986; Gray and Morley 1986), Particular attention is paid to studies which have recently suggested that NPY might be involved with the pathogenesis of two neurodegenerative disorders, Huntington's chorea and Alzheimer's disease."],
    "30605056": ["We review the role of the most important proteins and peptides in AD pathogenesis."],
    "30624452": ["Fibrillation of amyloid peptides induces human diseases such as Alzheimer's disease, which has become a huge challenge."],
    "31048034": ["Pre-administered IP before an ICV injection of amyloid Abeta25-35 peptide, a pharmacological model of Alzheimer's disease, OZP002 prevented the learning deficits induced by the peptide after one week in the Y-maze, passive avoidance and novel object tests."],
    "31138770": ["Compelling evidence implicates self-assembly of amyloid-beta (Abeta 1-42) peptides into soluble oligomers and fibrils as a major underlying event in Alzheimer's disease (AD) pathogenesis."],
    "31749959": ["Failure to clear these peptides appears to cause the development of Alzheimer's disease (AD)."],
    "32093407": ["One- and Two-Electron Oxidations of beta-Amyloid     25-35       by Carbonate Radical Anion (CO     3           *-      ) and Peroxymonocarbonate (HCO     4           -      ): Role of Sulfur in Radical Reactions and Peptide Aggregation.The beta-amyloid (Abeta) peptide plays a key role in the pathogenesis of Alzheimer's disease."],
    "32827572": ["Accumulation of amyloid peptides in the brain plays a key role in the pathogenesis of Alzheimer's disease (AD)."],
    "32845146": ["The Abeta     21-30       peptide fragment is a decapeptide fragment of the complete Abeta42 peptide which is a hypothesized cause of Alzheimer's disease via amyloid fibrillogenesis."],
    "32857496": ["Deposition and aggregation of beta-amyloid (Abeta) peptides are demonstrated to be closely related to the pathogenesis of Alzheimer's disease (AD)."],
    "32973564": ["Though accumulation of neuron-derived Abeta peptides is considered the primary influence driving AD and CAA pathogenesis, recent studies highlighted the importance of the physiological role of the beta-amyloid precursor protein (APP) in endothelial cell homeostasis, suggesting a potential role of this protein in maintaining vascular stability."],
    "33642533": ["Extracellular Zn     2+       dynamics, which serves bidirectionally and involved in cognitive activity and cognitive decline, is modified by extracellular glutamate signaling and the presence of amyloid-beta     1-42       (Abeta     1-42      ), a causative peptide in Alzheimer's disease (AD) pathogenesis."],
    "33668038": ["Extracellular aggregation of the beta-amyloid (Abeta) peptide into toxic multimers in the brain is a prominent event occurring in the pathogenesis of Alzheimer's disease (AD), and a large amount of Abeta in the blood is derived from platelets."],
    "33959916": ["These small peptides are attributed to the pathogenesis of both AD and CAA, suggesting an important index for disease stage and progression."],
    "34219248": ["Age, hypercholesterolemia, and vitamin D deficiency are risk factors that increase the brain accumulation of pathogenic beta-amyloid peptides (40 and 42), precursors leading to Alzheimer's disease (AD) in humans."],
    "34852746": ["BACKGROUND: Alzheimer's disease (AD) is a chronic neurodegenerative disease where no specific disease-modifying treatment is currently available. beta-secretase (BACE1) is considered the potential and rationale target because it is involved in the rate-limiting step, which produces toxic Abeta42 peptides leading to deposits in the form of amyloid plaques extracellularly leading to AD."],
    "35006003": ["Production and deposition of beta-amyloid peptides (Abeta) are among the major hallmarks of the pathogenesis of Alzheimer's disease (AD)."],
    "35109277": ["ApoE binds to Sortilin, which mediates uptake of ApoE containing lipoproteins into neurons, and to amyloid-b (Ab) peptide, which is thought to play important roles in the pathogenesis of AD."],
    "35263093": ["Aggregation of beta-amyloid (Abeta42) peptide in the neural extracellular space leads to cellular dysfunction, resulting in Alzheimer's disease (AD)."],
    "35309680": ["Methods: Intracerebroventricular amyloid-beta [Abeta(1-42)] peptide was used to induce AD in Abeta rats."],
    "35908946": ["Furthermore, human Abeta     1-42      , a causative peptide in Alzheimer's disease pathogenesis captures extracellular Zn     2+       and readily taken up into hippocampal neurons followed by intracellular Zn     2+       dysregulation."],
    "36641678": ["To date, conflicting pathogenic and neuroprotective roles for this peptide and its analogs for AD pathogenesis have been described."],
    "37076912": ["CONCLUSIONS: In conclusion, 5-mer peptides prevent short-term memory deficit in Abeta25-35 induced AD model mouse by reducing the aggregated Abeta25-35."],
    "37214891": ["Aggregation of Abeta peptides has been known as a key contributor to the etiology of Alzheimer's disease."],
    "37265546": ["Aggregation of Abeta peptides is an initial event of AD pathogenesis."],
    "37413816": ["Aggregation of Abeta peptides is a key contributor to the etiology of Alzheimer's disease."],
    "37625763": ["Amyloid beta (Abeta), a peptide produced by the proteolytic processing of amyloid precursor protein (APP), is known as a key mediator of brain damage involved in the pathogenesis of Alzheimer's disease (AD)."],
    "37741318": ["AIMS: Evidence indicates accumulating Abeta peptides in brain activates immune responses in neuronal and peripheral system, which may collaboratively influence pathogenesis of Alzheimer's disease (AD)."],
    "38142891": ["This review briefly elaborates on the pathogenesis of AD and analyzes the regulatory effects of endogenous and exogenous peptides on the pathogenesis of AD, thereby providing new therapeutic targets for AD and a theoretical basis for the application of bioactive peptides as adjunctive therapies for AD."],
    "38241093": ["Beta amyloid peptide Abeta 1-42 (Abeta42) has a unique dual role in the human organism, as both the peptide with an important physiological function and one of the most toxic biological compounds provoking Alzheimer's disease (AD)."],
    "38292476": ["The self-assembly of Abeta peptides into toxic oligomers and fibrils is the primary cause of Alzheimer's disease."],
    "38578892": ["However, the poor track record of clinical trials based on this hypothesis suggests that the accumulation of these peptides is not the only cause of AD."],
    "38630150": ["In the present study, we firstly found that Abeta peptides induced AD-like neuroinflammation upregulation and downregulated the level of autophagy."],
    "10210631": ["We discuss these findings in terms of a theory of reference processing, the Informational Load Hypothesis, which views referential impairments in AD as the consequence of normal discourse processing in the context of a working memory impairment."],
    "10516307": ["Recent observations have begun to challenge this assumption by suggesting that earlier Abeta assemblies formed during the process of fibrillogenesis may also play a role in AD pathogenesis."],
    "10616034": ["The fact that IL-6 is detectable in early stage diffuse plaques encourages the speculation that the acute-phase process is crucial to the pathogenesis of AD."],
    "10854253": ["This suggests that an altered function of mutated PSs accounts for a fundamental process leading to AD."],
    "11131295": ["Unregulated systemic immune processes are secondary but important as a driving-force role in AD pathogenesis."],
    "11378240": ["It also suggests that synaptic loss observed in pathological conditions such as Alzheimer's disease, may be the result of the disease process and not a consequence of normal aging."],
    "11755016": ["Chronic neuroinflammatory processes including glial activation may play a role in the pathogenesis of Alzheimer's disease (AD)."],
    "11976212": ["The different categories of AD may be due to processes that augment to different degrees the innate cellular aging rate, that is, mitochondrial superoxide radical (SO) formation."],
    "12212771": ["In particular, they modulate processes that govern the function and metabolism of proteins key to the pathogenesis of AD, including tau and amyloid precursor protein (APP)."],
    "12212799": ["Gamma-secretase processing of the amyloid-beta precursor protein (APP) releases the amyloid-beta peptide, which is widely held to be involved in the pathogenesis of Alzheimer's disease."],
    "12392058": ["Because this process is a central event in the pathogenesis of AD, gamma-secretase is believed to be an excellent therapeutic target."],
    "12435432": ["Fe65 modulates trafficking and processing of APP, including production of the beta-amyloid peptide that is believed to be central to the pathogenesis of Alzheimer's disease."],
    "12436384": ["With the advent of further understanding of the neurodegenerative processes that cause AD, new treatments that may slow down the progression of the disease will be available."],
    "12792666": ["Genetic and neuropathological studies suggest that processing of amyloid precursor protein (APP) to yield amyloid beta-protein (Abeta) plays an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "1288358": ["The processing of the amyloid beta/A4 protein has been implicated in the pathogenesis of AD."],
    "14501020": ["Calpains modulate processes that govern the function and metabolism of proteins key to the pathogenesis of Alzheimer's disease, including tau and amyloid precursor protein."],
    "14506131": ["These studies demonstrate that APP processing, A beta metabolism and A beta deposition are regulated by genetic background and that analysis of these phenotypes in mice should provide new insights into the factors that regulate AD pathogenesis."],
    "1467582": ["A fundamental process in the pathogenesis of Alzheimer's disease (AD) is the breakdown of the cytoskeleton."],
    "14716023": ["Data suggesting that late onset AD risk factors play a role in Abeta turnover in the brain have shifted some of the research focus to the study of Abeta clearance and degradation and the impact of these processes on the etiology of Alzheimer's disease (AD)."],
    "14746246": ["Angiogenic brain damage and Alzheimer's disease caused by a progressing degenerative process are listed among the most frequent causes of dementia."],
    "15342738": ["Alzheimer's disease (AD) may be caused by the abnormal processing of the amyloid precursor protein (APP) and the accumulation of beta-amyloid (Abeta)."],
    "15377701": ["CONCLUSIONS: Polymorphisms within IL-1A influence the degree of brain microglial cell activation, especially in bearers of APOE epsilon4 allele, reinforcing the importance of neuroinflammatory processes in the pathogenesis of AD, and supporting the rationale for treating the disease with inflammation modulating drugs."],
    "15467394": ["Alzheimer's beta-secretase (BACE1) cleaves amyloid precursor protein to produce amyloid beta-peptide, which is a crucial initiation process of the pathogenesis of Alzheimer's disease."],
    "15784960": ["Beta-amyloid (Abeta) peptides are derived from the endoproteolytic processing of amyloid precursor protein (APP) and play a key role in the pathogenesis of Alzheimer's disease (AD)."],
    "15949039": ["In some individuals this initially positive process becomes highly overregulated by genetic or/and epigenetic risk factors and after many years of accumulations lead eventually to AD."],
    "16109164": ["These data suggest that infection can directly alter the processing of a transmembranal protein intimately linked to the aetiology of AD."],
    "16128148": ["The vast number of physiological parameters involved in the poorly understood processes responsible for AD yields a large combination of parameters that can be manipulated and studied."],
    "16251213": ["The reactivity of posterior cingulate and hippocampal structures to cholinergic challenge suggests a key role of the cholinergic system in the functional processes that lead to Alzheimer's disease."],
    "16275806": ["It states that abnormal amyloid processing and accumulation is the primary causative factor of AD and other associated neuropathologic abnormalities are of secondary consequence."],
    "16641106": ["APP also is cleaved intracytoplasmically at Asp-664 to generate a second cytotoxic peptide, APP-C31, but whether this C-terminal processing of APP plays a role in the pathogenesis of AD is unknown."],
    "16766195": ["Overexpression of PCTAIRE 3 in cell culture suggests that the protein acts indirectly to stimulate phosphorylation at the pT231 and pS235 sites on tau, residues that are modified early in the process of AD pathogenesis."],
    "16785601": ["Evidence in the literature suggests that gonadotropins may be involved in processes that contribute to the etiology/pathogenesis of AD such as inflammation, cholesterol homeostasis, and insulin status."],
    "16869341": ["Recent understanding of this process has confirmed that interactions between AGEs and their receptor (RAGE) may play a role in the pathogenesis of diabetic complications and AD."],
    "16884489": ["In this review, we summarize the arguments showing that calpains modulate processes that govern the function and metabolism of these two key proteins in the pathogenesis of Alzheimer's disease."],
    "16892365": ["A central element in the pathophysiology of Alzheimer's disease (AD) is the formation of amyloid plaques, which result from abnormal processing of the amyloid precursor protein (APP)."],
    "16898674": ["In accord with this view, nonsteroidal anti-inflammatory drugs and antioxidants suppress early pathogenic processes leading to Alzheimer's disease, thus decreasing the risk of developing the disease."],
    "17006763": ["Since these proteins are involved directly or indirectly in microtubule destabilization and hyperphosphorylation of tau, and also in APP processing we hypothesize that cell cycle disturbance may be important contributor in the pathogenesis of AD."],
    "17009917": ["Clinicians and researchers in the AD field face great challenges: the pathophysiological processes that cause AD are not well understood, definite diagnosis of AD requires autopsy, and therapeutic options are limited to treating the symptoms rather than the cause of the disease."],
    "17047298": ["Numerous studies now indicate that protein synthesis and protein degradation are significantly altered in Alzheimer's disease (AD), with impairments in these two processes potentially contributing to AD pathogenesis."],
    "17261781": ["Evidence from experimental and epidemiological studies suggests a role of sex hormones in the pathogenic process leading to neurodegenerative diseases, (i.e., Alzheimer's and Parkinson's disease)."],
    "17400334": ["Processing of the amyloid precursor protein (APP) to produce amyloid-beta (Abeta) peptide is increasingly believed to be of central importance in AD pathogenesis."],
    "17401045": ["This is in accordance with reports that lithium inhibits crucial processes in the pathogenesis of Alzheimer's disease."],
    "17512513": ["OBJECTIVES: A neuroinflammatory process, triggered by amyloid-beta (Abeta)-peptide, is thought to play a central role in the neurodegenerative process leading to Alzheimer's disease (AD)."],
    "17623998": ["Both estimates of controlled and to a lesser extent automatic uses of memory were greater for the EC than the AD subjects, indicating that the stem completion impairment in AD may not be entirely attributable to a deficiency in controlled memory processes but also due to reduced automatic processing."],
    "17644063": ["Processing of APP by BACE1 plays a crucial role in the pathogenesis of Alzheimer disease (AD)."],
    "18024114": ["Alzheimer's disease is a pathology putting even at the moment multiple questioning as for its etiopathogeny, which results credibly from several processes."],
    "18081741": ["This process may play a significant role in the pathogenesis of AD and aging."],
    "18299393": ["Presenilin 1 (PS1) plays a critical role in the gamma-secretase processing of the amyloid precursor protein to generate the beta-amyloid peptide, which accumulates in plaques in the pathogenesis of Alzheimer's disease (AD)."],
    "18410513": ["In this study, we evaluated the cognitive performance in rodent models of hypercholesterolemia in relation to neuroinflammatory changes and amyloid precursor protein (APP) processing, the two key parameters of Alzheimer's disease pathogenesis."],
    "18487847": ["All these processes are involved in the pathogenesis of AD."],
    "18577840": ["The key strategy for establishment of diagnostic and therapeutic approaches to AD is sensitive and specific detection of the incipient neuropathology characteristics of AD, combined with emerging treatments that counteract molecular processes in AD pathogenesis."],
    "18650430": ["Specifically, molecular characterization of the secretases involved in Abeta production has facilitated cell biological investigations on APP processing and advanced efforts to model AD pathogenesis in animal models."],
    "1890972": ["A number of neurological disorders including Alzheimer and Parkinson disease have been suggested to be caused by processes leading to lipid peroxidation."],
    "19041409": ["In this review, we summarize the current understanding of the roles of lipoprotein receptors and cholesterol in APP trafficking and processing and their implication for AD pathogenesis and therapy."],
    "19271231": ["Alterations in amyloid precursor protein (APP) processing and amyloid-beta (Abeta) accumulation, key molecules associated with Alzheimer;s disease pathogenesis, may therefore contribute to retinal damage."],
    "19306098": ["Disruptions in Abeta processing have been hypothesised to be the major cause of AD (the amyloid cascade hypothesis)."],
    "19355848": ["CONCLUSIONS: The present animal imaging system would substantially facilitate establishment of a safe and effective therapeutic strategy targeting multiple key processes in the AD pathogenesis."],
    "19357271": ["Understanding how APP processing is regulated under physiological conditions may provide new insights into AD pathogenesis."],
    "19589380": ["The data demonstrate that VEGF may affect APP processing, at least in vitro, suggesting a role of VEGF in the pathogenesis of Alzheimer's disease."],
    "19642202": ["In AD, the extracellular deposition of fibrillogenic amyloid-beta peptides (Abeta) occurs as a result of aberrant processing of the full-length Abeta precursor protein (APP)."],
    "19686046": ["By comparing to age-matched controls, we reasoned that such analysis could help in understanding potential mechanisms involved in upstream processes in AD pathogenesis."],
    "20060898": ["In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models."],
    "20061651": ["Our findings suggests that an imbalance in iron homeostasis is a precursor to the neurodegenerative processes leading to AD and that iron imbalance is not necessarily unique to affected regions."],
    "20122289": ["This review aims to highlight the importance of the immune processes involved in AD pathogenesis based on the outcomes of the two major inflammation-relevant treatment strategies against AD developed and tested to date in animal studies and human clinical trials - the use of anti-inflammatory drugs and immunisation against Abeta."],
    "20226030": ["Depression can be a risk factor for the development of AD or it can be developed secondary to the neurodegenerative process."],
    "20463393": ["Mechanistically, recent reports suggest that mitochondrial fission/fusion and mitophagy are altered in AD and in in vitro models of disease, and since both processes are reported to be protective, this review will discuss the role of mitochondrial fission/fusion and mitophagy in the pathogenesis of AD."],
    "20580938": ["Experimental data show that cholesterol can modulate central processes in the pathogenesis of Alzheimer's disease (AD)."],
    "20734314": ["The structural and mechanistic observations based on these simulations agree with the recent NMR experiments and provide the driving force and structural origin for the Abeta42 aggregation process to cause AD."],
    "20948726": ["Because AD historically has been defined by neuropathologic criteria, treatment strategies have been aimed at diminishing the pathologic end result of the disease process, namely neurodegenerative changes associated with extracellular amyloid-beta-containing plaques, as well as intracellular neurofibrillary tangles of the hyper-phosphorylated microtubule protein, tau."],
    "21085570": ["SIGNIFICANCE: Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process."],
    "21145918": ["These observations support the suggestion of a key role of the cholinergic system in the functional processes that lead to AD."],
    "21210060": ["Many neurodegenerative diseases including Parkinson's disease (PD) and Alzheimer's disease (AD) are the result of neurodegenerative processes."],
    "21257235": ["A recent publication suggested that hypocretin (Hcrt, orexin) may mediate the neuropathological process leading to Alzheimer's disease (AD) and that antagonism of hypocretin receptors decreases this process."],
    "2129870": ["Alteration in PUFA desaturation/elongation processes and resultant membrane abnormalities may play a key role in the pathogenesis of Alzheimer's disease."],
    "21303349": ["Iron, copper, and zinc are some of the metals, which intensify this process and contribute for the pathogenesis of AD."],
    "21305033": ["BACKGROUND AND PURPOSE: Cognitive impairment resulting from cerebrovascular insufficiency has been termed vascular cognitive impairment, and is generally accepted to be distinct from Alzheimer's disease resulting from a neurodegenerative process."],
    "21321391": ["Shift of AbetaPP processing in favor of the amyloidogenic pathway is a key event in the pathogenesis of Alzheimer's disease (AD)."],
    "21680755": ["While the general notion that vascular and metabolic dysfunctions contribute to the etiology of AD is becoming accepted, recent research suggests novel mechanisms by which these/such processes could possibly contribute to AD pathogenesis."],
    "21693162": ["Beta-amyloid (Abeta) is a major pathogenic peptide for Alzheimer's disease (AD) and is generated by the processing of amyloid precursor protein (APP)."],
    "21829458": ["Abeta peptides, generated by processing of the Amyloid Precursor Protein (APP), are thought to play a central role in the pathogenesis of AD."],
    "21876254": ["Although it is still debatable whether tau aggregation is harmful or protective for the cell, detailed analysis of molecular mechanisms underlying this process seems to be of great importance for understanding AD pathogenesis."],
    "21891862": ["Amyloid-beta (Abeta) aggregation is a recognized key process in the pathogenesis of Alzheimer's disease (AD)."],
    "21942868": ["In addition, we showed that TMS has also been used to assess neuroplasticity changes in AD supporting the notion that cortical excitability is changed in AD due to the neurodegenerative process."],
    "21960299": ["While physiological function(s) of APP still remain a matter of debate, consensus exists that the proteolytic processing of this protein represents a critical event in the life of neurons and that abnormalities in this process are instrumental in Alzheimer's disease (AD) pathogenesis."],
    "2203106": ["This result suggests that the sprouting process may involve a reactivation of certain developmental mechanisms and that this may possibly contribute to the etiology of Alzheimer's disease."],
    "22037310": ["This is illustrated by the exchange reaction between amyloid-beta (Abeta) monomers and polydisperse, NMR-invisible ('dark') protofibrils, a process of significant interest because the accumulation of toxic, aggregated forms of Abeta, from small oligomers to very large assemblies, has been implicated in the aetiology of Alzheimer's disease."],
    "22045482": ["Chronic stress, associated with altered memory and other neurological processes, is thought to influence the pathogenesis of AD."],
    "22144675": ["APP processing and amyloid-beta production play a central role in Alzheimer disease pathogenesis."],
    "22170863": ["APP processing is linked to Alzheimer disease (AD) pathogenesis, which is consistent with a common mechanism involving toxic APP metabolites in both dementias."],
    "22184106": ["The prolyl isomerase Pin1 and glycogen synthase kinase-3beta (GSK3beta) have been shown to have the opposite effects on APP processing and Tau hyperphosphorylation, relevant to the pathogenesis of AD."],
    "22214391": ["The initial neurodegenerative process that causes AD is unknown."],
    "22272623": ["Whether or not inflammation represents a possible cause of AD or occurs as a consequence of the disease process, or, alternatively, whether the inflammatory response might be beneficial to slow the disease progression remains to be elucidated."],
    "22356903": ["Our investigation demonstrated the presence of loci of susceptibility for AD in the WD ATP7B gene, supporting a role of copper dysfunction in contributing or accelerating neurodegenerative processes leading to AD."],
    "22450454": ["Four articles in the journal Alzheimer's and Dementia in 2011 describe new criteria for Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI) due to the AD pathophysiological process (MCI due to AD), as well as the underlying rationale for them."],
    "22454637": ["Inflammation is a complex process that has a key role to play in the pathogenesis of Alzheimer's disease."],
    "22479317": ["CONCLUSIONS: Gradual saturation of gamma-secretase with its substrate can be the pathogenic process in different alleged causes of AD."],
    "22558227": ["Although the pathogenic nature of this mutation needs further confirmation, our findings suggest that the Abeta N-terminal region potentially modulates APP processing and Abeta aggregation, and further provides a genetic indication of the importance of Zn(2+) and Cu(2+) in the etiology of AD."],
    "22594617": ["Interactions between miR-103 and miR-107 to genes were revealed playing a role in processes leading to AD."],
    "22819647": ["Coordination of redox active metal ions such as copper or iron to the amyloid-beta (Abeta) peptide has been linked to deleterious processes encountered in the etiology of Alzheimer disease (AD), such as Abeta aggregation and reactive oxygen species (ROS) production."],
    "22867901": ["Alzheimer's disease is the most common progressive neurodegenerative disorder characterized by the abnormal deposition of amyloid plaques, likely as a consequence of an incorrect processing of the amyloid-beta precursor protein (AbetaPP)."],
    "22899726": ["Alzheimer's disease (AD) could result from a multifactorial process involving both genetic predisposition and exposure to environmental factors like pesticides."],
    "23020178": ["Processing of Abeta-precursor protein (APP) plays an important role in Alzheimer's disease (AD) pathogenesis."],
    "23114667": ["REVIEW SUMMARY: Four articles in the journal Alzheimer's & Dementia in 2011 describe new criteria for AD dementia and mild cognitive impairment (MCI) due to the AD pathophysiological process (MCI due to AD) and the underlying rationale for them."],
    "23131555": ["During the process of fibrillation, the Abeta42 takes the form of protofibrils with strong neurotoxicity, and is thus believed to play a crucial role in the pathogenesis of AD."],
    "23142975": ["Cleavage of the amyloid precursor protein by enzymes commonly referred to as beta- and gamma-secretase constitute an important process in the pathogenesis of Alzheimer's disease (AD)."],
    "23166730": ["These processes are implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "23365075": ["Inflammatory changes, typified by activated microglia, particularly adjacent to Abeta plaques, are also a characteristic of the disease, but it is unclear whether these contribute to the pathogenesis of AD or are a consequence of the progressive neurodegenerative processes."],
    "23372648": ["Since synaptic alteration is the best pathologic correlate of cognitive dysfunction in AD, the spatial association of M/LMW Abeta peptide accumulation with pathology of MAP2 within neuronal processes and synaptic compartments early in the disease process reinforces the importance of intraneuronal Abeta accumulation in AD pathogenesis."],
    "23623603": ["Amyloid beta (Abeta) plays a major role in Alzheimer's disease (AD), and neuroinflammatory processes mediated by Abeta plaque-induced microglial cells and astrocytes contribute to AD pathogenesis."],
    "23809366": ["Scientists are investigating other molecular and cellular pathways and processes that contribute to AD pathogenesis."],
    "23827971": ["We will shortly introduce the function of Beclin 1 interactome in autophagy and phagocytosis, review the recent evidence indicating that Beclin 1 regulates autophagy and APP processing in AD, and finally examine the potential mechanisms through which Beclin 1 dysfunction could be involved in the pathogenesis of AD."],
    "23831375": ["Alzheimer's disease and prion diseases are neuropathological disorders that are caused by abnormal processing and aggregation of amyloid and prion proteins."],
    "2386197": ["The focus of research on the neurofibrillary pathology (NFP) of Alzheimer disease has been not only to determine the component forming the paired helical filaments but also to determine whether they result from abnormal processes affecting a single protein."],
    "24033439": ["AIMS: Phosphorylation, conformational changes and cleavage of tau protein have been widely suggested to contribute to abnormal tau processing in the pathogenesis of Alzheimer's disease, as well as in other tauopathies."],
    "24205136": ["Soluble oligomeric amyloid beta peptide (Abeta) generated from processing of the amyloid precursor protein (APP) plays a central role in the pathogenesis of Alzheimer's Disease (AD) and through actions at glutamatergic synapses affects excitability and plasticity."],
    "24279329": ["These processes may be important in AD pathogenesis, as proper intracellular sorting, processing and export of APP are affected by how it is glycosylated."],
    "24333192": ["Converging evidence indicates that processes occurring in and around neuronal dendrites are central to the pathogenesis of Alzheimer's disease."],
    "24463342": ["Brain network dysfunction in Alzheimer's disease (AD) involves many proteins (enzymes), processes and pathways, which overlap and influence one another in AD pathogenesis."],
    "24469452": ["Taken together, these results suggest that Fbxo2 regulates APP levels and processing in the brain and may play a role in modulating AD pathogenesis."],
    "24476230": ["Recent research has thus focused on investigating the molecular and cellular pathways and processes involved in AD pathogenesis to support the development of effective disease-modifying agents."],
    "24478167": ["Many neurodegenerative diseases, like Parkinson's, Alzheimer's, or Huntington's disease, occur as a result of amyloid protein fibril formation and cell death induced by this process."],
    "24506061": ["TMS has been used to assess neuroplastic changes in Alzheimer's disease (AD), corroborating findings that cortical physiology is altered in AD due to the underlying neurodegenerative process."],
    "24516000": ["The amyloid precursor protein (APP) and its processing are widely believed to be central for the etiology of Alzheimer's disease (AD) and appear essential for neuronal development and cell homeostasis in mammals."],
    "24524150": ["One feasible approach to improve the diagnostic and prognostic performance of AD biomarkers is to measure upstream events of amyloid precursor protein (APP) processing, which are at the core of the initial phase of AD pathogenesis."],
    "24559299": ["Such interactions between Abeta and ferrihydrite shed light upon the processes of AD pathogenesis, while providing potential targets for future therapies."],
    "24578544": ["A better knowledge of long-term trajectories of cognitive decline is a central feature of the study of the process leading to Alzheimer's dementia."],
    "24735980": ["The impairment of the PI3K/Akt/mTOR axis in DS population might represent a key-contributing factor to the neurodegenerative process that culminates in Alzheimer-like dementia."],
    "25045220": ["Alzheimer's disease (AD) is the most common form of dementia caused by neurodegenerative process and is tightly related to amyloid beta (Abeta) and neurofibrillary tangles."],
    "25053581": ["Therefore, this study indicates a regulatory role of D678H in APP sorting and processing, and provides genetic evidence for the importance of APP sorting in AD pathogenesis."],
    "25118934": ["All these findings suggest that APP672-699 region is critical for human wild-type APP processing and may provide new clues for the pathogenesis of sporadic AD."],
    "25281744": ["Abeta is generated by the proteolytic processing of the amyloid precursor protein (APP), and alterations to this processing can result in Alzheimer disease."],
    "25316600": ["Amyloid precursor protein processing and the subsequent generation of amyloid beta (Abeta) are central to the pathogenesis of Alzheimer's disease, as soluble, oligomeric Abeta is thought to be the toxic species driving disease progression."],
    "25352592": ["On the other hand, gamma-secretase-mediated processing of amyloid precursor protein leads to the production of amyloid beta (Abeta) peptides that play an important role in the pathogenesis of Alzheimer disease."],
    "25365422": ["The aggregation of amyloid-beta (Abeta) peptide and its deposition in parts of the brain form the central processes in the etiology of Alzheimer disease (AD)."],
    "25591151": ["Although aggregates can be functional under certain circumstances, this process often leads to the disruption of the cellular protein homeostasis (proteostasis), eventually leading to devastating diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), or transmissible spongiform encephalopathies (TSEs)."],
    "25636033": ["Tumor suppressor molecules play a pivotal role in regulating DNA repair, cell proliferation, and cell death, which are also important processes in the pathogenesis of Alzheimer's disease."],
    "25727637": ["Such process might be important for the pathogenesis of AD, and inhibition of LPC generation could be a therapeutic target for the disease."],
    "25766617": ["Disturbances in the sleep-wake cycle and circadian rhythms are common symptoms of Alzheimer Disease (AD), and they have generally been considered as late consequences of the neurodegenerative processes."],
    "26227906": ["Cyclin-dependent kinase 5 (Cdk5), a unique member of the cyclin-dependent kinases (Cdks), is reported to intimately associate with the process of the pathogenesis of AD."],
    "26242258": ["While the process leading to the development of AD is complex and multifactorial, and the etiology of AD is not completely known, it is nowadays clear that AD is a multifaceted illness requiring the combination of synergetic treatment strategies."],
    "26270969": ["A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow the identification of preclinical AD due to AD neuropathological processes."],
    "26484900": ["CONCLUSION: Anxiety and irritability are associated with greater amyloid deposition in the neurodegenerative process leading to AD."],
    "26519433": ["Most processes associated with AD pathogenesis, such as inflammation, synaptic dysfunction, and hyper-phosphorylation of tau are dependent on protein kinase activity."],
    "26583091": ["Our study suggests that Abeta25-35 induces autophagy and the PI3K/AKT/mTOR/p70S6K pathway is involved in the process, which improves our understanding of the pathogenesis of AD and provides an additional model for AD research."],
    "26629788": ["The conversion of soluble monomers to amyloid Abeta fibrils is a complicated process and involves several transient oligomeric species, which are widely believed to be highly toxic and play a crucial role in the etiology of AD."],
    "26792010": ["The neuropathological processes eventually leading to Alzheimer's disease (AD) are thought to start decades before the appearance of clinical symptoms and the clinical diagnosis of AD dementia."],
    "26878581": ["In this review, we analyze issues concerning processes of generation of two proteins (beta-amyloid peptide and Tau-protein) in the cell, which are believed to play the key role in AD genesis."],
    "26993139": ["The cellular and molecular mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies."],
    "27012953": ["APP is subjected to several PTMs (proteolytic processing, glycosylation, sulfation, and phosphorylation) during its course of processing, resulting in Abeta deposition, leading to AD."],
    "27183464": ["INTRODUCTION: Neuroinflammatory processes play an important role in the pathogenesis of Alzheimer's disease (AD)."],
    "27196068": ["In this study, we examined the effects of ABCG1 and ABCG4 on amyloid precursor protein (APP) processing, the product of which, amyloid beta (Abeta), is involved in the pathogenesis of Alzheimer's disease."],
    "27454922": ["In the absence of Abeta, hippocampal tau deposition may be insufficient for the neurodegenerative process that leads to AD."],
    "27524794": ["Characteristic features of Alzheimer's disease are memory loss, plaques resulting from abnormal processing of amyloid precursor protein (APP), and presence of neurofibrillary tangles and dystrophic neurites containing hyperphosphorylated tau."],
    "27671345": ["BACKGROUND: It is widely accepted that neuroinflammatory processes play an important role in the pathogenesis of Alzheimer's disease (AD) and high levels of cytokines and chemokines are detected around Abeta plaques."],
    "27713140": ["Although the mechanisms causing the neurodegenerative process are largely unknown, increasing evidence highlights a critical role of immunity in the pathogenesis of Alzheimer's disease."],
    "27723573": ["GTM-1 is a drug that reverses Alzheimer's Disease (AD) development specifically induced by thapsgargin (TG) and endoplasmic reticulum (ER) has been reported to be a pilot process that leads to AD formation."],
    "27856911": ["Our work provides insights into postsynaptic processes in AD pathogenesis and challenges a purely pathogenic role of tau phosphorylation in neuronal toxicity."],
    "2813376": ["The present data extend earlier findings of abnormal processing of neurofilaments and tau protein in Alzheimer disease and, together with reported abnormal processing of cerebrovascular amyloid beta-protein, suggest that inhibition of the processing of multiple proteins is basic to the pathogenesis of Alzheimer disease, whereas formation of plaques and tangles could be merely the most striking histologic result."],
    "28157316": ["In conclusion, these data suggest dysregulation of the proteins and processes identified as early events in pathogenesis of AD following Abeta accumulation."],
    "28209190": ["BACKGROUND: Disturbed amyloid precursor protein (APP) processing is considered to be central to the pathogenesis of Alzheimer's disease (AD)."],
    "28569173": ["Together, these results indicate that an ApoE2 or ApoE3 mediated positive regulation of BDNF may be protective while ApoE4 related defects in BDNF processing could lead to AD pathophysiology."],
    "28612181": ["This finding identifies a point mutation in LRP1 which slows LRP1-CT-mediated APP endocytosis and amyloidogenic processing, while enhancing APP alpha-secretase cleavage, thus demonstrating a potential novel target for slowing AD pathogenesis."],
    "28626014": ["The results demonstrate that APP673 regulates APP processing, and the BACE1 cleavage site selection is critical for amyloidogenesis in AD pathogenesis, and implicate a pharmaceutical potential for targeting the APP673 site for AD drug development.", "The results demonstrate that APP673 regulates APP processing and the BACE1 cleavage site selection is critical for amyloidogenesis in AD pathogenesis, and implicate a pharmaceutical potential for targeting the APP673 site for AD drug development.SIGNIFICANCE STATEMENT beta-site APP cleaving enzyme 1 (BACE1) is essential for amyloid beta protein production."],
    "28759721": ["The amyloid aggregation process of amyloid beta1-42 peptide is responsible for Alzheimer's disease, affecting millions of elderly people worldwide."],
    "28812474": ["A number of studies demonstrated compelling evidence of the importance of oxidative processes in AD pathogenesis."],
    "28825683": ["Given the importance of the GABAergic system in neuronal function and homeostasis, in the maintenance of the excitatory/inhibitory balance, and in the processes of learning and memory, such changes in GABAergic function could be an important factor in both early and later stages of AD pathogenesis."],
    "28892789": ["Though the causes of Alzheimer's disease (AD) are yet to be understood, much evidence has suggested that excessive amyloid-beta (Abeta) accumulation due to abnormal amyloid-beta precursor protein (APP) processing and Abeta metabolism are crucial processes towards AD pathogenesis."],
    "28965829": ["Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis."],
    "29079430": ["Insulin dysfunction is known as an essential process in the pathogenesis of sporadic Alzheimer's disease (AD)."],
    "29097202": ["However, abnormal processing of APP leads to excessive production of beta-amyloid (Abeta) in the central nervous system (CNS), an event which is regarded as a primary cause of Alzheimer's disease (AD)."],
    "29124681": ["However, their single actions cannot explain the extent of brain damage observed in this disorder, and the characterization of co-adjuvant involved in the early toxic processes evoked in AD is essential."],
    "29223769": ["The processes involved in the pathogenesis of AD have been shown to overlap with those found in cognitive decline in patients with Obstructive Sleep Apnoea (OSA)."],
    "29277576": ["Amyloid precursor protein (APP) processing is central in Alzheimer's disease (AD) pathogenesis."],
    "29407908": ["Dysfunctional accumulation of amyloid-beta (Abeta) protein stimulated by Cu2+ is considered as a key process in the pathogenesis of Alzheimer's disease (AD)."],
    "29410161": ["Minor species of amyloid beta-peptide (Abeta), such as Abeta-(1-43) and pyroglutaminated Abeta-(3-42) (Abeta-(3pE-42)), have been suggested to be involved in the initiation of the Abeta aggregation process, which is closely associated with the etiology of Alzheimer's disease."],
    "29695619": ["The endoplasmic reticulum (ER) stress response is regarded as an important process in the aetiology of Alzheimer's disease (AD)."],
    "30149452": ["These data suggest that A?-associated clinical progression is consistent with clinical-pathological models of AD, whereas progression in the absence of elevated A? deposition may be the result of neuropathological processes other than AD that accumulate with age."],
    "30167602": ["Toxic aggregation of monomeric amyloid beta (Abeta) into oligomers followed by the formation of fibrils is a causative process in the pathogenesis of Alzheimer's disease."],
    "30200516": ["Considering the involvement of (mis)folding processes in AD aetiology, targeting molecular chaperones represents a promising therapeutic perspective."],
    "30407837": ["The aggregation of amyloid beta-proteins (Abeta) has been recognized as a key process in the pathogenesis of Alzheimer's disease (AD), so inhibiting Abeta aggregation is an important strategy to prevent the onset and treatment of AD."],
    "30574086": ["There is general agreement that the neuropathological processes leading to Alzheimer's disease (AD) begin decades before the clinical onset."],
    "30590039": ["Abnormalities of the endolysosomal and autophagy systems are found in Alzheimer's disease, but it is not clear whether defects in these systems are a cause or consequence of degenerative processes in the disease."],
    "30662636": ["These results suggested that SQYZ has the ability to improve the cognitive impairment and ameliorate the neural pathological changes in AD, and the therapeutic mechanism may be related to the modulation of multiple processes related to AD pathogenesis, especially anti-neuroinflammation, promotion of stress recovery and improvement of energy metabolism."],
    "30790387": ["BACKGROUND: In the past few decades, it has been demonstrated with animal models and clinical studies that a chronic inflammatory process significantly contributes to Alzheimer's disease (AD) pathogenesis."],
    "30795987": ["Molecular studies in rodent models suggest a direct contribution of astrocytes to neuroinflammatory and neurodegenerative processes causing Alzheimer's disease; however, these models might insufficiently mimic the human disease, because rodent astrocytes differ considerably in morphology, functionality, and gene expression."],
    "30949921": ["PURPOSE OF REVIEW: Nutrition is known to modulate the immune system and may alter neuroinflammatory processes implicated in the pathogenesis of Alzheimer's disease (AD) and progression of neurodegeneration."],
    "31058201": ["Alzheimer's disease (AD) is a lifelong progressive neurodegenerativa disease related with accumulation of amyloid beta peptide (Abeta) produced by processing of amyloid precursor protein (APP) in the brain."],
    "31086058": ["These compounds accompany thermal processing of protein-containing foods and are known to impact on ageing, pathogenesis of diabetes mellitus and Alzheimer's disease in mammals."],
    "31465249": ["In late 2016, we solicited a series of reviews covering the variety of processes that appeared to be involved in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease (AD)."],
    "31477183": ["BACKGROUND: Alzheimer's disease results from a neurodegenerative process that starts well before the diagnosis can be made."],
    "31507373": ["Till now, it is far from clear what role autophagy plays in AD, a causative role, a protective role, or just a consequence of the disease process itself."],
    "31583531": ["In this review, we discuss the current molecular understanding of how alterations in the AS process contribute to AD pathogenesis."],
    "31600762": ["It is thus likely that lifestyle and environmental factors contribute to neurodegenerative processes implicated in the pathogenesis of AD."],
    "31808139": ["Chronic cerebral hypoperfusion (CCH) is a major contributor to cognitive decline and degenerative processes leading to Alzheimer's disease, vascular dementia, and aging."],
    "31911114": ["We propose that CNS APOE is involved in processes in the normal brains that in later years apply specifically to processes of AD pathogenesis."],
    "32062666": ["Vascular processes even proceed AD neuropathology, implicating a causal role in the etiology of AD."],
    "32365768": ["We provide a comprehensive overview of processes associated with AD pathogenesis and biomarkers, current knowledge on AD-related biomarkers derived from on human and animal brains and body fluids, comparisons of biomarkers obtained in human AD and frequently used animal AD models, and emerging body-fluid-based biomarkers."],
    "32415525": ["MiR-539-5p Decreases amyloid beta-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3beta Pathways in APP/PS1 Double Transgenic Mice.The production of amyloid beta (Abeta) and tau hyperphosphorylation have been identified as key processes in Alzheimer's disease (AD) pathogenesis."],
    "32418657": ["The convergence of pathogenic mutations on one functional pathway, the amyloidogenic cleavage of APP, strongly supports the significance of this process in AD pathogenesis."],
    "32468556": ["Detecting Common Pathways and Key Molecules of Neurodegenerative Diseases from the Topology of Molecular Networks.MotivationNeurodegenerative diseases (NDs), including amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, and Huntington's disease, occur as a result of neurodegenerative processes."],
    "32548880": ["Multitargeted directed ligands (MTDLs) have been considered to be a feasible way to treat AD due to the multiple neuropathological processes in AD."],
    "32664217": ["Individuals residing close to busy roads are at higher risk of developing AD, and nanomaterials that are specifically generated by traffic-related processes have been detected in human brains."],
    "33325586": ["The imbalance of amyloid-beta (Abeta) production and clearance causes aggregation of Abeta     1-42       monomers to form fibrils and amyloid plaques, which is an indispensable process in the pathogenesis of Alzheimer's disease (AD), and eventually leads to pathological changes and cognitive impairment."],
    "33543132": ["These findings provide support for a causal relationship between two crucial processes in Alzheimer's disease pathogenesis and suggest that targeting inflammation, particularly tumour necrosis factor, may have beneficial downstream effects on ameliorating aberrant protein aggregation and accumulation."],
    "33887256": ["We monitor early stages of beta-amyloid (Abeta     1-40      ) aggregation, one of key processes leading to Alzheimer's disease (AD), in the presence of high glucose concentrations by measuring Abeta     1- 40       intrinsic fluorescence."],
    "34118718": ["beta-Amyloid (Abeta) triggered proteopathic and immunopathic processes are a postulated cause of Alzheimer's disease (AD)."],
    "34135909": ["Emerging evidence suggests that both central and peripheral immunological processes play an important role in the pathogenesis of Alzheimer's disease (AD), but regulatory mechanisms remain unknown."],
    "34440878": ["Dysfunctions of both glucose metabolism and mitochondrial dynamics have been recognized as the main upstream events of the degenerative processes leading to AD."],
    "34563212": ["BACKGROUND: Increasing evidence for a direct contribution of astrocytes to neuroinflammatory and neurodegenerative processes causing Alzheimer's disease comes from molecular and functional studies in rodent models."],
    "35109055": ["BACKGROUND: There is a growing appreciation that systemic factors, such as chronic inflammation, metabolic disorders, vascular dysfunction and gut microbiota dysbiosis, are highly connected and traverse a complex route across multiple pathophysiological processes that play crucial roles in Alzheimer's disease (AD) pathogenesis."],
    "35749963": ["Due to the central role of the amyloid aggregation process in the early phase of AD pathogenesis, we aimed at developing a lipidomic approach to evaluate the amyloid toxic effects on differentiated human neuroblastoma derived SH-SY5Y cells."],
    "35780617": ["The review aims to provide a comprehensive understanding of the neuroinflammatory processes causing AD, giving a brief overview of the disease interventions."],
    "35821178": ["Mounting evidence indicates that intensified neuroinflammatory processes play a pivotal role in the pathogenesis of AD."],
    "36090249": ["This review attempts to elucidate the process of Regulated cell death, how it gets unregulated in response to different intra and extracellular stressors, various forms of unregulated cell death, their interplay and their role in pathogenesis of Alzheimer's Disease in both human and experimental models of AD."],
    "36464806": ["DISCUSSION: The identification of these novel gene-trait associations offers new perspectives into the role of rare coding variation in the distinct pathophysiological processes culminating in AD, which may lead to identification of novel therapeutic and diagnostic targets."],
    "36551781": ["The processes that cause AD are still under investigation and there are no available therapies to halt it."],
    "36702317": ["Liquid-liquid phase separation of protein tau: An emerging process in Alzheimer's disease pathogenesis."],
    "37027506": ["This led to the alternative hypothesis that in AD, part of WMH may be secondary to AD-related processes."],
    "37258519": ["Neuroinflammation is believed to be a key process in Alzheimer's disease (AD) pathogenesis."],
    "37382195": ["The gene ontology (GO) analysis manifests that the included processes are close to the pathogenesis of AD."],
    "37638691": ["Tau-dependent cell cycle re-entry and NiMA inhibition occur in cultured neurons within a few hours of exposure to AbetaOs, and thus may represent seminal processes in AD pathogenesis."],
    "37759477": ["The results revealed that oxidative phosphorylation and mitochondrial-related pathways are significantly down-regulated in both tissues of Tg2576 mice, supporting the role of these processes in the pathogenesis of AD."],
    "38479477": ["Besides this, agmatine has been shown to modulate amyloid beta (Abeta) production, aggregation, and clearance, key processes implicated in AD pathogenesis."],
    "7745947": ["BACKGROUND: Dysregulation in the processing of the Alzheimer precursor protein (APP) is thought to be central to the deposition of the beta-A4 peptide and to the pathogenesis of Alzheimer's disease."],
    "7838304": ["APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease."],
    "8122883": ["The persistence of abnormalities in KGDHC and particularly in its E2k component in FAD fibroblasts indicates that abnormalities of this autosomally coded nuclear component are an intrinsic part of the AD process, and the possible role of this abnormality in the pathogenesis of AD is discussed."],
    "8157623": ["Based on these observations, we postulate that the accumulation of insoluble A beta N-42 in Alzheimer Disease is due to the anomalous processing of the C-terminal region."],
    "8250938": ["These results implicate PLA2 in regulating APP processing and secretion, which may have important implications for understanding the pathogenesis of Alzheimer's Disease."],
    "8326828": ["These data support and extend the hypothesis that complement mediated processes are related to beta-amyloid deposition and may be involved in the pathogenesis of AD."],
    "8427604": ["Elucidation of the mechanisms regulating the expression of the human APP gene might therefore be an important step forward in understanding the processes leading to Alzheimer's disease."],
    "8687017": ["Excessive amyloidogenic pathway of APP processing may be the final common pathway involved in the pathogenesis of AD."],
    "8841658": ["Abnormal processing of beta-amyloid precursor protein (APP) and precipitation of amyloidogenic beta A4 peptide have been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "8875116": ["The data presented here support the hypothesis that unpaired proteolytic processes could be involved in the pathogenesis of Alzheimer's disease and suggest that the levels of urinary acid-stable inhibitors may prove to be useful markers of the disease."],
    "8922411": ["apoE is involved in processes of degeneration and regeneration after nerve lesions as well as in the pathogenesis of Alzheimer's disease (AD)."],
    "9161470": ["Lowering of blood pressure in dementia, especially Alzheimer's disease, may be due to the dementia process itself or to the characteristics of the disease."],
    "9199880": ["Reactive oxygen-mediated processes are though to contribute to the pathogenesis of Alzheimer's disease (AD)."],
    "9462872": ["In addition apoE has also been implicated in neural regenerative processes and in the etiology of Alzheimer's disease."],
    "9754878": ["The processing of beta-amyloid precursor protein (betaAPP) and its metabolites plays an important role in the pathogenesis of Alzheimer's disease (AD) and Down's syndrome."],
    "9809105": ["The pathogenic process that causes AD has not been fully delineated; however, it clearly leads to neuropathology characterized by neuritic plaques, neurofibrillary tangles, and loss of cholinergic neurons in the nucleus basalis of Meynert."],
    "9850931": ["Alzheimer's disease is a neurodegenerative disorder comprising multisystem atrophies probably caused by multifactorial processes."],
    "10079962": ["Approximately 30% of patients who die after a single episode of severe head injury show intracerebral deposition of beta-amyloid protein (A beta), a protein that is thought to be central to the pathogenesis of Alzheimer's disease."],
    "10349860": ["These results suggest the possibility that altered presenilin gene products in stress conditions may also participate in the pathogenesis of AD."],
    "10369525": ["This paper discusses the biochemical evidence that links each protein to AD, various animal and cell models that have been used in these investigations, and the putative interactions between these proteins that lead to AD."],
    "10867209": ["For example, apoE can interact with amyloid beta-protein and tau, proteins central to the pathogenesis of AD."],
    "11072133": ["Calsenilin was discovered by virtue of its interaction with both presenilin-1 and -2, proteins that are involved in the etiology of Alzheimer's disease."],
    "11973456": ["By comparing the CSF proteome between Alzheimer disease (AD) patients and controls it may be possible to identify proteins that play a role in the disease process and thus to study the pathogenesis of AD."],
    "12020852": ["Accumulation of beta-amyloid (Abeta) protein in brain is an important characteristic for the etiology of Alzheimer's disease."],
    "12419469": ["These results support the hypothesis that oxidative damage to lipid, protein, and DNA is an important early event in the pathogenesis of AD."],
    "12429067": ["Although the precise molecular mechanism underlying presenilin function or dysfunction remains elusive, presenilins are thought to be part of a complex of proteins that has 'gamma-secretase cleavage' activity, which is clearly central in the pathogenesis of Alzheimer's disease."],
    "12716134": ["Abnormal activity of these proteins in brain may contribute to the pathogenesis of Alzheimer's disease, a neurodegenerative condition characterized by focal amyloid deposits with neurofibrillary tangles."],
    "12893422": ["Since the HPC patients can be regarded as preclinical AD patients, our results suggest the accumulation of these proteins involved in the initial steps of AD pathogenesis."],
    "12972157": ["Recent biological studies indicate the importance of anterior-pharynx defective-1 (APH-1) proteins in Alzheimer's disease (AD) pathogenesis."],
    "15304237": ["The beta amyloid (A beta) protein is a key molecule in the pathogenesis of Alzheimer's disease (AD)."],
    "15456259": ["Beta-secretase (BACE) is a critical enzyme in the production of beta-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD)."],
    "15663474": ["Increased damage to proteins by glycation, oxidation and nitration has been implicated in neuronal cell death leading to Alzheimer's disease (AD)."],
    "15686969": ["These findings open new perspectives for the study of the possible crosstalk between these proteins in the pathogenesis of AD."],
    "15975080": ["This article will review the current knowledge of PS1 function in protein trafficking and discuss its potential role in AD pathogenesis."],
    "16472206": ["After much initial debate for and against the role of amyloid in Alzheimer's disease (AD), mutations on the amyloid precursor protein (APP) and processing pathways that increase levels of the amyloid b peptide of 42 residues (Abeta42) have established that faulty function or processing of these proteins are responsible for AD pathogenesis."],
    "16883086": ["By comparing the CSF proteome of AD patients and controls it might be possible to identify proteins that play a role in the disease process and thus study the pathogenesis of AD."],
    "17369839": ["Polyglutamine (polyQ) diseases are classified as conformational neurodegenerative diseases, like Alzheimer and Parkinson diseases, and they are caused by proteins with an abnormally expanded polyQ stretch."],
    "17699523": ["Despite the functional importance of this protein in Alzheimer disease pathogenesis, the functional correlation to the structural domain of RTN3 remained unclear."],
    "17761554": ["OBJECTIVE: Serine protease inhibitors (serpins), the acute phase reactants and regulators of the proteolytic processing of proteins, have been recognized as potential contributors to the pathogenesis of Alzheimer disease (AD)."],
    "17904250": ["We provide evidence that normal aging involves loss of Reelin neurons, reduced production and elimination of the extracellular deposits, whereas a prenatal immune challenge or the expression of AD-causing gene products, result in earlier, higher, and more persistent levels of Reelin-positive deposits."],
    "1791973": ["It has been speculated that this protein, or the lack of it, may be involved in the aetiology of Alzheimer's disease (AD)."],
    "18374273": ["Thus, the study of the complex interplay of proteins that are involved in or modify Abeta production is very important to gain insight into the pathogenesis of AD."],
    "19478666": ["PURPOSE OF REVIEW: This article reviews recent developments in the field of amyloid imaging using PET, specifically the ability to quantify the amount and distribution of brain beta-amyloid, the protein that occupies a central position in leading theories of the pathogenesis of Alzheimer's disease."],
    "21248114": ["Presenilin 1 (PS1) is an integral component of gamma-secretase and is also a protein closely linked to the etiology of Alzheimer's disease (AD)."],
    "2128596": ["These data suggest that an intrinsic property of AD cells is the progressive reduced ability to interact with normal biologic signals provided by proteins such as interferons which in turn may contribute to the pathogenesis of AD."],
    "21694447": ["The CD147 protein interacts with other proteins such as cyclophilin A (CyPA), Cyclophilin B (CyPB), sterol carrier protein (SCP), caveolin-1 and integrins, and can influence amyloid-beta (Abeta) peptide levels, a protein that is central to Alzheimer's disease (AD) pathogenesis."],
    "21944696": ["The formation and accumulation of D-aspartate residue (D-Asp) in proteins caused by oxidative stress leads to dysfunction and/or denaturation of proteins, and is consequently responsible for aging-related misfolding diseases such as cataracts, prion disease, and Alzheimer's disease."],
    "22138302": ["The association between apolipoprotein E (apoE) and amyloid-beta peptide (Abeta) may significantly impact the function of both proteins, thus affecting the etiology of Alzheimer's disease (AD)."],
    "22683528": ["Based on the studies that have been conducted so far amyloid beta-peptide (Abeta), a protein found in senile plaques, one of the key pathological hallmarks of AD, has been reported to be critical in the pathogenesis of AD."],
    "22926141": ["These observations led us to conclude that VDAC1 interacts with Abeta, and phosphorylated tau may in turn block mitochondrial pores, leading to mitochondrial dysfunction in AD pathogenesis."],
    "22971592": ["The neuroprotective effects of SA in a mouse model of amyloid beta (Abeta)(1-42) protein-induced Alzheimer's disease (AD) were investigated.", "Neuroprotective effect of sinapic acid in a mouse model of amyloid beta(1-42) protein-induced Alzheimer's disease."],
    "23600477": ["AREAS COVERED: Here, the properties and diverse functions of ubiquilin-1 protein in the context of the pathogenesis of AD and other neurodegenerative disorders are discussed."],
    "23697802": ["Near-complete fragmentation of proteins up to 29 kDa is achieved with UVPD including the unambiguous localization of a single residue mutation and several protein modifications on Pin1 (Q13526), a protein implicated in the development of Alzheimer's disease and in cancer pathogenesis."],
    "23748076": ["Here we have shown a novel function of Caspr in pathogenesis of Alzheimer's disease (AD)."],
    "23866266": ["The discovery of neuroinflammatory changes, including dramatic proliferation of activated glia overexpressing a chromosome 2 gene product--the pluripotent immune cytokine interleukin-1 (IL-1)--and a chromosome 21 gene product--S100B--in the brains of fetuses, neonates, and children with DS opened the possibility that early events in Alzheimer pathogenesis were driven by cytokines."],
    "24028865": ["In summary, we provide further evidence for interactions of PrP(C) with proteins that are known to be the key players in AD pathogenesis."],
    "24269629": ["In the last five years our group has been involved in unraveling the neurobiology of this protein and investigating its relationship with cellular and molecular events of functional importance in AD pathogenesis."],
    "25108596": ["The neuroprotective effects of baicalin on pathological changes and behavioral deficits were explored in a mouse model of amyloid beta (Abeta)(1-42) protein-induced Alzheimer's disease (AD)."],
    "25589722": ["Disturbances on AbetaPP and secretases intracellular trafficking and, consequently, in their localization may affect dynamic interactions between these proteins with consequences in the AD pathogenesis."],
    "26438529": ["We review the literature regarding the biological functions of these six proteins and their putative role in AD pathogenesis."],
    "27037841": ["The sialylation of proteins varies during development, aging, and pathogenesis of degenerative diseases such as Morbus Alzheimer, diabetes mellitus type II, or myopathies."],
    "28217771": ["Amyloid fibrils are formed by the aberrant aggregation of proteins into highly ordered beta-sheet structures and are believed to be the root cause of several neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Prion diseases, etc. and have been the subject of extensive biochemical, biophysical and clinical studies."],
    "28415805": ["The dysregulation of these proteins can cause diseases such as Alzheimer's disease, tumorigenesis etc. and may also lead to drug resistance."],
    "28550247": ["(A?), including A?42, proteins thought critical in the pathogenesis of Alzheimer's disease (AD)."],
    "2888020": ["The defect in the inherited autosomal dominant form of Alzheimer's disease, familial Alzheimer's disease (FAD), has been mapped to the same approximate region of chromosome 21 by genetic linkage to anonymous DNA markers, raising the possibility that this gene product, which could be important in the pathogenesis of Alzheimer's disease, is also the site of the inherited defect in FAD (ref. 5)."],
    "29076790": ["Misfolded beta-sheet structures of proteins leading to neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD) are in the spotlight since long."],
    "29774507": ["Here we focus on CALM, a protein containing an ANTH domain, which is implicated in the pathogenesis of blood cancers and Alzheimer disease, and discuss how alteration of CALM function is involved in these diseases."],
    "30282354": ["Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease."],
    "30906244": ["The disruption of iron metabolism and iron transport proteins have been implicated in the pathogenesis of Alzheimer's disease (AD)."],
    "31281238": ["Increasing evidence links proteins of the S100 family to the pathogenesis of Alzheimer's disease (AD)."],
    "31507405": ["Amyloid-beta (Abeta) deposits and some proteins play essential roles in the pathogenesis of Alzheimer's disease (AD)."],
    "33815938": ["Cleavage of this protein by beta-secretase can lead to the formation of amyloid-beta (Abeta) peptide plaque, which leads to Alzheimer's disease."],
    "33833046": ["Diverse gene products contribute to the pathogenesis of Alzheimer's disease (AD)."],
    "34129723": ["Continued evaluation of these proteins will determine to what extent they can aid in the discrimination of MCI patients with and without an underlying AD etiology, and if they have the potential to contribute to a better understanding of the AD continuum."],
    "34627984": ["MATERIALS AND METHODS: 60 APP/PS1 double transgenic AD mice (Mt) and 60 Ass1-40 protein-induced AD mice (Mi) were divided into 3 groups according to the dose of BdNlRB: BdNlRB-100, BdNlRB-200 and BdNlRB-400, with 100, 200 and 400 mg/kg*weight, respectively."],
    "35188507": ["Because long-lived proteins do not have the corrective regeneration capabilities of most other proteins, points of isomerism and epimerization that accumulate within the proteins can severely hamper their functions and can lead to serious diseases like Alzheimer's disease, cancer and cataracts."],
    "35877305": ["Tau and beta-amyloid (Abeta) proteins are major contributors to the etiology of AD."],
    "36983903": ["Since the protein is able to establish protein-protein interaction (PPI) in different contexts and aggregation-prone proteins and the PPI networks are relevant for AD pathogenesis, and due to the relevance of finding new AD markers in peripheral biofluids, we thought it was interesting to study the possible involvement of cystatin B in PPIs in saliva and to evaluate differences and similarities between AD and age-matched elderly healthy controls (HC)."],
    "36994753": ["This article describes the Abeta protein and its role in AD, summarizing the evidence showing that altered Abeta clearance from the brain may lead to the imbalance, toxic buildup and misfolding of the protein - triggering a cascade of cellular, molecular and systematic events that ultimately lead to AD."],
    "37127251": ["Accumulating evidence indicates that impaired autophagic function for removal of damaged mitochondria and protein aggregates such as amyloid and tau protein aggregates may contribute to the pathogenesis of AD."],
    "37454217": ["We aimed at validating the potential value of these proteins as new CSF biomarkers for AD and their possible involvement in AD pathogenesis, with specific interest on the preclinical phase of the disease."],
    "37724426": ["Further technical advancement of glial proteomics will enable us to identify proteins within individual cells and specific cell types, thus significantly enhancing our comprehension of AD pathogenesis."],
    "38151346": ["In this article, we conduct a comprehensive review on the primary functions of multiple Rab proteins and their involvement in the pathogenesis of AD."],
    "7542371": ["The results are further discussed in view of the known or anticipated physiological functions of the proteins examined and of their possible role in the etiology of Alzheimer's disease."],
    "8856006": ["Two of these loci, encoding the beta-amyloid precursor protein and apolipoprotein E, have gene products that are well characterized and of evident significance in the pathogenesis of AD."],
    "8910899": ["We suggest that this long transcript may alter the normal pathway for processing of amyloid precursor protein, the protein which appears to be central in the pathogenesis of AD."],
    "9697696": ["A2M, LRP1 (encoding the alpha-2M receptor) and the genes for two other LRP ligands, APOE and APP (encoding the amyloid beta-protein precursor), have now all been genetically linked to AD, suggesting that these proteins may participate in a common neuropathogenic pathway leading to AD."],
    "9804283": ["Identification of these proteins and their binding affinities for Abeta are needed to assess their potential role in the pathogenesis of Alzheimer's disease."],
    "9838173": ["An indirect role for these proteins has been previously suggested in the etiology of AD."],
    "31855046": ["Effects of recurrent sevoflurane anesthesia on cognitive functions with streptozotocin induced Alzheimer disease."],
    "31997154": ["Tannic Acid Ameliorates STZ-Induced Alzheimer's Disease-Like Impairment of Memory, Neuroinflammation, Neuronal Death and Modulates Akt Expression.", "Our study highlights that treatment with TA prevents memory deficits and reestablishes Akt and pAkt expression, protecting against neuronal death and neuroinflammation in STZ-induced SDAT in rats.", "Tannic Acid Ameliorates STZ-Induced Alzheimer's Disease-Like Impairment of Memory, Neuroinflammation, Neuronal Death and Modulates Akt Expression.Tannic acid (TA) is a hydrolysable glycosidic polyphenol polymer of gallic acid, which possesses neuroprotective properties.", "TA treatment protected against the impairment of memory in STZ-induced SDAT."],
    "32038117": ["Phosphoinositide 3-kinase inhibitor AS605240 ameliorates streptozotocin-induced Alzheimer's disease like sporadic dementia in experimental rats.The quest for chemical entities able to curb the action of the phosphoinositide 3-kinase, (PI3K)/protein kinase B (AKT) signaling pathways is evolving as a potential therapeutic strategy for the treatment and/or prevention of neurodegenerative disorders including Alzheimer's disease (AD).", "In conclusion, our study demonstrated that AS605240 exhibited immense potential in attenuating STZ-induced sporadic AD features in rats and may be developed as a therapeutic agent in the treatment and management of sporadic AD.", "Phosphoinositide 3-kinase inhibitor AS605240 ameliorates streptozotocin-induced Alzheimer's disease like sporadic dementia in experimental rats."],
    "32202739": ["[Streptozocin-induced Alzheimer's disease as an independent risk factor for the development of hyperglycemia in Wistar rats].", "METHODS: Male Wistar rats were injected with streptozocin (STZ) in the lateral ventricles of the brain to induce AD or saline (sham operated animals - SO) during stereotactic operations.", "[Streptozocin-induced Alzheimer's disease as an independent risk factor for the development of hyperglycemia in Wistar rats].BACKGROUND: In recent years the theme of the relationship of Alzheimers disease (AD) and metabolic disorders has been widely discussed."],
    "32336744": ["Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in STZ-induced Alzheimer's disease rats."],
    "32365983": ["Orthosiphon stamineus     Standardized Extract Reverses Streptozotocin-induced Alzheimer's Disease-Like Condition in a Rat Model.Alzheimer's disease (AD) is a chronic neurodegenerative brain disease that is characterized by impairment in cognitive functioning as well as the presence of intraneuronal neurofibrillary tangles (NFTs) and extracellular senile plaques.", "Orthosiphon stamineus     Standardized Extract Reverses Streptozotocin-induced Alzheimer's Disease-Like Condition in a Rat Model."],
    "32473247": ["Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model.Alzheimer's disease (AD) is closely associated with neuroinflammation development in the brain.", "Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model."],
    "32480228": ["In vivo, streptozotocin induced AD in mice model was established and Hibiscus extracts were tested at a dose of 200 mg kg     -1       compared to celecoxib (30 mg/kg).", "A potent natural neuroprotective agent for the prevention of streptozotocin-induced Alzheimer's disease in mice."],
    "32522682": ["Eight days after AD induction by streptozotocin (STZ), mice were subjected to the swimming exercise for four weeks."],
    "32566864": ["In Silico Study and Pharmacological Evaluation of Eplerinone as an Anti-Alzheimer's Drug in STZ-Induced Alzheimer's Disease Model.Alzheimer's disease (AD) is the neurodegenerative disorder characterized by impairment of higher intellectual dysfunctions associated with changes in the cognitive, behavioral, and social activities.", "In Silico Study and Pharmacological Evaluation of Eplerinone as an Anti-Alzheimer's Drug in STZ-Induced Alzheimer's Disease Model."],
    "32599128": ["Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.", "Taken together, these data demonstrated that rapamycin improved STZ-induced AD-like tauopathies and memory deficit in mice via improving p70S6K and AKT/AMPK/GSK-3beta signaling and decreasing AGEs."],
    "32728854": ["Thus, NR1-dependent mitochondrial calcium accumulation could be considered as a major attribute to the animal model of ICV-STZ-induced AD-like manifestations."],
    "32738031": ["Moreover, oral administration of ISO protects hippocampal neurons from STZ-induced neurotoxicity and significantly improves the cognitive and behavioural impairment in STZ-induced AD rats.", "Protective effects of isoquercitrin on streptozotocin-induced neurotoxicity.Alzheimer's disease (AD) is characterized by irreversible and progressive memory loss and has no effective treatment."],
    "32876502": ["Also these NPs acquired a high concentration in mice brain and better pharmacokinetic profile than ALN solution (intranasal) CS-ALN-NPs were then evaluated against intracerebroventricular-streptozotocin (ICV-STZ) induced Alzheimer's disease (AD)-like pathologies in mice."],
    "32903692": ["Streptozotocin Induces Alzheimer's Disease-Like Pathology in Hippocampal Neuronal Cells    via     CDK5/Drp1-Mediated Mitochondrial Fragmentation.", "We also determined that inhibition of mitochondrial fragmentation suppresses STZ-induced AD-like pathology.", "Furthermore, we found that phosphorylation of Drp1 was induced by CDK5, and inhibition of CDK5 suppresses STZ-induced mitochondrial fragmentation and AD-like pathology."],
    "33352241": ["Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.", "CONCLUSION: These findings indicate that RGLS prevented learning and memory impairments in the present rat model of streptozotocin-induced sporadic Alzheimer's disease, and these effects depended on a decrease in Abeta expression and Tau hyperphosphorylation and the modulation of BDNF-TrkB signaling in the hippocampus.", "RESULTS: Treatment with RGLS (360 and 720 mg/kg) significantly enhanced memory in the rat model of STZ-induced sporadic Alzheimer's disease and reversed the streptozotocin-induced increases in Abeta expression and Tau protein expression and phosphorylation at Ser199, Ser202, and Ser396."],
    "33479638": ["Five synthetic sulfonamides derived from carvacrol, a natural product and a small molecule with druglike properties, were evaluated with respect to their effects on the cognitive deficits of animals with streptozotocin (STZ)-induced Alzheimer's disease (AD)."],
    "33732137": ["Conclusion:     A bilateral hippocampal microinjection of STZ could induce not only AD-like behavioral performance in mice, but also adaptive changes of synaptic plasticity against neuroinflammatory and endocrinal injuries."],
    "33814439": ["Enhancement of O-GlcNAcylation to moderate levels by using low-dose OGA inhibitor in ICV-STZ mice prevented STZ-induced body weight loss, rescued cognitive impairments, and restored AD-like pathologies, including hyperphosphorylation of tau and abnormalities in synaptic proteins and neuroinflammation."],
    "33877499": ["Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.", "Groups II-VII were given STZ (3 mg/kg, ICV) on 1st and 3rd day of treatment to induce AD."],
    "34116571": ["In the current study, the protective effect of beta boswellic acid on streptozotocin-induced sporadic Alzheimer's disease was surveyed."],
    "34170261": ["Hippocampal and intraperitoneal injections of streptozocin were used to induce AD and diabetes in male Wistar rats, followed by intranasal administration of a single dose of TSP-1-hEDSCs and intraperitoneal administration of artemisinin for 4 weeks."],
    "34235591": ["Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and Abeta     (1-42)       analysis."],
    "34306309": ["Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice."],
    "34319254": ["BACKGROUND: To explore the effect of albiflorin (AL) on streptozotocin (STZ)-induced Alzheimer's disease (AD) in rats."],
    "34320500": ["Zuoguiwan Ameliorates Cognitive Deficits and Neuro-Inflammation in Streptozotocin-Induced Alzheimer's Disease Rats."],
    "34428446": ["Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/beta-catenin, AMPK/mTOR signaling pathways."],
    "34706756": ["We found for the first time that both of them could ameliorate cognitive deficits in the STZ-induced AD rats.", "Furthermore, both UTE and URE significantly enhanced Akt activation, down regulated the activation of glycogen synthase kinase 3beta (GSK-3beta), and induced the nuclear translocation of Nrf2 in the STZ-induced AD rats.", "Morris water maze (MWM) test was conducted to assess the neurological functions in the STZ-induced AD rats."],
    "34715140": ["Deferoxamine preconditioning enhances the protective effects of stem cells in streptozotocin-induced Alzheimer's disease."],
    "34792730": ["The aim of this study was to evaluate the effects of inosine on memory, neuroinflammatory cytokines, neurotrophic factors, expression of purinergic receptors, and morphological changes in the hippocampus and cerebral cortex of the rats with AD induced by streptozotocin (STZ)."],
    "34802394": ["This study investigated the neuroprotective effect of green tea (GT) on cognitive disorder, inflammation, and oxidative stress in the streptozotocin (STZ)- induced AD model."],
    "34967205": ["Behavioral data from Morris water maze (MWM), open field (OF), novel object recognition (NOR), Y maze, and radial arm maze (RAM) tests showed that 0.5 MUg nanoformulation (GOc-PP-siRNA     GSK3beta      ) intranasally for 7 days improved spatial memory, rescued anxiety like behavior, improved visual and working memory, and rescued exploratory behavior in STZ-induced sAD rats.", "Our results showed that siRNA mediated knockdown of the GSK3beta gene reduced expression of amyloid pathway genes (APP and BACE1), which was further confirmed by reduced amyloid beta (Abeta) levels in the    in vitro     STZ-induced sAD model."],
    "34968163": ["After the model of streptozotocin-induced AD mice with brain insulin resistance was established, the mice were treated with Magnolol or miR-200c antagomiR."],
    "35027835": ["To evaluate whether DMF reduces neuroinflammation based on the peripheral inflammatory response inhibition, we determined peripheral inflammatory mediators in young and aged rats with the ICV-STZ-induced AD pathology following DMF therapy."],
    "35048324": ["In addition, a significant increase in amino acid neurotransmitters occurred in the hippocampus, whereas a significant decrease was obtained in the cortex of STZ-induced AD rats."],
    "35106732": ["The Methylglyoxal/RAGE/NOX-2 Pathway is Persistently Activated in the Hippocampus of Rats with STZ-Induced Sporadic Alzheimer's Disease."],
    "35108957": ["Streptozotocin-induced sporadic Alzheimer's disease: Behavioral effects in female rats."],
    "35150419": ["Several studies have shown the neuroprotective role of capsaicin against oxidative damage, behavioral impairment, with 6-hydroxydopamine (6-OHDA) induced Parkinson's disease, pentylenetetrazol-induced seizures, global cerebral ischemia, and streptozotocin-induced Alzheimer's disease."],
    "35163003": ["Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study."],
    "35192144": ["Thus, the current investigation was undertaken to investigate the therapeutic potential of the PDE-4 inhibitor roflumilast (RFM) against intracerebroventricular (ICV) streptozotocin (STZ)-induced sporadic AD in rats."],
    "35316021": ["We investigated the possible neuroprotective potential of the dual MAGL/FAAH inhibitor JZL-195 (20 mg/kg) against ICV-STZ-induced sporadic Alzheimer's disease (SAD) in Swiss albino mice using donepezil (5 mg/kg) as the standard."],
    "35395244": ["KEY FINDINGS: ICV-STZ-induced AD mice displayed impaired learning and memory functions which were improved by metformin treatment.", "In hippocampal and cortical tissues of ICV-STZ-induced AD mice, insulin receptor (IR) and Akt expressions were unchanged, while phosphorylated insulin receptor (pIR) and pAkt expressions decreased compared to control."],
    "35510084": ["Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer's disease in Wistar rats.", "Investigations were conducted to evaluate the behavioral activities of STZ-induced AD experimental rats under STZ + GelMA + Gal treatment."],
    "35527550": ["METHODS: Rats were randomly assigned to the control (C), experimental periodontitis (P), Alzheimer's disease (AD), and experimental periodontitis with streptozotocin-induced AD (AD-P) groups.", "OBJECTIVE: To assess the impact of experimental periodontitis on cognitive function deficits in a rat model of streptozotocin-induced AD and determine the mechanisms underlying these effects.", "Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model."],
    "35556434": ["The streptozotocin (STZ) -induced AD model mimics respiratory problems seen in humans and exhibits neuronal hyperactivity in the nucleus tractus solitarii (nTS), the central integration site for respiratory afferents in the brainstem."],
    "35679720": ["This study investigated the effects of drug delivery of COQ10 by exosomes derived from adipose-derived stem cells (ADSCs-Exo) on cognition, memory, and neuronal proliferation in a rat model of Streptozotocin (STZ)-induced AD."],
    "35834993": ["Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation.", "OBJECTIVE: To establish an Alzheimer's disease (AD) mouse model, investigate the behavioral performance changes and intracerebral molecular changes induced by bilateral intracerebroventricular injection of streptozotocin (STZ/I.C.V), and explore the potential pathogenesis of AD."],
    "35843421": ["These findings indicate that RES could ameliorate STZ-induced AD-like neuropathological injuries, the mechanism of which could be partly related to its regulation of BDNF expression and synaptic plasticity-associated proteins in the hippocampus.", "The purpose of this study was to investigate the therapeutic effect of RES in Alzheimer's disease (AD)-like behavioral dysfunction induced by streptozotocin (STZ) and explore it's potential mechanism of action."],
    "35936440": ["All groups except group I were injected with Streptozotocin on the first day and third day of treatment at the dose of 3 mg/kg through an intracerebroventricular route to induce Alzheimer's disease."],
    "36108371": ["Morris water maze (MWM) test was performed to determine the learning and memory functions of the STZ-induced AD rats.", "The current experimental findings also amply demonstrated that PA could improve the cognitive and memory impairments in the STZ-induced AD rat model."],
    "36145723": ["In vivo studies performed in a streptozotocin-induced AD model confirmed that HG@MSN-CCM reverted the cognitive deficit in mice, acting as a potential formulation in the treatment of AD."],
    "36288088": ["In a streptozocin-induced AD-like mouse model, behavioral tests showed that    SZM679     apparently ameliorated learning and memory dysfunction."],
    "36301335": ["The role of sleep deprivation in streptozotocin-induced Alzheimer's disease-like sporadic dementia in rats with respect to the serum level of oxidative and inflammatory markers."],
    "36518345": ["Embelin prevents amyloid-beta accumulation via modulation of SOD1 in a Streptozotocin-induced AD-like condition: An evidence from    in vitro     investigation."],
    "36521513": ["Synaptic Loss and Gliosis in the Nucleus Tractus Solitarii with Streptozotocin-Induced Alzheimer's Disease."],
    "36536049": ["Streptozotocin-induced Alzheimer's disease investigation by one-dimensional plasmonic grating chip.", "The next step was to measure the activity of neuron cells injected with different concentrations of STZ (0.5, 1, 2 mM) to induce the formation of Alzheimer's disease in the cultured neuron cells.", "Streptozotocin (STZ) is used to induce Alzheimer's disease experimentally."],
    "36610115": ["Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models."],
    "36631849": ["The molecular mechanisms underlying the progression of STZ-induced AD pathology were analyzed two weeks after the final injection."],
    "36725243": ["This study investigated the mechanism of Danggui Shaoyao Powder(DSP) against mitophagy in rat model of Alzheimer's disease(AD) induced by streptozotocin(STZ) based on PTEN induced putative kinase 1(PINK1)-Parkin signaling pathway."],
    "36926592": ["Melatonin reduces beta-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer's disease model."],
    "37043150": ["AD and diabetes were induced using streptozotocin."],
    "37072341": ["These findings demonstrate for the first time that the anti-AD effect of PHS is associated with the regulation of primary bile acid biosynthesis and taurine and hypotaurine metabolism in STZ-induced AD rats.", "The results revealed that ptimary bile acid biosynthesis and taurine and hypotaurine metabolism were significantly correlated with STZ-induced AD rats."],
    "37114959": ["In this study, we investigate the neuroprotective effects of this plant on Streptozotocin (STZ)-induced AD in rats."],
    "37267300": ["Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis."],
    "37273654": ["The present study aims to investigate the effect of the iTBS protocol on the animal model of STZ-induced sAD-like pathology in the context of antioxidant, anti-inflammatory, and anti-amyloidogenic effects in the cortex, striatum, hippocampus, and cerebellum."],
    "37275760": ["The effect of intracerebroventricular injection of insulin (Ins) and oral cinnamon extract (Cinn) on glucose transporter (GLUT) 1, 3, and 4 gene expressions in the hippocampus and spatial memory in a streptozotocin (STZ)-induced AD rat model was investigated in the present study."],
    "37296210": ["Retraction Note: Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer's disease: emphasis on inhibition of beta-amyloid, COX-2, alpha-, beta - secretases and APH1a."],
    "37309299": ["IN administration of the NPs to streptozotocin (STZ) induced AD-like models lead to a significant number of entrances of the treated rats to the target arm in the radial arm water maze (RAWM) test."],
    "37351177": ["Methods:     Using a streptozotocin (STZ)-induced sporadic AD rat model, we investigated the effects of high-intensity interval training on AD pathologies.", "Results:     High-intensity interval training (HIIT) alleviates cognitive dysfunction in STZ-induced AD-like rat models and provides neuroprotection against neurodegeneration, neuronal damage, and neuronal loss."],
    "37473980": ["These results imply that silibinin exerts neuroprotective effect on an STZ-induced sporadic AD model by downregulating ferroptotic damage and thus the downstream STING-mediated neuroinflammation."],
    "37598127": ["Interestingly, Nobiletin ameliorated STZ-induced AD through enhancing the motor performance and repressing memory defects.", "The citrus flavonoid \\Nobiletin\\ impedes STZ-induced Alzheimer's disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism."],
    "37665449": ["In conclusion, our results suggest that Voglibose has potent neuroprotective effects against the ICV-STZ-induced AD model.", "Voglibose attenuates cognitive impairment, Abeta aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer's disease rat model."],
    "37755583": ["Protective Effects of Repetitive Transcranial Magnetic Stimulation Against Streptozotocin-Induced Alzheimer's Disease."],
    "37780033": ["AD was induced by streptozotocin(STZ; 3 mg/kg, intracerebroventricular (ICV)) and the treatment groups received injections of CM [(200 ul, intraperitoneally (i.p.), and/or PRP (100 ul, intravenously(i.v)] for 8 days."],
    "37834398": ["This study used inductively coupled plasma mass spectrometry (ICP-MS) to examine the levels of metals in the blood plasma, frontal cortex, and hippocampus of Wistar rats with AD induced by streptozotocin (STZ)."],
    "37882235": ["Taken together, our data indicated that Pirh2 is critically involved in STZ induced AD pathogenesis through its interaction with ER-chaperone GRP78, improves the neuronal connectivity, affects the altered level of chaperones, co-chaperones, & autophagic markers, and collectively inhibits the Abeta aggregation."],
    "38006400": ["Streptozotocin-induced AD rat model was used to verify important targets and predicted pathways."],
    "38031940": ["Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.", "We aimed to evaluate the effect of TQ alone or in combination with MEM on memory and hippocampal morphology in an STZ-induced rat AD model."],
    "38333746": ["The present study evaluated whether inhibiting AMPK and activating mTOR could stop metformin from improving memory in rats with streptozotocin (STZ) -induced Alzheimer's disease."],
    "38430352": ["Thus, the aim of this study was to evaluate the effect of treatment with blackberry extract in a model of AD induced by streptozotocin (STZ) and compare it with metformin treatment."],
    "38486405": ["OBJECTIVES: The present study was conducted to investigate the efficacy of GW9508 administered peripherally on cognitive dysfunction in streptozotocin (STZ)-induced AD mice."],
    "38570152": ["Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease."],
    "38688962": ["Intracerebroventricular injection of STZ (3 mg/kg) induced experimental AD and the rats were treated with low dose (200 mg/kg), high dose (400 mg/kg) of ORV and donepezil (10 mg/kg) for 21 days.", "The STZ-induced AD caused cognitive and behavioural deficits demonstrated by considerable increases in acetylcholinesterase activity and escape latency compared to sham control."],
    "20110613": ["In contrast, sporadic AD has been proposed to start with an insulin-resistant brain state (IRBS).We investigated the effect of IRBS induced by intracerebroventricularly (icv) administered streptozotocin (STZ) on behavior, glycogen synthase kinase-3 (GSK) alpha/beta content, and the formation of AD-like morphological hallmarks Abeta and tau protein in AbetaPP Tg2576 mice."],
    "20683499": ["In the present study, the effect of crocins on sporadic Alzheimer's disease induced by intracerebroventricular (icv) streptozocin (STZ) in male rats was investigated."],
    "21465495": ["These results suggest that antioxidant property is involved, at least in part, in the neuroprotective effect of (MeOPhSe)(2) on SDAT induced by STZ in mice."],
    "21701788": ["Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats."],
    "22886014": ["Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose."],
    "22959057": ["Thus, the aim of the current study was to investigate the therapeutic effect of p,p'-methoxyl-diphenyl diselenide [(MeOPhSe)(2)], an organoselenium compound, against streptozotocin (STZ)-induced sporadic dementia of Alzheimer's type (SDAT) in rats."],
    "23210085": ["Effect of Royal Jelly on spatial learning and memory in rat model of streptozotocin-induced sporadic Alzheimer's disease."],
    "23351237": ["Role of testosterone in memory impairment of Alzheimer disease induced by Streptozotocin in male rats."],
    "23457495": ["Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimer's disease model of cynomolgus monkeys (Macaca fascicularis)."],
    "23562514": ["Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats."],
    "23603201": ["Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease."],
    "23681104": ["Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats."],
    "24117480": ["Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease."],
    "24329968": ["Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3beta pathway in streptozotocin-induced alzheimer rat model.", "Because geniposide is thought to act as a GLP-1 receptor agonist, we investigated the potential therapeutic effect of geniposide on STZ-induced AD model in rats."],
    "24503167": ["Furthermore, it was observed that the expressions of COX-2 and iNOS were significantly up-regulated in STZ-induced AD rats and down-regulated strongly (P<0.05) by Rg5 compared with control rats.", "Acetylcholinesterase (AChE) activity was also significantly reduced by Rg5 whereas choline acetyltransferase (ChAT) activity was remarkably increased in the cortex and hippocampus of STZ-induced AD rats (P<0.05)."],
    "24667360": ["Therefore, PM and EJ extracts contain cognitive enhancers as well as neuroprotective agents against STZ induced AD.", "Therefore, in the present study, the neuroprotective roles of PM and EJ for ameliorating the streptozotocin (STZ) induced AD have been tested in rat model.", "Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease."],
    "24719136": ["In this study, we investigated whether Agm treatment could attenuate apoptosis and improve cognitive decline in a STZ-induced Alzheimer rat model.", "Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model.", "RESULTS: Agm suppressed the accumulation of amyloid beta and enhanced insulin signal transduction in STZ-induced Alzheimer rats [experimetal control (EC) group].", "MATERIALS AND METHODS: We studied the effect of Agm on AD pathology using a STZ-induced Alzheimer rat model."],
    "24769303": ["Centrally administered streptozotocin (STZ), is known to cause Alzheimer's like memory deterioration."],
    "24877042": ["Treadmill exercise alleviates impairment of spatial learning ability through enhancing cell proliferation in the streptozotocin-induced Alzheimer's disease rats.", "Decreased cell proliferation with decrement of BDNF and TrkB expressions in the hippocampus were observed in the STZ-induced Alzheimer's disease rats."],
    "25096625": ["To determine whether mitochondrial perturbation is associated with the contribution of diabetes to AD progression, we characterized mouse models of streptozotocin (STZ)-induced type 1 diabetes and transgenic AD mouse models with diabetes."],
    "25114075": ["AMPK activation ameliorates Alzheimer's disease-like pathology and spatial memory impairment in a streptozotocin-induced Alzheimer's disease model in rats."],
    "25268773": ["Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's model.", "Here, we found that the intraperitoneal administration of magnesium sulfate increased the brain magnesium levels and protected learning and memory capacities in streptozotocin-induced sporadic AD model rats."],
    "25446674": ["Notably, saxagliptin (SAX), the DPP-4 inhibitor, recently showed efficacy in ameliorating streptozotocin-induced Alzheimer's disease; however, its effect on Parkinson's disease (PD) has not yet been elucidated."],
    "25890375": ["Among these models, streptozotocin, PolyI:C-induced, and p25 neuroinflammation models are compatible with the inflammation hypothesis of Alzheimer's disease."],
    "26330820": ["Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism."],
    "26638997": ["This study was designed to compare the beneficial effects of erythropoietin and/or curcumin in intracerebro-ventricular (ICV) streptozotocin-induced Alzheimer's like disease in rats.", "Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer's dementia in rats: Erythropoietin versus curcumin.", "In conclusion, ICV-streptozotocin-induced Alzheimer's dementia activates hippocampal Fas ligand-mediated apoptosis, which could be reduced by erythropoietin and/or curcumin treatment."],
    "27035793": ["The present study aimed to investigate the effect of luteolin, a flavonoid compound, on memory impairment in a streptozotocin (STZ)-induced Alzheimer's rat model."],
    "27087133": ["Thus, the aim of the current study was to investigate the effect of NAC against streptozotocin (STZ) induced AD in mice."],
    "27585561": ["This study investigates the streptozotocin (STZ)-induced AD model at three different times (2, 4 and 8 weeks afterwards) and in male and female rats, evaluating cognitive deficit, cholinergic neurotransmission, glucose uptake, glutathione content and specific glial markers (GFAP and S100B protein) in the hippocampus of the rat."],
    "27746125": ["The present study aimed to investigate the effects of berberine (BRB) on spatial and learning memory, anxiety, acetylcholinesterase activity and cell death in an experimental model of intracerebroventricular streptozotocin (ICV-STZ) induced sporadic Alzheimer's-like dementia."],
    "27913964": ["However, especially in mice, several characteristics involved in the streptozotocin (STZ)-induced AD pathology are not well known."],
    "28106557": ["Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer's Disease Rat Model."],
    "28188358": ["Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer's disease mouse model: possible involvement of the cholinergic system."],
    "28299625": ["The effects of lipoic acid on redox status in brain regions and systemic circulation in streptozotocin-induced sporadic Alzheimer's disease model."],
    "28342971": ["Here we show for the first time the potential neuroprotective effect of a novel dual GLP-1/GIP receptor agonist (DA-JC4) in the icv. streptozotocin (STZ)-induced AD rat model."],
    "28382978": ["Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model."],
    "28397428": ["Twelve rats with Alzheimer's disease, induced by STZ injection (3 mg/kg) into both lateral ventricles using a stereotaxic frame (bilaterally ICV-STZ), were divided into 2 groups 5 days after the STZ injection: one treated with rhEPO 5000 (IU/kg/day, i.p.) and the other with 0.9% NaCl (1 mL/kg/day, i.p.) for 2 weeks."],
    "28480351": ["MATERIAL AND METHODS: AD was induced by administering streptozotocin i.e."],
    "28687315": ["The main purpose of this study was to investigate the involvement of Nox2 in memory, in AD-related brain abnormalities, oxidative damage, inflammation and neuronal death in the hippocampus in the streptozotocin (STZ)-induced AD-like state by comparing the effects of that drug on mice lacking gp91phox-/- and wild-type (Wt) mice."],
    "28702935": ["Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer's disease.", "Therefore, the present study was aimed to investigate the neuroprotective effects of vitamin D3 on ICV-STZ induced sporadic AD."],
    "28929339": ["Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model."],
    "28987281": ["We found that STZ-induced AD impaired LTP in the dentate granule cells."],
    "29126976": ["Involvement of glucose related energy crisis and endoplasmic reticulum stress: Insinuation of streptozotocin induced Alzheimer's like pathology."],
    "29132093": ["Thus, we investigated the possible efficacy of the AChE inhibitor 2-[(6-Nitro-2-benzothiazolyl)amino]-2-oxoethyl4-[2-(N,N-dimethylamino)ethyl] piperazine-1 carbodithioate (BPCT) in a streptozotocin (STZ)-induced Alzheimer's disease model (SADM)."],
    "29133125": ["The presented study demonstrated that in a rat model of STZ-induced AD both muscimol and baclofen at the tested doses exerted memory-enhancing and anti-inflammatory effects, as well as normalization of acetylcholine esterase and GABA expression.", "Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease."],
    "29232315": ["PURPOSE: This study aimed to examine the effects of swimming exercise pretreatment on a streptozotocin (STZ)-induced sporadic Alzheimer's disease (AD) rat model and provide an initial understanding of related molecular mechanisms."],
    "29501041": ["The animals were treated intracerebroventricularly with streptozotocin (STZ; 3 mg/kg) twice, on day 1 and 3, to induce AD-like condition, and the symptoms were evaluated after 14 days."],
    "29587242": ["In conclusion, the present study showed that treatment with ANT attenuated memory deficits, protected against oxidative damage in the brain, and restored AChE and ion pump activity in an STZ-induced SDAT in rats.", "ANT treatment protected against the worsening of memory in STZ-induced SDAT."],
    "29667108": ["5-Hydroxytryptamine receptor 6 antagonist, SB258585 exerts neuroprotection in a rat model of Streptozotocin-induced Alzheimer's disease."],
    "29765479": ["The present study was designed to investigate neuroprotective mechanism and therapeutic potential of evodiamine against intracerebroventricular streptozotocin (ICV-STZ)-induced experimental sporadic Alzheimer's disease in mice."],
    "29782959": ["Moreover, prominent declines in oxidative stress, neuro-inflammation, and apoptotic parameters were recorded upon its injection in STZ-induced SAD mouse model."],
    "29807069": ["Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer's disease: Involvement of PI3-kinase, eNOS and NFkappaB."],
    "29927658": ["Injection of L-T4 (10 MUg/kg) alleviated memory deficits and also improved factors of oxidative stress and BDNF level in the STZ-induced AD rats."],
    "30014576": ["Intracerebroventricular streptozotocin-induced Alzheimer's disease-like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex."],
    "30118774": ["The therapeutic effect of bergenin supplementation for 28 days, at three dose levels, was also evaluated in streptozotocin (3 mg/kg, ICV, unilateral) induced AD model in Wistar rats using Morris water maze and Y maze on 7th, 14th, 21st and 28th days."],
    "30171934": ["The observations were further confirmed by in vivo therapeutic effects in streptozotocin (STZ)-induced SAD rats in the context of altered biochemical and behavioral features."],
    "30333717": ["This study showed, for the first time, that the administration of an endocannabinoid can prevent AD-like effects induced by STZ, boosting further investigations about the modulation of endocannabinoid levels as a therapeutic approach for AD."],
    "30359566": ["The results of this study document a region-specific impact of STZ-induced AD in respiratory brainstem nuclei.", "Impaired chemoreflex correlates with decreased c-Fos in respiratory brainstem centers of the streptozotocin-induced Alzheimer's disease rat model."],
    "30481507": ["As cholesterol modifying agents have been supposed to alter AD like pathologies, the current study was designed to investigate the possible neuroprotective and therapeutic potential of ALN against ICV STZ induced experimental sporadic AD (SAD) in mice in a non-cholesterol dependent manner, using donepezil (5 mg/kg) as a reference standard."],
    "30641081": ["Twelve days after AD induction by streptozotocin (STZ), animals received either vehicle or MK-801 (NMDA receptor antagonist) in the hippocampus for 10 days."],
    "30684605": ["This study aimed at investigating the protective effect of NAD-299 (the selective 5-HT1A receptor antagonist) and TCB-2 (the potent5-HT2A receptor agonist) on the hippocampal oxidative stress biomarkers and the number of intact neurons in streptozotocin (STZ)-induced Alzheimer's disease in rats."],
    "30760053": ["Administration of hCG ameliorated the lowered density of hCG receptor-ir neurons in the cerebellum and prefrontal cortex in STZ-induced AD rats.", "We investigated the effects of different doses of hCG on hCG receptor density in the prefrontal cortex and cerebellum in a rat model of STZ-induced AD."],
    "31040784": ["Apelin-13 was found to significantly ameliorate STZ-induced AD-like phenotypes including congnitive deficit, cholinergic disfunction and the damage of neuron and synaptic plasticity."],
    "31068802": ["Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes."],
    "31086208": ["To further our studies, the protective effect of QTC-4-MeOBnE (0.1 and 1 mg/kg for 20 days) on STZ-induced sporadic AD mice was determined."],
    "31215291": ["Here, the possible protective effect of ABA was evaluated in streptozotocin (STZ)-induced AD rat model which were injected intracerebroventriculary (i.c.v.) with STZ (3 mg/kg)."],
    "31344367": ["In this study, the effects of yonk on cognitive behaviors as well as the pathological features in streptozotocin-induced SAD rat model were investigated."],
    "31480727": ["beta-Carotene: A Natural Compound Improves Cognitive Impairment and Oxidative Stress in a Mouse Model of Streptozotocin-Induced Alzheimer's Disease."],
    "31595805": ["Effects of tannic acid in streptozotocin-induced sporadic Alzheimer's Disease: insights into memory, redox status, Na+, K+-ATPase and acetylcholinesterase activity."],
    "31726088": ["Melatonin attenuates streptozotocin-induced Alzheimer-like features in hyperglycemic rats."],
    "31834453": ["OBJECTIVE: The objective is to evaluate the effects of inosine on the behavioral and neurochemical parameters in a rat model of Alzheimer's disease (AD) induced by streptozotocin (STZ)."],
    "33448390": ["As glucose hypometabolism in the brain is an early sign of Alzheimer's dementia (AD), the diabetogenic drug streptozotocin (STZ) has been used to induce Alzheimer-like pathology in rat brain by intracereboventricular injection (icv-STZ)."],
    "34536437": ["Animals were subjected to treadmill exercise eight weeks before and four weeks after ALD induction by streptozocin (STZ)."],
    "34554409": ["STZ (3 mg/kg) was injected through an intracerebroventricular route to induce AD-like dementia."],
    "11141480": ["The similar characteristics of microglia in the APP23 mice and in AD render the mouse model suitable to study the role of inflammatory processes during AD pathogenesis."],
    "11193142": ["The APP23 line is a suitable model to analyze the contribution of APP, A beta, and amyloid to the pathogenesis of Alzheimer's disease."],
    "14769913": ["These findings suggest a new model of AD pathogenesis in which a genomically orchestrated up-regulation of tumor suppressor-mediated differentiation and involution processes induces the spread of pathology along myelinated axons."],
    "1497790": ["Mendelian genetics is a possible model for Alzheimer's disease etiology."],
    "1741393": ["Ts 16 provides a model of spontaneous, genetically determined neurodegeneration that may be used to understand better the molecular pathogenesis of neuronal dysfunction in Alzheimer disease and Down syndrome."],
    "18068305": ["The present study was designed to determine the time-course of the shift from neuronal to glial induction in the expression of these proteins in Down's syndrome, sometimes referred to as a human model of Alzheimer-like beta-amyloid (Abeta) deposition."],
    "19096160": ["However, published data show that senescence-accelerated mouse (SAMP8), as a model of aging, display many features that are known to occur early in the pathogenesis of AD such as increased oxidative stress, amyloid-beta alterations, and tau phosphorylation.", "Here, the neurochemical, neuropathological, and behavioral alterations, characterized in SAMP8 mice are critically reviewed and discussed in relation to the potential use of this mouse model in the study of AD pathogenesis."],
    "2039382": ["The proposed model postulates a role for environmental agents in the pathogenesis of Alzheimer's disease and accounts for families that show an aggregation of cases but no apparent pattern of inheritance."],
    "20682182": ["We propose an integrative model on the pathogenesis of AD that includes several damage signals such as Abeta oligomers, oxygen free radicals, iron overload, homocysteine, cholesterol and LDL species."],
    "21471644": ["The findings demonstrate that the effect of icv-STZ is regionally specific, lending further support for the method as a model of AD pathogenesis."],
    "22112803": ["We have proposed a model which is consistent with most of the published data and current notions of AD pathogenesis and can serve as a hypothesis which can be tested."],
    "22203915": ["Together, these data support a model of AD pathogenesis in which soluble Abeta initiates synaptic dysfunction and loss, as well as pathological changes in tau, which contribute to both synaptic and neuronal loss."],
    "22459153": ["This model will allow the study of AD pathogenesis and testing of therapeutic strategies in a more relevant environment without experimental artifacts due to the overexpression of a single-mutant AbetaPP isoform using exogenous promoters."],
    "22523954": ["This model allowed us to study the role of amyloid-beta25-35 in the pathogenesis of Alzheimer's disease and to test anti-amyloid substances."],
    "22723178": ["So it might not be suitable to utilize the knockout murine model to explore biological function of Calhm1 in the pathogenesis of AD."],
    "22735677": ["We integrate biomarker findings into a comprehensive model of AD pathogenesis from healthy aging to cognitive decline, the resilience to cerebral amyloid load (RECAL) matrix."],
    "22785400": ["AD-type pathology demonstrated in genetically unmodified rabbits calls attention to the considerable potential of the model for investigation of AD pathogenesis, diagnostics, and therapeutics."],
    "22874668": ["Since in the brain and other tissues of these mice, wild-type human AbetaPP mRNA and protein levels are comparable to those of endogenous AbetaPP, this model may allow studies about the role of AbetaPP isoforms in the pathogenesis of AD."],
    "23011729": ["The significance of this data and accompanying model pertains to the role transport plays in neuronal function, connectivity, and survival, and has implications in the pathogenesis of neurological disorders, such as Alzheimer's, Huntington and Parkinson's diseases."],
    "23276384": ["The 3xTgAD mouse model was used to test the hypothesis that a ketone ester-based diet can ameliorate AD pathogenesis."],
    "23383380": ["In this review we analyze the current situation in the use of zebrafish as a model for AD, discussing the reasons to use this experimental paradigm in CNS investigation and analyzing the several strategies adopted to induce an AD-like pathology in zebrafish."],
    "23419876": ["The expression of GxxxG motifs on either reactant under consideration is in line with this model of Alzheimer's disease pathogenesis, which clearly differs from the amyloid Abeta cascade theory, and which can, furthermore, be understood as a basic model for apoptosis induction."],
    "24150111": ["Consequently, 3xTg-AD mice may be a useful model in elucidating the role of immune system in the etiology of AD."],
    "24239247": ["The aim of this study is to develop a predictive model using proton magnetic resonance spectroscopy (1H-MRS), a noninvasive technique that evaluates brain chemistry in vivo, for monitoring the clinical outcome of carriers of a fully penetrant mutation that causes AD."],
    "24346216": ["We present a new model for etiology of Alzheimer's disease (AD) which postulates early involvement of specialized neuroprotective mechanisms in the pathology of AD."],
    "24910393": ["A hypothetical model for the role of sleep and the Abeta diurnal pattern in AD pathogenesis is proposed."],
    "25008180": ["In this study, we investigated the interrelation between AD and diabetes using a high-fat diet (HFD) in a mouse model of genetically induced AD-like neuropathology (3xTg-AD)."],
    "25131634": ["The results of this single-population gene expression analysis at the time of septohippocampal deficits in a trisomic mouse model shed light on a vulnerable circuit that may cause the AD-like pathology invariably seen in DS that could help to identify mechanisms of degeneration, and provide novel gene targets for therapeutic interventions."],
    "2519521": ["The association of antibodies to cholinergic neurons with cognitive deficits in this rat model suggests that such antibodies may be involved in the pathogenesis of AD."],
    "25213090": ["Furthermore, our study identifies a number of genes already known to be altered in human AD, thus confirming the use of the 5XFAD strain as a valid model for understanding AD pathogenesis and for screening potential therapeutic molecules."],
    "25297091": ["Thus, generation of a macaque model of AD that links Abeta oligomers to tau and synaptic pathology has the potential to greatly advance our understanding of mechanisms centrally implicated in AD pathogenesis."],
    "25310732": ["The 'amyloid cascade hypothesis' (ACH) is the most influential model of the pathogenesis of Alzheimer's disease (AD)."],
    "25754641": ["RESULTS: Here, using a Drosophila model of AD, we provide evidence suggesting that changes in neuronal excitability underlie the effects of sleep loss on AD pathogenesis. beta-amyloid (Abeta) accumulation leads to reduced and fragmented sleep, while chronic sleep deprivation increases Abeta burden."],
    "25864576": ["Based on the schema of a well-received model of biomarker dynamics in AD pathogenesis, it has been postulated that SCD symptoms may result from compensatory changes in response to beta-amyloid accumulation and neurodegeneration."],
    "26295040": ["We used a mouse model of amyloid beta- (Abeta-) induced AD, which is characterized by reactive gliosis and neuroinflammation in the brain, and we evaluated the effect of pentamidine on the main S100B-mediated events."],
    "26461298": ["Similar results were obtained by using a C.elegans model of Amyloid beta (Alphabeta) -induced toxicity mimicking Alzheimer's disease."],
    "26696886": ["Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis."],
    "26759118": ["With this strategy, we identified a sequence of early events likely to account for disease onset and described a model that may facilitate efforts to decipher the factors triggering AD and to evaluate early neuroprotective strategies."],
    "26918610": ["By using a new model of SCCH, our study unravels new insights into the implication of severe chronic cerebral hypoperfusion in AD pathogenesis, mainly by altering microglial cell activity and consequently Abeta clearance."],
    "26959388": ["To establish a new mouse AD model that takes advantage of this benefit, we produced transgenic mice expressing amyloid-beta (Abeta), a causative element for AD, in their auditory hair cells."],
    "27121378": ["METHODS: Wild-type (WT), TRPA1(-/-), amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic (APP/PS1 Tg) mice, the mouse model of AD, and APP/PS1 Tg/TRPA1(-/-) mice were used to examine the role of TRPA1 in pathogenesis of AD."],
    "27569580": ["Collectively, our data show that the tTa:APPsi model is characterized by a lack of sex-related differences in APP expression, making this model useful in deciphering the mechanisms of sex differences in AD pathogenesis."],
    "28186729": ["Although the amyloid (abeta peptide, Abeta) hypothesis is 25 years old, is the dominant model of Alzheimer's disease (AD) pathogenesis, and guides the development of potential treatments, it is still controversial."],
    "28413635": ["The amyloid hypothesis has become the dominant model of AD pathogenesis; however, the details of the hypothesis are changing over time."],
    "28459436": ["The findings in these index cases support a model in which early development of occult hippocampal hyperexcitability may contribute to the pathogenesis of AD."],
    "28707174": ["The Puri-Li kinetic model is explored here to study the contribution of microglia and astroglia during the pathogenesis of Alzheimer's disease (AD)."],
    "29338754": ["Because the ADLPAPT mouse model recapitulates the main features of AD pathogenesis, the proteomic data derived from its hippocampus has significant utility as a novel resource for the research on the Abeta-tau axis and pathophysiological changes in vivo."],
    "2934737": ["This possibility suggests a model for the pathogenesis of Alzheimer disease involving beta protein."],
    "29615895": ["For the first model, 7-month-old Lanyu-miniature-pigs were given the abdominal aortic constriction operation to induce hypertension and their AD-related pathologies were assessed at 1, 2, and 3 months after the operation."],
    "29754213": ["The Puri-Li kinetic model is modified to include neuronal calcium ion homeostasis to study the effect of calcium ions on the production of amyloid-beta peptides (Abeta), microglia, and astroglia during the pathogenesis of Alzheimer's disease (AD)."],
    "30043649": ["CONCLUSION: Our study on Drosophila model suggests that dysregulation of gut microbiota may participate in AD pathogenesis by influencing SCFA level."],
    "30149447": ["The icv injection of STZ model and STZ exposed Neuro-2a cells may be potential experimental models for assessing molecules related to the pathogenesis of sAD."],
    "30557391": ["We show that mini-brains obtained from a non-AD control cell line are responsive to chemical compound induction, producing a shift of physiological Abeta concentrations, suggesting that this model can be used to identify environmental agents that may initiate the cascade of events ultimately leading to sporadic AD."],
    "30837279": ["The senescence-accelerated mouse-prone 8 (SAMP8) model has been used to study age-related neurodegenerative changes associated with aging and the pathogenesis of AD."],
    "30982098": ["In addition, on the basis of the new genetic landscape, resulting from the recent high-throughput genomic approaches and emerging neurobiological information, we propose an over-arching model in which the focal adhesion pathway and the related cell signalling are key elements in AD pathogenesis."],
    "31342431": ["In this chapter, we demonstrate the use of all-atom molecular dynamics simulations to model the self-aggregation of a six-residue amyloidogenic peptide derived from amyloid beta, a 39-43 residue-long peptide associated with the pathogenesis of Alzheimer's disease."],
    "31421155": ["In conclusion, we suggest that cerebral organoids are a suitable AD model for scientific study, and that will provide us a novel insight into the understanding of the pathogenesis of AD."],
    "31450503": ["Blood platelets frequently serve as peripheral model for studying AD pathogenesis and might represent a reasonable biomarker source."],
    "31551757": ["Studies on these biological mechanisms together with the use of the AOF model have the potential to shed light on key molecular pathways underlying AD pathogenesis for the development of precision medicine approaches that take sex and hormonal status into account."],
    "31608251": ["This study assessed the effects of probiotic supplementation on spatial learning and memory, long-term potentiation (LTP), paired-pulse facilitation (PPF) ratios, nitric oxide (NO) concentrations, and lipid profiles in a rat model of amyloid beta (Abeta)(1-42)-induced Alzheimer's disease (AD)."],
    "34473990": ["This study establishes an excellent model to investigate the mechanism of activity-dependent hTau release and to better understand the role of phosphorylated tau release in the pathogenesis of AD since it relates to alterations in the early stage of neurodegeneration associated with increased neuronal activity."],
    "34585626": ["An AD-like homocysteine (Hcy) rat model was established to evaluate the effects of miR-132-3p on AD pathogenesis    in vivo    ."],
    "7739409": ["A model is proposed to explain the aetiology of Alzheimer's disease."],
    "8450928": ["Here we review current evidence in support of the cortical disconnection/cortical connectivity model of Alzheimer disease (AD) pathogenesis, a model which predicts that one of the first events in AD is damage to the entorhinal cortex and/or subiculum resulting in the disconnection of the hippocampal formation and neocortex, and the subsequent progression of the disease in a stepwise fashion along cortico-cortical connections."],
    "9115271": ["This model provides important clues to the potential functions of different parts of the presenilin molecule and how these might relate to the pathogenesis of Alzheimer's disease."],
    "9126173": ["The proposed mouse model may explain familial resistance to AD in man, provide extremely valuable insights into the etiology of AD, and suggest means for its prevention."],
    "9330979": ["Requiring urgent resolution is whether cellular changes seen in brains of aging normals represent merely the earliest phase of typical AD (and therefore a good model for Alzheimer pathogenesis), or rather reflect a totally different aging syndrome distinct from AD."],
    "31902262": ["Here, the effects of CGA on beta-amyloid protein (Abeta)-induced cell models were investigated, aiming to provide a direction for Abeta-induced AD."],
    "31922154": ["This new analytical strategy allows the direct detection and identification of all possible Asp, isoAsp, and Ser stereoisomers in Abeta, and may contribute to a better understanding of the pathogenesis of AD."],
    "31969500": ["Methods: After estradiol (E2) treatment in Abeta-induced AD cell model, reactive oxygen species (ROS), TXNIP, and apoptosis levels were detected."],
    "32023927": ["Genetic studies, biochemical data, and animal models have suggested that Abeta is responsible for the pathogenesis of AD (i.e., the amyloid hypothesis)."],
    "32212051": ["Taken together, the results of this meta-analysis clarified circulating autoantibodies to Abeta levels in AD patients and suggested that endogenous IgG and IgM-class antibodies to Abeta may play a role in the pathogenesis of AD."],
    "32341098": ["Beta-amyloid (Abeta) is thought to play a critical role in Alzheimer's disease (AD), and application of soluble oligomeric forms of Abeta produce AD-like impairments in cognition and synaptic plasticity in experimental systems."],
    "32355946": ["In this review, emerging evidence highlights the importance of the Abeta cascade hypothesis and indicates a significant role of Abeta and its aggregates as biomarkers in the pathogenesis of AD; we present an up-to-date summary on Abeta-based biosensor systems."],
    "32375443": ["Conclusion:     The inhibitor of mTOR rapamycin can improve the cognitive dysfunction of mice with AD induced by Abeta(1-42) and reduce deposition of Abeta(1-42) in the hippocampus, and the possible mechanism is rapamycin depressing the phosphorylation of mTOR as the same as Up-regulation the expression level of Homer3."],
    "32377164": ["A   beta     plays an important role in the pathogenesis of AD."],
    "32430275": ["The deposition of Abeta in the brain due to impaired Abeta clearance is considered as an important cause of AD."],
    "32479003": ["Effect of the King Oyster Culinary-Medicinal Mushroom Pleurotus eryngii (Agaricomycetes) Basidiocarps Powder to Ameliorate Memory and Learning Deficit in Ability in Abeta-Induced Alzheimer's Disease C57BL/6J Mice Model.One of the major causes of Alzheimer's disease (AD) is oxidative stress, which accelerates beta-amyloid peptide (AP) plaque and neurofibrillary tangle accumulation in the brain.", "Effect of the King Oyster Culinary-Medicinal Mushroom Pleurotus eryngii (Agaricomycetes) Basidiocarps Powder to Ameliorate Memory and Learning Deficit in Ability in Abeta-Induced Alzheimer's Disease C57BL/6J Mice Model.", "The aim of this study was to investigate the proximate and functional composition of P. eryngii, and evaluate the cognitive effects of low (LPE), medium (MPE), and high (HPE) P. eryngii dosages in an Abeta-induced Alzheimer's disease C57BL/6J mouse model."],
    "32496898": ["Abeta (1-42) was injected intracerebroventricularly to healthy male mouse to induce AD-like behavioral manifestations on Day-1 (D-1) of the experimental protocol."],
    "32531337": ["Ion channel formation by N-terminally truncated Abeta (4-42): relevance for the pathogenesis of Alzheimer's disease."],
    "32556928": ["As AD develops and progresses, mitophagy diminishes insoluble Abeta, and mitochondrial dysfunction seems to be a determining factor in the pathogenesis of AD."],
    "32587293": ["Such findings strongly implicate Abeta in the altered iron handling and increased oxidative stress observed in AD pathogenesis."],
    "32592731": ["Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Abeta-induced neuronal toxicity.Alzheimer's disease (AD) is a dementing, neurodegenerative disorder characterized by increased accumulation of beta-amyloid peptides (Abeta), degeneration of hippocampal neurons and the gradual development of learning and memory deficits."],
    "32599696": ["We also summarize the characteristics and pathogenicity such as the size, morphology and cytotoxicity of dimers, trimers, Abeta*56 and spherical oligomers, and suggest that Abetaos may play a different role at different phases of AD pathogenesis, resulting in differential consequences on neuronal synaptotoxicity and survival."],
    "32790274": ["Synthetic and biophysical studies on the toxic conformer in amyloid beta with the E22Delta mutation in Alzheimer pathology.The toxic conformer of the 40- or 42-mer-Abeta (Abeta40, Abeta42) with a turn at positions 22 and 23 plays a role in oligomer formation, leading to neurotoxicity as part of the pathogenesis of Alzheimer disease (AD)."],
    "32827351": ["DISCUSSION: Refining the molecular mechanisms connecting tau, Abeta, and apoE with cerebrovascular pathologies is critical for greater understanding of AD pathogenesis and establishing effective therapeutic interventions for the disease."],
    "32950104": ["Melatonin Induction of APP Intracellular Domain 50 SUMOylation Alleviates AD through Enhanced Transcriptional Activation and Abeta Degradation.The amyloid precursor protein (APP) intracellular domain (AICD) is implicated in the pathogenesis of Alzheimer's disease (AD), but post-translational modification of AICD has rarely been studied and its role in AD is unknown."],
    "33665647": ["Here, we review emerging evidence for a critical nexus among Abeta, tau, and the lysosomal protease cathepsin D (CatD) that we hypothesize may play a pivotal role in the etiology of AD.", "Despite a wealth of experimental and genetic evidence implicating both Abeta and tau in the pathogenesis of AD, the precise molecular links between these two pathological hallmarks have remained surprisingly elusive.", "Future research into these novel mechanistic links among Abeta, tau and CatD promises to expand our understanding of the etiology of AD and could potentially lead to novel therapeutic approaches for combatting this devastating disease of brain and mind."],
    "33912008": ["Evidence implicates elevated soluble oligomeric Abeta as one of the primary triggers during the prodromic phase leading to AD, effected largely via hyperphosphorylation of the microtubule-associated protein tau."],
    "33953832": ["Oral Administration of Gintonin Protects the Brains of Mice against A   beta    -Induced Alzheimer Disease Pathology: Antioxidant and Anti-Inflammatory Effects."],
    "34214643": ["Moreover, the concurrence of neuroinflammation and Abeta dyshomeostasis, which by reciprocal interactions drive the vicious cycle of neurodegeneration, contradicts Abeta as the primary trigger of AD."],
    "34272583": ["Our data indicate an essential role for intracellular prion-like Abeta and its synaptic spread in the pathogenesis of AD."],
    "34356865": ["AD has two significant pathological hallmarks: extracellular senile plaques composed of amyloid beta-peptide (Abeta) and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein, and the aggregation of Abeta, which starts in earlier stages, is usually claimed to be the primary cause of AD."],
    "34371202": ["Can platelet activation result in increased plasma Abeta levels and contribute to the pathogenesis of Alzheimer's disease?"],
    "34435574": ["Moreover, the mechanism of action of L7 on improving Abeta-induced AD was preliminarily investigated, and the results uncovered that the neuroprotective effects of L7 was might exerte via intervening Abeta-induced pyroptosis through NLRP3-caspase-1-GSDMD axis and ameliorating neuronal apoptosis by mitochondrial apoptosis pathway."],
    "34608607": ["However, intermediate soluble oligomers of Abeta are now recognized as initiators of the pathogenic cascade leading to AD."],
    "34655726": ["Genetic studies, biochemical data, and animal models have suggested that Abeta is a critical species in the pathogenesis of AD."],
    "34672433": ["CONCLUSIONS: Our findings confirmed that 6D11 has a therapeutic effect in APP/PS1 transgenic AD mouse model and Abeta-induced AD cell model, and the effect exerted via increase of neurogenesis and cell differentiation by transduction of Abeta peptide signal."],
    "34810230": ["Therefore, the predominant processing of C99 and enrichment of Abeta in late endosomes and lysosomes may be critical events in the molecular cascade leading to AD."],
    "34946712": ["The complete characterization of the copper complexes made with phenHH, phenHGH and H'phenH' is reported, along with the ability of ligands to remove Cu from Abeta, and to prevent the formation of reactive oxygen species catalyzed by Cu and Cu-Abeta, including in presence of zinc, the second metal ions important in the etiology of Alzheimer's disease."],
    "35098860": ["The mouse model of AD and the cell model induced by Abeta were established."],
    "35181336": ["CBD was found to alleviate the progression of Abeta-induced AD but not tau protein-induced AD or alpha-syn-induced Parkinson's disease."],
    "35292372": ["Abeta     (1-42)       was injected into the hippocampus of the animals to induce AD-like pathology."],
    "35452628": ["We found that: 1) Recognition memory impairment in Abeta-induced Alzheimer's disease model was associated with the reduction in TREM2 which induced microglial activation and neuroinflammation; 2) Exercise activated the TREM2 pathway, which was necessary for inhibiting microglial activation and neuroinflammation, leading to improved recognition memory in the Alzheimer's disease model."],
    "35786817": ["CONCLUSION: The tau deletion mutation significantly improved the synaptic damage caused by Abeta, and tau protein played an indispensable role in the synaptic dysfunction caused by Abeta, suggesting that Abeta and tau have close interactions in the pathogenesis of AD."],
    "35865745": ["Opinions are divided about whether there is enough evidence to definitely consider Abeta as a causative substance of AD."],
    "36074939": ["According to the amyloid cascade hypothesis, Abeta is the critical early initiator of AD pathogenesis."],
    "36120034": ["More importantly,    1c     could ameliorate the impaired learning and memory in Abeta-induced AD mice."],
    "36200197": ["Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Improve Composited Abeta-induced Alzheimer's Disease Model Rats' Memory and Neuroplasticity Disorders."],
    "36233130": ["Abeta and its isoforms are important factors in the Alzheimer's disease (AD) pathogenesis."],
    "36321205": ["Hippocampal injection of Abeta was used to induce AD.", "Abeta induced AD by Abeta plaques formation and increasing step-through latency time."],
    "36399096": ["Modulation of the effect of the epsilon4 alleles by    TOMM40     and    APOC1     variants indicates the potential genetic mechanism of differential roles of Abeta and tau in AD pathogenesis."],
    "36399277": ["Abeta and Tau Prions Causing Alzheimer's Disease."],
    "36809522": ["The present research aimed to investigate the possible protective effect of RJ on learning and memory in a rat model of Abeta-induced AD."],
    "36856542": ["The exact pathogenic mechanisms linking Abeta to AD pathogenesis remain however not fully understood."],
    "36899831": ["Of note, miRNA-146a-5p was exclusively dysregulated in the Abeta-induced AD model."],
    "37264159": ["Extensive studies indicate that beta-amyloid (Abeta) aggregation is pivotal for Alzheimer's disease (AD) progression; however, cumulative evidence suggests that Abeta itself is not sufficient to trigger AD-associated degeneration, and whether other additional pathological factors drive AD pathogenesis remains unclear."],
    "37342418": ["However, whether Abeta itself is a key toxic agent in AD pathogenesis and the precise mechanism of Abeta-elicited neurotoxicity are still debated."],
    "37372012": ["Reactive oxygen species (ROS) and lipid peroxidation (LPO) assays were performed and showed that the levels of ROS and LPO were markedly reduced in the caffeic acid-treated mice, as compared to Abeta-induced AD mice brains."],
    "37401257": ["However, the histidine behaviors of Abeta(1-42) are unconfirmed, which is the key point to understanding the pathogenesis of Alzheimer's disease."],
    "37849639": ["Within the framework of the ACH2.0, AD is triggered by amyloid-beta protein precursor (AbetaPP)-derived    intraneuronal     Abeta (   i    Abeta) and is driven by    i    Abeta produced in the AbetaPP-independent pathway and retained intraneuronally."],
    "37858630": ["Examples include the self-assembly of phenylalanine, which causes phenylketonuria; Abeta, which causes Alzheimer's disease; the tau protein, which causes both Alzheimer's and Parkinson's diseases; and alpha-synuclein, which causes Parkinson's illness."],
    "37886704": ["Retracted: Oral Administration of Gintonin Protects the Brains of Mice against A   beta    -Induced Alzheimer Disease Pathology: Antioxidant and Anti-Inflammatory Effects."],
    "38008888": ["We reported that UA treatment significantly alleviated memory decline in Abeta-induced AD model mice and APP23/PS45 double transgenic AD model mice."],
    "38178136": ["And the relation between the peripheral blood Abeta and tau tangles of brain, another crucial pathologic factor contributing to the pathogenesis of AD, is also ambiguous.", "In the present review, we summarize recent studies on the roles of peripheral blood Abeta and the peripheral innate immune cells in the pathogenesis of AD.", "More recently, the anti-Abeta monoclonal antibodies are approved for treatment of AD patients through declining the peripheral blood Abeta mechanism of action to enhance plasma and central nervous system (CNS) Abeta clearance, leading to a decrease Abeta burden in brain and improving cognitive function, which clearly indicates that the levels of the peripheral blood Abeta impacted on the Abeta burden in brain and involved in the pathogenesis of AD."],
    "38434588": ["This observation, along with the failure of previous clinical trials targeting Abeta or Tau and the modest success of recent trials using Abeta monoclonal antibodies, has led to a reappraisal of the view that Abeta accumulation is the sole factor in the pathogenesis of AD."],
    "38559176": ["It is well known that Abeta and tau proteins are deposited stereotypically in brain regions to cause Alzheimer's disease."],
    "38612434": ["In conclusion, we have identified DDX24 as a protein with a potential role in Abeta-induced AD pathology."]
  },
  "assertions": [
    {
      "subj": "Aluminum",
      "subj_cui": "C0002367",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 74,
      "pmid_refs": ["10612066", "10656181", "11307619", "11470314", "12039845", "12755500", "1436075", "14507468", "1490420", "15201486", "15666086", "15688540", "1575096", "15998000", "1614358", "16988476", "17004365", "1708474", "17119287", "17467804", "1784417", "18228200", "18571827", "19376155", "19744735", "19939225", "2016974", "21157018", "21440537", "21567285", "21614097", "21889563", "22467401", "22512666", "22878356", "23085282", "23103708", "23494944", "23806774", "24202576", "24343096", "24793376", "24806729", "25312136", "2614472", "26494454", "27709498", "30090569", "30315452", "30315453", "30337026", "30624431", "30764938", "31175888", "31321719", "31332715", "31460853", "3412205", "7016437", "7430560", "7606282", "7746806", "7845533", "8014196", "8167440", "8574016", "8772802", "8950699", "9187935", "9401741", "9423325", "9510431", "9861186", "9863396"]
    },
    {
      "subj": "aluminum_chloride",
      "subj_cui": "C0102840",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 77,
      "pmid_refs": ["22464639", "23821590", "25613582", "25630717", "25842984", "26306462", "26622218", "26897372", "28003750", "28499970", "28514831", "28650335", "28697918", "28715867", "29448848", "29770796", "30010139", "30537804", "30624431", "30802512", "31014012", "31103976", "31137621", "31148478", "31460853", "31553175", "31734542", "31860774", "32030557", "32329360", "32383521", "32932753", "33327909", "33582452", "33587299", "33971493", "34070220", "34103557", "34208063", "34354404", "34537230", "34542066", "34706318", "34727278", "34954699", "34971104", "35236271", "35243060", "35453412", "35507244", "35525893", "35596040", "36015156", "36194986", "36246933", "36290710", "36312298", "36385687", "36462588", "36554305", "36678510", "36761834", "37035098", "37242536", "37323056", "37368609", "37380861", "37454825", "37505462", "37631278", "37851769", "38052316", "38074017", "38090736", "38141332", "38181932", "38448794"]
    },
    {
      "subj": "Alzheimers_Disease",
      "subj_cui": "C0002395",
      "predicate": "CAUSES",
      "obj": "Cessation_of_life",
      "obj_cui": "C0011065",
      "ev_count": 336,
      "pmid_refs": ["10404929", "10459279", "10681274", "10822478", "10934557", "10993580", "11182240", "11279271", "11400868", "11433428", "11726544", "11803006", "12410910", "12861345", "12907842", "14769384", "15519530", "15526713", "15639804", "15825927", "15883266", "16189900", "16199521", "16712493", "16787840", "17017864", "17115369", "17192682", "17401657", "18042001", "1830977", "18322383", "18406539", "18488798", "18631956", "18647630", "18800967", "19036982", "19177976", "19426951", "19864195", "19897016", "19903243", "19912228", "20064601", "20298981", "20345790", "20383807", "20615444", "20664211", "20667675", "20739349", "20926742", "21155625", "21238939", "21374507", "21414557", "21694457", "21695038", "21766442", "21793014", "21840361", "21920373", "22133718", "22212311", "22254735", "22265578", "2231117", "22404854", "22543304", "22681044", "22696871", "22778828", "22888398", "23106978", "23113839", "23161037", "23170058", "23376032", "23397250", "23399672", "23424127", "23507120", "23507421", "23624206", "23650720", "23653484", "23742787", "23984328", "24201446", "24471710", "24689364", "24818261", "24838579", "24846640", "24850589", "24878198", "24922524", "25075874", "25220527", "25250042", "25405415", "25408208", "25472798", "25609918", "25833944", "25857971", "25954942", "2597884", "25984581", "25989911", "26022359", "26265552", "26435705", "26470401", "26510980", "26517378", "26690394", "2680026", "2682166", "26983930", "27127760", "27182464", "27190276", "27235708", "27570871", "27758699", "27776890", "27942104", "28043897", "28246336", "28396328", "28417590", "28426958", "28442216", "28490901", "28542120", "28624131", "28634681", "28825647", "28889269", "29024348", "29060753", "29061973", "29164499", "29270150", "29336270", "29372919", "29446066", "29538632", "29549645", "29677545", "29714994", "29749899", "29772289", "29862455", "29932100", "30039745", "30106219", "30108425", "30110946", "30171866", "30236015", "30243157", "30328325", "30371351", "30486438", "30532546", "30545070", "30560544", "30565076", "30707915", "30740125", "30747418", "30881282", "30922415", "31068785", "31201463", "31211444", "31262433", "31354494", "31379558", "31422384", "31430752", "31524171", "31540705", "31592230", "31689949", "31704512", "31837630", "31848379", "31862920", "31866858", "31871211", "31989900", "32097673", "32157811", "32241275", "32265696", "32327491", "32337953", "32341952", "32481301", "32486897", "32515311", "32531244", "32593336", "32600151", "32628119", "32709243", "32807227", "3285438", "32894711", "33011665", "33047398", "33126501", "33138782", "33282526", "33316174", "33434704", "33438444", "33500732", "33529936", "33532133", "33532699", "33750334", "33756057", "33802718", "33839469", "33916001", "34021875", "34030620", "34098466", "34208980", "34219726", "34228042", "34229061", "34273065", "34350508", "34353220", "34424488", "34522196", "34535721", "34572985", "34577590", "34606321", "34646644", "34687637", "34707479", "34712129", "34751889", "34867153", "34891761", "34971144", "35023084", "35109084", "35109462", "35186657", "35218718", "35280344", "35289055", "35431257", "35458896", "35486224", "35556967", "35599847", "35624938", "35665670", "35748395", "35784755", "35836098", "35858523", "35887134", "35961638", "35968378", "36165518", "36197131", "36268188", "36408377", "36475205", "36502321", "36537919", "36583187", "36589440", "36593834", "36674771", "36708701", "36780546", "36841050", "36842068", "36918389", "36940723", "36961417", "36993752", "36995136", "37038213", "37109528", "37208979", "37256433", "37304012", "37375767", "37486697", "37507902", "37612307", "37672968", "37679478", "37693600", "37955252", "37997077", "38131985", "38137554", "38213663", "38326859", "38371416", "38381402", "38414336", "38429957", "38612514", "38640743", "3876409", "7485229", "7921490", "7997077", "8195568", "8195569", "8610107", "8752460", "9154214", "9165306", "9333421", "9413702", "9460797", "9520072", "9647903"]
    },
    {
      "subj": "Alzheimers_Disease",
      "subj_cui": "C0002395",
      "predicate": "CAUSES",
      "obj": "Disease",
      "obj_cui": "C0012634",
      "ev_count": 252,
      "pmid_refs": ["10559765", "10993489", "11450439", "11513911", "11532247", "11585670", "11813874", "11816795", "11935076", "12459889", "12464614", "12473185", "12587940", "12629906", "12845151", "12884970", "12900170", "14599482", "14720176", "14758647", "15172740", "15219712", "15708428", "15723159", "15964666", "16139258", "16250840", "16396232", "16471078", "16472207", "16624449", "16752360", "16782202", "16914877", "16999991", "17119296", "17229880", "17245412", "17305591", "17556794", "17557921", "17605000", "17940659", "17981707", "17986152", "1814411", "18245893", "18289026", "18302763", "18378224", "18629638", "1877089", "18855662", "1927686", "19288120", "19424834", "19746990", "20021415", "20049724", "20054780", "20064547", "20157260", "20308790", "20431570", "20471965", "20497615", "20558146", "20608291", "20676620", "20840725", "20936705", "21091946", "21150306", "21439035", "2149746", "2184091", "21902668", "22079091", "22178988", "22251135", "22374313", "22458501", "22784036", "22795785", "22805236", "22815194", "22922141", "23036020", "23104637", "23395747", "23546882", "23604855", "23695007", "23834172", "23847532", "23850509", "24032632", "24059309", "24059311", "24059319", "24124693", "24190781", "24198785", "24204258", "24486820", "24737939", "24778618", "24852227", "24951455", "25080056", "25120477", "25225492", "25516763", "2554169", "25597552", "25680928", "25792373", "25847999", "25954942", "26236550", "26396519", "26398935", "26401704", "26470401", "26499250", "26567746", "26639971", "26733416", "26741695", "26756385", "26801191", "2690095", "26907663", "27058526", "27100611", "27414695", "27498879", "27514990", "27628303", "27943641", "28228716", "28294067", "2836376", "28364127", "28516241", "28527207", "28680398", "28739984", "28829364", "28947385", "29109429", "29151989", "29206067", "29228201", "29492246", "29551631", "29552692", "29630139", "29660940", "29689726", "29745345", "29856605", "30033062", "30040725", "30136680", "30315452", "30340518", "30415068", "30445661", "30465785", "30521994", "30609547", "30632506", "30741678", "30760863", "30819626", "30877738", "30932886", "31030513", "31122236", "31332445", "31403949", "31577960", "31771153", "32065096", "32292421", "32390857", "32592177", "32625049", "32719612", "32727580", "32955528", "32958234", "33035604", "33078674", "33178313", "33228179", "33384577", "33642365", "33673244", "34161823", "34200581", "34481234", "34589757", "34657885", "34765631", "34842276", "35346005", "35555555", "35710783", "35805958", "35832342", "35965800", "35986296", "36073854", "36324230", "36399267", "36469008", "36552984", "36671568", "37158125", "37163849", "37366656", "37395272", "37452088", "37476485", "37580797", "37631373", "37654709", "37848007", "37855293", "37875373", "38064104", "38300883", "38357597", "38473858", "38623383", "7582040", "7583683", "7653697", "7877576", "7967720", "8090716", "8239278", "8446172", "8528377", "8861021", "8881379", "9520006", "9546791", "9749615", "9990552"]
    },
    {
      "subj": "Alzheimers_Disease",
      "subj_cui": "C0002395",
      "predicate": "CAUSES",
      "obj": "Functional_disorder",
      "obj_cui": "C0277785",
      "ev_count": 70,
      "pmid_refs": ["11640946", "12451676", "14675724", "14970312", "15249195", "15950763", "16998901", "17413025", "17416103", "17908035", "18201950", "18480253", "19332976", "19350381", "19551456", "19614678", "19774105", "19839939", "19860724", "20445057", "20816785", "21219931", "21237171", "21429865", "21799246", "22101739", "22726800", "22753410", "22879025", "23011810", "23799536", "23979025", "24024140", "24251395", "24251604", "24715417", "24918635", "24954589", "25230232", "25359615", "25552414", "25710536", "25753421", "25821477", "26118731", "26275910", "26484912", "26487830", "26529297", "27199641", "27430312", "27748454", "27897204", "27910888", "28003750", "28081713", "28208063", "28869759", "28988799", "29116174", "29156571", "29274876", "29388925", "29776894", "30031108", "30108498", "30166454", "30244163", "30474638", "7699466"]
    },
    {
      "subj": "Amyloid",
      "subj_cui": "C0002716",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 270,
      "pmid_refs": ["10219973", "10589538", "10670439", "10818502", "10899442", "11019859", "11145990", "11181832", "11388427", "11455613", "11475420", "11496136", "11602326", "11701593", "11818564", "11848621", "11886820", "11967228", "12119153", "12214051", "12423367", "12496118", "12598899", "12600718", "12751917", "12821522", "12970358", "13130516", "14511676", "14640701", "14713297", "15071107", "15099019", "15181252", "15189029", "15240683", "15340356", "15452193", "15474359", "15565529", "15974916", "16170650", "16271725", "16289381", "16420415", "16539391", "16542055", "16581185", "16624948", "16626708", "1669714", "16723396", "16762454", "16822591", "16908985", "16945610", "16962711", "17013614", "17050537", "17086547", "17287054", "17374949", "17517969", "17531157", "17553417", "17566645", "17620492", "17650113", "17722071", "17907956", "18167346", "18304698", "18357680", "18395981", "18413473", "18422968", "18452319", "18473932", "18855672", "19270530", "19360426", "19572401", "19594760", "19610108", "19631265", "19634775", "19657023", "19678545", "19699263", "19794916", "19827625", "19843960", "19903023", "19957250", "20074226", "20101562", "20101719", "20164555", "2025422", "20306540", "20348021", "20362424", "20429609", "20456003", "20583856", "20637185", "20665950", "20674676", "20675873", "20972410", "21222605", "21233670", "21270904", "21315759", "21318523", "21395066", "21472290", "21476939", "21480689", "21504387", "21706413", "21839813", "21897007", "21961303", "22031884", "22042506", "22202113", "22288451", "22342932", "22351073", "22702727", "22727791", "22833976", "23036978", "23134284", "23300647", "23383341", "23420027", "23512986", "23516302", "23662474", "23794448", "23942088", "24162852", "24277156", "24287378", "24491999", "24985739", "25066110", "25108368", "25639816", "25686760", "25686800", "25714795", "26073444", "26244661", "26411291", "26440073", "26594145", "26618706", "26786779", "26883101", "27018282", "27071404", "27072891", "27072999", "27106205", "27303604", "27318146", "27481595", "27634977", "27710900", "27867033", "27922847", "28261990", "28271324", "28320296", "28352309", "28509380", "28592267", "28756148", "28774853", "28815614", "28866757", "28900376", "2890206", "28993924", "29158049", "29191087", "29311595", "29427089", "29444819", "29966723", "30126231", "30127003", "30220236", "30232325", "30483749", "30572184", "30723404", "30786665", "30868421", "30936829", "30946834", "30959405", "31095505", "31108937", "31164812", "31193333", "31211853", "31299145", "31301179", "31332160", "31458243", "31482248", "31629115", "31639294", "31722781", "31876283", "32035959", "32046518", "32350803", "32353422", "32508629", "32831200", "3288032", "32907613", "33092519", "33186671", "33480241", "33509204", "34123738", "34299592", "34488020", "34520451", "35109309", "36420978", "36856252", "37774681", "38352874", "38473975", "7491048", "7565212", "7708775", "7750567", "7763339", "7812796", "7822152", "8131745", "8146663", "8159255", "8185566", "8489324", "8604204", "8606673", "8706841", "8740984", "8761337", "8997415", "9116244", "9168112", "9348103", "9399697", "9630681", "9683325", "9794144", "9865931", "9928821"]
    },
    {
      "subj": "Amyloid_beta_Peptides",
      "subj_cui": "C0078939",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 215,
      "pmid_refs": ["31949779", "31991578", "32028683", "32046252", "32142821", "32210564", "32272441", "32307772", "32354467", "32372339", "32444869", "32580638", "32683653", "32733240", "32848600", "32973471", "32975365", "32990912", "33010207", "33066971", "33074279", "33132896", "33189440", "33208229", "33224974", "33225679", "33238667", "33258115", "33279620", "33310049", "33353018", "33359145", "33386802", "33400522", "33401892", "33414705", "33426095", "33495810", "33503934", "33508037", "33535469", "33560154", "33571523", "33571524", "33624157", "33716668", "33727592", "33750486", "33785017", "33803769", "33828600", "33845371", "33848635", "33851209", "33875089", "33876786", "33898246", "33908427", "33935701", "33967797", "33976546", "33977265", "34006557", "34051062", "34053209", "34078792", "34080759", "34084446", "34086399", "34099032", "34133880", "34151790", "34280181", "34285489", "34286787", "34294676", "34299316", "34343891", "34407949", "34411643", "34446574", "34502282", "34628876", "34654465", "34669098", "34671708", "34677321", "34695393", "34715093", "34733055", "34789556", "34798299", "34801648", "34832029", "34838849", "34856900", "34861133", "34867177", "34878807", "34943094", "34971171", "35013124", "35019536", "35043380", "35108926", "35109138", "35109187", "35122611", "35134462", "35148068", "35156141", "35212149", "35214143", "35281253", "35294796", "35306343", "35372522", "35443153", "35443198", "35459147", "35474400", "35531555", "35631608", "35656096", "35663520", "35666692", "35741166", "35742862", "35759136", "35762411", "35928227", "35956985", "36015135", "36044812", "36058175", "36084891", "36093396", "36120782", "36144245", "36155521", "36214002", "36221865", "36284704", "36361906", "36362046", "36422822", "36438603", "36510132", "36544574", "36549596", "36596482", "36610160", "36623626", "36630532", "36651694", "36674792", "36680733", "36704637", "36803816", "36816173", "36866639", "36868776", "36878848", "36889654", "36945328", "36945751", "36978955", "37068195", "37101809", "37105250", "37173803", "37179042", "37212117", "37239068", "37245024", "37263123", "37307834", "37348174", "37506558", "37607046", "37609338", "37619312", "37626631", "37628913", "37654789", "37663321", "37667395", "37718800", "37728399", "37758932", "37853914", "37905874", "37921143", "37935338", "37976283", "37983764", "38053635", "38071408", "38143280", "38163326", "38188833", "38194817", "38211684", "38242524", "38287166", "38344035", "38455162", "38473727", "38475929", "38497073", "38534427", "38615460"]
    },
    {
      "subj": "Amyloid_beta_Protein",
      "subj_cui": "C0078939",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 144,
      "pmid_refs": ["10195200", "10206645", "10379578", "10479682", "10632583", "10878808", "10933822", "10944232", "10959033", "10978191", "11099491", "11140685", "11193150", "11227137", "11378243", "11549733", "12052174", "12153480", "12196135", "12740129", "12740439", "12937642", "1418219", "14522007", "1461350", "14659572", "15286183", "15363895", "15485850", "15850663", "15944381", "15975058", "15975082", "16324726", "16364890", "16597736", "16650774", "16752395", "16771827", "17069749", "17073707", "17076655", "17108166", "17286590", "17331655", "17376966", "17507561", "17767011", "18275940", "18359102", "18400214", "18404827", "18515070", "18537546", "18554321", "18650433", "18728806", "19167357", "1933692", "19337829", "19384407", "19402778", "19407341", "19710311", "19786811", "19890727", "19930651", "20097446", "20129098", "20348104", "20558149", "20586699", "20600609", "20616783", "20659435", "21197086", "21375783", "21423554", "21487536", "21924918", "22086139", "22285195", "22543851", "23041348", "23182244", "23427404", "23789343", "23844122", "23991168", "24052108", "24566726", "24680748", "24823497", "24840308", "24936619", "24962158", "25169677", "25655625", "25881896", "26394756", "26401936", "26463138", "26496862", "26614753", "26839237", "27058526", "27406082", "27543203", "27546887", "27641666", "27873937", "27940601", "28131834", "28371680", "28567323", "29056865", "2907602", "29086767", "29165985", "29214278", "29478851", "29549749", "30346704", "30448407", "30532948", "31349027", "31478183", "7650762", "7695621", "7777509", "8033965", "8084515", "8086012", "8239276", "8239277", "8321160", "8380642", "8636108", "9007411", "9799084", "9830016", "9844014", "9928821"]
    },
    {
      "subj": "Amyloid_beta_Protein_Precursor",
      "subj_cui": "C0085151",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 251,
      "pmid_refs": ["10215996", "10329382", "10466897", "10591213", "10607841", "10670439", "10727079", "10742146", "10997291", "11004129", "11029529", "11099780", "11238726", "11277983", "11432978", "11528419", "11536196", "11536323", "11706973", "11741910", "11840170", "11851430", "11935293", "12011466", "12213230", "12214125", "12223532", "12463910", "12473667", "12496118", "12540236", "12670422", "12694406", "12749853", "12948653", "1415269", "14507929", "14598315", "14973371", "15035625", "15067372", "15114629", "15171563", "15197738", "15207262", "1521868", "15268750", "15274612", "15689559", "15824102", "15955598", "15989509", "16140161", "16252002", "16375745", "16446073", "1669714", "16822978", "16930452", "17119293", "17239395", "17303345", "17307738", "17319802", "17360920", "17405930", "17490685", "17536333", "17596704", "17620134", "17961921", "18237744", "18266116", "18275940", "18304698", "18395981", "18413473", "18468996", "18538664", "18599481", "18776243", "18781290", "18833287", "18953033", "18996484", "19075758", "19130181", "19239106", "19433918", "19544621", "19619643", "19699790", "19786811", "20016085", "20053918", "20140888", "20167227", "20348021", "20395961", "20703260", "21034527", "21034535", "2113416", "2115075", "21331224", "21516353", "21605029", "21626267", "21785276", "21798242", "22120156", "22166205", "22303960", "22494386", "22510281", "22734645", "22940630", "22952038", "22973448", "23289174", "23365231", "23368879", "23475515", "23585889", "23613819", "23691241", "23863461", "23899629", "23907250", "23926111", "24009040", "24086147", "24305823", "24361736", "24466315", "24556009", "24748914", "24827165", "24859793", "24880964", "24936619", "25043039", "25101540", "25126078", "2514387", "25194880", "25528641", "25534782", "25740230", "25740315", "25951880", "26007212", "26070242", "26145164", "26188042", "26312828", "26597721", "26614345", "26623517", "26814888", "26862204", "27062894", "27079722", "27094130", "27133790", "27303258", "28360418", "28371615", "28595039", "28941357", "28946017", "28963516", "28966576", "29052089", "29080748", "29090690", "29101243", "29106038", "29546477", "29661886", "29687167", "29984654", "30207230", "30630900", "30951743", "31011484", "31143098", "31204041", "31453210", "31597094", "31779518", "31806024", "31915254", "31960113", "32105841", "32219307", "32331992", "32342327", "32471175", "32588983", "32711019", "32921309", "32975365", "33309748", "33380425", "33551786", "34058678", "34229070", "34366358", "34532568", "34830236", "35120450", "35377629", "35453040", "35543350", "35579846", "35882892", "36412210", "36442651", "36579387", "36717226", "36966431", "37183375", "37240173", "37387352", "37830617", "38311171", "7536093", "7758106", "7822152", "7845465", "7897394", "7898047", "7950974", "7952845", "8028788", "8117426", "8251141", "8648890", "8787835", "9168112", "9295226", "9438067", "9574821", "9582384", "9593752", "9811864", "9839536", "9869322", "9930726"]
    },
    {
      "subj": "Apolipoprotein_E_APOE",
      "subj_cui": "C0003595|348",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 68,
      "pmid_refs": ["10420066", "10655544", "10775884", "10818522", "10899434", "11005255", "11145984", "11165374", "11212354", "11980062", "12214015", "12355988", "12573540", "12661900", "14511323", "14757931", "15159602", "15634227", "15716586", "16198584", "16641890", "17166269", "17854398", "18205697", "18430993", "18580587", "19116777", "19472365", "20348021", "20538374", "21676498", "22482075", "22502767", "22883744", "23541982", "24154541", "24894353", "24971061", "26401939", "26413387", "26582899", "27104063", "27922847", "28218653", "29376871", "30032423", "30140051", "30194628", "30804776", "31062326", "31623648", "32027932", "35639372", "7615568", "7619525", "7695621", "7761390", "8809843", "8813351", "8832646", "9073026", "9307253", "9326451", "9523562", "9700208", "9740234", "9751198", "9844032"]
    },
    {
      "subj": "APP_gene",
      "subj_cui": "C1364818",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 240,
      "pmid_refs": ["10561592", "10653285", "10704308", "10869810", "10956426", "11150636", "11467851", "11513577", "11590033", "11595492", "11684351", "11899259", "11906199", "12025858", "12034808", "12128086", "12165357", "12214126", "12235837", "12384498", "12450704", "12453675", "12491772", "12600720", "12794314", "12835512", "12944403", "12972166", "15094512", "15181249", "15223066", "15234966", "15294135", "15364896", "15364953", "15365148", "15519283", "15615644", "15668631", "15672443", "15850663", "16054018", "16226718", "16250840", "16289870", "16377636", "16472119", "16472155", "16539675", "16645451", "16651627", "16786033", "16794858", "16865398", "16954700", "16979587", "17055579", "17080204", "17194489", "17316541", "17393484", "17493709", "17521225", "17687040", "17827153", "18053791", "18056412", "18245849", "18252750", "18393801", "18509986", "18537540", "18571334", "18571499", "18590917", "18606218", "18650431", "18723506", "18760331", "18835787", "18847222", "18926803", "18956886", "19026087", "19081767", "19094587", "19124085", "19221413", "19222911", "19275251", "19288120", "19295161", "19501112", "19515914", "19551456", "19725915", "19774677", "20045708", "20135308", "20153835", "20478062", "20684593", "20704753", "20720123", "20732423", "20824130", "20855613", "21166677", "21214928", "21274428", "21318512", "21348837", "21350608", "21442216", "21446542", "21464905", "21502851", "21527912", "21605029", "21740063", "21896486", "21944886", "22288403", "22300406", "22327103", "22407769", "22468783", "22482075", "22540007", "22545812", "22613765", "22660329", "22675658", "22727994", "22840746", "22891248", "23143229", "23279783", "23279943", "23324234", "23436150", "23474291", "23582659", "23651610", "23713771", "23756182", "24130920", "24148205", "24418687", "24491999", "24529520", "24747018", "24803005", "24900405", "25108425", "25152012", "25193466", "25391447", "25465238", "25815792", "25856695", "25858471", "25908557", "26007213", "26071020", "26104317", "26168900", "26230612", "26235069", "26314631", "26316988", "26403946", "26444772", "26515666", "26529393", "26606631", "26642316", "26818522", "26861514", "26896721", "27157482", "27418961", "27420352", "27554967", "27630262", "27665848", "27806872", "28082052", "28183246", "28231543", "28352309", "28411131", "28413720", "28502705", "28582770", "28657440", "28711595", "28826585", "28846851", "29124171", "29260173", "29332044", "29495486", "29544432", "29568268", "29702072", "29733614", "29849984", "29886524", "29887142", "29945247", "30021335", "30087609", "30185465", "30257562", "30318785", "30322673", "30542277", "30564549", "30579679", "30622228", "30713632", "30814820", "30842555", "30911686", "30950339", "31093882", "31171765", "31301179", "31325011", "31349027", "31403945", "31524157", "31625272", "31642314", "31647947", "34453977", "35491248", "8766821", "9065490"]
    },
    {
      "subj": "APP_protein_human",
      "subj_cui": "C0611285",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 299,
      "pmid_refs": ["10212241", "10729621", "10880853", "10899433", "10949910", "11483961", "11588612", "11786314", "11815632", "11912198", "12025816", "12025858", "12063304", "12074840", "12176077", "12359256", "12391610", "12392766", "12446966", "12446972", "12493601", "12607822", "12846562", "14646594", "14698294", "14732699", "15065253", "15267231", "15304503", "15341515", "15347683", "15502844", "15633014", "15880461", "15882358", "15955457", "15959937", "15975052", "16255678", "16364896", "16446073", "16595673", "16696577", "16781151", "16817891", "16893185", "16897184", "16946102", "17035538", "17054909", "17169612", "17177887", "17382287", "17404210", "17428603", "17471072", "17495608", "17511455", "17551018", "17606418", "17876751", "17897958", "17997700", "18063474", "18252750", "18258258", "18385378", "18387708", "18400162", "18411275", "18471993", "18625450", "18930548", "18957217", "19057576", "19075706", "19122666", "19198114", "19277012", "19352532", "19402777", "19450545", "19469700", "19558683", "19646546", "19751725", "19782682", "19837693", "19841277", "19862643", "19906677", "19926793", "19928820", "20008660", "20014755", "20021564", "20026079", "20030227", "20088802", "20157254", "20447471", "20456731", "20483339", "20514639", "20590832", "20596738", "20643087", "20674685", "20691893", "20721410", "20858952", "20974113", "21068297", "21091946", "21223993", "21297277", "21491887", "21513747", "21527912", "21559427", "21629967", "21712440", "21858698", "21958962", "22044482", "22090477", "22102917", "22202057", "22267726", "22279212", "22332002", "22384101", "22514691", "22528098", "22544746", "22551668", "22570624", "22621900", "22735675", "22834820", "22879596", "22886024", "22988239", "23023105", "23092134", "23196551", "23232068", "23237322", "23249207", "23270374", "23387074", "23420419", "23456036", "23461850", "23509904", "23525279", "23565721", "23585568", "23659495", "23708585", "23714261", "23948943", "24008925", "24081144", "24251391", "24295810", "24361736", "24366271", "24446231", "24494584", "24503618", "24503620", "24512022", "24566006", "24649396", "24815946", "24832605", "25221640", "25456402", "25505877", "25533654", "25553446", "25650940", "25747232", "25818846", "25825723", "25997382", "26023729", "26024352", "26092626", "26271894", "26359500", "26491725", "26593432", "26652010", "26794527", "26868929", "26890786", "26963025", "26981406", "27030596", "27093940", "27137996", "27151330", "27163800", "27392871", "27441457", "27562438", "27580372", "27660034", "27663971", "27750416", "27769888", "27777990", "27796749", "27884599", "28017718", "28052060", "28096459", "28260388", "28288354", "28360830", "28400058", "28562008", "28569090", "28570778", "28650319", "28670737", "28674340", "28687859", "28861757", "28870815", "28889204", "28941799", "28985224", "28987946", "29118109", "29132916", "29138762", "29161341", "29192843", "29199321", "29210443", "29224965", "29310862", "29315574", "29440986", "29448601", "29491833", "29619615", "29648443", "29658548", "29743204", "29764453", "29781021", "29899186", "29905953", "29906302", "29927573", "29945719", "30043821", "30086173", "30214656", "30260016", "30264333", "30268822", "30345755", "30362029", "30402707", "30426203", "30480246", "30486385", "30551397", "30675620", "30704515", "30794963", "30830576", "30900203", "30911827", "30913789", "30949973", "30964132", "31048748", "31164420", "31234321", "31247730", "31365254", "31367507", "31368868", "31369984", "31595293", "31607898", "31796114", "31809572", "31814468", "7556364", "7777177"]
    },
    {
      "subj": "Dementia",
      "subj_cui": "C0497327",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 61,
      "pmid_refs": ["10867221", "12480441", "15608634", "16037976", "16046825", "16092095", "16401890", "17143085", "18041446", "19672571", "20596916", "21542885", "22492589", "22574282", "23100439", "23338285", "23707728", "23828739", "24505903", "25083748", "25435921", "2545826", "26161148", "26862951", "26882509", "27040140", "27554603", "27890830", "28522216", "28729192", "29226870", "29383688", "29389553", "29957266", "30424485", "30696930", "30942758", "30949934", "30998476", "31182772", "31248465", "31356838", "31486140", "32615251", "33126501", "33207563", "33396415", "33472953", "34237255", "35493944", "36113115", "36254682", "36362376", "37223834", "37425748", "37543811", "37629545", "38491393", "8739399", "9058061", "9625186"]
    },
    {
      "subj": "Disease",
      "subj_cui": "C0012634",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 77,
      "pmid_refs": ["10570621", "10879068", "11006125", "11741391", "12480441", "12740808", "14758627", "15340159", "16120299", "17337008", "17892369", "17922309", "18041446", "1976213", "19777328", "20059701", "20305996", "20413848", "20442493", "20552018", "20601643", "21391278", "21504127", "22886015", "2313044", "23811083", "24059308", "24899710", "25435363", "26283893", "26618971", "27094492", "27313503", "27699087", "28122529", "28261376", "28387677", "29301530", "2941815", "30546389", "30696930", "30740049", "30937343", "31127574", "31228376", "31456206", "31521231", "31605538", "31607780", "31894361", "31900899", "32225073", "32696388", "33302541", "33457489", "33512819", "33629978", "33806317", "34439596", "34609116", "35463002", "35563253", "36430144", "36431219", "36436686", "37000425", "37693644", "37811614", "37934647", "38064104", "38203429", "38549636", "7542917", "8198393", "8290042", "8871938", "8912490"]
    },
    {
      "subj": "Functional_disorder",
      "subj_cui": "C0277785",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 150,
      "pmid_refs": ["10737603", "10790719", "11447838", "12387703", "12453672", "12476348", "1453480", "14689635", "15639790", "15781969", "15847115", "16002400", "16078048", "16178023", "16569229", "16814428", "17168642", "17512984", "17558294", "17678440", "17696767", "1776729", "17786024", "17911214", "17959149", "17986027", "18322383", "18641892", "18949251", "19182481", "19389700", "19417214", "19496804", "19519498", "19544621", "19682326", "19853658", "19907182", "20016833", "20061648", "20107079", "20127811", "20463402", "20512543", "20553766", "20555132", "20661404", "20730022", "20840064", "21046564", "21112383", "21143177", "21244356", "21336338", "21450370", "21514369", "2165009", "22024748", "22391273", "22539855", "22751174", "22833458", "22914888", "22922216", "22961084", "22995655", "23107435", "23126372", "23151073", "23382999", "23494712", "23756733", "23948929", "24171818", "24252187", "24450113", "24512632", "24610177", "24664866", "24684730", "24713000", "24728903", "24902900", "25045655", "25062013", "25106114", "25322927", "25400096", "25465240", "25511446", "25531259", "25533203", "25688079", "26075247", "26126792", "26186010", "26311408", "26359500", "26380416", "26440450", "26500157", "26601965", "26647379", "26829765", "26869037", "26949964", "26976084", "27073745", "27340665", "27439966", "27556379", "27581448", "27599716", "27629410", "27634555", "27634936", "27653553", "27834780", "27987381", "28131207", "28237964", "28299814", "28531191", "28934248", "28956268", "28988799", "29089996", "29124106", "29127191", "29255835", "29320772", "29354787", "29516292", "29551631", "29777753", "29863022", "29992725", "30009706", "30144541", "30292394", "30296191", "30352630", "30362531", "30472149", "30478411", "30481567", "3539000", "7280699", "8892355", "9452785"]
    },
    {
      "subj": "Genes",
      "subj_cui": "C0017337",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 69,
      "pmid_refs": ["10210960", "10349334", "10464576", "11290552", "12227924", "12235837", "12489805", "12491772", "15584876", "15917099", "18005339", "18161858", "18165854", "19173769", "19902022", "19912889", "21440575", "22482075", "22618995", "23111619", "23669301", "23811083", "23833557", "25362032", "25432889", "25845235", "26289409", "26394601", "26742512", "27345973", "27345998", "28666362", "28855300", "29262769", "29675796", "29692703", "30315455", "30740125", "30797548", "31043483", "32019384", "32429084", "32741831", "32804129", "33310624", "33512697", "33712570", "34308907", "34892435", "35045380", "35108947", "35120450", "35768560", "35955777", "37302034", "37796069", "37855447", "38306048", "38343132", "7845336", "8220418", "8357032", "8740984", "8787186", "8904781", "9622002", "9666901", "9772024", "9851443"]
    },
    {
      "subj": "Inflammation",
      "subj_cui": "C0021368",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 105,
      "pmid_refs": ["10869806", "11715204", "11738475", "11754998", "11755000", "12099698", "12973747", "15473667", "15644140", "15665405", "15681802", "15748779", "16192374", "16384684", "16478525", "16602061", "16787834", "17027528", "17262990", "17767011", "17949824", "19914323", "20011709", "20160456", "20195797", "20933033", "21143138", "21567187", "21920632", "21951392", "22342162", "23046210", "23533697", "23566485", "24369524", "24384767", "24413537", "24557039", "24631395", "25051986", "25554493", "26103884", "26587902", "26899953", "26910914", "26913031", "27010693", "27357286", "27412235", "27829994", "28460142", "28977138", "29249963", "29393440", "29562537", "29628886", "30403186", "30564548", "30661858", "30777084", "30929586", "30968773", "31233762", "31312547", "31451750", "31680874", "31865964", "31867568", "32444542", "32606694", "32765394", "32781098", "32916195", "33422142", "33737171", "33881288", "33977208", "34023945", "34025357", "34032945", "34245502", "34260075", "34340010", "34384901", "34403662", "34856902", "35145898", "35327563", "35601620", "36204826", "36340795", "36675125", "36982996", "37251647", "37332353", "37337817", "38157740", "8712791", "8892340", "8892348", "8996832", "9545438", "9550286", "9651139"]
    },
    {
      "subj": "MAPT",
      "subj_cui": "4137",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 60,
      "pmid_refs": ["15615644", "16262633", "16953147", "17044033", "17077307", "17360920", "17361031", "17562708", "18583940", "18690834", "18855662", "19742193", "20422200", "20683187", "20730022", "20926667", "21348938", "22401494", "22922102", "23052602", "23517246", "23659495", "23828739", "23904623", "24027553", "24076336", "24493463", "24785461", "24936619", "25169677", "25442111", "26563932", "26943044", "27034421", "27079722", "27152883", "27651066", "28186985", "28420695", "28580182", "28655349", "29237931", "29278891", "29554190", "29782836", "29954063", "30278184", "30382187", "30744518", "30864847", "31016584", "31308793", "31524157", "31796124", "7532213", "7533559", "7566354", "7822152", "7891887", "8764598"]
    },
    {
      "subj": "Mutation",
      "subj_cui": "C0026882",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 188,
      "pmid_refs": ["10037473", "10352866", "10381410", "10448055", "10518543", "10526115", "10624576", "10662826", "10671319", "10764737", "10891589", "10934557", "10951459", "11193801", "11300728", "11321043", "11398010", "11406330", "11447832", "11466028", "11684347", "11695101", "11701593", "11714100", "11813874", "11816793", "11851296", "11876645", "11899259", "12068009", "12125371", "12185765", "12230303", "12402229", "12489805", "12527416", "12876480", "1303172", "1365885", "14563691", "14566063", "15094078", "15639313", "15722417", "15834426", "15989638", "15992373", "16407539", "16478768", "1671712", "16805926", "16873960", "16917905", "16941492", "17114823", "17344096", "17366635", "17514900", "17947293", "18369390", "18675468", "18694898", "18727676", "18852354", "1900373", "19363265", "19625741", "19823103", "19924286", "19932144", "20173332", "20452980", "20461595", "20523046", "20655969", "20678067", "20858971", "21318527", "21368062", "21482412", "21501974", "21919498", "21971471", "22122678", "22153900", "22297172", "22307680", "22618995", "22749011", "22944690", "23327526", "23579031", "23649480", "23761040", "24029002", "24099007", "24409422", "24704512", "24773620", "25069482", "25239621", "2602419", "26108876", "26146489", "26282939", "26350633", "26756738", "26852951", "26925509", "27313629", "27325702", "27498054", "27557896", "28054745", "28103467", "28181072", "28495961", "28739993", "28753424", "28841371", "28898051", "29103038", "29182052", "29440563", "29494861", "29670961", "29857474", "29915376", "30021643", "30040714", "30510423", "30626721", "30632506", "30904577", "31109937", "31135820", "31198028", "31295475", "31578030", "31697913", "31699328", "32216003", "32241222", "32894632", "32925067", "32954172", "32966331", "33188256", "33218200", "33255694", "33494218", "33965374", "34133918", "34207526", "34725778", "35109404", "35421846", "35602652", "35850649", "36139715", "36503128", "36704504", "37024647", "37357229", "37919079", "37990912", "7584064", "7697197", "7761987", "7763337", "7937606", "8215975", "8618867", "8733749", "8867023", "8918895", "9052714", "9117566", "9562460", "9623986", "9667817", "9674758", "9678319", "9720489", "9740395", "9850912", "9920359"]
    },
    {
      "subj": "Nerve_Degeneration",
      "subj_cui": "C0027746",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 83,
      "pmid_refs": ["10928742", "11226152", "15036597", "15197750", "15704193", "17017913", "17197420", "18067990", "18157656", "18645613", "18648646", "19114068", "19264902", "19373562", "19683527", "19685437", "19801631", "19903025", "20080301", "20594619", "21371450", "21547225", "21663966", "21786197", "22232001", "22266106", "22505366", "23151073", "23701948", "23783773", "24514870", "25399848", "25511446", "25713139", "26083882", "26555572", "26557086", "26880859", "26898910", "27111252", "27776205", "27879212", "28094792", "28157684", "28861684", "29159058", "30041064", "30058479", "30120962", "30595042", "31121578", "31686097", "31689310", "32143546", "32183332", "32651317", "32795415", "32813239", "32903806", "33180216", "33290860", "33337366", "33459705", "33495355", "33788812", "33977208", "34072862", "34087544", "34100423", "34681867", "35283778", "35346299", "36012707", "36091826", "37190116", "37477796", "38020769", "38542219", "8423065", "8620894", "9223085", "9514829", "9700651"]
    },
    {
      "subj": "Oxidative_Stress",
      "subj_cui": "C0242606",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 232,
      "pmid_refs": ["10507060", "10568522", "10681271", "10850732", "10867210", "10899439", "11068183", "11079778", "11232594", "11578751", "11640950", "11708617", "11738475", "11771743", "11884366", "11890747", "12488575", "12870699", "12893008", "14656990", "14661103", "15036353", "15039034", "15096699", "15105265", "15120069", "15141484", "15370876", "15380154", "15500684", "15614428", "15635602", "15723615", "15753151", "16181112", "16271804", "16298240", "16311508", "16337883", "16399210", "16538519", "16624449", "16703529", "16860790", "16873963", "16930434", "17121373", "17210195", "17279615", "17460216", "17664130", "17707551", "17761673", "17764625", "17996678", "18084903", "18297609", "18427999", "18524497", "18539391", "18565274", "18662010", "18762245", "18780972", "18822368", "19166318", "19200343", "19250756", "19345730", "19907182", "19950527", "20026169", "20236039", "20302830", "20381316", "20541661", "20555132", "20564553", "20586698", "20691758", "20933033", "20966918", "21357903", "21426072", "21463622", "21551909", "21605062", "21631359", "22008267", "22137893", "22172527", "22406441", "22430645", "22500616", "22539855", "22541290", "22664577", "22708607", "22811764", "22998047", "23107435", "23200807", "23228953", "23254632", "23420079", "23480224", "23849337", "24372221", "24423585", "24788773", "24846973", "25322927", "25462645", "25511446", "25620241", "26171115", "26295822", "26500157", "26587902", "26629876", "26890100", "27010693", "27040443", "27129593", "27252059", "27351675", "27386059", "27498145", "27774420", "27796749", "28332351", "28448946", "28970897", "29090409", "29109370", "29112116", "29512790", "29574628", "29951441", "30112360", "30151968", "30498443", "30689517", "30694418", "30729451", "30984280", "31006097", "31022822", "31057691", "31117312", "31151322", "31165850", "31173752", "31247877", "31403949", "31424393", "31462605", "31495239", "31521745", "31585875", "31607444", "31686372", "31766696", "31939658", "31945778", "32035419", "32124703", "32171783", "32180930", "32277437", "32329360", "32444542", "32504391", "32594052", "32606694", "32730855", "32737764", "32765394", "32829453", "32920833", "33052996", "33081348", "33114450", "33239403", "33264657", "33476985", "33488846", "33567524", "33633844", "33679375", "33774476", "33811448", "33897425", "34107282", "34403662", "34662512", "34932880", "35049930", "35226474", "35280979", "35341471", "35395415", "35411685", "35474814", "35961386", "36014181", "36091821", "36091826", "36139869", "36476438", "36587558", "36635346", "36744334", "36999542", "37231172", "37385075", "37453560", "37465125", "37516225", "37718506", "37962427", "37979715", "38057817", "38251163", "38396988", "38565372", "38571463", "8871938", "8871940", "9562500", "9887447"]
    },
    {
      "subj": "Peptides",
      "subj_cui": "C0030956",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 121,
      "pmid_refs": ["10196523", "10440895", "10825171", "10940223", "11409035", "11437372", "11544033", "11606220", "12182949", "12414694", "12435726", "12475558", "14766758", "15126696", "15211591", "15248287", "15314264", "15326604", "15544501", "15878503", "15909112", "16033885", "16830133", "16880006", "17276414", "17348862", "17385278", "17559680", "17881287", "18220930", "18221260", "18232509", "18284028", "18341423", "18544674", "18634756", "19237574", "19238376", "19442147", "19509405", "19595795", "19939231", "20371995", "20388523", "20418805", "21383152", "21740063", "21813692", "21855336", "21889458", "21939202", "22206488", "22351782", "22468783", "22552903", "22610977", "22711819", "22947874", "23245572", "23262458", "23410038", "23425062", "23573456", "23614719", "23708321", "23719722", "24192706", "24410826", "25504599", "25621019", "25809804", "26749845", "26827638", "27030769", "27044452", "27118677", "27565738", "27721583", "27807285", "28145081", "28193770", "28795459", "28978359", "29337241", "2950070", "29568268", "30605056", "30624452", "31048034", "31138770", "31749959", "32093407", "32827572", "32845146", "32857496", "32973564", "33642533", "33668038", "33959916", "34219248", "34669098", "34852746", "35006003", "35109277", "35263093", "35309680", "35908946", "36641678", "37076912", "37214891", "37265546", "37413816", "37625763", "37741318", "38142891", "38241093", "38292476", "38578892", "38630150"]
    },
    {
      "subj": "Process",
      "subj_cui": "C1522240",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 255,
      "pmid_refs": ["10210631", "10349334", "10516307", "10616034", "10818522", "10854253", "10899439", "11131295", "11140685", "11378240", "11755016", "11771743", "11976212", "12212771", "12212799", "12392058", "12435432", "12436384", "12740808", "12751917", "12792666", "1288358", "14501020", "14506131", "1467582", "14716023", "14746246", "15342738", "15377701", "15467394", "15784960", "15949039", "16109164", "16128148", "16251213", "16275806", "16641106", "16766195", "16785601", "16869341", "16884489", "16892365", "16898674", "17006763", "17009917", "17047298", "17261781", "17279615", "17400334", "17401045", "17512513", "17623998", "17644063", "18024114", "18081741", "18299393", "18410513", "18487847", "18577840", "18650430", "1890972", "19041409", "19271231", "19306098", "19355848", "19357271", "19589380", "19642202", "19686046", "20060898", "20061651", "20122289", "20226030", "20463393", "20580938", "20734314", "20948726", "21085570", "21145918", "21210060", "21257235", "2129870", "21303349", "21305033", "21321391", "21567187", "21680755", "21693162", "21829458", "21876254", "21891862", "21942868", "21960299", "2203106", "22037310", "22045482", "22144675", "22170863", "22184106", "22214391", "22272623", "22356903", "22450454", "22454637", "22479317", "22558227", "22594617", "22819647", "22867901", "22899726", "23020178", "23114667", "23131555", "23142975", "23166730", "23365075", "23372648", "23623603", "23809366", "23827971", "23831375", "2386197", "24033439", "24205136", "24279329", "24333192", "24463342", "24469452", "24476230", "24478167", "24506061", "24516000", "24524150", "24559299", "24578544", "24735980", "25045220", "25053581", "25118934", "25281744", "25316600", "25352592", "25365422", "25591151", "25636033", "25727637", "25766617", "26227906", "26242258", "26270969", "26484900", "26519433", "26583091", "26629788", "26642316", "26792010", "26878581", "26993139", "27012953", "27079722", "27183464", "27196068", "27454922", "27524794", "27671345", "27713140", "27723573", "27856911", "2813376", "28157316", "28209190", "28569173", "28612181", "28626014", "28759721", "28812474", "28825683", "28892789", "28965829", "29079430", "29097202", "29124681", "29223769", "29277576", "29407908", "29410161", "29695619", "30149452", "30167602", "30200516", "30407837", "30574086", "30590039", "30662636", "30790387", "30795987", "30949921", "31058201", "31086058", "31465249", "31477183", "31507373", "31583531", "31600762", "31704512", "31808139", "31911114", "32062666", "32365768", "32415525", "32418657", "32468556", "32548880", "32664217", "33325586", "33543132", "33887256", "34118718", "34135909", "34440878", "34563212", "35109055", "35749963", "35780617", "35805958", "35821178", "36090249", "36464806", "36551781", "36702317", "37027506", "37258519", "37382195", "37638691", "37759477", "38479477", "7745947", "7838304", "8122883", "8157623", "8250938", "8326828", "8427604", "8687017", "8841658", "8875116", "8922411", "9161470", "9199880", "9462872", "9754878", "9809105", "9850931"]
    },
    {
      "subj": "Proteins",
      "subj_cui": "C0033684",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 74,
      "pmid_refs": ["10079962", "10349860", "10369525", "10867209", "11072133", "11973456", "12020852", "12419469", "12429067", "12716134", "12893422", "12972157", "15304237", "15456259", "15663474", "15686969", "15975080", "16472206", "16883086", "17369839", "17699523", "17761554", "17904250", "1791973", "18374273", "19478666", "21248114", "2128596", "21694447", "21944696", "22138302", "22683528", "22926141", "22971592", "23600477", "23697802", "23748076", "23866266", "24028865", "24269629", "25108596", "25589722", "26438529", "27037841", "28217771", "28415805", "28550247", "2888020", "29076790", "29774507", "30282354", "30906244", "31281238", "31507405", "31686372", "33815938", "33833046", "34129723", "34627984", "35188507", "35877305", "36983903", "36994753", "37127251", "37454217", "37724426", "38151346", "38473975", "7542371", "8856006", "8910899", "9697696", "9804283", "9838173"]
    },
    {
      "subj": "streptozocin",
      "subj_cui": "C0038432",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 86,
      "pmid_refs": ["31855046", "31997154", "32038117", "32202739", "32336744", "32365983", "32473247", "32480228", "32504391", "32522682", "32566864", "32599128", "32728854", "32738031", "32876502", "32903692", "33352241", "33479638", "33732137", "33814439", "33877499", "34116571", "34170261", "34235591", "34306309", "34319254", "34320500", "34428446", "34706756", "34715140", "34792730", "34802394", "34967205", "34968163", "35027835", "35048324", "35106732", "35108957", "35150419", "35163003", "35192144", "35316021", "35395244", "35510084", "35527550", "35556434", "35679720", "35834993", "35843421", "35936440", "36108371", "36145723", "36288088", "36301335", "36436686", "36518345", "36521513", "36536049", "36610115", "36631849", "36725243", "36926592", "37043150", "37072341", "37114959", "37267300", "37273654", "37275760", "37296210", "37309299", "37351177", "37473980", "37598127", "37629545", "37665449", "37755583", "37780033", "37834398", "37882235", "38006400", "38031940", "38333746", "38430352", "38486405", "38570152", "38688962"]
    },
    {
      "subj": "Streptozocin",
      "subj_cui": "C0038432",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 75,
      "pmid_refs": ["20110613", "20683499", "21465495", "21701788", "22886014", "22959057", "23210085", "23351237", "23457495", "23562514", "23603201", "23681104", "24117480", "24329968", "24503167", "24667360", "24719136", "24769303", "24877042", "25096625", "25114075", "25268773", "25446674", "25890375", "26330820", "26638997", "27035793", "27087133", "27585561", "27746125", "27913964", "28106557", "28188358", "28299625", "28342971", "28382978", "28397428", "28480351", "28687315", "28702935", "28929339", "28987281", "29126976", "29132093", "29133125", "29232315", "29501041", "29587242", "29667108", "29765479", "29782959", "29807069", "29927658", "30014576", "30118774", "30171934", "30333717", "30359566", "30481507", "30521994", "30641081", "30684605", "30760053", "31040784", "31068802", "31086208", "31215291", "31344367", "31480727", "31595805", "31726088", "31834453", "33448390", "34536437", "34554409"]
    },
    {
      "subj": "Study_models",
      "subj_cui": "C0026336",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 69,
      "pmid_refs": ["11141480", "11193142", "14769913", "1497790", "1741393", "18068305", "19096160", "2039382", "20682182", "21471644", "22112803", "22203915", "22459153", "22523954", "22723178", "22735677", "22785400", "22874668", "23011729", "23276384", "23383380", "23419876", "24150111", "24239247", "24346216", "24910393", "25008180", "25131634", "2519521", "25213090", "25297091", "25310732", "25754641", "25864576", "26295040", "26461298", "26696886", "26759118", "26918610", "26959388", "27121378", "27569580", "28186729", "28413635", "28459436", "28707174", "29338754", "2934737", "29615895", "29754213", "30043649", "30149447", "30220236", "30557391", "30837279", "30982098", "31342431", "31421155", "31450503", "31551757", "31608251", "34473990", "34585626", "7739409", "8450928", "9115271", "9126173", "9330979"]
    },
    {
      "subj": "SUCLA2_gene_SUCLA2",
      "subj_cui": "C1420510|8803",
      "predicate": "CAUSES",
      "obj": "Alzheimers_Disease",
      "obj_cui": "C0002395",
      "ev_count": 66,
      "pmid_refs": ["31902262", "31922154", "31969500", "32023927", "32212051", "32341098", "32355946", "32375443", "32377164", "32430275", "32479003", "32496898", "32531337", "32556928", "32587293", "32592731", "32599696", "32790274", "32827351", "32950104", "33665647", "33912008", "33953832", "34214643", "34272583", "34356865", "34371202", "34435574", "34608607", "34655726", "34672433", "34810230", "34946712", "35098860", "35181336", "35292372", "35452628", "35453040", "35786817", "35865745", "35956985", "36074939", "36120034", "36200197", "36233130", "36321205", "36399096", "36399277", "36549596", "36809522", "36856542", "36899831", "37179042", "37264159", "37342418", "37372012", "37401257", "37849639", "37858630", "37886704", "38008888", "38178136", "38434588", "38559176", "38612434", "38612514"]
    }
  ]
}